S	227
T	16
Phosphorylation	0	15	NN	phosphorylation	O	_	_
of	16	18	IN	of	O	_	_
ASPP2	19	24	NN	aspp2	O	_	_
by	25	27	IN	by	O	_	_
RAS	28	31	NN	ra	B-GENE	_	_
/	31	32	:	/	B-GENE	_	_
MAPK	32	36	NN	mapk	I-GENE	_	_
Pathway	37	44	NN	pathway	O	_	_
Is	45	47	VBZ	be	O	_	_
Critical	48	56	JJ	critical	O	_	_
for	57	60	IN	for	O	_	_
Its	61	64	PRP$	its	O	_	_
Full	65	69	JJ	full	O	_	_
Pro-Apoptotic	70	83	JJ	pro-apoptotic	O	_	_
Function	84	92	NN	function	O	_	_
.	92	93	.	.	O	_	_
D	1
0
0	2	prep_of
0	4	prep_by
0	5	punct
0	9	dep
7	6	nn
9	7	nsubj
9	8	cop
9	14	prep_for
14	11	poss
14	12	amod
14	13	amod
EOX
Y	1
ROOT	0	0	16	1	FRAG	0	0	16	4	NP	0	0	5	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	RAS	4	4	5	0	:	0	5	6	1	/	5	5	6	0	S	1	6	15	2	NP	1	6	8	2	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	Pathway	7	7	8	0	VP	1	8	15	2	VBZ	0	8	9	1	Is	8	8	9	0	ADJP	0	9	15	2	JJ	0	9	10	1	Critical	9	9	10	0	PP	0	10	15	2	IN	0	10	11	1	for	10	10	11	0	NP	3	11	15	4	PRP$	0	11	12	1	Its	11	11	12	0	JJ	0	12	13	1	Full	12	12	13	0	JJ	0	13	14	1	Pro-Apoptotic	13	13	14	0	NN	0	14	15	1	Function	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	33
We	94	96	PRP	we	O	_	_
reported	97	105	VBD	report	O	_	_
recently	106	114	RB	recently	O	_	_
that	115	119	IN	that	O	_	_
apoptosis	120	129	NN	apoptosis	B-GENE	_	_
stimulating	130	141	NN	stimulating	I-GENE	_	_
protein	142	149	NN	protein	I-GENE	_	_
of	150	152	IN	of	O	_	_
p53	153	156	NN	p53	B-GENE	_	_
(	157	158	CD	(	I-GENE	_	_
ASPP	158	162	NN	aspp	I-GENE	_	_
)	162	163	NN	)	I-GENE	_	_
2	164	165	CD	2	I-GENE	_	_
,	165	166	,	,	O	_	_
an	167	169	DT	a	O	_	_
activator	170	179	NN	activator	O	_	_
of	180	182	IN	of	O	_	_
p53	183	186	NN	p53	B-GENE	_	_
,	186	187	,	,	O	_	_
co-operates	188	199	VBZ	co-operate	O	_	_
with	200	204	IN	with	O	_	_
oncogenic	205	214	JJ	oncogenic	B-GENE	_	_
RAS	215	218	NN	ra	I-GENE	_	_
to	219	221	TO	to	O	_	_
enhance	222	229	VB	enhance	O	_	_
the	230	233	DT	the	O	_	_
transcription	234	247	NN	transcription	O	_	_
and	248	251	CC	and	O	_	_
apoptotic	252	261	JJ	apoptotic	O	_	_
function	262	270	NN	function	O	_	_
of	271	273	IN	of	O	_	_
p53	274	277	NN	p53	B-GENE	_	_
.	277	278	.	.	O	_	_
D	1

1	0	nsubj
1	2	advmod
1	19	ccomp
6	4	nn
6	5	nn
6	7	prep
6	15	appos
11	8	nn
11	10	nn
11	12	dep
15	14	det
15	17	prep_of
19	3	mark
19	6	nsubj
19	22	prep_with
19	24	xcomp
22	21	amod
24	23	aux
24	29	dobj
26	28	conj_and
29	25	det
29	26	nn
29	28	nn
29	31	prep_of
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	32	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	32	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	32	2	NP	0	4	19	4	NP	0	4	13	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	13	2	NP	3	8	12	4	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	NN	0	11	12	1	-RRB-	11	11	12	0	NP	0	12	13	1	CD	0	12	13	1	2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	DT	0	14	15	1	an	14	14	15	0	NN	0	15	16	1	activator	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	,	0	18	19	1	,	18	18	19	0	VP	0	19	32	3	VBZ	0	19	20	1	co-operates	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	with	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	oncogenic	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	S	0	23	32	1	VP	1	23	32	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	32	2	VB	0	24	25	1	enhance	24	24	25	0	NP	0	25	32	2	NP	2	25	30	3	DT	0	25	26	1	the	25	25	26	0	NP	0	26	29	3	NN	0	26	27	1	transcription	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	JJ	0	28	29	1	apoptotic	28	28	29	0	NN	0	29	30	1	function	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	of	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	8
However	279	286	RB	however	O	_	_
,	286	287	,	,	O	_	_
the	288	291	DT	the	O	_	_
detailed	292	300	JJ	detailed	O	_	_
mechanism	301	310	NN	mechanism	O	_	_
remains	311	318	VBZ	remain	O	_	_
unknown	319	326	JJ	unknown	O	_	_
.	326	327	.	.	O	_	_
D	1
6
4	2	det
4	3	amod
6	0	advmod
6	4	nsubj
6	5	cop
EOX
Y	1
ROOT	0	0	8	1	S	3	0	8	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	1	5	7	2	VBZ	0	5	6	1	remains	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unknown	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	18
Here	328	332	RB	here	O	_	_
we	333	335	PRP	we	O	_	_
show	336	340	VBP	show	O	_	_
that	341	345	IN	that	O	_	_
ASPP2	346	351	NN	aspp2	B-GENE	_	_
is	352	354	VBZ	be	O	_	_
a	355	356	DT	a	O	_	_
novel	357	362	JJ	novel	O	_	_
substrate	363	372	NN	substrate	O	_	_
of	373	375	IN	of	O	_	_
mitogen	376	383	NN	mitogen	B-GENE	_	_
activated	384	393	VBN	activate	I-GENE	_	_
protein	394	401	NN	protein	I-GENE	_	_
kinase	402	408	NN	kinase	I-GENE	_	_
(	409	410	CD	(	B-GENE	_	_
MAPK	410	414	NN	mapk	I-GENE	_	_
)	414	415	NN	)	O	_	_
.	415	416	.	.	O	_	_
D	1

2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	12	prep_of
12	10	nn
12	11	amod
16	13	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	2	0	18	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	17	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	17	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	17	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	17	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	17	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	17	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	NN	0	10	11	1	mitogen	10	10	11	0	VBN	0	11	12	1	activated	11	11	12	0	NN	0	12	13	1	protein	12	12	13	0	NP	3	13	17	4	NN	0	13	14	1	kinase	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
Phosphorylation	417	432	NN	phosphorylation	O	_	_
of	433	435	IN	of	O	_	_
ASPP2	436	441	NN	aspp2	B-GENE	_	_
by	442	444	IN	by	O	_	_
MAPK	445	449	NN	mapk	B-GENE	_	_
is	450	452	VBZ	be	O	_	_
required	453	461	VBN	require	O	_	_
for	462	465	IN	for	O	_	_
RAS	466	469	NN	ra	O	_	_
induced	470	477	VBD	induce	O	_	_
increased	478	487	VBN	increase	O	_	_
binding	488	495	VBG	bind	O	_	_
to	496	498	TO	to	O	_	_
p53	499	502	NN	p53	B-GENE	_	_
and	503	506	CC	and	O	_	_
increased	507	516	VBD	increase	O	_	_
transactivation	517	532	NN	transactivation	O	_	_
of	533	535	IN	of	O	_	_
pro-apoptotic	536	549	JJ	pro-apoptotic	O	_	_
genes	550	555	NNS	gene	O	_	_
.	555	556	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	9	advcl
6	15	advcl
9	7	mark
9	8	nsubj
9	10	dobj
9	15	conj_and
10	11	amod
10	13	prep_to
15	8	nsubj
15	16	dobj
16	19	prep_of
19	18	amod
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	20	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	20	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	20	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	20	2	NP	0	8	9	1	NN	0	8	9	1	RAS	8	8	9	0	VP	0	9	20	3	VP	0	9	14	2	VBD	0	9	10	1	induced	9	9	10	0	NP	0	10	14	2	NP	0	10	12	2	VBN	0	10	11	1	increased	10	10	11	0	VBG	0	11	12	1	binding	11	11	12	0	PP	0	12	14	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	VP	0	15	20	2	VBD	0	15	16	1	increased	15	15	16	0	NP	0	16	20	2	NP	0	16	17	1	NN	0	16	17	1	transactivation	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	JJ	0	18	19	1	pro-apoptotic	18	18	19	0	NNS	0	19	20	1	genes	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	19
In	557	559	IN	in	O	_	_
contrast	560	568	NN	contrast	O	_	_
,	568	569	,	,	O	_	_
an	570	572	DT	a	O	_	_
ASPP2	573	578	NN	aspp2	B-GENE	_	_
phosphorylation	579	594	NN	phosphorylation	O	_	_
mutant	595	601	NN	mutant	O	_	_
exhibits	602	610	VBZ	exhibit	O	_	_
reduced	611	618	VBN	reduce	O	_	_
p53	619	622	NN	p53	B-GENE	_	_
binding	623	630	NN	binding	O	_	_
and	631	634	CC	and	O	_	_
fails	635	640	VBZ	fail	O	_	_
to	641	643	TO	to	O	_	_
enhance	644	651	VB	enhance	O	_	_
transactivation	652	667	NN	transactivation	O	_	_
and	668	671	CC	and	O	_	_
apoptosis	672	681	NN	apoptosis	O	_	_
.	681	682	.	.	O	_	_
D	1
7
6	3	det
6	4	nn
6	5	nn
7	1	prep_in
7	6	nsubj
7	8	dep
7	12	conj_and
8	10	dobj
10	9	nn
12	6	nsubj
12	14	xcomp
14	13	aux
14	15	dobj
14	17	dobj
15	17	conj_and
EOX
Y	1
ROOT	0	0	19	1	S	3	0	19	5	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	3	3	7	4	DT	0	3	4	1	an	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	NN	0	6	7	1	mutant	6	6	7	0	VP	0	7	18	3	VP	0	7	11	2	VBZ	0	7	8	1	exhibits	7	7	8	0	VP	0	8	11	2	VBN	0	8	9	1	reduced	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	p53	9	9	10	0	NN	0	10	11	1	binding	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	18	2	VBZ	0	12	13	1	fails	12	12	13	0	S	0	13	18	1	VP	1	13	18	2	TO	0	13	14	1	to	13	13	14	0	VP	0	14	18	2	VB	0	14	15	1	enhance	14	14	15	0	NP	0	15	18	3	NN	0	15	16	1	transactivation	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NN	0	17	18	1	apoptosis	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	21
Thus	683	687	RB	thus	O	_	_
phosphorylation	688	703	NN	phosphorylation	O	_	_
of	704	706	IN	of	O	_	_
ASPP2	707	712	NN	aspp2	B-GENE	_	_
by	713	715	IN	by	O	_	_
RAS	716	719	NN	ra	B-GENE	_	_
/	719	720	:	/	B-GENE	_	_
MAPK	720	724	NN	mapk	I-GENE	_	_
pathway	725	732	NN	pathway	O	_	_
provides	733	741	VBZ	provide	O	_	_
a	742	743	DT	a	O	_	_
novel	744	749	JJ	novel	O	_	_
link	750	754	NN	link	O	_	_
between	755	762	IN	between	O	_	_
RAS	763	766	NN	ra	B-GENE	_	_
and	767	770	CC	and	O	_	_
p53	771	774	NN	p53	B-GENE	_	_
in	775	777	IN	in	O	_	_
regulating	778	788	VBG	regulate	O	_	_
apoptosis	789	798	NN	apoptosis	O	_	_
.	798	799	.	.	O	_	_
D	1
1
1	0	advmod
1	3	prep_of
1	5	prep_by
1	6	punct
1	9	dep
8	7	nn
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	FRAG	0	0	21	4	NP	0	0	6	2	NP	1	0	4	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	2
Introduction	800	812	NN	introduction	O	_	_
.	812	813	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Introduction	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	13
p53	814	817	NN	p53	B-GENE	_	_
is	818	820	VBZ	be	O	_	_
the	821	824	DT	the	O	_	_
most	825	829	RBS	most	O	_	_
commonly	830	838	RB	commonly	O	_	_
mutated	839	846	VBN	mutate	O	_	_
tumour	847	853	NN	tumour	O	_	_
suppressor	854	864	NN	suppressor	O	_	_
protein	865	872	NN	protein	O	_	_
thus	873	877	RB	thus	O	_	_
far	878	881	RB	far	O	_	_
identified	882	892	VBN	identify	O	_	_
.	892	893	.	.	O	_	_
D	1
8
5	3	advmod
5	4	advmod
8	0	nsubj
8	1	cop
8	2	det
8	5	amod
8	6	nn
8	7	nn
8	11	vmod
10	9	advmod
11	10	advmod
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	1	1	NN	0	0	1	1	p53	0	0	1	0	VP	1	1	12	2	VBZ	0	1	2	1	is	1	1	2	0	NP	0	2	12	2	NP	4	2	9	5	DT	0	2	3	1	the	2	2	3	0	ADJP	2	3	6	3	RBS	0	3	4	1	most	3	3	4	0	RB	0	4	5	1	commonly	4	4	5	0	VBN	0	5	6	1	mutated	5	5	6	0	NN	0	6	7	1	tumour	6	6	7	0	NN	0	7	8	1	suppressor	7	7	8	0	NN	0	8	9	1	protein	8	8	9	0	VP	1	9	12	2	ADVP	1	9	11	2	RB	0	9	10	1	thus	9	9	10	0	RB	0	10	11	1	far	10	10	11	0	VBN	0	11	12	1	identified	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	35
Although	894	902	IN	although	O	_	_
p53	903	906	NN	p53	B-GENE	_	_
is	907	909	VBZ	be	O	_	_
mutated	910	917	VBN	mutate	O	_	_
in	918	920	IN	in	O	_	_
more	921	925	JJR	more	O	_	_
than	926	930	IN	than	O	_	_
50	931	933	CD	50	O	_	_
%	933	934	NN	%	O	_	_
of	935	937	IN	of	O	_	_
tumours	938	945	NNS	tumour	O	_	_
,	945	946	,	,	O	_	_
its	947	950	PRP$	its	O	_	_
mutation	951	959	NN	mutation	O	_	_
rate	960	964	NN	rate	O	_	_
varies	965	971	VBZ	vary	O	_	_
significantly	972	985	RB	significantly	O	_	_
between	986	993	IN	between	O	_	_
different	994	1003	JJ	different	O	_	_
types	1004	1009	NNS	type	O	_	_
of	1010	1012	IN	of	O	_	_
human	1013	1018	JJ	human	O	_	_
cancer	1019	1025	NN	cancer	O	_	_
,	1025	1026	,	,	O	_	_
with	1027	1031	IN	with	O	_	_
a	1032	1033	DT	a	O	_	_
particularly	1034	1046	RB	particularly	O	_	_
high	1047	1051	JJ	high	O	_	_
incidence	1052	1061	NN	incidence	O	_	_
in	1062	1064	IN	in	O	_	_
colorectal	1065	1075	JJ	colorectal	O	_	_
and	1076	1079	CC	and	O	_	_
pancreatic	1080	1090	JJ	pancreatic	O	_	_
tumours	1091	1098	NNS	tumour	O	_	_
.	1098	1099	.	.	O	_	_
D	1
15
3	0	mark
3	1	nsubjpass
3	2	auxpass
3	8	prep_in
6	5	mwe
7	6	quantmod
8	7	num
8	10	prep_of
14	12	poss
14	13	nn
15	3	advcl
15	14	nsubj
15	16	advmod
15	19	prep_between
15	28	prep_with
19	18	amod
19	22	prep_of
22	21	amod
27	26	advmod
28	25	det
28	27	amod
28	33	prep_in
30	32	conj_and
33	30	amod
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	SBAR	1	0	11	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	p53	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	mutated	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	11	2	NP	1	5	9	2	QP	1	5	8	2	XS	1	5	7	2	JJR	0	5	6	1	more	5	5	6	0	IN	0	6	7	1	than	6	6	7	0	CD	0	7	8	1	50	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	tumours	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	PRP$	0	12	13	1	its	12	12	13	0	NN	0	13	14	1	mutation	13	13	14	0	NN	0	14	15	1	rate	14	14	15	0	VP	0	15	34	5	VBZ	0	15	16	1	varies	15	15	16	0	ADVP	0	16	17	1	RB	0	16	17	1	significantly	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	between	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	JJ	0	18	19	1	different	18	18	19	0	NNS	0	19	20	1	types	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	of	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	human	21	21	22	0	NN	0	22	23	1	cancer	22	22	23	0	,	0	23	24	1	,	23	23	24	0	PP	0	24	34	2	IN	0	24	25	1	with	24	24	25	0	NP	0	25	34	2	NP	2	25	29	3	DT	0	25	26	1	a	25	25	26	0	ADJP	1	26	28	2	RB	0	26	27	1	particularly	26	26	27	0	JJ	0	27	28	1	high	27	27	28	0	NN	0	28	29	1	incidence	28	28	29	0	PP	0	29	34	2	IN	0	29	30	1	in	29	29	30	0	NP	1	30	34	2	ADJP	0	30	33	3	JJ	0	30	31	1	colorectal	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	JJ	0	32	33	1	pancreatic	32	32	33	0	NNS	0	33	34	1	tumours	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	18
Interestingly	1100	1113	RB	interestingly	O	_	_
,	1113	1114	,	,	O	_	_
the	1115	1118	DT	the	O	_	_
mediator	1119	1127	NN	mediator	O	_	_
of	1128	1130	IN	of	O	_	_
signal	1131	1137	NN	signal	B-GENE	_	_
transduction	1138	1150	NN	transduction	I-GENE	_	_
RAS	1151	1154	NN	ra	I-GENE	_	_
is	1155	1157	VBZ	be	O	_	_
also	1158	1162	RB	also	O	_	_
commonly	1163	1171	RB	commonly	O	_	_
mutated	1172	1179	VBN	mutate	O	_	_
in	1180	1182	IN	in	O	_	_
these	1183	1188	DT	these	O	_	_
particular	1189	1199	JJ	particular	O	_	_
tumour	1200	1206	NN	tumour	O	_	_
types	1207	1212	NNS	type	O	_	_
.	1212	1213	.	.	O	_	_
D	1
11
3	2	det
3	7	prep_of
7	5	nn
7	6	nn
11	0	advmod
11	3	nsubjpass
11	8	auxpass
11	9	advmod
11	10	advmod
11	16	prep_in
16	13	det
16	14	amod
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	mediator	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	NN	0	5	6	1	signal	5	5	6	0	NN	0	6	7	1	transduction	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	2	8	17	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	1	10	17	3	ADVP	0	10	11	1	RB	0	10	11	1	commonly	10	10	11	0	VBN	0	11	12	1	mutated	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	in	12	12	13	0	NP	3	13	17	4	DT	0	13	14	1	these	13	13	14	0	JJ	0	14	15	1	particular	14	14	15	0	NN	0	15	16	1	tumour	15	15	16	0	NNS	0	16	17	1	types	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
It	1214	1216	PRP	it	O	_	_
remains	1217	1224	VBZ	remain	O	_	_
unclear	1225	1232	JJ	unclear	O	_	_
why	1233	1236	WRB	why	O	_	_
there	1237	1242	EX	there	O	_	_
exists	1243	1249	VBZ	exist	O	_	_
such	1250	1254	PDT	such	O	_	_
a	1255	1256	DT	a	O	_	_
tight	1257	1262	JJ	tight	O	_	_
association	1263	1274	NN	association	O	_	_
between	1275	1282	IN	between	O	_	_
the	1283	1286	DT	the	O	_	_
p53	1287	1290	NN	p53	B-GENE	_	_
and	1291	1294	CC	and	I-GENE	_	_
RAS	1295	1298	NN	ra	I-GENE	_	_
mutation	1299	1307	NN	mutation	I-GENE	_	_
status	1308	1314	NN	status	O	_	_
[	1315	1316	CD	[	O	_	_
1	1316	1317	CD	1	O	_	_
]	1317	1318	NN	]	O	_	_
.	1318	1319	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	5	advcl
5	3	advmod
5	4	expl
5	9	dobj
5	16	dobj
9	6	dep
9	7	det
9	8	amod
9	12	prep_between
9	16	conj_and
12	11	det
16	14	nn
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	20	3	VBZ	0	1	2	1	remains	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	unclear	2	2	3	0	SBAR	1	3	20	2	WHADVP	0	3	4	1	WRB	0	3	4	1	why	3	3	4	0	S	1	4	20	2	NP	0	4	5	1	EX	0	4	5	1	there	4	4	5	0	VP	0	5	20	2	VBZ	0	5	6	1	exists	5	5	6	0	NP	1	6	20	4	PDT	0	6	7	1	such	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	DT	0	7	8	1	a	7	7	8	0	JJ	0	8	9	1	tight	8	8	9	0	NN	0	9	10	1	association	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	between	10	10	11	0	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	NN	0	15	16	1	mutation	15	15	16	0	NN	0	16	17	1	status	16	16	17	0	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	1	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	33
We	1320	1322	PRP	we	O	_	_
reported	1323	1331	VBD	report	O	_	_
recently	1332	1340	RB	recently	O	_	_
that	1341	1345	IN	that	O	_	_
apoptosis	1346	1355	NN	apoptosis	B-GENE	_	_
stimulating	1356	1367	NN	stimulating	I-GENE	_	_
protein	1368	1375	NN	protein	I-GENE	_	_
of	1376	1378	IN	of	O	_	_
p53	1379	1382	NN	p53	B-GENE	_	_
(	1383	1384	CD	(	I-GENE	_	_
ASPP	1384	1388	NN	aspp	I-GENE	_	_
)	1388	1389	NN	)	I-GENE	_	_
2	1390	1391	CD	2	I-GENE	_	_
co-operates	1392	1403	NNS	co-operate	O	_	_
with	1404	1408	IN	with	O	_	_
oncogenic	1409	1418	JJ	oncogenic	B-GENE	_	_
RAS	1419	1422	NN	ra	I-GENE	_	_
to	1423	1425	TO	to	O	_	_
enhance	1426	1433	VB	enhance	O	_	_
the	1434	1437	DT	the	O	_	_
transcription	1438	1451	NN	transcription	O	_	_
and	1452	1455	CC	and	O	_	_
apoptotic	1456	1465	JJ	apoptotic	O	_	_
function	1466	1474	NN	function	O	_	_
of	1475	1477	IN	of	O	_	_
p53	1478	1481	NN	p53	B-GENE	_	_
in	1482	1484	IN	in	O	_	_
cancer	1485	1491	NN	cancer	O	_	_
cells	1492	1497	NNS	cell	O	_	_
[	1498	1499	VBP	[	O	_	_
2	1499	1500	CD	2	O	_	_
]	1500	1501	CD	]	O	_	_
.	1501	1502	.	.	O	_	_
D	1

1	0	nsubj
1	2	advmod
1	29	conj_and
6	4	nn
6	5	nn
6	10	prep_of
10	8	nn
11	3	mark
11	6	nsubj
11	13	dobj
11	18	xcomp
13	12	num
13	16	prep_with
16	15	amod
18	17	aux
18	20	dobj
20	19	det
23	22	amod
23	25	prep_of
25	28	prep_in
28	27	nn
29	23	nsubj
29	31	dobj
31	30	number
EOX
Y	1
ROOT	0	0	33	1	S	0	0	33	4	S	1	0	21	2	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	21	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	21	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	21	2	NP	0	4	11	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	VP	0	11	21	3	NN	0	11	12	1	-RRB-	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NNS	0	13	14	1	co-operates	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	with	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	oncogenic	15	15	16	0	NN	0	16	17	1	RAS	16	16	17	0	S	0	17	21	1	VP	1	17	21	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	21	2	VB	0	18	19	1	enhance	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	transcription	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	S	1	22	32	2	NP	0	22	29	2	NP	1	22	24	2	JJ	0	22	23	1	apoptotic	22	22	23	0	NN	0	23	24	1	function	23	23	24	0	PP	0	24	29	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	29	2	NP	0	25	26	1	NN	0	25	26	1	p53	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	in	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	cancer	27	27	28	0	NNS	0	28	29	1	cells	28	28	29	0	VP	0	29	32	2	VBP	0	29	30	1	[	29	29	30	0	NP	0	30	32	1	QP	1	30	32	2	CD	0	30	31	1	2	30	30	31	0	CD	0	31	32	1	]	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	28
This	1503	1507	DT	this	O	_	_
may	1508	1511	MD	may	O	_	_
be	1512	1514	VB	be	O	_	_
achieved	1515	1523	VBN	achieve	O	_	_
via	1524	1527	IN	via	O	_	_
the	1528	1531	DT	the	O	_	_
ability	1532	1539	NN	ability	O	_	_
of	1540	1542	IN	of	O	_	_
active	1543	1549	JJ	active	O	_	_
RAS	1550	1553	NN	ra	O	_	_
to	1554	1556	TO	to	O	_	_
induce	1557	1563	VB	induce	O	_	_
ASPP2	1564	1569	NN	aspp2	O	_	_
,	1569	1570	,	,	O	_	_
thereby	1571	1578	RB	thereby	O	_	_
promoting	1579	1588	VBG	promote	O	_	_
ASPP2	1589	1594	NN	aspp2	O	_	_
's	1594	1596	POS	's	O	_	_
interaction	1597	1608	NN	interaction	O	_	_
with	1609	1613	IN	with	O	_	_
p53	1614	1617	NN	p53	B-GENE	_	_
and	1618	1621	CC	and	O	_	_
enhancing	1622	1631	VBG	enhance	O	_	_
the	1632	1635	DT	the	O	_	_
activity	1636	1644	NN	activity	O	_	_
of	1645	1647	IN	of	O	_	_
p53	1648	1651	NN	p53	B-GENE	_	_
.	1651	1652	.	.	O	_	_
D	1
3
3	0	nsubjpass
3	1	aux
3	2	auxpass
3	6	prep_via
3	11	xcomp
3	15	ccomp
3	22	ccomp
6	5	det
6	9	prep_of
9	8	amod
11	10	aux
11	12	dobj
15	14	advmod
15	18	dobj
15	22	conj_and
18	16	poss
18	20	prep_with
22	24	dobj
24	23	det
24	26	prep_of
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	27	2	MD	0	1	2	1	may	1	1	2	0	VP	1	2	27	2	VB	0	2	3	1	be	2	2	3	0	VP	0	3	27	5	VBN	0	3	4	1	achieved	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	via	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	ability	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	active	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	induce	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	ASPP2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	S	1	14	27	2	ADVP	0	14	15	1	RB	0	14	15	1	thereby	14	14	15	0	VP	0	15	27	3	VP	0	15	21	2	VBG	0	15	16	1	promoting	15	15	16	0	NP	0	16	21	2	NP	1	16	19	2	NP	0	16	18	2	NN	0	16	17	1	ASPP2	16	16	17	0	POS	0	17	18	1	's	17	17	18	0	NN	0	18	19	1	interaction	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	p53	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	0	22	27	2	VBG	0	22	23	1	enhancing	22	22	23	0	NP	0	23	27	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	activity	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	of	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	p53	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	13
However	1653	1660	RB	however	O	_	_
,	1660	1661	,	,	O	_	_
the	1662	1665	DT	the	O	_	_
detailed	1666	1674	JJ	detailed	O	_	_
mechanism	1675	1684	NN	mechanism	O	_	_
underlying	1685	1695	VBG	underlie	O	_	_
this	1696	1700	DT	this	O	_	_
observation	1701	1712	NN	observation	O	_	_
remains	1713	1720	VBZ	remain	O	_	_
to	1721	1723	TO	to	O	_	_
be	1724	1726	VB	be	O	_	_
elucidated	1727	1737	VBN	elucidate	O	_	_
.	1737	1738	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	5	vmod
5	7	dobj
7	6	det
8	0	advmod
8	4	nsubj
8	11	xcomp
11	9	aux
11	10	auxpass
EOX
Y	1
ROOT	0	0	13	1	S	3	0	13	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	0	5	8	2	VBG	0	5	6	1	underlying	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	this	6	6	7	0	NN	0	7	8	1	observation	7	7	8	0	VP	0	8	12	2	VBZ	0	8	9	1	remains	8	8	9	0	S	0	9	12	1	VP	1	9	12	2	TO	0	9	10	1	to	9	9	10	0	VP	1	10	12	2	VB	0	10	11	1	be	10	10	11	0	VP	0	11	12	1	VBN	0	11	12	1	elucidated	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	22
Activated	1739	1748	VBN	activate	O	_	_
RAS	1749	1752	NN	ra	B-GENE	_	_
promotes	1753	1761	VBZ	promote	O	_	_
the	1762	1765	DT	the	O	_	_
protein	1766	1773	NN	protein	B-GENE	_	_
kinase	1774	1780	NN	kinase	I-GENE	_	_
activity	1781	1789	NN	activity	O	_	_
of	1790	1792	IN	of	O	_	_
RAF	1793	1796	NN	raf	B-GENE	_	_
,	1796	1797	,	,	O	_	_
which	1798	1803	WDT	which	O	_	_
phosphorylates	1804	1818	VBZ	phosphorylate	O	_	_
and	1819	1822	CC	and	O	_	_
activates	1823	1832	VBZ	activate	O	_	_
MEK	1833	1836	NN	mek	B-GENE	_	_
(	1837	1838	NN	(	O	_	_
also	1838	1842	RB	also	O	_	_
known	1843	1848	VBN	know	O	_	_
as	1849	1851	IN	as	O	_	_
MAPKK	1852	1857	NNP	MAPKK	B-GENE	_	_
)	1857	1858	CD	)	O	_	_
.	1858	1859	.	.	O	_	_
D	1

0	1	dobj
0	2	dep
0	6	nsubj
6	3	det
6	4	nn
6	5	nn
6	8	prep_of
6	11	rcmod
6	13	rcmod
11	10	nsubj
11	13	conj_and
13	10	nsubj
15	14	nn
15	17	vmod
17	16	advmod
17	19	prep_as
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	promotes	2	2	3	0	NP	0	3	21	4	NP	3	3	7	4	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	protein	4	4	5	0	NN	0	5	6	1	kinase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	RAF	8	8	9	0	,	0	9	10	1	,	9	9	10	0	SBAR	1	10	21	2	WHNP	0	10	11	1	WDT	0	10	11	1	which	10	10	11	0	S	0	11	21	1	VP	0	11	21	4	VBZ	0	11	12	1	phosphorylates	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VBZ	0	13	14	1	activates	13	13	14	0	NP	0	14	21	2	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	-LRB-	15	15	16	0	VP	1	16	21	3	ADVP	0	16	17	1	RB	0	16	17	1	also	16	16	17	0	VBN	0	17	18	1	known	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	as	18	18	19	0	NP	0	19	21	2	NNP	0	19	20	1	MAPKK	19	19	20	0	CD	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	22
MEK	1860	1863	NN	mek	B-GENE	_	_
phosphorylates	1864	1878	VBZ	phosphorylate	O	_	_
and	1879	1882	CC	and	O	_	_
activates	1883	1892	VBZ	activate	O	_	_
a	1893	1894	DT	a	O	_	_
mitogen	1895	1902	NN	mitogen	B-GENE	_	_
activated	1903	1912	VBN	activate	I-GENE	_	_
protein	1913	1920	NN	protein	I-GENE	_	_
kinase	1921	1927	NN	kinase	I-GENE	_	_
(	1928	1929	CD	(	B-GENE	_	_
MAPK	1929	1933	NN	mapk	I-GENE	_	_
/	1933	1934	:	/	B-GENE	_	_
ERK	1934	1937	NN	erk	I-GENE	_	_
)	1937	1938	NN	)	O	_	_
,	1938	1939	,	,	O	_	_
a	1940	1941	DT	a	O	_	_
serine	1942	1948	NN	serine	O	_	_
/	1948	1949	:	/	O	_	_
threonine-selective	1949	1968	JJ	threonine-selective	O	_	_
protein	1969	1976	NN	protein	O	_	_
kinase	1977	1983	NN	kinase	O	_	_
.	1983	1984	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	conj_and
1	5	dobj
3	0	nsubj
5	4	det
5	6	vmod
6	8	dobj
8	7	nn
8	10	dep
10	20	dep
13	11	punct
13	12	nn
13	16	appos
13	17	punct
16	15	det
20	18	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	MEK	0	0	1	0	VP	0	1	21	4	VBZ	0	1	2	1	phosphorylates	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	21	2	NP	1	4	6	2	DT	0	4	5	1	a	4	4	5	0	NN	0	5	6	1	mitogen	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	activated	6	6	7	0	NP	0	7	21	2	NP	1	7	9	2	NN	0	7	8	1	protein	7	7	8	0	NN	0	8	9	1	kinase	8	8	9	0	NP	0	9	21	2	NP	1	9	18	3	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	MAPK	10	10	11	0	PRN	1	11	18	3	:	0	11	12	1	/	11	11	12	0	NP	0	12	17	3	NP	1	12	14	2	NN	0	12	13	1	ERK	12	12	13	0	NN	0	13	14	1	-RRB-	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	a	15	15	16	0	NN	0	16	17	1	serine	16	16	17	0	:	0	17	18	1	/	17	17	18	0	NP	2	18	21	3	JJ	0	18	19	1	threonine-selective	18	18	19	0	NN	0	19	20	1	protein	19	19	20	0	NN	0	20	21	1	kinase	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	26
The	1985	1988	DT	the	O	_	_
MAPK	1989	1993	NN	mapk	O	_	_
enzymes	1994	2001	NNS	enzyme	O	_	_
require	2002	2009	VBP	require	O	_	_
a	2010	2011	DT	a	O	_	_
specific	2012	2020	JJ	specific	O	_	_
phosphorylation	2021	2036	NN	phosphorylation	O	_	_
sequence	2037	2045	NN	sequence	O	_	_
where	2046	2051	WRB	where	O	_	_
a	2052	2053	DT	a	O	_	_
serine	2054	2060	NN	serine	O	_	_
or	2061	2063	CC	or	O	_	_
threonine	2064	2073	NN	threonine	O	_	_
is	2074	2076	VBZ	be	O	_	_
followed	2077	2085	VBN	follow	O	_	_
by	2086	2088	IN	by	O	_	_
proline	2089	2096	NN	proline	O	_	_
(	2097	2098	CD	(	O	_	_
S	2098	2099	NN	s	O	_	_
/	2099	2100	:	/	O	_	_
TP	2100	2102	NN	tp	O	_	_
)	2102	2103	CD	)	O	_	_
[	2104	2105	CD	[	O	_	_
3	2105	2106	CD	3	O	_	_
]	2106	2107	NN	]	O	_	_
.	2107	2108	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	7	dobj
3	14	advcl
7	4	det
7	5	amod
7	6	nn
10	9	det
10	12	conj_or
14	8	advmod
14	10	nsubjpass
14	12	nsubjpass
14	13	auxpass
14	15	prep
15	16	dep
16	18	dep
16	19	punct
16	20	dep
20	24	dep
23	22	number
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	NNS	0	2	3	1	enzymes	2	2	3	0	VP	0	3	25	3	VBP	0	3	4	1	require	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	specific	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	sequence	7	7	8	0	SBAR	1	8	25	2	WHADVP	0	8	9	1	WRB	0	8	9	1	where	8	8	9	0	S	1	9	25	2	NP	1	9	13	4	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	serine	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	NN	0	12	13	1	threonine	12	12	13	0	VP	1	13	25	2	VBZ	0	13	14	1	is	13	13	14	0	VP	0	14	25	2	VBN	0	14	15	1	followed	14	14	15	0	PP	0	15	25	2	IN	0	15	16	1	by	15	15	16	0	FRAG	0	16	25	3	NP	0	16	19	2	NP	0	16	17	1	NN	0	16	17	1	proline	16	16	17	0	NP	1	17	19	2	CD	0	17	18	1	-LRB-	17	17	18	0	NN	0	18	19	1	S	18	18	19	0	:	0	19	20	1	/	19	19	20	0	NP	0	20	25	2	NP	0	20	22	2	NN	0	20	21	1	TP	20	20	21	0	CD	0	21	22	1	-RRB-	21	21	22	0	NP	1	22	25	2	QP	1	22	24	2	CD	0	22	23	1	[	22	22	23	0	CD	0	23	24	1	3	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	31
It	2109	2111	PRP	it	O	_	_
was	2112	2115	VBD	be	O	_	_
shown	2116	2121	VBN	show	O	_	_
that	2122	2126	IN	that	O	_	_
endogenous	2127	2137	JJ	endogenous	O	_	_
RAS	2138	2141	NN	ra	O	_	_
is	2142	2144	VBZ	be	O	_	_
necessary	2145	2154	JJ	necessary	O	_	_
for	2155	2158	IN	for	O	_	_
the	2159	2162	DT	the	O	_	_
full	2163	2167	JJ	full	O	_	_
apoptotic	2168	2177	JJ	apoptotic	O	_	_
activity	2178	2186	NN	activity	O	_	_
of	2187	2189	IN	of	O	_	_
ASPP2	2190	2195	NN	aspp2	B-GENE	_	_
,	2195	2196	,	,	O	_	_
which	2197	2202	WDT	which	O	_	_
suggests	2203	2211	VBZ	suggest	O	_	_
that	2212	2216	IN	that	O	_	_
RAS	2217	2220	NN	ra	B-GENE	_	_
signalling	2221	2231	NN	signalling	O	_	_
may	2232	2235	MD	may	O	_	_
modify	2236	2242	VB	modify	O	_	_
ASPP2	2243	2248	NN	aspp2	B-GENE	_	_
,	2248	2249	,	,	O	_	_
potentially	2250	2261	RB	potentially	O	_	_
via	2262	2265	IN	via	O	_	_
a	2266	2267	DT	a	O	_	_
phosphorylation	2268	2283	NN	phosphorylation	O	_	_
event	2284	2289	NN	event	O	_	_
.	2289	2290	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	7	ccomp
5	4	amod
7	3	mark
7	5	nsubj
7	6	cop
7	12	prep_for
12	9	det
12	10	amod
12	11	amod
12	14	prep_of
12	29	prep_via
14	17	rcmod
17	16	nsubj
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	aux
22	23	dobj
22	25	advmod
29	27	det
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	30	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	30	2	VBN	0	2	3	1	shown	2	2	3	0	SBAR	1	3	30	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	30	2	NP	1	4	6	2	JJ	0	4	5	1	endogenous	4	4	5	0	NN	0	5	6	1	RAS	5	5	6	0	VP	1	6	30	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	30	2	JJ	0	7	8	1	necessary	7	7	8	0	PP	0	8	30	2	IN	0	8	9	1	for	8	8	9	0	NP	0	9	30	3	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	full	10	10	11	0	JJ	0	11	12	1	apoptotic	11	11	12	0	NN	0	12	13	1	activity	12	12	13	0	PP	0	13	26	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	26	3	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	SBAR	1	16	26	2	WHNP	0	16	17	1	WDT	0	16	17	1	which	16	16	17	0	S	0	17	26	1	VP	0	17	26	2	VBZ	0	17	18	1	suggests	17	17	18	0	SBAR	1	18	26	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	26	2	NP	1	19	21	2	NN	0	19	20	1	RAS	19	19	20	0	NN	0	20	21	1	signalling	20	20	21	0	VP	1	21	26	2	MD	0	21	22	1	may	21	21	22	0	VP	0	22	26	4	VB	0	22	23	1	modify	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	,	0	24	25	1	,	24	24	25	0	ADVP	0	25	26	1	RB	0	25	26	1	potentially	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	via	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	a	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	NN	0	29	30	1	event	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	28
Phosphorylation	2291	2306	NN	phosphorylation	O	_	_
by	2307	2309	IN	by	O	_	_
RAS	2310	2313	NN	ra	B-GENE	_	_
/	2313	2314	:	/	B-GENE	_	_
MAPK	2314	2318	NN	mapk	I-GENE	_	_
modulates	2319	2328	VBZ	modulate	O	_	_
the	2329	2332	DT	the	O	_	_
activation	2333	2343	NN	activation	O	_	_
of	2344	2346	IN	of	O	_	_
most	2347	2351	JJS	most	O	_	_
of	2352	2354	IN	of	O	_	_
their	2355	2360	PRP$	they	O	_	_
substrates	2361	2371	NNS	substrate	O	_	_
and	2372	2375	CC	and	O	_	_
in	2376	2378	IN	in	O	_	_
some	2379	2383	DT	some	O	_	_
cases	2384	2389	NNS	case	O	_	_
the	2390	2393	DT	the	O	_	_
phosphorylation	2394	2409	NN	phosphorylation	O	_	_
mediates	2410	2418	VBZ	mediate	O	_	_
changes	2419	2426	NNS	change	O	_	_
in	2427	2429	IN	in	O	_	_
subcellular	2430	2441	JJ	subcellular	O	_	_
localisation	2442	2454	NN	localisation	O	_	_
[	2455	2456	NN	[	O	_	_
4	2456	2457	CD	4	O	_	_
]	2457	2458	NN	]	O	_	_
.	2458	2459	.	.	O	_	_
D	1
0
0	2	prep_by
0	3	punct
0	19	dep
5	4	nsubj
5	5	conj_and
5	7	dobj
5	9	prep_of
5	16	prep_in
5	18	pobj
7	6	det
9	12	prep_of
12	11	poss
16	15	det
18	17	det
19	5	dep
19	20	dobj
19	24	prep_in
19	26	nsubj
24	22	amod
24	23	nn
26	25	num
EOX
Y	1
ROOT	0	0	28	1	FRAG	0	0	28	4	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	by	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	SINV	1	4	27	3	S	1	4	19	2	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	0	5	19	3	VBZ	0	5	6	1	modulates	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	activation	7	7	8	0	PP	0	8	19	4	PP	0	8	13	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	13	2	NP	0	9	10	1	JJS	0	9	10	1	most	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	PRP$	0	11	12	1	their	11	11	12	0	NNS	0	12	13	1	substrates	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	in	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	some	15	15	16	0	NNS	0	16	17	1	cases	16	16	17	0	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	mediates	19	19	20	0	NP	0	20	21	1	NNS	0	20	21	1	changes	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	in	21	21	22	0	NP	2	22	25	3	JJ	0	22	23	1	subcellular	22	22	23	0	NN	0	23	24	1	localisation	23	23	24	0	NN	0	24	25	1	[	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	4	25	25	26	0	NN	0	26	27	1	]	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	16
ASPP2	2460	2465	NN	aspp2	B-GENE	_	_
belongs	2466	2473	VBZ	belong	O	_	_
to	2474	2476	TO	to	O	_	_
an	2477	2479	DT	a	O	_	_
evolutionarily	2480	2494	RB	evolutionarily	O	_	_
conserved	2495	2504	VBN	conserve	O	_	_
ASPP	2505	2509	NN	aspp	B-GENE	_	_
family	2510	2516	NN	family	I-GENE	_	_
of	2517	2519	IN	of	O	_	_
proteins	2520	2528	NNS	protein	O	_	_
,	2528	2529	,	,	O	_	_
alongside	2530	2539	IN	alongside	O	_	_
ASPP1	2540	2545	NN	aspp1	O	_	_
and	2546	2549	CC	and	O	_	_
iASPP	2550	2555	NN	iaspp	O	_	_
.	2555	2556	.	.	O	_	_
D	1
1
1	0	nsubj
1	7	prep_to
4	5	dep
7	3	det
7	4	amod
7	6	nn
7	9	prep_of
7	12	prep_alongside
7	14	prep_alongside
12	14	conj_and
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	15	2	VBZ	0	1	2	1	belongs	1	1	2	0	PP	0	2	15	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	15	4	NP	3	3	8	4	DT	0	3	4	1	an	3	3	4	0	ADJP	0	4	6	2	RB	0	4	5	1	evolutionarily	4	4	5	0	S	0	5	6	1	VP	0	5	6	1	VBN	0	5	6	1	conserved	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	NN	0	7	8	1	family	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	proteins	9	9	10	0	,	0	10	11	1	,	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	alongside	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	ASPP1	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	iASPP	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	22
All	2557	2560	DT	all	O	_	_
three	2561	2566	CD	three	O	_	_
contain	2567	2574	VBP	contain	O	_	_
signature	2575	2584	NN	signature	O	_	_
sequences	2585	2594	NNS	sequence	O	_	_
in	2595	2597	IN	in	O	_	_
their	2598	2603	PRP$	they	O	_	_
C-termini	2604	2613	NNS	c-terminus	O	_	_
;	2613	2614	:	;	O	_	_
ankyrin	2615	2622	NN	ankyrin	B-GENE	_	_
repeats	2623	2630	NNS	repeat	O	_	_
,	2630	2631	,	,	O	_	_
SH3	2632	2635	NN	sh3	B-GENE	_	_
domain	2636	2642	NN	domain	I-GENE	_	_
and	2643	2646	CC	and	O	_	_
proline	2647	2654	NN	proline	O	_	_
rich	2655	2659	JJ	rich	O	_	_
sequences	2660	2669	NNS	sequence	O	_	_
[	2670	2671	VBP	[	O	_	_
5	2671	2672	CD	5	O	_	_
]	2672	2673	CD	]	O	_	_
.	2673	2674	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	4	dobj
2	18	parataxis
4	3	nn
4	7	prep_in
7	6	poss
10	9	nn
10	13	conj_and
10	17	conj_and
13	12	nn
17	15	nn
17	16	amod
18	10	nsubj
18	13	nsubj
18	17	nsubj
18	20	dobj
20	19	number
EOX
Y	1
ROOT	0	0	22	1	S	0	0	22	4	S	1	0	8	2	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	8	2	VBP	0	2	3	1	contain	2	2	3	0	NP	0	3	8	2	NP	1	3	5	2	NN	0	3	4	1	signature	3	3	4	0	NNS	0	4	5	1	sequences	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	in	5	5	6	0	NP	1	6	8	2	PRP$	0	6	7	1	their	6	6	7	0	NNS	0	7	8	1	C-termini	7	7	8	0	:	0	8	9	1	;	8	8	9	0	S	1	9	21	2	NP	0	9	18	5	NP	1	9	11	2	NN	0	9	10	1	ankyrin	9	9	10	0	NNS	0	10	11	1	repeats	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SH3	12	12	13	0	NN	0	13	14	1	domain	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	proline	15	15	16	0	JJ	0	16	17	1	rich	16	16	17	0	NNS	0	17	18	1	sequences	17	17	18	0	VP	0	18	21	2	VBP	0	18	19	1	[	18	18	19	0	NP	0	19	21	1	QP	1	19	21	2	CD	0	19	20	1	5	19	19	20	0	CD	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	11
ASPP2	2675	2680	NN	aspp2	B-GENE	_	_
binds	2681	2686	VBZ	bind	O	_	_
to	2687	2689	TO	to	O	_	_
RAS	2690	2693	NN	ra	O	_	_
through	2694	2701	IN	through	O	_	_
its	2702	2705	PRP$	its	O	_	_
N-terminus	2706	2716	NN	n-terminus	O	_	_
[	2717	2718	CD	[	O	_	_
2,6	2718	2721	CD	2,6	O	_	_
]	2721	2722	NN	]	O	_	_
.	2722	2723	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	prep_to
1	6	prep_through
1	9	dep
6	5	poss
8	7	number
9	8	num
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	binds	1	1	2	0	PP	0	2	4	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	10	3	IN	0	4	5	1	through	4	4	5	0	NP	1	5	7	2	PRP$	0	5	6	1	its	5	5	6	0	NN	0	6	7	1	N-terminus	6	6	7	0	NP	1	7	10	2	QP	1	7	9	2	CD	0	7	8	1	[	7	7	8	0	CD	0	8	9	1	2,6	8	8	9	0	NN	0	9	10	1	]	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	14
The	2724	2727	DT	the	O	_	_
functions	2728	2737	NNS	function	O	_	_
of	2738	2740	IN	of	O	_	_
ASPP2	2741	2746	NN	aspp2	B-GENE	_	_
are	2747	2750	VBP	be	O	_	_
potentially	2751	2762	RB	potentially	O	_	_
controlled	2763	2773	VBN	control	O	_	_
by	2774	2776	IN	by	O	_	_
its	2777	2780	PRP$	its	O	_	_
binding	2781	2788	VBG	bind	O	_	_
partners	2789	2797	NNS	partner	O	_	_
and	2798	2801	CC	and	O	_	_
localisation	2802	2814	NN	localisation	O	_	_
.	2814	2815	.	.	O	_	_
D	1
6
1	0	det
1	3	prep_of
6	1	nsubjpass
6	4	auxpass
6	5	advmod
6	10	agent
6	12	agent
10	8	poss
10	9	amod
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	functions	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	13	2	VBP	0	4	5	1	are	4	4	5	0	ADJP	1	5	13	3	RB	0	5	6	1	potentially	5	5	6	0	VBN	0	6	7	1	controlled	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	13	3	NP	2	8	11	3	PRP$	0	8	9	1	its	8	8	9	0	VBG	0	9	10	1	binding	9	9	10	0	NNS	0	10	11	1	partners	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	localisation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	50
When	2816	2820	WRB	when	O	_	_
ASPP2	2821	2826	NN	aspp2	O	_	_
locates	2827	2834	VBZ	locate	O	_	_
at	2835	2837	IN	at	O	_	_
the	2838	2841	DT	the	O	_	_
cell-cell	2842	2851	JJ	cell-cell	O	_	_
junctions	2852	2861	NNS	junction	O	_	_
,	2861	2862	,	,	O	_	_
it	2863	2865	PRP	it	O	_	_
binds	2866	2871	VBZ	bind	O	_	_
and	2872	2875	CC	and	O	_	_
co-localises	2876	2888	VBZ	co-localise	O	_	_
with	2889	2893	IN	with	O	_	_
PAR3	2894	2898	NN	par3	B-GENE	_	_
via	2899	2902	IN	via	O	_	_
its	2903	2906	PRP$	its	O	_	_
N-terminus	2907	2917	NN	n-terminus	O	_	_
to	2918	2920	TO	to	O	_	_
maintain	2921	2929	VB	maintain	O	_	_
the	2930	2933	DT	the	O	_	_
integrity	2934	2943	NN	integrity	O	_	_
of	2944	2946	IN	of	O	_	_
cell	2947	2951	NN	cell	O	_	_
polarity	2952	2960	NN	polarity	O	_	_
and	2961	2964	CC	and	O	_	_
adherence	2965	2974	NN	adherence	O	_	_
junction	2975	2983	NN	junction	O	_	_
[	2984	2985	CD	[	O	_	_
7,8	2985	2988	CD	7,8	O	_	_
]	2988	2989	NN	]	O	_	_
,	2989	2990	,	,	O	_	_
whereas	2991	2998	IN	whereas	O	_	_
in	2999	3001	IN	in	O	_	_
the	3002	3005	DT	the	O	_	_
cytosol	3006	3013	NN	cytosol	O	_	_
/	3013	3014	:	/	O	_	_
nucleus	3014	3021	NN	nucleus	O	_	_
,	3021	3022	,	,	O	_	_
ASPP2	3023	3028	NN	aspp2	B-GENE	_	_
enhances	3029	3037	VBZ	enhance	O	_	_
p53	3038	3041	NN	p53	B-GENE	_	_
induced	3042	3049	JJ	induced	O	_	_
apoptosis	3050	3059	NN	apoptosis	O	_	_
in	3060	3062	IN	in	O	_	_
cancer	3063	3069	NN	cancer	O	_	_
cells	3070	3075	NNS	cell	O	_	_
[	3076	3077	VBP	[	O	_	_
9	3077	3078	CD	9	O	_	_
]	3078	3079	NN	]	O	_	_
.	3079	3080	.	.	O	_	_
D	1
39
2	0	advmod
2	1	nsubj
2	6	prep_at
6	4	det
6	5	amod
9	2	advcl
9	8	nsubj
9	11	conj_and
9	13	prep_with
11	8	nsubj
13	16	prep_via
16	15	poss
16	18	vmod
18	17	aux
18	20	dobj
20	19	det
20	23	prep_of
20	26	prep_of
23	22	nn
23	26	conj_and
23	29	dep
23	36	dep
26	25	nn
28	27	number
29	28	num
34	32	dep
34	33	det
36	31	mark
36	34	dep
36	35	punct
39	9	ccomp
39	11	ccomp
39	38	nsubj
39	46	ccomp
42	40	nn
42	41	amod
42	45	prep_in
45	44	nn
46	42	nsubj
46	48	dobj
48	47	num
EOX
Y	1
ROOT	0	0	50	1	S	3	0	50	5	S	3	0	37	4	SBAR	1	0	7	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	1	1	7	2	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	0	2	7	2	VBZ	0	2	3	1	locates	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	at	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	JJ	0	5	6	1	cell-cell	5	5	6	0	NNS	0	6	7	1	junctions	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	PRP	0	8	9	1	it	8	8	9	0	VP	0	9	37	4	VBZ	0	9	10	1	binds	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VBZ	0	11	12	1	co-localises	11	11	12	0	PP	0	12	37	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	37	2	NP	0	13	14	1	NN	0	13	14	1	PAR3	13	13	14	0	PP	0	14	37	2	IN	0	14	15	1	via	14	14	15	0	NP	1	15	37	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	N-terminus	16	16	17	0	S	0	17	37	1	VP	1	17	37	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	37	2	VB	0	18	19	1	maintain	18	18	19	0	NP	0	19	37	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	integrity	20	20	21	0	PP	0	21	37	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	37	3	NP	0	22	30	2	NP	0	22	27	3	NP	1	22	24	2	NN	0	22	23	1	cell	22	22	23	0	NN	0	23	24	1	polarity	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	adherence	25	25	26	0	NN	0	26	27	1	junction	26	26	27	0	NP	1	27	30	2	QP	1	27	29	2	CD	0	27	28	1	[	27	27	28	0	CD	0	28	29	1	7,8	28	28	29	0	NN	0	29	30	1	]	29	29	30	0	,	0	30	31	1	,	30	30	31	0	SBAR	1	31	37	2	IN	0	31	32	1	whereas	31	31	32	0	FRAG	2	32	37	3	X	1	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	cytosol	34	34	35	0	:	0	35	36	1	/	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	nucleus	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NN	0	38	39	1	ASPP2	38	38	39	0	VP	0	39	49	2	VBZ	0	39	40	1	enhances	39	39	40	0	SBAR	0	40	49	1	S	1	40	49	2	NP	0	40	46	2	NP	2	40	43	3	NN	0	40	41	1	p53	40	40	41	0	JJ	0	41	42	1	induced	41	41	42	0	NN	0	42	43	1	apoptosis	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	in	43	43	44	0	NP	1	44	46	2	NN	0	44	45	1	cancer	44	44	45	0	NNS	0	45	46	1	cells	45	45	46	0	VP	0	46	49	2	VBP	0	46	47	1	[	46	46	47	0	NP	1	47	49	2	CD	0	47	48	1	9	47	47	48	0	NN	0	48	49	1	]	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	17
It	3081	3083	PRP	it	O	_	_
also	3084	3088	RB	also	O	_	_
binds	3089	3094	VBZ	bind	O	_	_
ATG5	3095	3099	NN	atg5	B-GENE	_	_
and	3100	3103	CC	and	O	_	_
inhibits	3104	3112	VBZ	inhibit	O	_	_
RAS	3113	3116	NN	ra	O	_	_
induced	3117	3124	VBD	induce	O	_	_
autophagy	3125	3134	NN	autophagy	O	_	_
,	3134	3135	,	,	O	_	_
independently	3136	3149	RB	independently	O	_	_
of	3150	3152	IN	of	O	_	_
p53	3153	3156	NN	p53	B-GENE	_	_
[	3157	3158	CD	[	I-GENE	_	_
10	3158	3160	CD	10	I-GENE	_	_
]	3160	3161	NN	]	I-GENE	_	_
.	3161	3162	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	3	dobj
2	5	conj_and
5	0	nsubj
5	7	ccomp
7	6	nsubj
7	8	dobj
8	15	rcmod
10	12	prep_of
14	13	number
15	10	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	2	0	17	4	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	also	1	1	2	0	VP	0	2	16	3	VP	0	2	4	2	VBZ	0	2	3	1	binds	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ATG5	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	VP	0	5	16	2	VBZ	0	5	6	1	inhibits	5	5	6	0	SBAR	0	6	16	1	S	1	6	16	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	VP	0	7	16	2	VBD	0	7	8	1	induced	7	7	8	0	NP	0	8	16	3	NP	0	8	9	1	NN	0	8	9	1	autophagy	8	8	9	0	,	0	9	10	1	,	9	9	10	0	RRC	1	10	16	2	ADVP	0	10	13	2	RB	0	10	11	1	independently	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	1	13	16	2	QP	1	13	15	2	CD	0	13	14	1	[	13	13	14	0	CD	0	14	15	1	10	14	14	15	0	NN	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	16
Thus	3163	3167	RB	thus	O	_	_
it	3168	3170	PRP	it	O	_	_
is	3171	3173	VBZ	be	O	_	_
important	3174	3183	JJ	important	O	_	_
to	3184	3186	TO	to	O	_	_
find	3187	3191	VB	find	O	_	_
the	3192	3195	DT	the	O	_	_
molecular	3196	3205	JJ	molecular	O	_	_
event	3206	3211	NN	event	O	_	_
that	3212	3216	WDT	that	O	_	_
controls	3217	3225	VBZ	control	O	_	_
the	3226	3229	DT	the	O	_	_
localisation	3230	3242	NN	localisation	O	_	_
of	3243	3245	IN	of	O	_	_
ASPP2	3246	3251	NN	aspp2	B-GENE	_	_
.	3251	3252	.	.	O	_	_
D	1
3
3	0	advmod
3	1	nsubj
3	2	cop
3	5	xcomp
5	4	aux
5	8	dobj
8	6	det
8	7	amod
8	10	rcmod
10	9	nsubj
10	12	dobj
12	11	det
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	it	1	1	2	0	VP	1	2	15	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	15	2	JJ	0	3	4	1	important	3	3	4	0	S	0	4	15	1	VP	1	4	15	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	15	2	VB	0	5	6	1	find	5	5	6	0	NP	0	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	JJ	0	7	8	1	molecular	7	7	8	0	NN	0	8	9	1	event	8	8	9	0	SBAR	1	9	15	2	WHNP	0	9	10	1	WDT	0	9	10	1	that	9	9	10	0	S	0	10	15	1	VP	0	10	15	2	VBZ	0	10	11	1	controls	10	10	11	0	NP	0	11	15	2	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	localisation	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	14
Here	3253	3257	RB	here	O	_	_
we	3258	3260	PRP	we	O	_	_
show	3261	3265	VBP	show	O	_	_
that	3266	3270	IN	that	O	_	_
ASPP2	3271	3276	NN	aspp2	B-GENE	_	_
is	3277	3279	VBZ	be	O	_	_
a	3280	3281	DT	a	O	_	_
novel	3282	3287	JJ	novel	O	_	_
substrate	3288	3297	NN	substrate	O	_	_
of	3298	3300	IN	of	O	_	_
RAS	3301	3304	NN	ra	B-GENE	_	_
/	3304	3305	:	/	B-GENE	_	_
MAPK	3305	3309	NN	mapk	I-GENE	_	_
.	3309	3310	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
10	12	dep
12	11	punct
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	13	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	13	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	13	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	13	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	13	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	RAS	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	MAPK	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	24
Phosphorylation	3311	3326	NN	phosphorylation	O	_	_
of	3327	3329	IN	of	O	_	_
ASPP2	3330	3335	NN	aspp2	B-GENE	_	_
by	3336	3338	IN	by	O	_	_
MAPK	3339	3343	NN	mapk	B-GENE	_	_
is	3344	3346	VBZ	be	O	_	_
required	3347	3355	VBN	require	O	_	_
for	3356	3359	IN	for	O	_	_
the	3360	3363	DT	the	O	_	_
RAS	3364	3367	NN	ra	O	_	_
induced	3368	3375	VBD	induce	O	_	_
translocation	3376	3389	NN	translocation	O	_	_
of	3390	3392	IN	of	O	_	_
ASPP2	3393	3398	NN	aspp2	B-GENE	_	_
,	3398	3399	,	,	O	_	_
which	3400	3405	WDT	which	O	_	_
results	3406	3413	VBZ	result	O	_	_
in	3414	3416	IN	in	O	_	_
the	3417	3420	DT	the	O	_	_
increased	3421	3430	VBN	increase	O	_	_
binding	3431	3438	NN	binding	O	_	_
to	3439	3441	TO	to	O	_	_
p53	3442	3445	NN	p53	B-GENE	_	_
.	3445	3446	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	10	advcl
9	8	det
10	7	mark
10	9	nsubj
10	11	dobj
11	13	prep_of
13	16	rcmod
16	15	nsubj
16	20	prep_in
20	18	det
20	19	amod
20	22	prep_to
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	23	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	23	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	23	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	23	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	VP	0	10	23	2	VBD	0	10	11	1	induced	10	10	11	0	NP	0	11	23	2	NP	0	11	12	1	NN	0	11	12	1	translocation	11	11	12	0	PP	0	12	23	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	23	3	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	,	0	14	15	1	,	14	14	15	0	SBAR	1	15	23	2	WHNP	0	15	16	1	WDT	0	15	16	1	which	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBZ	0	16	17	1	results	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	VBN	0	19	20	1	increased	19	19	20	0	NN	0	20	21	1	binding	20	20	21	0	PP	0	21	23	2	TO	0	21	22	1	to	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	p53	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Consequently	3447	3459	RB	consequently	O	_	_
,	3459	3460	,	,	O	_	_
the	3461	3464	DT	the	O	_	_
pro-apoptotic	3465	3478	JJ	pro-apoptotic	O	_	_
activity	3479	3487	NN	activity	O	_	_
of	3488	3490	IN	of	O	_	_
ASPP2	3491	3496	NN	aspp2	B-GENE	_	_
is	3497	3499	VBZ	be	O	_	_
increased	3500	3509	VBN	increase	O	_	_
by	3510	3512	IN	by	O	_	_
the	3513	3516	DT	the	O	_	_
RAS	3517	3520	NN	ra	B-GENE	_	_
/	3520	3521	:	/	I-GENE	_	_
Raf/MAPK	3521	3529	NN	raf/mapk	B-GENE	_	_
signalling	3530	3540	NN	signalling	O	_	_
cascade	3541	3548	NN	cascade	O	_	_
as	3549	3551	IN	as	O	_	_
ASPP2	3552	3557	NN	aspp2	B-GENE	_	_
phosphorylation	3558	3573	NN	phosphorylation	O	_	_
mutant	3574	3580	JJ	mutant	O	_	_
fails	3581	3586	VBZ	fail	O	_	_
to	3587	3589	TO	to	O	_	_
do	3590	3592	VB	do	O	_	_
so	3593	3595	RB	so	O	_	_
.	3595	3596	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	6	prep_of
8	0	advmod
8	4	nsubjpass
8	7	auxpass
8	11	agent
11	10	det
11	19	dep
11	20	rcmod
15	13	nn
15	14	nn
15	18	prep_as
18	17	nn
19	12	punct
19	15	dep
20	22	xcomp
22	21	aux
22	23	advmod
EOX
Y	1
ROOT	0	0	25	1	S	3	0	25	5	ADVP	0	0	1	1	RB	0	0	1	1	Consequently	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	pro-apoptotic	3	3	4	0	NN	0	4	5	1	activity	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	24	2	VBZ	0	7	8	1	is	7	7	8	0	VP	0	8	24	2	VBN	0	8	9	1	increased	8	8	9	0	PP	0	9	24	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	24	2	NP	0	10	20	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	20	2	:	0	12	13	1	/	12	12	13	0	S	1	13	20	2	NP	0	13	19	2	NP	2	13	16	3	NN	0	13	14	1	Raf/MAPK	13	13	14	0	NN	0	14	15	1	signalling	14	14	15	0	NN	0	15	16	1	cascade	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	as	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	ADJP	0	19	20	1	JJ	0	19	20	1	mutant	19	19	20	0	SBAR	0	20	24	1	S	0	20	24	1	VP	0	20	24	2	VBZ	0	20	21	1	fails	20	20	21	0	S	0	21	24	1	VP	1	21	24	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	24	2	VB	0	22	23	1	do	22	22	23	0	ADVP	0	23	24	1	RB	0	23	24	1	so	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	21
Thus	3597	3601	RB	thus	O	_	_
phosphorylation	3602	3617	NN	phosphorylation	O	_	_
of	3618	3620	IN	of	O	_	_
ASPP2	3621	3626	NN	aspp2	B-GENE	_	_
by	3627	3629	IN	by	O	_	_
RAS	3630	3633	NN	ra	B-GENE	_	_
/	3633	3634	:	/	B-GENE	_	_
MAPK	3634	3638	NN	mapk	I-GENE	_	_
pathway	3639	3646	NN	pathway	O	_	_
provides	3647	3655	VBZ	provide	O	_	_
a	3656	3657	DT	a	O	_	_
novel	3658	3663	JJ	novel	O	_	_
link	3664	3668	NN	link	O	_	_
between	3669	3676	IN	between	O	_	_
RAS	3677	3680	NN	ra	B-GENE	_	_
and	3681	3684	CC	and	O	_	_
p53	3685	3688	NN	p53	B-GENE	_	_
in	3689	3691	IN	in	O	_	_
regulating	3692	3702	VBG	regulate	O	_	_
apoptosis	3703	3712	NN	apoptosis	O	_	_
.	3712	3713	.	.	O	_	_
D	1
1
1	0	advmod
1	3	prep_of
1	5	prep_by
1	6	punct
1	9	dep
8	7	nn
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	FRAG	0	0	21	4	NP	0	0	6	2	NP	1	0	4	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	2
Results	3714	3721	NNS	result	O	_	_
.	3721	3722	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NNS	0	0	1	1	Results	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	8
ASPP2	3723	3728	NN	aspp2	B-GENE	_	_
is	3729	3731	VBZ	be	O	_	_
a	3732	3733	DT	a	O	_	_
novel	3734	3739	JJ	novel	O	_	_
substrate	3740	3749	NN	substrate	O	_	_
of	3750	3752	IN	of	O	_	_
MAPK	3753	3757	NN	mapk	O	_	_
.	3757	3758	.	.	O	_	_
D	1
4
4	0	nsubj
4	1	cop
4	2	det
4	3	amod
4	6	prep_of
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	7	2	VBZ	0	1	2	1	is	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	a	2	2	3	0	JJ	0	3	4	1	novel	3	3	4	0	NN	0	4	5	1	substrate	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	20
It	3759	3761	PRP	it	O	_	_
has	3762	3765	VBZ	have	O	_	_
recently	3766	3774	RB	recently	O	_	_
been	3775	3779	VBN	be	O	_	_
shown	3780	3785	VBN	show	O	_	_
that	3786	3790	IN	that	O	_	_
oncogenic	3791	3800	JJ	oncogenic	O	_	_
RAS	3801	3804	NN	ra	O	_	_
can	3805	3808	MD	can	O	_	_
enhance	3809	3816	VB	enhance	O	_	_
the	3817	3820	DT	the	O	_	_
apoptotic	3821	3830	JJ	apoptotic	O	_	_
function	3831	3839	NN	function	O	_	_
of	3840	3842	IN	of	O	_	_
p53	3843	3846	NN	p53	B-GENE	_	_
via	3847	3850	IN	via	I-GENE	_	_
ASPP1	3851	3856	NN	aspp1	I-GENE	_	_
and	3857	3860	CC	and	O	_	_
ASPP2	3861	3866	NN	aspp2	B-GENE	_	_
.	3866	3867	.	.	O	_	_
D	1
4
4	0	nsubjpass
4	1	aux
4	2	advmod
4	3	auxpass
4	9	ccomp
7	6	amod
9	5	mark
9	7	nsubj
9	8	aux
9	12	dobj
12	10	det
12	11	amod
12	14	prep_of
14	16	prep_via
14	18	prep_via
16	18	conj_and
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	2	1	19	3	VBZ	0	1	2	1	has	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	VP	1	3	19	2	VBN	0	3	4	1	been	3	3	4	0	VP	0	4	19	2	VBN	0	4	5	1	shown	4	4	5	0	SBAR	1	5	19	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	19	2	NP	1	6	8	2	JJ	0	6	7	1	oncogenic	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	1	8	19	2	MD	0	8	9	1	can	8	8	9	0	VP	0	9	19	2	VB	0	9	10	1	enhance	9	9	10	0	NP	0	10	19	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	apoptotic	11	11	12	0	NN	0	12	13	1	function	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	2	NP	0	14	15	1	NN	0	14	15	1	p53	14	14	15	0	PP	0	15	19	2	IN	0	15	16	1	via	15	15	16	0	NP	0	16	19	3	NN	0	16	17	1	ASPP1	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NN	0	18	19	1	ASPP2	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	19
Mechanistically	3868	3883	RB	mechanistically	O	_	_
ASPP1	3884	3889	NN	aspp1	B-GENE	_	_
and	3890	3893	CC	and	O	_	_
ASPP2	3894	3899	NN	aspp2	B-GENE	_	_
bind	3900	3904	VBP	bind	O	_	_
RAS-GTP	3905	3912	NN	ras-gtp	O	_	_
and	3913	3916	CC	and	O	_	_
potentiates	3917	3928	VBZ	potentiate	O	_	_
RAS	3929	3932	NN	ra	B-GENE	_	_
signalling	3933	3943	NN	signalling	O	_	_
to	3944	3946	TO	to	O	_	_
enhance	3947	3954	VB	enhance	O	_	_
p53	3955	3958	NN	p53	B-GENE	_	_
mediated	3959	3967	JJ	mediated	O	_	_
apoptosis	3968	3977	NN	apoptosis	O	_	_
[	3978	3979	NN	[	O	_	_
2	3979	3980	CD	2	O	_	_
]	3980	3981	NN	]	O	_	_
.	3981	3982	.	.	O	_	_
D	1
4
1	3	conj_and
4	0	advmod
4	1	nsubj
4	3	nsubj
4	5	dobj
4	7	conj_and
4	17	dobj
7	1	nsubj
7	9	dobj
7	11	xcomp
9	8	nn
11	10	aux
11	12	dobj
17	13	amod
17	14	nn
17	15	nn
17	16	num
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Mechanistically	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	ASPP1	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	VP	0	4	18	4	VP	0	4	6	2	VBP	0	4	5	1	bind	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS-GTP	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	VP	0	7	13	3	VBZ	0	7	8	1	potentiates	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	enhance	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	4	13	18	5	JJ	0	13	14	1	mediated	13	13	14	0	NN	0	14	15	1	apoptosis	14	14	15	0	NN	0	15	16	1	[	15	15	16	0	CD	0	16	17	1	2	16	16	17	0	NN	0	17	18	1	]	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	31
As	3983	3985	IN	as	O	_	_
RAS	3986	3989	NN	ra	O	_	_
is	3990	3992	VBZ	be	O	_	_
upstream	3993	4001	JJ	upstream	O	_	_
of	4002	4004	IN	of	O	_	_
several	4005	4012	JJ	several	O	_	_
signalling	4013	4023	NN	signalling	O	_	_
cascades	4024	4032	NNS	cascade	O	_	_
[	4033	4034	VBP	[	O	_	_
13	4034	4036	CD	13	O	_	_
]	4036	4037	CD	]	O	_	_
,	4037	4038	,	,	O	_	_
we	4039	4041	PRP	we	O	_	_
queried	4042	4049	VBD	query	O	_	_
whether	4050	4057	IN	whether	O	_	_
the	4058	4061	DT	the	O	_	_
activity	4062	4070	NN	activity	O	_	_
of	4071	4073	IN	of	O	_	_
ASPP2	4074	4079	NN	aspp2	B-GENE	_	_
is	4080	4082	VBZ	be	O	_	_
regulated	4083	4092	VBN	regulate	O	_	_
by	4093	4095	IN	by	O	_	_
the	4096	4099	DT	the	O	_	_
activation	4100	4110	NN	activation	O	_	_
of	4111	4113	IN	of	O	_	_
a	4114	4115	DT	a	O	_	_
RAS	4116	4119	NN	ra	B-GENE	_	_
mediated	4120	4128	VBD	mediate	O	_	_
signalling	4129	4139	NN	signalling	O	_	_
pathway	4140	4147	NN	pathway	O	_	_
.	4147	4148	.	.	O	_	_
D	1
13
3	0	mark
3	1	nsubj
3	2	cop
3	7	prep_of
3	8	rcmod
7	5	amod
7	6	nn
8	10	dobj
10	9	num
13	3	advcl
13	12	nsubj
13	20	ccomp
16	15	det
16	18	prep_of
20	14	mark
20	16	nsubjpass
20	19	auxpass
20	23	agent
23	22	det
23	26	prep_of
26	25	det
26	27	vmod
27	29	dobj
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	3	0	31	5	SBAR	1	0	11	2	IN	0	0	1	1	As	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	11	3	NP	0	3	4	1	JJ	0	3	4	1	upstream	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	JJ	0	5	6	1	several	5	5	6	0	NN	0	6	7	1	signalling	6	6	7	0	NNS	0	7	8	1	cascades	7	7	8	0	SBAR	0	8	11	1	S	0	8	11	1	VP	0	8	11	2	VBP	0	8	9	1	[	8	8	9	0	NP	1	9	11	2	CD	0	9	10	1	13	9	9	10	0	CD	0	10	11	1	]	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	we	12	12	13	0	VP	0	13	30	2	VBD	0	13	14	1	queried	13	13	14	0	SBAR	1	14	30	2	IN	0	14	15	1	whether	14	14	15	0	S	1	15	30	2	NP	0	15	19	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	30	2	VBZ	0	19	20	1	is	19	19	20	0	VP	0	20	30	2	VBN	0	20	21	1	regulated	20	20	21	0	PP	0	21	30	2	IN	0	21	22	1	by	21	21	22	0	NP	0	22	30	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	30	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	30	2	NP	1	25	27	2	DT	0	25	26	1	a	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	30	2	VBD	0	27	28	1	mediated	27	27	28	0	NP	1	28	30	2	NN	0	28	29	1	signalling	28	28	29	0	NN	0	29	30	1	pathway	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	15
One	4149	4152	CD	one	O	_	_
of	4153	4155	IN	of	O	_	_
the	4156	4159	DT	the	O	_	_
most	4160	4164	RBS	most	O	_	_
studied	4165	4172	VBN	study	O	_	_
downstream	4173	4183	JJ	downstream	O	_	_
pathways	4184	4192	NNS	pathway	O	_	_
of	4193	4195	IN	of	O	_	_
RAS	4196	4199	NN	ra	O	_	_
signalling	4200	4210	NN	signalling	O	_	_
is	4211	4213	VBZ	be	O	_	_
the	4214	4217	DT	the	O	_	_
Raf-MAPK	4218	4226	NN	raf-mapk	B-GENE	_	_
pathway	4227	4234	NN	pathway	O	_	_
.	4234	4235	.	.	O	_	_
D	1
13
0	2	prep_of
2	3	advmod
2	4	vmod
4	6	dobj
6	5	amod
6	9	prep_of
9	8	nn
13	0	nsubj
13	10	cop
13	11	det
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	10	2	NP	0	0	1	1	CD	0	0	1	1	One	0	0	1	0	PP	0	1	10	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	10	2	NP	0	2	4	2	DT	0	2	3	1	the	2	2	3	0	RBS	0	3	4	1	most	3	3	4	0	VP	0	4	10	2	VBN	0	4	5	1	studied	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	downstream	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	VP	1	10	14	2	VBZ	0	10	11	1	is	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	Raf-MAPK	12	12	13	0	NN	0	13	14	1	pathway	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	15
Interestingly	4236	4249	RB	interestingly	O	_	_
,	4249	4250	,	,	O	_	_
we	4251	4253	PRP	we	O	_	_
observed	4254	4262	VBD	observe	O	_	_
two	4263	4266	CD	two	O	_	_
conserved	4267	4276	VBN	conserve	O	_	_
putative	4277	4285	JJ	putative	O	_	_
MAPK	4286	4290	NN	mapk	B-GENE	_	_
phosphorylation	4291	4306	NN	phosphorylation	O	_	_
sites	4307	4312	NNS	site	O	_	_
in	4313	4315	IN	in	O	_	_
ASPP1	4316	4321	NN	aspp1	B-GENE	_	_
and	4322	4325	CC	and	O	_	_
ASPP2	4326	4331	NN	aspp2	B-GENE	_	_
.	4331	4332	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	4	dobj
4	5	vmod
5	9	dobj
9	6	amod
9	7	nn
9	8	nn
9	11	prep_in
9	13	prep_in
11	13	conj_and
EOX
Y	1
ROOT	0	0	15	1	S	3	0	15	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	14	2	VBD	0	3	4	1	observed	3	3	4	0	NP	0	4	14	2	NP	0	4	5	1	CD	0	4	5	1	two	4	4	5	0	VP	0	5	14	2	VBN	0	5	6	1	conserved	5	5	6	0	NP	0	6	14	2	NP	3	6	10	4	JJ	0	6	7	1	putative	6	6	7	0	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	phosphorylation	8	8	9	0	NNS	0	9	10	1	sites	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	14	3	NN	0	11	12	1	ASPP1	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	21
The	4333	4336	DT	the	O	_	_
ASPP1	4337	4342	NN	aspp1	B-GENE	_	_
sites	4343	4348	NNS	site	I-GENE	_	_
are	4349	4352	VBP	be	O	_	_
at	4353	4355	IN	at	O	_	_
residues	4356	4364	NNS	residue	O	_	_
671	4365	4368	CD	671	O	_	_
and	4369	4372	CC	and	O	_	_
746	4373	4376	CD	746	O	_	_
,	4376	4377	,	,	O	_	_
and	4378	4381	CC	and	O	_	_
the	4382	4385	DT	the	O	_	_
ASPP2	4386	4391	NN	aspp2	B-GENE	_	_
sites	4392	4397	NNS	site	I-GENE	_	_
are	4398	4401	VBP	be	O	_	_
at	4402	4404	IN	at	O	_	_
residues	4405	4413	NNS	residue	O	_	_
698	4414	4417	CD	698	O	_	_
and	4418	4421	CC	and	O	_	_
827	4422	4425	CD	827	O	_	_
.	4437	4438	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	prep_at
3	8	prep_at
3	14	conj_and
5	6	num
5	8	conj_and
13	11	det
13	12	nn
14	13	nsubj
14	16	prep_at
14	19	prep_at
16	17	num
16	19	conj_and
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	5	S	1	0	9	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP1	1	1	2	0	NNS	0	2	3	1	sites	2	2	3	0	VP	0	3	9	2	VBP	0	3	4	1	are	3	3	4	0	PP	0	4	9	2	IN	0	4	5	1	at	4	4	5	0	NP	0	5	9	4	NNS	0	5	6	1	residues	5	5	6	0	CD	0	6	7	1	671	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	CD	0	8	9	1	746	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	S	1	11	20	2	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NNS	0	13	14	1	sites	13	13	14	0	VP	0	14	20	2	VBP	0	14	15	1	are	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	at	15	15	16	0	NP	0	16	20	4	NNS	0	16	17	1	residues	16	16	17	0	CD	0	17	18	1	698	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	CD	0	19	20	1	827	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
We	4439	4441	PRP	we	O	_	_
thus	4442	4446	RB	thus	O	_	_
tested	4447	4453	VBD	test	O	_	_
whether	4454	4461	IN	whether	O	_	_
RAS	4462	4465	NN	ra	B-GENE	_	_
activation	4466	4476	NN	activation	O	_	_
may	4477	4480	MD	may	O	_	_
regulate	4481	4489	VB	regulate	O	_	_
ASPP2	4490	4495	NN	aspp2	B-GENE	_	_
phosphorylation	4496	4511	NN	phosphorylation	O	_	_
.	4511	4512	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	7	ccomp
5	4	nn
7	3	mark
7	5	nsubj
7	6	aux
7	9	dobj
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	2	0	11	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	thus	1	1	2	0	VP	0	2	10	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	10	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	10	2	NP	1	4	6	2	NN	0	4	5	1	RAS	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	VP	1	6	10	2	MD	0	6	7	1	may	6	6	7	0	VP	0	7	10	2	VB	0	7	8	1	regulate	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	24
An	4513	4515	DT	a	O	_	_
in	4516	4518	FW	in	O	_	_
vitro	4519	4524	FW	vitro	O	_	_
phophorylation	4525	4539	NN	phophorylation	O	_	_
assay	4540	4545	NN	assay	O	_	_
was	4546	4549	VBD	be	O	_	_
performed	4550	4559	VBN	perform	O	_	_
with	4560	4564	IN	with	O	_	_
a	4565	4566	DT	a	O	_	_
purified	4567	4575	VBN	purify	O	_	_
C-terminus	4576	4586	NN	c-terminus	O	_	_
fragment	4587	4595	NN	fragment	O	_	_
of	4596	4598	IN	of	O	_	_
ASPP2	4599	4604	NN	aspp2	O	_	_
(	4605	4606	CD	(	O	_	_
693-1128	4606	4614	CD	693-1128	O	_	_
)	4614	4615	NN	)	O	_	_
containing	4616	4626	VBG	contain	O	_	_
both	4627	4631	CC	both	O	_	_
MAPK	4632	4636	NN	mapk	O	_	_
putative	4637	4645	JJ	putative	O	_	_
phosphorylation	4646	4661	NN	phosphorylation	O	_	_
sites	4662	4667	NNS	site	O	_	_
.	4667	4668	.	.	O	_	_
D	1

0	3	rcmod
0	4	dep
2	1	nn
3	2	advmod
6	0	nsubjpass
6	5	auxpass
6	11	prep_with
11	8	det
11	9	amod
11	10	nn
11	13	prep_of
16	15	num
16	17	vmod
17	18	prep
18	22	pobj
22	19	nn
22	20	amod
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	4	NP	0	0	5	2	NP	0	0	4	2	DT	0	0	1	1	An	0	0	1	0	RRC	1	1	4	2	ADVP	1	1	3	2	FW	0	1	2	1	in	1	1	2	0	FW	0	2	3	1	vitro	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phophorylation	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	assay	4	4	5	0	VP	1	5	15	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	15	2	VBN	0	6	7	1	performed	6	6	7	0	PP	0	7	15	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	15	2	NP	3	8	12	4	DT	0	8	9	1	a	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	C-terminus	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NP	0	15	23	2	NP	1	15	17	2	CD	0	15	16	1	693-1128	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	VP	0	17	23	2	VBG	0	17	18	1	containing	17	17	18	0	PP	0	18	23	2	CC	0	18	19	1	both	18	18	19	0	NP	3	19	23	4	NN	0	19	20	1	MAPK	19	19	20	0	JJ	0	20	21	1	putative	20	20	21	0	NN	0	21	22	1	phosphorylation	21	21	22	0	NNS	0	22	23	1	sites	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
When	4669	4673	WRB	when	O	_	_
compared	4674	4682	VBN	compare	O	_	_
to	4683	4685	TO	to	O	_	_
p38	4686	4689	NN	p38	B-GENE	_	_
SAPK	4690	4694	NN	sapk	I-GENE	_	_
,	4694	4695	,	,	O	_	_
MAPK1	4696	4701	NN	mapk1	B-GENE	_	_
was	4702	4705	VBD	be	O	_	_
clearly	4706	4713	RB	clearly	O	_	_
able	4714	4718	JJ	able	O	_	_
to	4719	4721	TO	to	O	_	_
phosphorylate	4722	4735	VB	phosphorylate	O	_	_
the	4736	4739	DT	the	O	_	_
ASPP2	4740	4745	NN	aspp2	O	_	_
fragment	4746	4754	NN	fragment	O	_	_
in	4755	4757	FW	in	O	_	_
vitro	4758	4763	FW	vitro	O	_	_
.	4799	4800	.	.	O	_	_
D	1
9
1	0	advmod
1	4	prep_to
4	3	nn
9	1	advcl
9	6	nsubj
9	7	cop
9	8	advmod
9	11	xcomp
11	10	aux
11	14	dobj
11	16	advmod
14	12	det
14	13	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	SBAR	1	0	5	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	0	1	5	1	VP	0	1	5	2	VBN	0	1	2	1	compared	1	1	2	0	PP	0	2	5	2	TO	0	2	3	1	to	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	p38	3	3	4	0	NN	0	4	5	1	SAPK	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK1	6	6	7	0	VP	2	7	17	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	clearly	8	8	9	0	ADJP	0	9	17	2	JJ	0	9	10	1	able	9	9	10	0	S	0	10	17	1	VP	1	10	17	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	17	3	VB	0	11	12	1	phosphorylate	11	11	12	0	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	ADVP	1	15	17	2	FW	0	15	16	1	in	15	15	16	0	FW	0	16	17	1	vitro	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	60
As	4801	4803	IN	as	O	_	_
shown	4804	4809	VBN	show	O	_	_
in	4810	4812	IN	in	O	_	_
,	4822	4823	,	,	O	_	_
histone	4824	4831	NN	histone	B-GENE	_	_
2B	4832	4834	NN	2b	I-GENE	_	_
phosphorylated	4835	4849	VBN	phosphorylate	O	_	_
by	4850	4852	IN	by	O	_	_
p38	4853	4856	NN	p38	B-GENE	_	_
SAPK	4857	4861	NN	sapk	I-GENE	_	_
had	4862	4865	VBD	have	O	_	_
high	4866	4870	JJ	high	O	_	_
levels	4871	4877	NNS	level	O	_	_
of	4878	4880	IN	of	O	_	_
incorporated	4881	4893	JJ	incorporated	O	_	_
32P	4894	4897	NN	32p	O	_	_
,	4897	4898	,	,	O	_	_
suggesting	4899	4909	VBG	suggest	O	_	_
that	4910	4914	IN	that	O	_	_
p38	4915	4918	NN	p38	B-GENE	_	_
SAPK	4919	4923	NN	sapk	O	_	_
was	4924	4927	VBD	be	O	_	_
active	4928	4934	JJ	active	O	_	_
;	4934	4935	:	;	O	_	_
while	4936	4941	IN	while	O	_	_
under	4942	4947	IN	under	O	_	_
the	4948	4951	DT	the	O	_	_
same	4952	4956	JJ	same	O	_	_
conditions	4957	4967	NNS	condition	O	_	_
,	4967	4968	,	,	O	_	_
ASPP2	4969	4974	NN	aspp2	O	_	_
(	4975	4976	CD	(	O	_	_
693-1128	4976	4984	CD	693-1128	O	_	_
)	4984	4985	NN	)	O	_	_
fragment	4986	4994	NN	fragment	O	_	_
phosphorylated	4995	5009	VBN	phosphorylate	O	_	_
by	5010	5012	IN	by	O	_	_
p38	5013	5016	NN	p38	B-GENE	_	_
SAPK	5017	5021	NN	sapk	O	_	_
had	5022	5025	VBD	have	O	_	_
very	5026	5030	RB	very	O	_	_
low	5031	5034	JJ	low	O	_	_
levels	5035	5041	NNS	level	O	_	_
of	5042	5044	IN	of	O	_	_
incorporated	5045	5057	JJ	incorporated	O	_	_
32P	5058	5061	NN	32p	O	_	_
,	5061	5062	,	,	O	_	_
indicating	5063	5073	VBG	indicate	O	_	_
that	5074	5078	IN	that	O	_	_
p38	5079	5082	NN	p38	B-GENE	_	_
SAPK	5083	5087	NN	sapk	I-GENE	_	_
is	5088	5090	VBZ	be	O	_	_
not	5091	5094	RB	not	O	_	_
an	5095	5097	DT	a	O	_	_
efficient	5098	5107	JJ	efficient	O	_	_
kinase	5108	5114	NN	kinase	O	_	_
for	5115	5118	IN	for	O	_	_
ASPP2	5119	5124	NN	aspp2	B-GENE	_	_
phosphorylation	5125	5140	NN	phosphorylation	O	_	_
.	5140	5141	.	.	O	_	_
D	1
10
1	0	mark
1	2	prep
5	4	nn
5	6	vmod
6	9	agent
9	8	nn
10	1	advcl
10	5	nsubj
10	12	dobj
10	17	vmod
12	11	amod
12	15	prep_of
15	14	amod
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	cop
22	39	parataxis
28	26	det
28	27	amod
28	30	appos
34	32	num
34	35	vmod
35	38	agent
38	37	nn
39	24	mark
39	28	prep_under
39	34	nsubj
39	42	dobj
39	47	vmod
41	40	advmod
42	41	amod
42	45	prep_of
45	44	amod
47	55	ccomp
50	49	nn
55	48	mark
55	50	nsubj
55	51	cop
55	52	neg
55	53	det
55	54	amod
55	58	prep_for
58	57	nn
EOX
Y	1
ROOT	0	0	60	1	S	3	0	60	5	SBAR	1	0	3	2	IN	0	0	1	1	As	0	0	1	0	S	0	1	3	1	VP	0	1	3	2	VBN	0	1	2	1	shown	1	1	2	0	PP	0	2	3	1	IN	0	2	3	1	in	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	10	2	NP	1	4	6	2	NN	0	4	5	1	histone	4	4	5	0	NN	0	5	6	1	2B	5	5	6	0	VP	0	6	10	2	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	by	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	p38	8	8	9	0	NN	0	9	10	1	SAPK	9	9	10	0	VP	0	10	59	4	VBD	0	10	11	1	had	10	10	11	0	NP	0	11	16	2	NP	1	11	13	2	JJ	0	11	12	1	high	11	11	12	0	NNS	0	12	13	1	levels	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	incorporated	14	14	15	0	NN	0	15	16	1	32P	15	15	16	0	,	0	16	17	1	,	16	16	17	0	S	0	17	59	1	VP	0	17	59	2	VBG	0	17	18	1	suggesting	17	17	18	0	SBAR	1	18	59	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	59	4	NP	1	19	21	2	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	VP	1	21	23	2	VBD	0	21	22	1	was	21	21	22	0	ADJP	0	22	23	1	JJ	0	22	23	1	active	22	22	23	0	:	0	23	24	1	;	23	23	24	0	SBAR	1	24	59	2	IN	0	24	25	1	while	24	24	25	0	S	2	25	59	3	PP	0	25	32	2	IN	0	25	26	1	under	25	25	26	0	NP	0	26	32	3	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NNS	0	28	29	1	conditions	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	ASPP2	30	30	31	0	CD	0	31	32	1	-LRB-	31	31	32	0	NP	0	32	39	2	NP	2	32	35	3	CD	0	32	33	1	693-1128	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	NN	0	34	35	1	fragment	34	34	35	0	VP	0	35	39	2	VBN	0	35	36	1	phosphorylated	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	by	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	p38	37	37	38	0	NN	0	38	39	1	SAPK	38	38	39	0	VP	0	39	59	4	VBD	0	39	40	1	had	39	39	40	0	NP	0	40	46	2	NP	1	40	43	2	ADJP	1	40	42	2	RB	0	40	41	1	very	40	40	41	0	JJ	0	41	42	1	low	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	of	43	43	44	0	NP	1	44	46	2	JJ	0	44	45	1	incorporated	44	44	45	0	NN	0	45	46	1	32P	45	45	46	0	,	0	46	47	1	,	46	46	47	0	S	0	47	59	1	VP	0	47	59	2	VBG	0	47	48	1	indicating	47	47	48	0	SBAR	1	48	59	2	IN	0	48	49	1	that	48	48	49	0	S	1	49	59	2	NP	1	49	51	2	NN	0	49	50	1	p38	49	49	50	0	NN	0	50	51	1	SAPK	50	50	51	0	VP	2	51	59	3	VBZ	0	51	52	1	is	51	51	52	0	RB	0	52	53	1	not	52	52	53	0	NP	0	53	59	2	NP	2	53	56	3	DT	0	53	54	1	an	53	53	54	0	JJ	0	54	55	1	efficient	54	54	55	0	NN	0	55	56	1	kinase	55	55	56	0	PP	0	56	59	2	IN	0	56	57	1	for	56	56	57	0	NP	1	57	59	2	NN	0	57	58	1	ASPP2	57	57	58	0	NN	0	58	59	1	phosphorylation	58	58	59	0	.	0	59	60	1	.	59	59	60	0
EOS
T	22
The	5142	5145	DT	the	O	_	_
phosphorylated	5146	5160	VBN	phosphorylate	B-GENE	_	_
ASPP2	5161	5166	NN	aspp2	I-GENE	_	_
fragment	5167	5175	NN	fragment	I-GENE	_	_
by	5176	5178	IN	by	O	_	_
MAPK1	5179	5184	NN	mapk1	B-GENE	_	_
was	5185	5188	VBD	be	O	_	_
digested	5189	5197	VBN	digest	O	_	_
by	5198	5200	IN	by	O	_	_
trypsin	5201	5208	NN	trypsin	B-GENE	_	_
and	5209	5212	CC	and	O	_	_
fractioned	5213	5223	VBN	fraction	O	_	_
on	5224	5226	IN	on	O	_	_
a	5227	5228	DT	a	O	_	_
high	5229	5233	JJ	high	O	_	_
performance	5234	5245	NN	performance	O	_	_
liquid	5246	5252	JJ	liquid	O	_	_
chromatography	5253	5267	NN	chromatography	O	_	_
(	5268	5269	CD	(	O	_	_
HPLC	5269	5273	NN	hplc	O	_	_
)	5273	5274	NN	)	O	_	_
.	5274	5275	.	.	O	_	_
D	1
7
0	1	vmod
1	3	dobj
1	5	agent
3	2	nn
7	0	nsubjpass
7	6	auxpass
7	9	agent
7	11	conj_and
11	0	nsubjpass
11	17	prep_on
17	13	det
17	14	amod
17	15	nn
17	16	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	6	2	NP	0	0	1	1	DT	0	0	1	1	The	0	0	1	0	VP	0	1	6	3	VBN	0	1	2	1	phosphorylated	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	ASPP2	2	2	3	0	NN	0	3	4	1	fragment	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	MAPK1	5	5	6	0	VP	1	6	21	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	21	4	VP	0	7	10	2	VBN	0	7	8	1	digested	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	trypsin	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	fractioned	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	on	12	12	13	0	NP	4	13	18	5	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	high	14	14	15	0	NN	0	15	16	1	performance	15	15	16	0	JJ	0	16	17	1	liquid	16	16	17	0	NN	0	17	18	1	chromatography	17	17	18	0	NP	2	18	21	3	CD	0	18	19	1	-LRB-	18	18	19	0	NN	0	19	20	1	HPLC	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	10
Each	5276	5280	DT	each	O	_	_
eluted	5281	5287	VBN	elute	O	_	_
fraction	5288	5296	NN	fraction	O	_	_
was	5297	5300	VBD	be	O	_	_
measured	5301	5309	VBN	measure	O	_	_
for	5310	5313	IN	for	O	_	_
its	5314	5317	PRP$	its	O	_	_
radioactivity	5318	5331	NN	radioactivity	O	_	_
content	5332	5339	NN	content	O	_	_
.	5364	5365	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_for
8	6	poss
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	Each	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	eluted	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	fraction	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	measured	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	for	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	NN	0	7	8	1	radioactivity	7	7	8	0	NN	0	8	9	1	content	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	12
The	5366	5369	DT	the	O	_	_
fractions	5370	5379	NNS	fraction	O	_	_
representing	5380	5392	VBG	represent	O	_	_
these	5393	5398	DT	these	O	_	_
radioactive	5399	5410	JJ	radioactive	O	_	_
peaks	5411	5416	NNS	peak	O	_	_
were	5417	5421	VBD	be	O	_	_
analysed	5422	5430	VBN	analyse	O	_	_
by	5431	5433	IN	by	O	_	_
mass	5434	5438	NN	mass	O	_	_
spectrometry	5439	5451	NN	spectrometry	O	_	_
.	5451	5452	.	.	O	_	_
D	1
7
1	0	det
1	2	vmod
2	5	dobj
5	3	det
5	4	amod
7	1	nsubjpass
7	6	auxpass
7	10	agent
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	6	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	fractions	1	1	2	0	VP	0	2	6	2	VBG	0	2	3	1	representing	2	2	3	0	NP	2	3	6	3	DT	0	3	4	1	these	3	3	4	0	JJ	0	4	5	1	radioactive	4	4	5	0	NNS	0	5	6	1	peaks	5	5	6	0	VP	1	6	11	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	11	2	VBN	0	7	8	1	analysed	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	by	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	mass	9	9	10	0	NN	0	10	11	1	spectrometry	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	41
Of	5453	5455	IN	of	O	_	_
the	5456	5459	DT	the	O	_	_
two	5460	5463	CD	two	O	_	_
radioactive	5464	5475	JJ	radioactive	O	_	_
peaks	5476	5481	NNS	peak	O	_	_
,	5481	5482	,	,	O	_	_
one	5483	5486	CD	one	O	_	_
represented	5487	5498	VBD	represent	O	_	_
the	5499	5502	DT	the	O	_	_
linker	5503	5509	NN	linker	O	_	_
region	5510	5516	NN	region	O	_	_
between	5517	5524	IN	between	O	_	_
the	5525	5528	DT	the	O	_	_
GST	5529	5532	NN	gst	O	_	_
and	5533	5536	CC	and	O	_	_
our	5537	5540	PRP$	we	O	_	_
ASPP2	5541	5546	NN	aspp2	O	_	_
fragment	5547	5555	NN	fragment	O	_	_
and	5556	5559	CC	and	O	_	_
the	5560	5563	DT	the	O	_	_
other	5564	5569	JJ	other	O	_	_
corresponded	5570	5582	VBD	correspond	O	_	_
to	5583	5585	TO	to	O	_	_
a	5586	5587	DT	a	O	_	_
fragment	5588	5596	NN	fragment	O	_	_
of	5597	5599	IN	of	O	_	_
the	5600	5603	DT	the	O	_	_
same	5604	5608	JJ	same	O	_	_
mass	5609	5613	NN	mass	O	_	_
as	5614	5616	IN	as	O	_	_
that	5617	5621	DT	that	O	_	_
containing	5622	5632	VBG	contain	O	_	_
the	5633	5636	DT	the	O	_	_
second	5637	5643	JJ	second	O	_	_
putative	5644	5652	JJ	putative	O	_	_
phosphorylation	5653	5668	NN	phosphorylation	O	_	_
site	5669	5673	NN	site	O	_	_
,	5673	5674	,	,	O	_	_
serine	5675	5681	NN	serine	O	_	_
827	5682	5685	CD	827	O	_	_
.	5685	5686	.	.	O	_	_
D	1
7
4	1	det
4	2	num
4	3	amod
7	4	prep_of
7	6	nsubj
7	21	ccomp
10	8	det
10	9	nn
10	13	prep_between
10	17	prep_between
13	12	det
13	17	conj_and
13	20	conj_and
17	15	poss
17	16	nn
17	20	conj_and
20	19	det
21	10	nsubj
21	24	prep_to
21	31	prepc_as
24	23	det
24	28	prep_of
28	26	det
28	27	amod
31	30	nsubj
31	36	dobj
36	32	det
36	33	amod
36	34	amod
36	35	nn
36	38	appos
38	39	num
EOX
Y	1
ROOT	0	0	41	1	S	3	0	41	5	PP	0	0	5	2	IN	0	0	1	1	Of	0	0	1	0	NP	3	1	5	4	DT	0	1	2	1	the	1	1	2	0	CD	0	2	3	1	two	2	2	3	0	JJ	0	3	4	1	radioactive	3	3	4	0	NNS	0	4	5	1	peaks	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	CD	0	6	7	1	one	6	6	7	0	VP	0	7	40	2	VBD	0	7	8	1	represented	7	7	8	0	SBAR	0	8	40	1	S	1	8	40	2	NP	0	8	21	2	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	linker	9	9	10	0	NN	0	10	11	1	region	10	10	11	0	PP	0	11	21	2	IN	0	11	12	1	between	11	11	12	0	NP	0	12	21	3	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	GST	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	0	15	21	3	NP	2	15	18	3	PRP$	0	15	16	1	our	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NN	0	17	18	1	fragment	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	JJ	0	20	21	1	other	20	20	21	0	VP	0	21	40	3	VBD	0	21	22	1	corresponded	21	21	22	0	PP	0	22	29	2	TO	0	22	23	1	to	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	DT	0	23	24	1	a	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	PP	0	25	29	2	IN	0	25	26	1	of	25	25	26	0	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NN	0	28	29	1	mass	28	28	29	0	PP	0	29	40	2	IN	0	29	30	1	as	29	29	30	0	S	1	30	40	2	NP	0	30	31	1	DT	0	30	31	1	that	30	30	31	0	VP	0	31	40	2	VBG	0	31	32	1	containing	31	31	32	0	NP	0	32	40	3	NP	4	32	37	5	DT	0	32	33	1	the	32	32	33	0	JJ	0	33	34	1	second	33	33	34	0	JJ	0	34	35	1	putative	34	34	35	0	NN	0	35	36	1	phosphorylation	35	35	36	0	NN	0	36	37	1	site	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	40	2	NN	0	38	39	1	serine	38	38	39	0	CD	0	39	40	1	827	39	39	40	0	.	0	40	41	1	.	40	40	41	0
EOS
T	13
Hence	5687	5692	RB	hence	O	_	_
ASPP2	5693	5698	NN	aspp2	O	_	_
can	5699	5702	MD	can	O	_	_
be	5703	5705	VB	be	O	_	_
phosphorylated	5706	5720	VBN	phosphorylate	O	_	_
at	5721	5723	IN	at	O	_	_
serine	5724	5730	NN	serine	O	_	_
827	5731	5734	CD	827	O	_	_
by	5735	5737	IN	by	O	_	_
MAPK1	5738	5743	NN	mapk1	B-GENE	_	_
in	5744	5746	FW	in	O	_	_
vitro	5747	5752	FW	vitro	O	_	_
.	5752	5753	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubjpass
4	2	aux
4	3	auxpass
4	6	prep_at
4	11	advmod
6	7	num
6	9	prep_by
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	S	2	0	13	4	ADVP	0	0	1	1	RB	0	0	1	1	Hence	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	2	MD	0	2	3	1	can	2	2	3	0	VP	1	3	12	2	VB	0	3	4	1	be	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	phosphorylated	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	at	5	5	6	0	NP	0	6	10	2	NP	0	6	8	2	NN	0	6	7	1	serine	6	6	7	0	CD	0	7	8	1	827	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	MAPK1	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	4
MAPK	5764	5768	NN	mapk	O	_	_
phosphorylates	5769	5783	VBZ	phosphorylate	O	_	_
ASPP2	5784	5789	NN	aspp2	B-GENE	_	_
.	5789	5790	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	dobj
EOX
Y	1
ROOT	0	0	4	1	S	1	0	4	3	NP	0	0	1	1	NN	0	0	1	1	MAPK	0	0	1	0	VP	0	1	3	2	VBZ	0	1	2	1	phosphorylates	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	17
(	5791	5792	NN	(	O	_	_
A	5792	5793	NN	a	O	_	_
)	5793	5794	CD	)	O	_	_
ASPP1	5795	5800	NN	aspp1	B-GENE	_	_
and	5801	5804	CC	and	O	_	_
ASPP2	5805	5810	NN	aspp2	B-GENE	_	_
have	5811	5815	VBP	have	O	_	_
two	5816	5819	CD	two	O	_	_
conserved	5820	5829	VBN	conserve	O	_	_
putative	5830	5838	JJ	putative	O	_	_
MAPK2	5839	5844	NN	mapk2	B-GENE	_	_
phosphorylation	5845	5860	NN	phosphorylation	O	_	_
sites	5861	5866	NNS	site	O	_	_
in	5867	5869	IN	in	O	_	_
their	5870	5875	PRP$	they	O	_	_
C-terminus	5876	5886	NN	c-terminus	O	_	_
.	5886	5887	.	.	O	_	_
D	1
6
1	3	dep
1	5	conj_and
6	1	nsubj
6	5	nsubj
6	7	dobj
7	8	vmod
8	12	dobj
12	9	amod
12	10	nn
12	11	nn
12	15	prep_in
15	14	poss
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	6	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	1	2	4	2	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	ASPP1	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	0	6	16	2	VBP	0	6	7	1	have	6	6	7	0	NP	0	7	16	2	NP	0	7	8	1	CD	0	7	8	1	two	7	7	8	0	VP	0	8	16	2	VBN	0	8	9	1	conserved	8	8	9	0	NP	0	9	16	2	NP	3	9	13	4	JJ	0	9	10	1	putative	9	9	10	0	NN	0	10	11	1	MAPK2	10	10	11	0	NN	0	11	12	1	phosphorylation	11	11	12	0	NNS	0	12	13	1	sites	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	in	13	13	14	0	NP	1	14	16	2	PRP$	0	14	15	1	their	14	14	15	0	NN	0	15	16	1	C-terminus	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	19
(	5888	5889	NN	(	O	_	_
B	5889	5890	NN	b	O	_	_
)	5890	5891	CD	)	O	_	_
The	5892	5895	DT	the	O	_	_
C-terminus	5896	5906	NN	c-terminus	O	_	_
fragment	5907	5915	NN	fragment	O	_	_
of	5916	5918	IN	of	O	_	_
ASPP2	5919	5924	NN	aspp2	B-GENE	_	_
is	5925	5927	VBZ	be	O	_	_
phosphorylated	5928	5942	VBN	phosphorylate	O	_	_
in	5943	5945	FW	in	O	_	_
vitro	5946	5951	FW	vitro	O	_	_
by	5952	5954	IN	by	O	_	_
MAPK1	5955	5960	NN	mapk1	B-GENE	_	_
(	5961	5962	CD	(	O	_	_
left	5962	5966	VBD	leave	O	_	_
panel	5967	5972	NN	panel	O	_	_
)	5972	5973	NN	)	O	_	_
.	5973	5974	.	.	O	_	_
D	1
9
1	5	dep
5	3	det
5	4	nn
5	7	prep_of
9	1	nsubjpass
9	8	auxpass
9	11	advmod
9	13	agent
11	10	nn
13	15	vmod
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	NP	0	3	8	2	NP	2	3	6	3	DT	0	3	4	1	The	3	3	4	0	NN	0	4	5	1	C-terminus	4	4	5	0	NN	0	5	6	1	fragment	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	18	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	18	3	VBN	0	9	10	1	phosphorylated	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	18	2	NP	0	13	15	2	NN	0	13	14	1	MAPK1	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	VP	0	15	18	2	VBD	0	15	16	1	left	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	panel	16	16	17	0	NN	0	17	18	1	-RRB-	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	11
The	5975	5978	DT	the	O	_	_
intensity	5979	5988	NN	intensity	O	_	_
of	5989	5991	IN	of	O	_	_
phosphorylation	5992	6007	NN	phosphorylation	O	_	_
is	6008	6010	VBZ	be	O	_	_
quantified	6011	6021	VBN	quantify	O	_	_
(	6022	6023	RB	(	O	_	_
middle	6023	6029	JJ	middle	O	_	_
panel	6030	6035	NN	panel	O	_	_
)	6035	6036	NN	)	O	_	_
.	6036	6037	.	.	O	_	_
D	1

1	0	det
1	3	prep_of
5	1	nsubjpass
5	4	auxpass
9	7	amod
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	intensity	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phosphorylation	3	3	4	0	VP	1	4	10	2	VBZ	0	4	5	1	is	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	quantified	5	5	6	0	NP	2	6	10	3	ADJP	1	6	8	2	RB	0	6	7	1	-LRB-	6	6	7	0	JJ	0	7	8	1	middle	7	7	8	0	NN	0	8	9	1	panel	8	8	9	0	NN	0	9	10	1	-RRB-	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	25
The	6038	6041	DT	the	O	_	_
MAPK1	6042	6047	NN	mapk1	O	_	_
phosphorylated	6048	6062	VBN	phosphorylate	B-GENE	_	_
ASPP2	6063	6068	NN	aspp2	I-GENE	_	_
fragment	6069	6077	NN	fragment	I-GENE	_	_
was	6078	6081	VBD	be	O	_	_
digested	6082	6090	VBN	digest	O	_	_
with	6091	6095	IN	with	O	_	_
trypsin	6096	6103	NN	trypsin	O	_	_
and	6104	6107	CC	and	O	_	_
chromatographed	6108	6123	NN	chromatographed	O	_	_
and	6124	6127	CC	and	O	_	_
the	6128	6131	DT	the	O	_	_
radioactive	6132	6143	JJ	radioactive	O	_	_
peptides	6144	6152	NNS	peptide	O	_	_
were	6153	6157	VBD	be	O	_	_
measured	6158	6166	VBN	measure	O	_	_
by	6167	6169	IN	by	O	_	_
mass	6170	6174	NN	mass	O	_	_
spectrometry	6175	6187	NN	spectrometry	O	_	_
(	6188	6189	RB	(	O	_	_
right	6189	6194	JJ	right	O	_	_
panel	6195	6200	NN	panel	O	_	_
)	6200	6201	NN	)	O	_	_
.	6201	6202	.	.	O	_	_
D	1

1	0	det
1	2	vmod
2	4	dobj
4	3	nn
6	1	nsubjpass
6	5	auxpass
6	8	prep_with
6	10	prep_with
6	16	conj_and
8	10	conj_and
14	12	det
14	13	amod
16	14	nsubjpass
16	15	auxpass
16	17	prep
19	18	nn
23	19	nn
23	21	amod
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	0	0	25	4	S	1	0	11	2	NP	0	0	5	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK1	1	1	2	0	VP	0	2	5	2	VBN	0	2	3	1	phosphorylated	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	digested	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	trypsin	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	chromatographed	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	24	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	radioactive	13	13	14	0	NNS	0	14	15	1	peptides	14	14	15	0	VP	1	15	24	2	VBD	0	15	16	1	were	15	15	16	0	VP	0	16	24	2	VBN	0	16	17	1	measured	16	16	17	0	PP	0	17	24	2	IN	0	17	18	1	by	17	17	18	0	NP	3	18	24	4	NP	1	18	20	2	NN	0	18	19	1	mass	18	18	19	0	NN	0	19	20	1	spectrometry	19	19	20	0	ADJP	1	20	22	2	RB	0	20	21	1	-LRB-	20	20	21	0	JJ	0	21	22	1	right	21	21	22	0	NN	0	22	23	1	panel	22	22	23	0	NN	0	23	24	1	-RRB-	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	24
The	6203	6206	DT	the	O	_	_
first	6207	6212	JJ	first	O	_	_
peak	6213	6217	NN	peak	O	_	_
represents	6218	6228	VBZ	represent	O	_	_
the	6229	6232	DT	the	O	_	_
GST	6233	6236	NN	gst	O	_	_
linker	6237	6243	NN	linker	O	_	_
region	6244	6250	NN	region	O	_	_
whereas	6251	6258	IN	whereas	O	_	_
the	6259	6262	DT	the	O	_	_
second	6263	6269	JJ	second	O	_	_
presented	6270	6279	VBN	present	O	_	_
a	6280	6281	DT	a	O	_	_
region	6282	6288	NN	region	O	_	_
of	6289	6291	IN	of	O	_	_
equal	6292	6297	JJ	equal	O	_	_
mass	6298	6302	NN	mass	O	_	_
to	6303	6305	TO	to	O	_	_
the	6306	6309	DT	the	O	_	_
fragment	6310	6318	NN	fragment	O	_	_
containing	6319	6329	VBG	contain	O	_	_
serine	6330	6336	NN	serine	O	_	_
827	6337	6340	CD	827	O	_	_
.	6340	6341	.	.	O	_	_
D	1
3
2	0	det
2	1	amod
3	2	nsubj
3	7	dobj
3	11	advcl
7	4	det
7	5	nn
7	6	nn
10	9	det
11	8	mark
11	10	nsubj
11	13	dobj
11	19	prep_to
13	12	det
13	16	prep_of
16	15	amod
19	18	det
19	20	vmod
20	21	dobj
21	22	num
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	first	1	1	2	0	NN	0	2	3	1	peak	2	2	3	0	VP	0	3	23	3	VBZ	0	3	4	1	represents	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	GST	5	5	6	0	NN	0	6	7	1	linker	6	6	7	0	NN	0	7	8	1	region	7	7	8	0	SBAR	1	8	23	2	IN	0	8	9	1	whereas	8	8	9	0	S	1	9	23	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	second	10	10	11	0	VP	0	11	23	3	VBN	0	11	12	1	presented	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	DT	0	12	13	1	a	12	12	13	0	NN	0	13	14	1	region	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	of	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	equal	15	15	16	0	NN	0	16	17	1	mass	16	16	17	0	PP	0	17	23	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	fragment	19	19	20	0	VP	0	20	23	2	VBG	0	20	21	1	containing	20	20	21	0	NP	0	21	23	2	NN	0	21	22	1	serine	21	21	22	0	CD	0	22	23	1	827	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	23
(	6342	6343	NN	(	O	_	_
C	6343	6344	NN	c	O	_	_
)	6344	6345	CD	)	O	_	_
An	6346	6348	DT	a	O	_	_
in	6349	6351	FW	in	O	_	_
vitro	6352	6357	FW	vitro	O	_	_
phosphorylation	6358	6373	NN	phosphorylation	O	_	_
assay	6374	6379	NN	assay	O	_	_
was	6380	6383	VBD	be	O	_	_
performed	6384	6393	VBN	perform	O	_	_
on	6394	6396	IN	on	O	_	_
the	6397	6400	DT	the	O	_	_
ASPP2	6401	6406	NN	aspp2	B-GENE	_	_
C-terminus	6407	6417	NN	c-terminus	I-GENE	_	_
fragment	6418	6426	NN	fragment	I-GENE	_	_
with	6427	6431	IN	with	O	_	_
recombinant	6432	6443	JJ	recombinant	B-GENE	_	_
MAPK1	6444	6449	NN	mapk1	I-GENE	_	_
and	6450	6453	CC	and	O	_	_
non	6454	6457	JJ	non	O	_	_
radioactive	6458	6469	JJ	radioactive	O	_	_
ATP	6470	6473	NN	atp	O	_	_
.	6473	6474	.	.	O	_	_
D	1
9
1	3	dep
3	7	rcmod
5	4	nn
7	5	advmod
7	6	nn
9	1	nsubjpass
9	8	auxpass
9	14	prep_on
9	17	prep_with
9	21	prep_with
14	11	det
14	12	nn
14	13	nn
17	16	amod
17	21	conj_and
21	19	amod
21	20	amod
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	NP	0	3	8	2	DT	0	3	4	1	An	3	3	4	0	RRC	1	4	8	2	ADVP	1	4	6	2	FW	0	4	5	1	in	4	4	5	0	FW	0	5	6	1	vitro	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	assay	7	7	8	0	VP	1	8	22	2	VBD	0	8	9	1	was	8	8	9	0	VP	0	9	22	3	VBN	0	9	10	1	performed	9	9	10	0	PP	0	10	15	2	IN	0	10	11	1	on	10	10	11	0	NP	3	11	15	4	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NN	0	13	14	1	C-terminus	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	PP	0	15	22	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	22	3	NP	1	16	18	2	JJ	0	16	17	1	recombinant	16	16	17	0	NN	0	17	18	1	MAPK1	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	2	19	22	3	JJ	0	19	20	1	non	19	19	20	0	JJ	0	20	21	1	radioactive	20	20	21	0	NN	0	21	22	1	ATP	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
The	6475	6478	DT	the	O	_	_
phosphorylation	6479	6494	NN	phosphorylation	O	_	_
status	6495	6501	NN	status	O	_	_
of	6502	6504	IN	of	O	_	_
ASPP2	6505	6510	NN	aspp2	O	_	_
was	6511	6514	VBD	be	O	_	_
assessed	6515	6523	VBN	assess	O	_	_
using	6524	6529	VBG	use	O	_	_
the	6530	6533	DT	the	O	_	_
purified	6534	6542	VBN	purify	O	_	_
NGH.S4	6543	6549	NN	ngh.s4	B-GENE	_	_
phospho	6550	6557	NN	phospho	I-GENE	_	_
specific	6558	6566	JJ	specific	I-GENE	_	_
ASPP2	6567	6572	NN	aspp2	I-GENE	_	_
antibody	6573	6581	NN	antibody	I-GENE	_	_
(	6582	6583	CD	(	O	_	_
upper	6583	6588	JJ	upper	O	_	_
panel	6589	6594	NN	panel	O	_	_
)	6594	6595	NN	)	O	_	_
.	6595	6596	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	7	ccomp
7	11	dobj
7	14	dep
11	8	det
11	9	amod
11	10	nn
14	12	amod
14	13	nn
18	16	amod
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	NN	0	2	3	1	status	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	19	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	19	2	VBN	0	6	7	1	assessed	6	6	7	0	SBAR	0	7	19	1	S	0	7	19	2	VP	0	7	12	2	VBG	0	7	8	1	using	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	the	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	NGH.S4	10	10	11	0	NN	0	11	12	1	phospho	11	11	12	0	NP	0	12	19	2	NP	2	12	15	3	JJ	0	12	13	1	specific	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	antibody	14	14	15	0	NP	3	15	19	4	CD	0	15	16	1	-LRB-	15	15	16	0	JJ	0	16	17	1	upper	16	16	17	0	NN	0	17	18	1	panel	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	9
Total	6597	6602	JJ	total	O	_	_
ASPP2	6603	6608	NN	aspp2	O	_	_
is	6609	6611	VBZ	be	O	_	_
shown	6612	6617	VBN	show	O	_	_
in	6618	6620	IN	in	O	_	_
the	6621	6624	DT	the	O	_	_
lower	6625	6630	JJR	lower	O	_	_
panel	6631	6636	NN	panel	O	_	_
.	6636	6637	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
7	5	det
7	6	amod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJR	0	6	7	1	lower	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	14
(	6638	6639	NN	(	O	_	_
D	6639	6640	NN	d	O	_	_
)	6640	6641	CD	)	O	_	_
Saos2	6642	6647	NN	saos2	O	_	_
cells	6648	6653	NNS	cell	O	_	_
were	6654	6658	VBD	be	O	_	_
starved	6659	6666	VBN	starve	O	_	_
then	6667	6671	RB	then	O	_	_
stimulated	6672	6682	VBN	stimulate	O	_	_
with	6683	6687	IN	with	O	_	_
serum	6688	6693	NN	serum	O	_	_
and	6694	6697	CC	and	O	_	_
EGF	6698	6701	NN	egf	B-GENE	_	_
.	6701	6702	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	7	advmod
6	8	dep
8	10	prep_with
8	12	prep_with
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	D	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	13	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	13	3	VBN	0	6	7	1	starved	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	then	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBN	0	8	9	1	stimulated	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	13	3	NN	0	10	11	1	serum	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	EGF	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	32
At	6703	6705	IN	at	O	_	_
the	6706	6709	DT	the	O	_	_
indicated	6710	6719	JJ	indicated	O	_	_
times	6720	6725	NNS	time	O	_	_
the	6726	6729	DT	the	O	_	_
cells	6730	6735	NNS	cell	O	_	_
were	6736	6740	VBD	be	O	_	_
harvested	6741	6750	VBN	harvest	O	_	_
and	6751	6754	CC	and	O	_	_
either	6755	6761	CC	either	O	_	_
blotted	6762	6769	VBN	blot	O	_	_
for	6770	6773	IN	for	O	_	_
phospho	6774	6781	NN	phospho	O	_	_
/	6781	6782	:	/	O	_	_
total	6782	6787	JJ	total	O	_	_
MAPK	6788	6792	NN	mapk	O	_	_
(	6793	6794	NN	(	O	_	_
upper	6794	6799	JJ	upper	O	_	_
panel	6800	6805	NN	panel	O	_	_
)	6805	6806	NN	)	O	_	_
or	6807	6809	CC	or	O	_	_
immunoprecipitated	6810	6828	VBN	immunoprecipitate	O	_	_
for	6829	6832	IN	for	O	_	_
total	6833	6838	JJ	total	O	_	_
ASPP2	6839	6844	NN	aspp2	B-GENE	_	_
and	6845	6848	CC	and	O	_	_
blotted	6849	6856	VBN	blot	O	_	_
with	6857	6861	IN	with	O	_	_
NGH.S4	6862	6868	NN	ngh.s4	B-GENE	_	_
phospho-ASPP2	6869	6882	NN	phospho-aspp2	I-GENE	_	_
antibody	6883	6891	NN	antibody	I-GENE	_	_
.	6891	6892	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_at
7	5	nsubjpass
7	6	auxpass
7	9	advmod
7	10	conj_and
7	21	conj_and
10	5	nsubjpass
10	12	prep_for
10	21	conj_or
10	26	conj_or
16	13	punct
16	14	amod
16	15	nn
19	17	amod
19	18	nn
21	24	prep_for
21	26	conj_and
24	23	amod
26	30	prep_with
30	28	nn
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	2	0	32	4	PP	0	0	4	2	IN	0	0	1	1	At	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	indicated	2	2	3	0	NNS	0	3	4	1	times	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	31	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	31	4	VP	0	7	8	1	VBN	0	7	8	1	harvested	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	ADVP	0	9	10	1	CC	0	9	10	1	either	9	9	10	0	VP	0	10	31	3	VP	0	10	20	3	VBN	0	10	11	1	blotted	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	for	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	phospho	12	12	13	0	PRN	1	13	20	2	:	0	13	14	1	/	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	total	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	-LRB-	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	upper	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	-RRB-	19	19	20	0	CC	0	20	21	1	or	20	20	21	0	VP	0	21	31	3	VP	0	21	25	2	VBN	0	21	22	1	immunoprecipitated	21	21	22	0	PP	0	22	25	2	IN	0	22	23	1	for	22	22	23	0	NP	1	23	25	2	JJ	0	23	24	1	total	23	23	24	0	NN	0	24	25	1	ASPP2	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	VP	0	26	31	2	VBN	0	26	27	1	blotted	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	with	27	27	28	0	NP	2	28	31	3	NN	0	28	29	1	NGH.S4	28	28	29	0	NN	0	29	30	1	phospho-ASPP2	29	29	30	0	NN	0	30	31	1	antibody	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	27
(	6893	6894	NN	(	O	_	_
E	6894	6895	NN	e	O	_	_
)	6895	6896	CD	)	O	_	_
Total	6897	6902	JJ	total	O	_	_
cell	6903	6907	NN	cell	O	_	_
lysates	6908	6915	NNS	lysate	O	_	_
from	6916	6920	IN	from	O	_	_
HKe3	6921	6925	NN	hke3	B-GENE	_	_
ER	6926	6928	NN	er	I-GENE	_	_
:	6928	6929	:	:	O	_	_
HRASV12	6929	6936	NN	hrasv12	O	_	_
cells	6937	6942	NNS	cell	O	_	_
treated	6943	6950	VBN	treat	O	_	_
with	6951	6955	IN	with	O	_	_
or	6956	6958	CC	or	O	_	_
without	6959	6966	IN	without	O	_	_
4-OHT	6967	6972	NN	4-oht	O	_	_
were	6973	6977	VBD	be	O	_	_
transfected	6978	6989	VBN	transfect	O	_	_
with	6990	6994	IN	with	O	_	_
control	6995	7002	NN	control	O	_	_
siRNA	7003	7008	NN	sirna	O	_	_
or	7009	7011	CC	or	O	_	_
siRNA	7012	7017	NN	sirna	O	_	_
against	7018	7025	IN	against	O	_	_
ASPP2	7026	7031	NN	aspp2	B-GENE	_	_
.	7031	7032	.	.	O	_	_
D	1
18
1	5	npadvmod
1	8	prep_from
5	3	amod
5	4	nn
8	7	nn
8	11	dep
11	10	nn
11	12	vmod
12	12	conj_or
12	16	prep_with
12	16	prep_without
18	1	nsubjpass
18	17	auxpass
18	21	prep_with
18	23	prep_with
18	25	prep_against
21	20	nn
21	23	conj_or
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	17	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	E	1	1	2	0	PP	1	2	17	3	NP	3	2	6	4	CD	0	2	3	1	-RRB-	2	2	3	0	JJ	0	3	4	1	Total	3	3	4	0	NN	0	4	5	1	cell	4	4	5	0	NNS	0	5	6	1	lysates	5	5	6	0	IN	0	6	7	1	from	6	6	7	0	NP	0	7	17	3	NP	1	7	9	2	NN	0	7	8	1	HKe3	7	7	8	0	NN	0	8	9	1	ER	8	8	9	0	:	0	9	10	1	:	9	9	10	0	NP	0	10	17	2	NP	1	10	12	2	NN	0	10	11	1	HRASV12	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	VP	0	12	17	2	VBN	0	12	13	1	treated	12	12	13	0	PP	0	13	17	4	IN	0	13	14	1	with	13	13	14	0	CC	0	14	15	1	or	14	14	15	0	IN	0	15	16	1	without	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	4-OHT	16	16	17	0	VP	1	17	26	2	VBD	0	17	18	1	were	17	17	18	0	VP	0	18	26	3	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	24	4	NN	0	20	21	1	control	20	20	21	0	NN	0	21	22	1	siRNA	21	21	22	0	CC	0	22	23	1	or	22	22	23	0	NN	0	23	24	1	siRNA	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	against	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ASPP2	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	12
ASPP2	7033	7038	NN	aspp2	B-GENE	_	_
phosphorylation	7039	7054	NN	phosphorylation	O	_	_
was	7055	7058	VBD	be	O	_	_
detected	7059	7067	VBN	detect	O	_	_
with	7068	7072	IN	with	O	_	_
ES1	7073	7076	NN	es1	B-GENE	_	_
phospho-ASPP2	7077	7090	NN	phospho-aspp2	I-GENE	_	_
antibody	7091	7099	NN	antibody	I-GENE	_	_
and	7100	7103	CC	and	O	_	_
total	7104	7109	JJ	total	O	_	_
ASPP2	7110	7115	NN	aspp2	B-GENE	_	_
.	7115	7116	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	10	prep_with
7	5	nn
7	6	nn
7	10	conj_and
10	9	amod
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	11	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	detected	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	with	4	4	5	0	NP	0	5	11	3	NP	2	5	8	3	NN	0	5	6	1	ES1	5	5	6	0	NN	0	6	7	1	phospho-ASPP2	6	6	7	0	NN	0	7	8	1	antibody	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	total	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	21
A	7117	7118	DT	a	O	_	_
synthetic	7119	7128	JJ	synthetic	O	_	_
peptide	7129	7136	NN	peptide	O	_	_
encoding	7137	7145	VBG	encode	O	_	_
amino	7146	7151	NN	amino	O	_	_
acids	7152	7157	NNS	acid	O	_	_
824-832	7158	7165	CD	824-832	O	_	_
,	7165	7166	,	,	O	_	_
with	7167	7171	IN	with	O	_	_
a	7172	7173	DT	a	O	_	_
phosphoserine	7174	7187	NN	phosphoserine	O	_	_
at	7188	7190	IN	at	O	_	_
residue	7191	7198	NN	residue	O	_	_
827	7199	7202	CD	827	O	_	_
,	7202	7203	,	,	O	_	_
was	7204	7207	VBD	be	O	_	_
used	7208	7212	VBN	use	O	_	_
to	7213	7215	TO	to	O	_	_
raise	7216	7221	VB	raise	O	_	_
antibodies	7222	7232	NNS	antibody	O	_	_
.	7232	7233	.	.	O	_	_
D	1
16
2	0	det
2	1	amod
2	3	vmod
3	6	xcomp
5	4	nn
6	5	nsubj
6	10	prep_with
10	9	det
10	12	prep_at
12	13	num
16	2	nsubjpass
16	15	auxpass
16	18	xcomp
18	17	aux
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	15	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	synthetic	1	1	2	0	NN	0	2	3	1	peptide	2	2	3	0	VP	0	3	15	2	VBG	0	3	4	1	encoding	3	3	4	0	S	1	4	15	2	NP	1	4	6	2	NN	0	4	5	1	amino	4	4	5	0	NNS	0	5	6	1	acids	5	5	6	0	NP	0	6	15	4	NP	0	6	7	1	CD	0	6	7	1	824-832	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	14	2	IN	0	8	9	1	with	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	phosphoserine	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	at	11	11	12	0	NP	0	12	14	2	NN	0	12	13	1	residue	12	12	13	0	CD	0	13	14	1	827	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	1	15	20	2	VBD	0	15	16	1	was	15	15	16	0	VP	0	16	20	2	VBN	0	16	17	1	used	16	16	17	0	S	0	17	20	1	VP	1	17	20	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	20	2	VB	0	18	19	1	raise	18	18	19	0	NP	0	19	20	1	NNS	0	19	20	1	antibodies	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
A	7234	7235	DT	a	O	_	_
polyclonal	7236	7246	JJ	polyclonal	O	_	_
antibody	7247	7255	NN	antibody	O	_	_
NGH.S4	7256	7262	NN	ngh.s4	O	_	_
was	7263	7266	VBD	be	O	_	_
purified	7267	7275	VBN	purify	O	_	_
by	7276	7278	IN	by	O	_	_
affinity	7279	7287	NN	affinity	O	_	_
column	7288	7294	NN	column	O	_	_
purification	7295	7307	NN	purification	O	_	_
.	7307	7308	.	.	O	_	_
D	1
5
3	0	det
3	1	amod
3	2	nn
5	3	nsubjpass
5	4	auxpass
5	9	agent
9	7	nn
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	3	0	4	4	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	polyclonal	1	1	2	0	NN	0	2	3	1	antibody	2	2	3	0	NN	0	3	4	1	NGH.S4	3	3	4	0	VP	1	4	10	2	VBD	0	4	5	1	was	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	10	2	IN	0	6	7	1	by	6	6	7	0	NP	2	7	10	3	NN	0	7	8	1	affinity	7	7	8	0	NN	0	8	9	1	column	8	8	9	0	NN	0	9	10	1	purification	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	32
To	7309	7311	TO	to	O	_	_
test	7312	7316	VB	test	O	_	_
the	7317	7320	DT	the	O	_	_
efficacy	7321	7329	NN	efficacy	O	_	_
of	7330	7332	IN	of	O	_	_
the	7333	7336	DT	the	O	_	_
purified	7337	7345	VBN	purify	O	_	_
phospho	7346	7353	NN	phospho	O	_	_
specific	7354	7362	JJ	specific	O	_	_
antibody	7363	7371	NN	antibody	O	_	_
,	7371	7372	,	,	O	_	_
a	7373	7374	DT	a	O	_	_
non	7375	7378	JJ	non	O	_	_
radioactive	7379	7390	JJ	radioactive	O	_	_
in	7391	7393	FW	in	O	_	_
vitro	7394	7399	FW	vitro	O	_	_
phosphorylation	7400	7415	NN	phosphorylation	O	_	_
assay	7416	7421	NN	assay	O	_	_
was	7422	7425	VBD	be	O	_	_
performed	7426	7435	VBN	perform	O	_	_
on	7436	7438	IN	on	O	_	_
the	7439	7442	DT	the	O	_	_
purified	7443	7451	VBN	purify	O	_	_
GST-ASPP2	7452	7461	NN	gst-aspp2	B-GENE	_	_
fragment	7462	7470	NN	fragment	O	_	_
(	7471	7472	CD	(	O	_	_
693-1128	7472	7480	CD	693-1128	O	_	_
)	7480	7481	NN	)	O	_	_
with	7482	7486	IN	with	O	_	_
recombinant	7487	7498	JJ	recombinant	B-GENE	_	_
MAPK1	7499	7504	NN	mapk1	I-GENE	_	_
.	7504	7505	.	.	O	_	_
D	1
19
1	0	aux
1	3	dobj
3	2	det
3	9	prep_of
9	5	det
9	6	amod
9	7	nn
9	8	amod
9	17	appos
13	15	dep
15	14	nn
17	11	det
17	12	amod
17	13	dep
17	16	nn
19	1	csubjpass
19	18	auxpass
19	24	prep_on
24	21	det
24	22	amod
24	23	nn
24	30	prep_with
27	26	dep
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	S	0	0	18	1	VP	1	0	18	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	18	2	VB	0	1	2	1	test	1	1	2	0	NP	0	2	18	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	efficacy	3	3	4	0	PP	0	4	18	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	18	3	NP	4	5	10	5	DT	0	5	6	1	the	5	5	6	0	VBN	0	6	7	1	purified	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	4	11	18	5	DT	0	11	12	1	a	11	11	12	0	JJ	0	12	13	1	non	12	12	13	0	NAC	0	13	16	2	NP	0	13	14	1	JJ	0	13	14	1	radioactive	13	13	14	0	ADVP	1	14	16	2	FW	0	14	15	1	in	14	14	15	0	FW	0	15	16	1	vitro	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	NN	0	17	18	1	assay	17	17	18	0	VP	1	18	31	2	VBD	0	18	19	1	was	18	18	19	0	VP	0	19	31	2	VBN	0	19	20	1	performed	19	19	20	0	PP	0	20	31	2	IN	0	20	21	1	on	20	20	21	0	NP	0	21	31	2	NP	0	21	28	2	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	VBN	0	22	23	1	purified	22	22	23	0	NN	0	23	24	1	GST-ASPP2	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	ADJP	1	25	28	2	QP	1	25	27	2	CD	0	25	26	1	-LRB-	25	25	26	0	CD	0	26	27	1	693-1128	26	26	27	0	NN	0	27	28	1	-RRB-	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	with	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	recombinant	29	29	30	0	NN	0	30	31	1	MAPK1	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	18
shows	7516	7521	NNS	show	O	_	_
that	7522	7526	IN	that	O	_	_
the	7527	7530	DT	the	O	_	_
phospho	7531	7538	NN	phospho	O	_	_
specific	7539	7547	JJ	specific	O	_	_
antibody	7548	7556	NN	antibody	O	_	_
is	7557	7559	VBZ	be	O	_	_
specific	7560	7568	JJ	specific	O	_	_
for	7569	7572	IN	for	O	_	_
the	7573	7576	DT	the	O	_	_
ASPP2	7577	7582	NN	aspp2	B-GENE	_	_
fragment	7583	7591	NN	fragment	I-GENE	_	_
phosphorylated	7592	7606	VBN	phosphorylate	O	_	_
in	7607	7609	FW	in	O	_	_
vitro	7610	7615	FW	vitro	O	_	_
by	7616	7618	IN	by	O	_	_
MAPK	7619	7623	NN	mapk	O	_	_
.	7623	7624	.	.	O	_	_
D	1
12
0	7	dep
5	2	det
5	3	nn
5	4	amod
7	1	mark
7	5	nsubj
7	6	cop
7	11	prep_for
11	9	det
11	10	nn
12	0	nsubj
12	14	advmod
12	16	prep_by
14	13	nn
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	12	2	NP	0	0	1	1	NNS	0	0	1	1	shows	0	0	1	0	SBAR	1	1	12	2	IN	0	1	2	1	that	1	1	2	0	S	1	2	12	2	NP	3	2	6	4	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	phospho	3	3	4	0	JJ	0	4	5	1	specific	4	4	5	0	NN	0	5	6	1	antibody	5	5	6	0	VP	1	6	12	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	12	2	JJ	0	7	8	1	specific	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	for	8	8	9	0	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	VP	0	12	17	3	VBN	0	12	13	1	phosphorylated	12	12	13	0	ADVP	1	13	15	2	FW	0	13	14	1	in	13	13	14	0	FW	0	14	15	1	vitro	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	by	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	MAPK	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	47
To	7625	7627	TO	to	O	_	_
test	7628	7632	VB	test	O	_	_
whether	7633	7640	IN	whether	O	_	_
endogenous	7641	7651	JJ	endogenous	O	_	_
ASPP2	7652	7657	NN	aspp2	O	_	_
could	7658	7663	MD	could	O	_	_
be	7664	7666	VB	be	O	_	_
phosphorylated	7667	7681	VBN	phosphorylate	O	_	_
in	7682	7684	IN	in	O	_	_
cells	7685	7690	NNS	cell	O	_	_
,	7690	7691	,	,	O	_	_
Saos2	7692	7697	NN	saos2	O	_	_
cells	7698	7703	NNS	cell	O	_	_
were	7704	7708	VBD	be	O	_	_
grown	7709	7714	VBN	grow	O	_	_
in	7715	7717	IN	in	O	_	_
low	7718	7721	JJ	low	O	_	_
serum	7722	7727	NN	serum	O	_	_
for	7728	7731	IN	for	O	_	_
50	7732	7734	CD	50	O	_	_
hours	7735	7740	NNS	hour	O	_	_
to	7741	7743	TO	to	O	_	_
remove	7744	7750	VB	remove	O	_	_
all	7751	7754	DT	all	O	_	_
background	7755	7765	NN	background	O	_	_
stimulation	7766	7777	NN	stimulation	O	_	_
of	7778	7780	IN	of	O	_	_
RAS	7781	7784	NN	ra	O	_	_
,	7784	7785	,	,	O	_	_
after	7786	7791	IN	after	O	_	_
which	7792	7797	WDT	which	O	_	_
the	7798	7801	DT	the	O	_	_
cells	7802	7807	NNS	cell	O	_	_
were	7808	7812	VBD	be	O	_	_
stimulated	7813	7823	VBN	stimulate	O	_	_
with	7824	7828	IN	with	O	_	_
EGF	7829	7832	NN	egf	O	_	_
and	7833	7836	CC	and	O	_	_
20	7837	7839	CD	20	O	_	_
%	7839	7840	NN	%	O	_	_
fetal	7841	7846	JJ	fetal	O	_	_
calf	7847	7851	NN	calf	O	_	_
serum	7852	7857	NN	serum	O	_	_
(	7858	7859	CD	(	O	_	_
FCS	7859	7862	NN	fc	O	_	_
)	7862	7863	NN	)	O	_	_
.	7863	7864	.	.	O	_	_
D	1

1	0	aux
1	7	ccomp
4	3	amod
7	2	mark
7	4	nsubjpass
7	5	aux
7	6	auxpass
7	9	prep_in
12	11	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	17	prep_in
14	22	xcomp
17	16	amod
17	20	prep_for
20	19	num
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
27	34	rcmod
32	31	det
34	30	prep_after
34	32	nsubjpass
34	33	auxpass
34	36	prep_with
34	39	prep_with
36	39	conj_and
39	38	num
45	40	amod
45	41	nn
45	42	nn
45	44	nn
EOX
Y	1
ROOT	0	0	47	1	S	3	0	47	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	2	VB	0	1	2	1	test	1	1	2	0	SBAR	1	2	10	2	IN	0	2	3	1	whether	2	2	3	0	S	1	3	10	2	NP	1	3	5	2	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	10	2	MD	0	5	6	1	could	5	5	6	0	VP	1	6	10	2	VB	0	6	7	1	be	6	6	7	0	VP	0	7	10	2	VBN	0	7	8	1	phosphorylated	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	cells	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	Saos2	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	46	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	46	3	VBN	0	14	15	1	grown	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	JJ	0	16	17	1	low	16	16	17	0	NN	0	17	18	1	serum	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	50	19	19	20	0	NNS	0	20	21	1	hours	20	20	21	0	S	0	21	46	1	VP	1	21	46	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	46	2	VB	0	22	23	1	remove	22	22	23	0	NP	0	23	46	2	NP	2	23	26	3	DT	0	23	24	1	all	23	23	24	0	NN	0	24	25	1	background	24	24	25	0	NN	0	25	26	1	stimulation	25	25	26	0	PP	0	26	46	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	46	3	NP	0	27	28	1	NN	0	27	28	1	RAS	27	27	28	0	,	0	28	29	1	,	28	28	29	0	SBAR	1	29	46	2	WHPP	0	29	31	2	IN	0	29	30	1	after	29	29	30	0	WHNP	0	30	31	1	WDT	0	30	31	1	which	30	30	31	0	S	1	31	46	2	NP	1	31	33	2	DT	0	31	32	1	the	31	31	32	0	NNS	0	32	33	1	cells	32	32	33	0	VP	1	33	46	2	VBD	0	33	34	1	were	33	33	34	0	VP	0	34	46	2	VBN	0	34	35	1	stimulated	34	34	35	0	PP	0	35	46	2	IN	0	35	36	1	with	35	35	36	0	NP	0	36	46	3	NP	0	36	37	1	NN	0	36	37	1	EGF	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NP	0	38	46	2	NP	1	38	40	2	CD	0	38	39	1	20	38	38	39	0	NN	0	39	40	1	%	39	39	40	0	NP	5	40	46	6	JJ	0	40	41	1	fetal	40	40	41	0	NN	0	41	42	1	calf	41	41	42	0	NN	0	42	43	1	serum	42	42	43	0	CD	0	43	44	1	-LRB-	43	43	44	0	NN	0	44	45	1	FCS	44	44	45	0	NN	0	45	46	1	-RRB-	45	45	46	0	.	0	46	47	1	.	46	46	47	0
EOS
T	16
Phosphorylated	7865	7879	VBN	phosphorylate	O	_	_
endogenous	7880	7890	JJ	endogenous	O	_	_
ASPP2	7891	7896	NN	aspp2	O	_	_
was	7897	7900	VBD	be	O	_	_
detected	7901	7909	VBN	detect	O	_	_
by	7910	7912	IN	by	O	_	_
the	7913	7916	DT	the	O	_	_
phospho	7917	7924	NN	phospho	O	_	_
specific	7925	7933	JJ	specific	O	_	_
antibody	7934	7942	NN	antibody	O	_	_
30	7943	7945	CD	30	O	_	_
minutes	7946	7953	NNS	minute	O	_	_
after	7954	7959	IN	after	O	_	_
RAS	7960	7963	NN	ra	B-GENE	_	_
stimulation	7964	7975	NN	stimulation	O	_	_
.	7987	7988	.	.	O	_	_
D	1
0
0	2	dobj
0	4	auxpass
0	9	nsubjpass
2	1	amod
4	3	auxpass
4	7	agent
7	6	det
9	8	amod
9	11	dep
9	14	prep_after
11	10	num
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	SINV	0	0	16	4	VP	0	0	3	2	VBN	0	0	1	1	Phosphorylated	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	endogenous	1	1	2	0	NN	0	2	3	1	ASPP2	2	2	3	0	VP	1	3	8	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	8	2	VBN	0	4	5	1	detected	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	NP	0	8	15	3	NP	1	8	10	2	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	NP	1	10	12	2	CD	0	10	11	1	30	10	10	11	0	NNS	0	11	12	1	minutes	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	after	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	RAS	13	13	14	0	NN	0	14	15	1	stimulation	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	63
ASPP2	7989	7994	NN	aspp2	B-GENE	_	_
phosphorylation	7995	8010	NN	phosphorylation	O	_	_
was	8011	8014	VBD	be	O	_	_
rapid	8015	8020	JJ	rapid	O	_	_
and	8021	8024	CC	and	O	_	_
transient	8025	8034	JJ	transient	O	_	_
as	8035	8037	IN	as	O	_	_
3	8038	8039	CD	3	O	_	_
hours	8040	8045	NNS	hour	O	_	_
after	8046	8051	IN	after	O	_	_
EGF	8052	8055	NN	egf	B-GENE	_	_
stimulation	8056	8067	NN	stimulation	O	_	_
phosphorylated	8068	8082	VBN	phosphorylate	O	_	_
ASPP2	8083	8088	NN	aspp2	B-GENE	_	_
was	8089	8092	VBD	be	O	_	_
barely	8093	8099	RB	barely	O	_	_
detec	8100	8105	JJ	detec	O	_	_
Moreover	8112	8120	RB	moreover	O	_	_
,	8120	8121	,	,	O	_	_
with	8122	8126	IN	with	O	_	_
another	8127	8134	DT	another	O	_	_
different	8135	8144	JJ	different	O	_	_
phospho-ASPP2	8145	8158	NN	phospho-aspp2	O	_	_
antibody	8159	8167	NN	antibody	O	_	_
,	8167	8168	,	,	O	_	_
ES1	8169	8172	NN	es1	O	_	_
,	8172	8173	,	,	O	_	_
ASPP2	8174	8179	NN	aspp2	B-GENE	_	_
phosphorylation	8180	8195	NN	phosphorylation	O	_	_
was	8196	8199	VBD	be	O	_	_
also	8200	8204	RB	also	O	_	_
observed	8205	8213	VBN	observe	O	_	_
in	8214	8216	IN	in	O	_	_
a	8217	8218	DT	a	O	_	_
human	8219	8224	JJ	human	O	_	_
colon	8225	8230	NN	colon	O	_	_
cancer	8231	8237	NN	cancer	O	_	_
cell	8238	8242	NN	cell	O	_	_
line	8243	8247	NN	line	O	_	_
HKe3	8248	8252	NN	hke3	O	_	_
ER	8253	8255	NN	er	O	_	_
:	8255	8256	:	:	O	_	_
HRASV12	8256	8263	NN	hrasv12	O	_	_
cells	8264	8269	NNS	cell	O	_	_
,	8269	8270	,	,	O	_	_
in	8271	8273	IN	in	O	_	_
which	8274	8279	WDT	which	O	_	_
RAS	8280	8283	NN	ra	B-GENE	_	_
activation	8284	8294	NN	activation	O	_	_
is	8295	8297	VBZ	be	O	_	_
induced	8298	8305	VBN	induce	O	_	_
upon	8306	8310	IN	upon	O	_	_
the	8311	8314	DT	the	O	_	_
addition	8315	8323	NN	addition	O	_	_
of	8324	8326	IN	of	O	_	_
4-hydroxytamoxifen	8327	8345	JJ	4-hydroxytamoxifen	O	_	_
(	8346	8347	NN	(	O	_	_
4-OHT	8347	8352	NN	4-oht	O	_	_
)	8352	8353	CD	)	O	_	_
[	8354	8355	CD	[	O	_	_
2,10,11	8355	8362	CD	2,10,11	O	_	_
]	8362	8363	NN	]	O	_	_
.	8375	8376	.	.	O	_	_
D	1
31
1	0	nn
3	1	nsubj
3	2	cop
3	5	conj_and
3	8	prep_as
3	16	advcl
5	1	nsubj
8	7	num
11	10	nn
11	12	vmod
12	13	dobj
16	9	mark
16	11	nsubj
16	14	cop
16	15	advmod
16	17	advmod
16	23	prep_with
23	20	det
23	21	amod
23	22	nn
23	25	appos
28	27	nn
31	3	ccomp
31	5	ccomp
31	28	nsubjpass
31	29	auxpass
31	30	advmod
31	40	prep_in
40	33	det
40	34	amod
40	35	nn
40	36	nn
40	37	nn
40	38	nn
40	39	nn
40	43	dep
43	42	nn
43	50	rcmod
48	47	nn
50	46	prep_in
50	48	nsubjpass
50	49	auxpass
50	53	prep_upon
53	52	det
53	57	prep_of
57	55	amod
57	59	dep
59	61	dep
61	60	num
EOX
Y	1
ROOT	0	0	63	1	S	3	0	63	5	S	1	0	26	2	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	26	4	VBD	0	2	3	1	was	2	2	3	0	ADJP	0	3	6	3	JJ	0	3	4	1	rapid	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	JJ	0	5	6	1	transient	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	as	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	3	7	7	8	0	NNS	0	8	9	1	hours	8	8	9	0	SBAR	1	9	26	2	IN	0	9	10	1	after	9	9	10	0	S	1	10	26	2	NP	0	10	14	2	NP	1	10	12	2	NN	0	10	11	1	EGF	10	10	11	0	NN	0	11	12	1	stimulation	11	11	12	0	VP	0	12	14	2	VBN	0	12	13	1	phosphorylated	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	VP	1	14	26	5	VBD	0	14	15	1	was	14	14	15	0	ADJP	1	15	17	2	RB	0	15	16	1	barely	15	15	16	0	JJ	0	16	17	1	detec	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	Moreover	17	17	18	0	,	0	18	19	1	,	18	18	19	0	PP	0	19	26	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	26	3	NP	3	20	24	4	DT	0	20	21	1	another	20	20	21	0	JJ	0	21	22	1	different	21	21	22	0	NN	0	22	23	1	phospho-ASPP2	22	22	23	0	NN	0	23	24	1	antibody	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ES1	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	ASPP2	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	VP	2	29	62	3	VBD	0	29	30	1	was	29	29	30	0	ADVP	0	30	31	1	RB	0	30	31	1	also	30	30	31	0	VP	0	31	62	2	VBN	0	31	32	1	observed	31	31	32	0	PP	0	32	62	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	62	3	NP	7	33	41	8	DT	0	33	34	1	a	33	33	34	0	JJ	0	34	35	1	human	34	34	35	0	NN	0	35	36	1	colon	35	35	36	0	NN	0	36	37	1	cancer	36	36	37	0	NN	0	37	38	1	cell	37	37	38	0	NN	0	38	39	1	line	38	38	39	0	NN	0	39	40	1	HKe3	39	39	40	0	NN	0	40	41	1	ER	40	40	41	0	:	0	41	42	1	:	41	41	42	0	NP	0	42	62	3	NP	1	42	44	2	NN	0	42	43	1	HRASV12	42	42	43	0	NNS	0	43	44	1	cells	43	43	44	0	,	0	44	45	1	,	44	44	45	0	SBAR	1	45	62	2	WHPP	0	45	47	2	IN	0	45	46	1	in	45	45	46	0	WHNP	0	46	47	1	WDT	0	46	47	1	which	46	46	47	0	S	1	47	62	2	NP	1	47	49	2	NN	0	47	48	1	RAS	47	47	48	0	NN	0	48	49	1	activation	48	48	49	0	VP	1	49	62	2	VBZ	0	49	50	1	is	49	49	50	0	VP	0	50	62	2	VBN	0	50	51	1	induced	50	50	51	0	PP	0	51	62	2	IN	0	51	52	1	upon	51	51	52	0	NP	0	52	62	2	NP	1	52	54	2	DT	0	52	53	1	the	52	52	53	0	NN	0	53	54	1	addition	53	53	54	0	PP	0	54	62	2	IN	0	54	55	1	of	54	54	55	0	NP	0	55	62	2	NP	2	55	58	3	JJ	0	55	56	1	4-hydroxytamoxifen	55	55	56	0	NN	0	56	57	1	-LRB-	56	56	57	0	NN	0	57	58	1	4-OHT	57	57	58	0	NP	0	58	62	2	NP	0	58	60	1	QP	1	58	60	2	CD	0	58	59	1	-RRB-	58	58	59	0	CD	0	59	60	1	[	59	59	60	0	NP	1	60	62	2	CD	0	60	61	1	2,10,11	60	60	61	0	NN	0	61	62	1	]	61	61	62	0	.	0	62	63	1	.	62	62	63	0
EOS
T	21
The	8377	8380	DT	the	O	_	_
phospho	8381	8388	NN	phospho	O	_	_
specific	8389	8397	JJ	specific	O	_	_
antibody	8398	8406	NN	antibody	O	_	_
for	8407	8410	IN	for	O	_	_
ASPP2	8411	8416	NN	aspp2	B-GENE	_	_
is	8417	8419	VBZ	be	O	_	_
specific	8420	8428	JJ	specific	O	_	_
as	8429	8431	IN	as	O	_	_
knockdown	8432	8441	NN	knockdown	O	_	_
of	8442	8444	IN	of	O	_	_
ASPP2	8445	8450	NN	aspp2	B-GENE	_	_
resulted	8451	8459	VBD	result	O	_	_
in	8460	8462	IN	in	O	_	_
a	8463	8464	DT	a	O	_	_
lack	8465	8469	NN	lack	O	_	_
of	8470	8472	IN	of	O	_	_
detection	8473	8482	NN	detection	O	_	_
of	8483	8485	IN	of	O	_	_
phospho-ASPP2	8486	8499	NN	phospho-aspp2	O	_	_
.	8499	8500	.	.	O	_	_
D	1
7
3	0	det
3	1	nn
3	2	amod
3	5	prep_for
7	3	nsubj
7	6	cop
7	12	advcl
9	11	prep_of
12	8	mark
12	9	nsubj
12	15	prep_in
15	14	det
15	17	prep_of
17	19	prep_of
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	6	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phospho	1	1	2	0	JJ	0	2	3	1	specific	2	2	3	0	NN	0	3	4	1	antibody	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	1	6	20	3	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	specific	7	7	8	0	SBAR	1	8	20	2	IN	0	8	9	1	as	8	8	9	0	S	1	9	20	2	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	knockdown	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	VP	0	12	20	2	VBD	0	12	13	1	resulted	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	20	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	lack	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	20	2	NP	0	17	18	1	NN	0	17	18	1	detection	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	phospho-ASPP2	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	24
All	8501	8504	PDT	all	O	_	_
these	8505	8510	DT	these	O	_	_
demonstrate	8511	8522	VBP	demonstrate	O	_	_
that	8523	8527	IN	that	O	_	_
ASPP2	8528	8533	NN	aspp2	B-GENE	_	_
is	8534	8536	VBZ	be	O	_	_
a	8537	8538	DT	a	O	_	_
novel	8539	8544	JJ	novel	O	_	_
substrate	8545	8554	NN	substrate	O	_	_
of	8555	8557	IN	of	O	_	_
MAPK	8558	8562	NN	mapk	O	_	_
and	8563	8566	CC	and	O	_	_
Ser827	8567	8573	NN	ser827	O	_	_
of	8574	8576	IN	of	O	_	_
ASPP2	8577	8582	NN	aspp2	B-GENE	_	_
can	8583	8586	MD	can	O	_	_
be	8587	8589	VB	be	O	_	_
phosphorylated	8590	8604	VBN	phosphorylate	O	_	_
by	8605	8607	IN	by	O	_	_
RAS	8608	8611	NN	ra	B-GENE	_	_
/	8611	8612	:	/	B-GENE	_	_
MAPK	8612	8616	NN	mapk	I-GENE	_	_
pathway	8617	8624	NN	pathway	O	_	_
.	8624	8625	.	.	O	_	_
D	1
2
1	0	predet
2	1	nsubj
2	8	ccomp
2	17	conj_and
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
12	14	prep_of
17	12	nsubjpass
17	15	aux
17	16	auxpass
17	19	agent
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	0	0	24	4	S	1	0	11	2	NP	1	0	2	2	PDT	0	0	1	1	All	0	0	1	0	DT	0	1	2	1	these	1	1	2	0	VP	0	2	11	2	VBP	0	2	3	1	demonstrate	2	2	3	0	SBAR	1	3	11	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	11	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	MAPK	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	23	2	NP	0	12	15	2	NP	0	12	13	1	NN	0	12	13	1	Ser827	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	VP	1	15	23	2	MD	0	15	16	1	can	15	15	16	0	VP	1	16	23	2	VB	0	16	17	1	be	16	16	17	0	VP	0	17	23	2	VBN	0	17	18	1	phosphorylated	17	17	18	0	PP	0	18	23	2	IN	0	18	19	1	by	18	18	19	0	NP	0	19	23	2	NP	0	19	20	1	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	pathway	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	11
Raf	8626	8629	NN	raf	B-GENE	_	_
/	8629	8630	:	/	B-GENE	_	_
MAPK	8630	8634	NN	mapk	I-GENE	_	_
Pathway	8635	8642	NN	pathway	O	_	_
Activates	8643	8652	VBZ	activate	O	_	_
the	8653	8656	DT	the	O	_	_
Pro-Apoptotic	8657	8670	JJ	pro-apoptotic	O	_	_
Function	8671	8679	NN	function	O	_	_
of	8680	8682	IN	of	O	_	_
ASPP2	8683	8688	NN	aspp2	B-GENE	_	_
.	8688	8689	.	.	O	_	_
D	1
0
0	1	punct
0	4	dep
3	2	nn
4	3	nsubj
4	7	dobj
7	5	det
7	6	amod
7	9	prep_of
EOX
Y	1
ROOT	0	0	11	1	FRAG	0	0	11	4	NP	0	0	1	1	NN	0	0	1	1	Raf	0	0	1	0	:	0	1	2	1	/	1	1	2	0	S	1	2	10	2	NP	1	2	4	2	NN	0	2	3	1	MAPK	2	2	3	0	NN	0	3	4	1	Pathway	3	3	4	0	VP	0	4	10	2	VBZ	0	4	5	1	Activates	4	4	5	0	NP	0	5	10	2	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	Pro-Apoptotic	6	6	7	0	NN	0	7	8	1	Function	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ASPP2	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	20
One	8690	8693	CD	one	O	_	_
of	8694	8696	IN	of	O	_	_
the	8697	8700	DT	the	O	_	_
most	8701	8705	RBS	most	O	_	_
studied	8706	8713	VBN	study	O	_	_
downstream	8714	8724	JJ	downstream	O	_	_
pathways	8725	8733	NNS	pathway	O	_	_
of	8734	8736	IN	of	O	_	_
RAS	8737	8740	NN	ra	O	_	_
signalling	8741	8751	NN	signalling	O	_	_
is	8752	8754	VBZ	be	O	_	_
the	8755	8758	DT	the	O	_	_
Raf	8759	8762	NN	raf	B-GENE	_	_
/	8762	8763	:	/	B-GENE	_	_
MAPK	8763	8767	NN	mapk	I-GENE	_	_
pathway	8768	8775	NN	pathway	O	_	_
[	8776	8777	CD	[	O	_	_
13	8777	8779	CD	13	O	_	_
]	8779	8780	NN	]	O	_	_
.	8780	8781	.	.	O	_	_
D	1
18
0	2	prep_of
2	3	advmod
2	4	vmod
4	6	dobj
6	5	amod
6	9	prep_of
9	8	nn
15	13	punct
15	14	nn
15	17	dep
17	16	num
18	0	nsubj
18	10	cop
18	11	det
18	12	nn
18	15	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	10	2	NP	0	0	1	1	CD	0	0	1	1	One	0	0	1	0	PP	0	1	10	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	10	2	NP	0	2	4	2	DT	0	2	3	1	the	2	2	3	0	RBS	0	3	4	1	most	3	3	4	0	VP	0	4	10	2	VBN	0	4	5	1	studied	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	downstream	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	VP	1	10	19	2	VBZ	0	10	11	1	is	10	10	11	0	NP	3	11	19	4	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	Raf	12	12	13	0	PRN	1	13	18	2	:	0	13	14	1	/	13	13	14	0	FRAG	0	14	18	2	NP	1	14	16	2	NN	0	14	15	1	MAPK	14	14	15	0	NN	0	15	16	1	pathway	15	15	16	0	NP	1	16	18	2	CD	0	16	17	1	[	16	16	17	0	CD	0	17	18	1	13	17	17	18	0	NN	0	18	19	1	]	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	55
Knowing	8782	8789	VBG	know	O	_	_
ASPP2	8790	8795	NN	aspp2	B-GENE	_	_
is	8796	8798	VBZ	be	O	_	_
a	8799	8800	DT	a	O	_	_
substrate	8801	8810	NN	substrate	O	_	_
of	8811	8813	IN	of	O	_	_
MAPK	8814	8818	NN	mapk	B-GENE	_	_
,	8818	8819	,	,	O	_	_
we	8820	8822	PRP	we	O	_	_
thus	8823	8827	RB	thus	O	_	_
tested	8828	8834	VBD	test	O	_	_
whether	8835	8842	IN	whether	O	_	_
activation	8843	8853	NN	activation	O	_	_
of	8854	8856	IN	of	O	_	_
Raf	8857	8860	NN	raf	B-GENE	_	_
/	8860	8861	:	/	B-GENE	_	_
MAPK	8861	8865	NN	mapk	I-GENE	_	_
pathway	8866	8873	NN	pathway	O	_	_
is	8874	8876	VBZ	be	O	_	_
sufficient	8877	8887	JJ	sufficient	O	_	_
to	8888	8890	TO	to	O	_	_
regulate	8891	8899	VB	regulate	O	_	_
ASPP2	8900	8905	NN	aspp2	B-GENE	_	_
activity	8906	8914	NN	activity	O	_	_
using	8915	8920	VBG	use	O	_	_
a	8921	8922	DT	a	O	_	_
mutant	8923	8929	JJ	mutant	B-GENE	_	_
form	8930	8934	NN	form	I-GENE	_	_
of	8935	8937	IN	of	I-GENE	_	_
Raf	8938	8941	NN	raf	I-GENE	_	_
(	8942	8943	CD	(	B-GENE	_	_
Raf	8943	8946	NN	raf	I-GENE	_	_
CAAX	8947	8951	NN	caax	I-GENE	_	_
)	8951	8952	NN	)	O	_	_
,	8952	8953	,	,	O	_	_
which	8954	8959	WDT	which	O	_	_
is	8960	8962	VBZ	be	O	_	_
constitutively	8963	8977	RB	constitutively	O	_	_
present	8978	8985	JJ	present	O	_	_
at	8986	8988	IN	at	O	_	_
the	8989	8992	DT	the	O	_	_
plasma	8993	8999	NN	plasma	O	_	_
membrane	9000	9008	NN	membrane	O	_	_
,	9008	9009	,	,	O	_	_
so	9010	9012	IN	so	O	_	_
the	9013	9016	DT	the	O	_	_
Raf	9017	9020	NN	raf	B-GENE	_	_
pathway	9021	9028	NN	pathway	O	_	_
is	9029	9031	VBZ	be	O	_	_
constitutively	9032	9046	RB	constitutively	O	_	_
active	9047	9053	JJ	active	O	_	_
[	9054	9055	NN	[	O	_	_
14	9055	9057	CD	14	O	_	_
]	9057	9058	NN	]	O	_	_
.	9058	9059	.	.	O	_	_
D	1
4
1	0	amod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	10	ccomp
4	44	dep
4	50	ccomp
10	8	nsubj
10	9	advmod
10	19	ccomp
12	14	prep_of
14	17	dep
17	15	punct
17	16	nn
19	11	mark
19	12	nsubj
19	18	cop
19	21	xcomp
21	20	aux
21	23	dobj
23	22	nn
23	24	vmod
24	27	dobj
27	25	det
27	26	amod
27	28	prep
27	38	rcmod
33	29	nn
33	31	nn
33	32	nn
38	35	nsubj
38	36	cop
38	37	advmod
38	42	prep_at
42	40	det
42	41	nn
47	45	det
47	46	nn
50	47	nsubj
50	48	cop
50	49	advmod
50	51	iobj
51	53	dep
53	52	num
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	7	S	1	0	7	2	NP	1	0	2	2	VBG	0	0	1	1	Knowing	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	7	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	a	3	3	4	0	NN	0	4	5	1	substrate	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK	6	6	7	0	,	0	7	8	1	,	7	7	8	0	S	2	8	43	3	NP	0	8	9	1	PRP	0	8	9	1	we	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	43	2	VBD	0	10	11	1	tested	10	10	11	0	SBAR	1	11	43	2	IN	0	11	12	1	whether	11	11	12	0	S	1	12	43	2	NP	0	12	18	2	NP	0	12	13	1	NN	0	12	13	1	activation	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	18	2	NP	0	14	15	1	NN	0	14	15	1	Raf	14	14	15	0	PRN	1	15	18	2	:	0	15	16	1	/	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	MAPK	16	16	17	0	NN	0	17	18	1	pathway	17	17	18	0	VP	1	18	43	2	VBZ	0	18	19	1	is	18	18	19	0	ADJP	0	19	43	2	JJ	0	19	20	1	sufficient	19	19	20	0	S	0	20	43	1	VP	1	20	43	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	43	2	VB	0	21	22	1	regulate	21	21	22	0	NP	0	22	43	2	NP	1	22	24	2	NN	0	22	23	1	ASPP2	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	VP	0	24	43	2	VBG	0	24	25	1	using	24	24	25	0	NP	0	25	43	4	NP	2	25	28	3	DT	0	25	26	1	a	25	25	26	0	JJ	0	26	27	1	mutant	26	26	27	0	NN	0	27	28	1	form	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	4	29	34	5	NN	0	29	30	1	Raf	29	29	30	0	CD	0	30	31	1	-LRB-	30	30	31	0	NN	0	31	32	1	Raf	31	31	32	0	NN	0	32	33	1	CAAX	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	,	0	34	35	1	,	34	34	35	0	SBAR	1	35	43	2	WHNP	0	35	36	1	WDT	0	35	36	1	which	35	35	36	0	S	0	36	43	1	VP	1	36	43	2	VBZ	0	36	37	1	is	36	36	37	0	ADJP	1	37	43	3	RB	0	37	38	1	constitutively	37	37	38	0	JJ	0	38	39	1	present	38	38	39	0	PP	0	39	43	2	IN	0	39	40	1	at	39	39	40	0	NP	2	40	43	3	DT	0	40	41	1	the	40	40	41	0	NN	0	41	42	1	plasma	41	41	42	0	NN	0	42	43	1	membrane	42	42	43	0	,	0	43	44	1	,	43	43	44	0	IN	0	44	45	1	so	44	44	45	0	S	1	45	54	2	NP	2	45	48	3	DT	0	45	46	1	the	45	45	46	0	NN	0	46	47	1	Raf	46	46	47	0	NN	0	47	48	1	pathway	47	47	48	0	VP	1	48	54	3	VBZ	0	48	49	1	is	48	48	49	0	ADJP	1	49	51	2	RB	0	49	50	1	constitutively	49	49	50	0	JJ	0	50	51	1	active	50	50	51	0	NP	0	51	54	2	NP	0	51	52	1	NN	0	51	52	1	[	51	51	52	0	NP	1	52	54	2	CD	0	52	53	1	14	52	52	53	0	NN	0	53	54	1	]	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	26
The	9060	9063	DT	the	O	_	_
impact	9064	9070	NN	impact	O	_	_
of	9071	9073	IN	of	O	_	_
co-expression	9074	9087	NN	co-expression	O	_	_
of	9088	9090	IN	of	O	_	_
Raf	9091	9094	NN	raf	B-GENE	_	_
CAAX	9095	9099	NN	caax	I-GENE	_	_
with	9100	9104	IN	with	O	_	_
p53	9105	9108	NN	p53	B-GENE	_	_
and	9109	9112	CC	and	O	_	_
ASPP2	9113	9118	NN	aspp2	B-GENE	_	_
was	9119	9122	VBD	be	O	_	_
tested	9123	9129	VBN	test	O	_	_
by	9130	9132	IN	by	O	_	_
analysing	9133	9142	VBG	analyse	O	_	_
the	9143	9146	DT	the	O	_	_
transcriptional	9147	9162	JJ	transcriptional	O	_	_
activity	9163	9171	NN	activity	O	_	_
of	9172	9174	IN	of	O	_	_
p53	9175	9178	NN	p53	B-GENE	_	_
on	9179	9181	IN	on	O	_	_
the	9182	9185	DT	the	O	_	_
pro-apoptotic	9186	9199	JJ	pro-apoptotic	O	_	_
Bax	9200	9203	NN	bax	O	_	_
reporter	9204	9212	NN	reporter	O	_	_
.	9212	9213	.	.	O	_	_
D	1
12
1	0	det
1	3	prep_of
3	6	prep_of
6	5	nn
6	8	prep_with
6	10	prep_with
8	10	conj_and
12	1	nsubjpass
12	11	auxpass
12	14	agent
14	17	dobj
14	24	prep_on
17	15	det
17	16	amod
17	19	prep_of
24	21	det
24	22	amod
24	23	nn
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	11	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	impact	1	1	2	0	PP	0	2	11	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	11	2	NP	0	3	4	1	NN	0	3	4	1	co-expression	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	11	2	NP	1	5	7	2	NN	0	5	6	1	Raf	5	5	6	0	NN	0	6	7	1	CAAX	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	VP	1	11	25	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	25	2	VBN	0	12	13	1	tested	12	12	13	0	PP	0	13	25	2	IN	0	13	14	1	by	13	13	14	0	S	0	14	25	1	VP	0	14	25	3	VBG	0	14	15	1	analysing	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	transcriptional	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	p53	19	19	20	0	PP	0	20	25	2	IN	0	20	21	1	on	20	20	21	0	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	Bax	23	23	24	0	NN	0	24	25	1	reporter	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	22
Raf	9214	9217	NN	raf	B-GENE	_	_
CAAX	9218	9222	NN	caax	I-GENE	_	_
increases	9223	9232	VBZ	increase	O	_	_
Bax-luciferase	9233	9247	JJ	bax-luciferase	B-GENE	_	_
levels	9248	9254	NNS	level	O	_	_
by	9255	9257	IN	by	O	_	_
2.5	9258	9261	CD	2.5	O	_	_
fold	9262	9266	NN	fold	O	_	_
over	9267	9271	IN	over	O	_	_
the	9272	9275	DT	the	O	_	_
baseline	9276	9284	NN	baseline	O	_	_
of	9285	9287	IN	of	O	_	_
p53	9288	9291	NN	p53	B-GENE	_	_
and	9292	9295	CC	and	O	_	_
ASPP2	9296	9301	NN	aspp2	B-GENE	_	_
alone	9302	9307	RB	alone	O	_	_
(	9308	9309	RB	(	O	_	_
P	9309	9310	NN	p	O	_	_
=	9310	9311	JJ	=	O	_	_
0.05	9311	9315	CD	0.05	O	_	_
)	9315	9316	NN	)	O	_	_
.	9316	9317	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	4	dobj
2	5	prep
4	3	amod
7	6	number
7	10	prep_over
10	9	det
10	12	prep_of
10	14	prep_of
10	15	advmod
10	17	dep
12	14	conj_and
18	19	dep
20	7	amod
20	18	amod
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	NN	0	0	1	1	Raf	0	0	1	0	NN	0	1	2	1	CAAX	1	1	2	0	VP	0	2	21	3	VBZ	0	2	3	1	increases	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	Bax-luciferase	3	3	4	0	NNS	0	4	5	1	levels	4	4	5	0	PP	0	5	21	2	IN	0	5	6	1	by	5	5	6	0	NP	2	6	21	3	ADJP	0	6	18	2	ADJP	1	6	8	2	CD	0	6	7	1	2.5	6	6	7	0	NN	0	7	8	1	fold	7	7	8	0	PP	0	8	18	2	IN	0	8	9	1	over	8	8	9	0	NP	0	9	18	4	NP	0	9	15	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	baseline	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	RB	0	15	16	1	alone	15	15	16	0	RB	0	16	17	1	-LRB-	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	P	17	17	18	0	ADJP	0	18	20	2	JJ	0	18	19	1	=	18	18	19	0	NP	0	19	20	1	CD	0	19	20	1	0.05	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	21
This	9318	9322	DT	this	O	_	_
effect	9323	9329	NN	effect	O	_	_
is	9330	9332	VBZ	be	O	_	_
likely	9333	9339	JJ	likely	O	_	_
to	9340	9342	TO	to	O	_	_
be	9343	9345	VB	be	O	_	_
mediated	9346	9354	VBN	mediate	O	_	_
by	9355	9357	IN	by	O	_	_
ASPP2	9358	9363	NN	aspp2	B-GENE	_	_
as	9364	9366	IN	as	O	_	_
Raf	9367	9370	NN	raf	B-GENE	_	_
CAAX	9371	9375	NN	caax	I-GENE	_	_
had	9376	9379	VBD	have	O	_	_
little	9380	9386	JJ	little	O	_	_
effect	9387	9393	NN	effect	O	_	_
on	9394	9396	IN	on	O	_	_
p53	9397	9400	NN	p53	B-GENE	_	_
in	9401	9403	IN	in	O	_	_
its	9404	9407	PRP$	its	O	_	_
absence	9408	9415	NN	absence	O	_	_
.	9427	9428	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	6	xcomp
6	4	aux
6	5	auxpass
6	8	agent
6	12	advcl
11	10	nn
12	9	mark
12	11	nsubj
12	14	dobj
12	19	prep_in
14	13	amod
14	16	prep_on
19	18	poss
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	VP	1	2	20	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	20	2	JJ	0	3	4	1	likely	3	3	4	0	S	0	4	20	1	VP	1	4	20	2	TO	0	4	5	1	to	4	4	5	0	VP	1	5	20	2	VB	0	5	6	1	be	5	5	6	0	VP	0	6	20	3	VBN	0	6	7	1	mediated	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	SBAR	1	9	20	2	IN	0	9	10	1	as	9	9	10	0	S	1	10	20	2	NP	1	10	12	2	NN	0	10	11	1	Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	0	12	20	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	JJ	0	13	14	1	little	13	13	14	0	NN	0	14	15	1	effect	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	on	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	NP	1	18	20	2	PRP$	0	18	19	1	its	18	18	19	0	NN	0	19	20	1	absence	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	18
Activated	9439	9448	VBN	activate	O	_	_
Raf	9449	9452	NN	raf	B-GENE	_	_
enhances	9453	9461	VBZ	enhance	O	_	_
the	9462	9465	DT	the	O	_	_
transactivation	9466	9481	NN	transactivation	O	_	_
activity	9482	9490	NN	activity	O	_	_
of	9491	9493	IN	of	O	_	_
ASPP2	9494	9499	NN	aspp2	B-GENE	_	_
and	9500	9503	CC	and	O	_	_
p53	9504	9507	NN	p53	B-GENE	_	_
to	9508	9510	TO	to	O	_	_
the	9511	9514	DT	the	O	_	_
same	9515	9519	JJ	same	O	_	_
extent	9520	9526	NN	extent	O	_	_
as	9527	9529	IN	as	O	_	_
activated	9530	9539	VBN	activate	O	_	_
RAS	9540	9543	NN	ra	O	_	_
.	9543	9544	.	.	O	_	_
D	1
0
0	1	dobj
0	2	dep
0	5	nsubj
5	3	det
5	4	nn
5	7	prep_of
5	9	prep_of
7	9	conj_and
7	13	prep_to
13	11	det
13	12	amod
13	16	prep_as
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	SINV	0	0	18	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Raf	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	enhances	2	2	3	0	NP	0	3	17	2	NP	2	3	6	3	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	transactivation	4	4	5	0	NN	0	5	6	1	activity	5	5	6	0	PP	0	6	17	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	17	2	NP	0	7	10	3	NN	0	7	8	1	ASPP2	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NN	0	9	10	1	p53	9	9	10	0	PP	0	10	17	2	TO	0	10	11	1	to	10	10	11	0	NP	0	11	17	2	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	same	12	12	13	0	NN	0	13	14	1	extent	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	as	14	14	15	0	NP	1	15	17	2	VBN	0	15	16	1	activated	15	15	16	0	NN	0	16	17	1	RAS	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	19
(	9545	9546	NN	(	O	_	_
A	9546	9547	NN	a	O	_	_
)	9547	9548	CD	)	O	_	_
Saos2	9549	9554	NN	saos2	O	_	_
cells	9555	9560	NNS	cell	O	_	_
were	9561	9565	VBD	be	O	_	_
transfected	9566	9577	VBN	transfect	O	_	_
as	9578	9580	IN	as	O	_	_
indicated	9581	9590	VBN	indicate	O	_	_
with	9591	9595	IN	with	O	_	_
a	9596	9597	DT	a	O	_	_
Bax-luciferase	9598	9612	NN	bax-luciferase	B-GENE	_	_
reporter	9613	9621	NN	reporter	I-GENE	_	_
and	9622	9625	CC	and	O	_	_
the	9626	9629	DT	the	O	_	_
luciferase	9630	9640	NN	luciferase	B-GENE	_	_
activity	9641	9649	NN	activity	O	_	_
shown	9650	9655	VBN	show	O	_	_
.	9655	9656	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	advcl
8	7	mark
8	12	prep_with
8	16	prep_with
12	10	det
12	11	nn
12	16	conj_and
16	14	det
16	15	nn
16	17	vmod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	18	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	18	2	VBN	0	6	7	1	transfected	6	6	7	0	SBAR	1	7	18	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	18	1	VP	0	8	18	2	VBN	0	8	9	1	indicated	8	8	9	0	PP	0	9	18	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	18	3	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	NN	0	11	12	1	Bax-luciferase	11	11	12	0	NN	0	12	13	1	reporter	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	18	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	luciferase	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	VP	0	17	18	1	VBN	0	17	18	1	shown	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
*	9657	9658	SYM	*	O	_	_
P	9659	9660	NN	p	O	_	_
=	9660	9661	JJ	=	O	_	_
0.05	9661	9665	CD	0.05	O	_	_
(	9666	9667	NN	(	O	_	_
B	9667	9668	NN	b	O	_	_
)	9668	9669	CD	)	O	_	_
The	9670	9673	DT	the	O	_	_
value	9674	9679	NN	value	O	_	_
of	9680	9682	IN	of	O	_	_
ASPP2+	9683	9689	JJ	aspp2+	B-GENE	_	_
p53	9689	9692	NN	p53	I-GENE	_	_
was	9693	9696	VBD	be	O	_	_
taken	9697	9702	VBN	take	O	_	_
as	9703	9705	IN	as	O	_	_
1.0	9706	9709	CD	1.0	O	_	_
to	9710	9712	TO	to	O	_	_
reflect	9713	9720	VB	reflect	O	_	_
the	9721	9724	DT	the	O	_	_
fold	9725	9729	JJ	fold	O	_	_
increase	9730	9738	NN	increase	O	_	_
of	9739	9741	IN	of	O	_	_
ASPP2	9742	9747	NN	aspp2	B-GENE	_	_
and	9748	9751	CC	and	O	_	_
p53	9752	9755	NN	p53	B-GENE	_	_
in	9756	9758	IN	in	O	_	_
the	9759	9762	DT	the	O	_	_
presence	9763	9771	NN	presence	O	_	_
of	9772	9774	IN	of	O	_	_
activated	9775	9784	VBN	activate	O	_	_
Raf	9785	9788	NN	raf	B-GENE	_	_
and	9789	9792	CC	and	O	_	_
mutant	9793	9799	JJ	mutant	O	_	_
RAS	9800	9803	NN	ra	O	_	_
.	9803	9804	.	.	O	_	_
D	1
13
1	0	dep
1	2	amod
4	3	num
5	1	dep
8	5	dep
8	7	det
8	11	prep_of
11	10	amod
13	8	dep
13	12	auxpass
13	15	prep_as
13	17	xcomp
17	16	aux
17	20	dobj
17	27	prep_in
20	18	det
20	19	amod
20	22	prep_of
20	24	prep_of
22	24	conj_and
27	26	det
27	30	prep_of
27	33	prep_of
30	29	amod
30	33	conj_and
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	FRAG	1	0	35	3	X	1	0	12	2	X	1	0	7	2	X	1	0	5	2	X	0	0	1	1	SYM	0	0	1	1	*	0	0	1	0	NP	0	1	5	2	NP	0	1	3	2	NN	0	1	2	1	P	1	1	2	0	JJ	0	2	3	1	=	2	2	3	0	NP	1	3	5	2	CD	0	3	4	1	0.05	3	3	4	0	NN	0	4	5	1	-LRB-	4	4	5	0	NP	0	5	7	2	NN	0	5	6	1	B	5	5	6	0	CD	0	6	7	1	-RRB-	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	DT	0	7	8	1	The	7	7	8	0	NN	0	8	9	1	value	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	ASPP2+	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	34	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	34	3	VBN	0	13	14	1	taken	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	as	14	14	15	0	NP	0	15	16	1	CD	0	15	16	1	1.0	15	15	16	0	S	0	16	34	1	VP	1	16	34	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	34	3	VB	0	17	18	1	reflect	17	17	18	0	NP	0	18	25	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	JJ	0	19	20	1	fold	19	19	20	0	NN	0	20	21	1	increase	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	25	3	NN	0	22	23	1	ASPP2	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	NN	0	24	25	1	p53	24	24	25	0	PP	0	25	34	2	IN	0	25	26	1	in	25	25	26	0	NP	0	26	34	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	presence	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	0	29	34	3	NP	1	29	31	2	VBN	0	29	30	1	activated	29	29	30	0	NN	0	30	31	1	Raf	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NP	1	32	34	2	JJ	0	32	33	1	mutant	32	32	33	0	NN	0	33	34	1	RAS	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	10
**	9805	9807	SYM	**	O	_	_
P	9808	9809	NN	p	O	_	_
=	9809	9810	JJ	=	O	_	_
0.0055	9810	9816	CD	0.0055	O	_	_
;	9816	9817	:	;	O	_	_
****	9818	9822	CD	****	O	_	_
P	9823	9824	NN	p	O	_	_
=	9824	9825	JJ	=	O	_	_
0.0001	9825	9831	CD	0.0001	O	_	_
.	9831	9832	.	.	O	_	_
D	1
3
1	0	dep
2	1	dep
3	2	dep
3	6	dep
6	5	num
6	7	amod
7	8	dep
EOX
Y	1
ROOT	0	0	10	1	FRAG	0	0	10	3	FRAG	1	0	4	2	X	1	0	3	2	X	1	0	2	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	0	2	3	1	JJ	0	2	3	1	=	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	0.0055	3	3	4	0	:	0	4	5	1	;	4	4	5	0	FRAG	0	5	10	2	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	ADJP	0	7	9	2	JJ	0	7	8	1	=	7	7	8	0	NP	0	8	9	1	CD	0	8	9	1	0.0001	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	20
The	9833	9836	DT	the	O	_	_
effect	9837	9843	NN	effect	O	_	_
of	9844	9846	IN	of	O	_	_
Raf	9847	9850	NN	raf	B-GENE	_	_
CAAX	9851	9855	NN	caax	I-GENE	_	_
on	9856	9858	IN	on	O	_	_
ASPP2	9859	9864	NN	aspp2	B-GENE	_	_
and	9865	9868	CC	and	O	_	_
p53	9869	9872	NN	p53	B-GENE	_	_
was	9873	9876	VBD	be	O	_	_
compared	9877	9885	VBN	compare	O	_	_
to	9886	9888	TO	to	O	_	_
that	9889	9893	DT	that	O	_	_
of	9894	9896	IN	of	O	_	_
HRAS	9897	9901	NNP	HRAS	B-GENE	_	_
V12	9902	9905	NN	v12	I-GENE	_	_
or	9906	9908	CC	or	O	_	_
KRAS	9909	9913	NNP	KRAS	B-GENE	_	_
V12	9914	9917	NN	v12	I-GENE	_	_
.	9917	9918	.	.	O	_	_
D	1
9
1	0	det
1	4	prep_of
4	3	nn
4	6	prep_on
4	8	prep_on
6	8	conj_and
9	1	nsubj
9	11	prepc_compared_to
9	12	pobj
12	15	prep_of
12	18	prep_of
15	14	nn
15	18	conj_or
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	PP	0	2	9	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	9	2	NP	1	3	5	2	NN	0	3	4	1	Raf	3	3	4	0	NN	0	4	5	1	CAAX	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	on	5	5	6	0	NP	0	6	9	3	NN	0	6	7	1	ASPP2	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NN	0	8	9	1	p53	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	was	9	9	10	0	PP	0	10	19	2	VBN	0	10	11	1	compared	10	10	11	0	PP	0	11	19	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	DT	0	12	13	1	that	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	3	NP	1	14	16	2	NNP	0	14	15	1	HRAS	14	14	15	0	NN	0	15	16	1	V12	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	KRAS	17	17	18	0	NN	0	18	19	1	V12	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	17
All	9919	9922	DT	all	O	_	_
three	9923	9928	CD	three	O	_	_
activate	9929	9937	VBP	activate	O	_	_
ASPP2	9938	9943	NN	aspp2	B-GENE	_	_
and	9944	9947	CC	and	O	_	_
p53	9948	9951	NN	p53	B-GENE	_	_
transactivation	9952	9967	NN	transactivation	O	_	_
activity	9968	9976	NN	activity	O	_	_
to	9977	9979	TO	to	O	_	_
a	9980	9981	DT	a	O	_	_
similar	9982	9989	JJ	similar	O	_	_
extent	9990	9996	NN	extent	O	_	_
,	9996	9997	,	,	O	_	_
namely	9998	10004	RB	namely	O	_	_
2.5	10005	10008	CD	2.5	O	_	_
fold	10009	10013	NN	fold	O	_	_
.	10025	10026	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	7	dobj
2	11	prep_to
3	5	conj_and
7	3	nn
7	5	nn
7	6	nn
11	9	det
11	10	amod
11	15	appos
15	13	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	16	3	VBP	0	2	3	1	activate	2	2	3	0	NP	2	3	8	3	NP	0	3	6	3	NN	0	3	4	1	ASPP2	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NN	0	5	6	1	p53	5	5	6	0	NN	0	6	7	1	transactivation	6	6	7	0	NN	0	7	8	1	activity	7	7	8	0	PP	0	8	16	2	TO	0	8	9	1	to	8	8	9	0	NP	0	9	16	3	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	similar	10	10	11	0	NN	0	11	12	1	extent	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	2	13	16	3	RB	0	13	14	1	namely	13	13	14	0	CD	0	14	15	1	2.5	14	14	15	0	NN	0	15	16	1	fold	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	22
This	10027	10031	DT	this	O	_	_
suggests	10032	10040	VBZ	suggest	O	_	_
that	10041	10045	IN	that	O	_	_
the	10046	10049	DT	the	O	_	_
effect	10050	10056	NN	effect	O	_	_
of	10057	10059	IN	of	O	_	_
activated	10060	10069	VBN	activate	O	_	_
RAS	10070	10073	NN	ra	O	_	_
on	10074	10076	IN	on	O	_	_
ASPP2	10077	10082	NN	aspp2	B-GENE	_	_
and	10083	10086	CC	and	O	_	_
p53	10087	10090	NN	p53	B-GENE	_	_
is	10091	10093	VBZ	be	O	_	_
mediated	10094	10102	VBN	mediate	O	_	_
via	10103	10106	IN	via	O	_	_
the	10107	10110	DT	the	O	_	_
downstream	10111	10121	JJ	downstream	O	_	_
Raf	10122	10125	NN	raf	B-GENE	_	_
/	10126	10127	:	/	B-GENE	_	_
MAPK	10127	10131	NN	mapk	I-GENE	_	_
pathway	10132	10139	NN	pathway	O	_	_
.	10139	10140	.	.	O	_	_
D	1
1
1	0	nsubj
1	13	ccomp
4	3	det
4	7	prep_of
7	6	amod
7	9	prep_on
7	11	prep_on
9	11	conj_and
13	2	mark
13	4	nsubjpass
13	12	auxpass
13	17	prep_via
17	15	det
17	16	amod
17	20	dep
20	18	punct
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	21	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	1	2	21	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	21	2	NP	0	3	12	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	effect	4	4	5	0	PP	0	5	12	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	12	2	NP	1	6	8	2	VBN	0	6	7	1	activated	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	on	8	8	9	0	NP	0	9	12	3	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	21	2	VBZ	0	12	13	1	is	12	12	13	0	VP	0	13	21	2	VBN	0	13	14	1	mediated	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	via	14	14	15	0	NP	0	15	21	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	downstream	16	16	17	0	NN	0	17	18	1	Raf	17	17	18	0	PRN	1	18	21	2	:	0	18	19	1	/	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	MAPK	19	19	20	0	NN	0	20	21	1	pathway	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	12
ASPP2	10141	10146	NN	aspp2	B-GENE	_	_
phosphorylation	10147	10162	NN	phosphorylation	O	_	_
by	10163	10165	IN	by	O	_	_
MAPK	10166	10170	NN	mapk	O	_	_
is	10171	10173	VBZ	be	O	_	_
necessary	10174	10183	JJ	necessary	O	_	_
for	10184	10187	IN	for	O	_	_
ASPP2	10188	10193	NN	aspp2	B-GENE	_	_
full	10194	10198	JJ	full	O	_	_
pro-apoptotic	10199	10212	JJ	pro-apoptotic	O	_	_
activity	10213	10221	NN	activity	O	_	_
.	10221	10222	.	.	O	_	_
D	1
5
1	0	nn
1	3	prep_by
5	1	nsubj
5	4	cop
5	10	prep_for
10	7	nn
10	8	amod
10	9	amod
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	by	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	MAPK	3	3	4	0	VP	1	4	11	2	VBZ	0	4	5	1	is	4	4	5	0	ADJP	0	5	11	2	JJ	0	5	6	1	necessary	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	for	6	6	7	0	NP	3	7	11	4	NN	0	7	8	1	ASPP2	7	7	8	0	JJ	0	8	9	1	full	8	8	9	0	JJ	0	9	10	1	pro-apoptotic	9	9	10	0	NN	0	10	11	1	activity	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	24
To	10223	10225	TO	to	O	_	_
assess	10226	10232	VB	assess	O	_	_
the	10233	10236	DT	the	O	_	_
effect	10237	10243	NN	effect	O	_	_
of	10244	10246	IN	of	O	_	_
MAPK	10247	10251	NN	mapk	B-GENE	_	_
phosphorylation	10252	10267	NN	phosphorylation	O	_	_
on	10268	10270	IN	on	O	_	_
ASPP2	10271	10276	NN	aspp2	B-GENE	_	_
activity	10277	10285	NN	activity	O	_	_
,	10285	10286	,	,	O	_	_
alanine	10287	10294	NN	alanine	O	_	_
substitution	10295	10307	NN	substitution	O	_	_
mutants	10308	10315	NNS	mutant	O	_	_
of	10316	10318	IN	of	O	_	_
the	10319	10322	DT	the	O	_	_
two	10323	10326	CD	two	O	_	_
putative	10327	10335	JJ	putative	O	_	_
MAPK	10336	10340	NN	mapk	B-GENE	_	_
phosphorylation	10341	10356	NN	phosphorylation	O	_	_
sites	10357	10362	NNS	site	O	_	_
were	10363	10367	VBD	be	O	_	_
constructed	10368	10379	VBN	construct	O	_	_
.	10379	10380	.	.	O	_	_
D	1
22
1	0	aux
1	3	dobj
1	9	prep_on
3	2	det
3	6	prep_of
6	5	nn
9	8	nn
13	11	nn
13	12	nn
13	20	prep_of
20	15	det
20	16	num
20	17	amod
20	18	nn
20	19	nn
22	1	advcl
22	13	nsubjpass
22	21	auxpass
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	3	VB	0	1	2	1	assess	1	1	2	0	NP	0	2	7	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	effect	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	MAPK	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	on	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	activity	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	21	2	NP	2	11	14	3	NN	0	11	12	1	alanine	11	11	12	0	NN	0	12	13	1	substitution	12	12	13	0	NNS	0	13	14	1	mutants	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	of	14	14	15	0	NP	5	15	21	6	DT	0	15	16	1	the	15	15	16	0	CD	0	16	17	1	two	16	16	17	0	JJ	0	17	18	1	putative	17	17	18	0	NN	0	18	19	1	MAPK	18	18	19	0	NN	0	19	20	1	phosphorylation	19	19	20	0	NNS	0	20	21	1	sites	20	20	21	0	VP	1	21	23	2	VBD	0	21	22	1	were	21	21	22	0	VP	0	22	23	1	VBN	0	22	23	1	constructed	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	29
In	10381	10383	IN	in	O	_	_
conditions	10384	10394	NNS	condition	O	_	_
where	10395	10400	WRB	where	O	_	_
the	10401	10404	DT	the	O	_	_
cells	10405	10410	NNS	cell	O	_	_
were	10411	10415	VBD	be	O	_	_
starved	10416	10423	VBN	starve	O	_	_
of	10424	10426	IN	of	O	_	_
serum	10427	10432	NN	serum	O	_	_
,	10432	10433	,	,	O	_	_
these	10434	10439	DT	these	O	_	_
mutants	10440	10447	NNS	mutant	O	_	_
had	10448	10451	VBD	have	O	_	_
identical	10452	10461	JJ	identical	O	_	_
activity	10462	10470	NN	activity	O	_	_
to	10471	10473	TO	to	O	_	_
wild-type	10474	10483	JJ	wild-type	O	_	_
ASPP2	10484	10489	NN	aspp2	O	_	_
in	10490	10492	IN	in	O	_	_
their	10493	10498	PRP$	they	O	_	_
ability	10499	10506	NN	ability	O	_	_
to	10507	10509	TO	to	O	_	_
enhance	10510	10517	VB	enhance	O	_	_
the	10518	10521	DT	the	O	_	_
transactivation	10522	10537	NN	transactivation	O	_	_
function	10538	10546	NN	function	O	_	_
of	10547	10549	IN	of	O	_	_
p53	10550	10553	NN	p53	B-GENE	_	_
.	10565	10566	.	.	O	_	_
D	1
12
1	6	rcmod
4	3	det
6	2	advmod
6	4	nsubjpass
6	5	auxpass
6	8	prep_of
11	10	det
12	1	prep_in
12	11	nsubj
12	14	dobj
12	20	prep_in
14	13	amod
14	17	prep_to
17	16	amod
20	19	poss
20	22	vmod
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
EOX
Y	1
ROOT	0	0	29	1	S	3	0	29	5	PP	0	0	9	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	9	2	NP	0	1	2	1	NNS	0	1	2	1	conditions	1	1	2	0	SBAR	1	2	9	2	WHADVP	0	2	3	1	WRB	0	2	3	1	where	2	2	3	0	S	1	3	9	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	starved	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	serum	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	these	10	10	11	0	NNS	0	11	12	1	mutants	11	11	12	0	VP	0	12	28	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	JJ	0	13	14	1	identical	13	13	14	0	NN	0	14	15	1	activity	14	14	15	0	PP	0	15	18	2	TO	0	15	16	1	to	15	15	16	0	NP	1	16	18	2	JJ	0	16	17	1	wild-type	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	PP	0	18	28	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	28	3	PRP$	0	19	20	1	their	19	19	20	0	NN	0	20	21	1	ability	20	20	21	0	S	0	21	28	1	VP	1	21	28	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	28	2	VB	0	22	23	1	enhance	22	22	23	0	NP	0	23	28	2	NP	2	23	26	3	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	transactivation	24	24	25	0	NN	0	25	26	1	function	25	25	26	0	PP	0	26	28	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	28	1	NN	0	27	28	1	p53	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	35
However	10567	10574	RB	however	O	_	_
,	10574	10575	,	,	O	_	_
whereas	10576	10583	IN	whereas	O	_	_
activated	10584	10593	VBN	activate	O	_	_
Raf	10594	10597	NN	raf	B-GENE	_	_
CAAX	10598	10602	NN	caax	I-GENE	_	_
was	10603	10606	VBD	be	O	_	_
able	10607	10611	JJ	able	O	_	_
to	10612	10614	TO	to	O	_	_
stimulate	10615	10624	VB	stimulate	O	_	_
wild-type	10625	10634	JJ	wild-type	O	_	_
ASPP2	10635	10640	NN	aspp2	O	_	_
and	10641	10644	CC	and	O	_	_
ASPP2	10645	10650	NN	aspp2	O	_	_
(	10651	10652	CD	(	O	_	_
S698A	10652	10657	NN	s698a	O	_	_
)	10657	10658	CD	)	O	_	_
by	10659	10661	IN	by	O	_	_
2.5	10662	10665	CD	2.5	O	_	_
fold	10666	10670	NN	fold	O	_	_
,	10670	10671	,	,	O	_	_
it	10672	10674	PRP	it	O	_	_
was	10675	10678	VBD	be	O	_	_
unable	10679	10685	JJ	unable	O	_	_
to	10686	10688	TO	to	O	_	_
increase	10689	10697	VB	increase	O	_	_
the	10698	10701	DT	the	O	_	_
activity	10702	10710	NN	activity	O	_	_
of	10711	10713	IN	of	O	_	_
mutant	10714	10720	JJ	mutant	O	_	_
ASPP2	10721	10726	NN	aspp2	O	_	_
(	10727	10728	CD	(	O	_	_
S827A	10728	10733	NN	s827a	O	_	_
)	10733	10734	NN	)	O	_	_
.	10746	10747	.	.	O	_	_
D	1

5	3	amod
5	4	nn
7	2	mark
7	5	nsubj
7	6	cop
7	9	xcomp
9	8	aux
9	11	dobj
9	13	dobj
9	19	prep_by
11	10	amod
11	13	conj_and
13	15	dep
19	18	num
23	0	advmod
23	7	parataxis
23	21	nsubj
23	22	cop
23	25	xcomp
25	24	aux
25	27	iobj
27	26	det
27	30	prep_of
30	29	amod
33	32	nn
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	PRN	1	1	21	3	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	20	2	IN	0	2	3	1	whereas	2	2	3	0	S	1	3	20	2	NP	2	3	6	3	VBN	0	3	4	1	activated	3	3	4	0	NN	0	4	5	1	Raf	4	4	5	0	NN	0	5	6	1	CAAX	5	5	6	0	VP	1	6	20	2	VBD	0	6	7	1	was	6	6	7	0	ADJP	0	7	20	2	JJ	0	7	8	1	able	7	7	8	0	S	0	8	20	1	VP	1	8	20	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	20	3	VB	0	9	10	1	stimulate	9	9	10	0	NP	0	10	17	3	NP	1	10	12	2	JJ	0	10	11	1	wild-type	10	10	11	0	NN	0	11	12	1	ASPP2	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	0	13	17	2	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NP	0	15	17	2	NN	0	15	16	1	S698A	15	15	16	0	CD	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	by	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	2.5	18	18	19	0	NN	0	19	20	1	fold	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	0	21	22	1	PRP	0	21	22	1	it	21	21	22	0	VP	1	22	34	2	VBD	0	22	23	1	was	22	22	23	0	ADJP	0	23	34	2	JJ	0	23	24	1	unable	23	23	24	0	S	0	24	34	1	VP	1	24	34	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	34	3	VB	0	25	26	1	increase	25	25	26	0	NP	0	26	31	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	activity	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	mutant	29	29	30	0	NN	0	30	31	1	ASPP2	30	30	31	0	NP	2	31	34	3	CD	0	31	32	1	-LRB-	31	31	32	0	NN	0	32	33	1	S827A	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	25
These	10748	10753	DT	these	O	_	_
results	10754	10761	NNS	result	O	_	_
suggest	10762	10769	VBP	suggest	O	_	_
that	10770	10774	IN	that	O	_	_
MAPK	10775	10779	NN	mapk	B-GENE	_	_
phosphorylation	10780	10795	NN	phosphorylation	O	_	_
of	10796	10798	IN	of	O	_	_
ASPP2	10799	10804	NN	aspp2	B-GENE	_	_
Ser827	10805	10811	NN	ser827	O	_	_
is	10812	10814	VBZ	be	O	_	_
necessary	10815	10824	JJ	necessary	O	_	_
for	10825	10828	IN	for	O	_	_
Raf	10829	10832	NN	raf	B-GENE	_	_
CAAX	10833	10837	NN	caax	I-GENE	_	_
to	10838	10840	TO	to	O	_	_
stimulate	10841	10850	VB	stimulate	O	_	_
the	10851	10854	DT	the	O	_	_
full	10855	10859	JJ	full	O	_	_
transcriptional	10860	10875	JJ	transcriptional	O	_	_
activity	10876	10884	NN	activity	O	_	_
of	10885	10887	IN	of	O	_	_
p53	10888	10891	NN	p53	B-GENE	_	_
via	10892	10895	IN	via	I-GENE	_	_
ASPP2	10896	10901	NN	aspp2	I-GENE	_	_
.	10901	10902	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	10	ccomp
5	4	nn
5	8	prep_of
8	7	nn
10	3	mark
10	5	nsubj
10	9	cop
10	13	prep_for
10	15	xcomp
13	12	nn
15	14	aux
15	19	dobj
19	16	det
19	17	amod
19	18	amod
19	21	prep_of
21	23	prep_via
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	0	2	24	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	24	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	24	2	NP	0	4	9	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	Ser827	8	8	9	0	VP	1	9	24	3	VBZ	0	9	10	1	is	9	9	10	0	ADJP	0	10	14	2	JJ	0	10	11	1	necessary	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	S	0	14	24	1	VP	1	14	24	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	24	2	VB	0	15	16	1	stimulate	15	15	16	0	NP	0	16	24	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	JJ	0	17	18	1	full	17	17	18	0	JJ	0	18	19	1	transcriptional	18	18	19	0	NN	0	19	20	1	activity	19	19	20	0	PP	0	20	24	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	14
Phosphorylation	10913	10928	NN	phosphorylation	O	_	_
of	10929	10931	IN	of	O	_	_
ASPP2	10932	10937	NN	aspp2	B-GENE	_	_
by	10938	10940	IN	by	O	_	_
the	10941	10944	DT	the	O	_	_
Raf	10945	10948	NN	raf	B-GENE	_	_
/	10948	10949	:	/	B-GENE	_	_
MAPK	10949	10953	NN	mapk	I-GENE	_	_
pathway	10954	10961	NN	pathway	O	_	_
enhances	10962	10970	VBZ	enhance	O	_	_
p53	10971	10974	NN	p53	B-GENE	_	_
mediated	10975	10983	JJ	mediated	O	_	_
transactivation	10984	10999	NN	transactivation	O	_	_
.	10999	11000	.	.	O	_	_
D	1
0
0	2	prep_of
0	5	prep_by
0	6	punct
0	9	dep
5	4	det
8	7	nn
9	8	nsubj
9	12	dobj
12	10	nn
12	11	amod
EOX
Y	1
ROOT	0	0	14	1	FRAG	0	0	14	4	NP	0	0	6	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	by	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	Raf	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	13	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	13	2	VBZ	0	9	10	1	enhances	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	p53	10	10	11	0	JJ	0	11	12	1	mediated	11	11	12	0	NN	0	12	13	1	transactivation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	23
(	11001	11002	NN	(	O	_	_
A	11002	11003	NN	a	O	_	_
)	11003	11004	CD	)	O	_	_
Saos2	11005	11010	NN	saos2	O	_	_
cells	11011	11016	NNS	cell	O	_	_
were	11017	11021	VBD	be	O	_	_
transfected	11022	11033	VBN	transfect	O	_	_
with	11034	11038	IN	with	O	_	_
p53	11039	11042	NN	p53	B-GENE	_	_
and	11043	11046	CC	and	O	_	_
either	11047	11053	CC	either	O	_	_
wild-type	11054	11063	JJ	wild-type	O	_	_
or	11064	11066	CC	or	O	_	_
mutant	11067	11073	JJ	mutant	O	_	_
ASPP2	11074	11079	NN	aspp2	O	_	_
as	11080	11082	IN	as	O	_	_
indicated	11083	11092	VBN	indicate	O	_	_
together	11093	11101	RB	together	O	_	_
with	11102	11106	IN	with	O	_	_
a	11107	11108	DT	a	O	_	_
Bax-luciferase	11109	11123	NN	bax-luciferase	B-GENE	_	_
reporter	11124	11132	NN	reporter	I-GENE	_	_
.	11132	11133	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	16	conj_and
11	10	preconj
11	14	conj_or
14	13	amod
14	15	amod
16	11	nsubj
16	14	nsubj
16	21	prep_together_with
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	1	10	16	4	CC	0	10	11	1	either	10	10	11	0	NP	0	11	12	1	JJ	0	11	12	1	wild-type	11	11	12	0	CC	0	12	13	1	or	12	12	13	0	NP	1	13	16	3	JJ	0	13	14	1	mutant	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	VP	0	16	22	3	VBN	0	16	17	1	indicated	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	together	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	with	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	Bax-luciferase	20	20	21	0	NN	0	21	22	1	reporter	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	9
Luciferase	11134	11144	NN	luciferase	B-GENE	_	_
activity	11145	11153	NN	activity	O	_	_
is	11154	11156	VBZ	be	O	_	_
shown	11157	11162	VBN	show	O	_	_
following	11163	11172	VBG	follow	O	_	_
harvesting	11173	11183	NN	harvesting	O	_	_
of	11184	11186	IN	of	O	_	_
cells	11187	11192	NNS	cell	O	_	_
.	11192	11193	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	5	prep_following
5	7	prep_of
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	VBG	0	4	5	1	following	4	4	5	0	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	harvesting	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	cells	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Values	11194	11200	NNS	value	O	_	_
are	11201	11204	VBP	be	O	_	_
Relative	11205	11213	JJ	relative	O	_	_
Light	11214	11219	JJ	light	O	_	_
Units	11220	11225	NNS	unit	O	_	_
(	11226	11227	VBP	(	O	_	_
RLU	11227	11230	NN	rlu	O	_	_
)	11230	11231	NN	)	O	_	_
.	11231	11232	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
4	3	amod
5	4	nsubj
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Values	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	Relative	2	2	3	0	SBAR	0	3	8	1	S	1	3	8	2	NP	1	3	5	2	JJ	0	3	4	1	Light	3	3	4	0	NNS	0	4	5	1	Units	4	4	5	0	VP	0	5	8	2	VBP	0	5	6	1	-LRB-	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	RLU	6	6	7	0	NN	0	7	8	1	-RRB-	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	28
(	11233	11234	NN	(	O	_	_
B	11234	11235	NN	b	O	_	_
)	11235	11236	CD	)	O	_	_
Saos2	11237	11242	NN	saos2	O	_	_
cells	11243	11248	NNS	cell	O	_	_
were	11249	11253	VBD	be	O	_	_
transfected	11254	11265	VBN	transfect	O	_	_
with	11266	11270	IN	with	O	_	_
p53	11271	11274	NN	p53	B-GENE	_	_
,	11274	11275	,	,	O	_	_
constitutively	11276	11290	RB	constitutively	O	_	_
active	11291	11297	JJ	active	O	_	_
Raf	11298	11301	NN	raf	B-GENE	_	_
CAAX	11302	11306	NN	caax	I-GENE	_	_
and	11307	11310	CC	and	O	_	_
either	11311	11317	CC	either	O	_	_
wild-type	11318	11327	JJ	wild-type	O	_	_
or	11328	11330	CC	or	O	_	_
mutant	11331	11337	JJ	mutant	O	_	_
ASPP2	11338	11343	NN	aspp2	O	_	_
as	11344	11346	IN	as	O	_	_
indicated	11347	11356	VBN	indicate	O	_	_
together	11357	11365	RB	together	O	_	_
with	11366	11370	IN	with	O	_	_
a	11371	11372	DT	a	O	_	_
Bax-luciferase	11373	11387	NN	bax-luciferase	B-GENE	_	_
reporter	11388	11396	NN	reporter	I-GENE	_	_
.	11396	11397	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	21	advcl
8	13	appos
8	19	appos
11	10	advmod
13	11	amod
13	12	nn
13	19	conj_and
16	15	preconj
16	18	conj_or
19	16	amod
19	18	amod
21	20	mark
21	26	prep_together_with
26	24	det
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	27	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	27	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	20	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	20	3	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	20	3	NP	2	10	14	3	ADJP	1	10	12	2	RB	0	10	11	1	constitutively	10	10	11	0	JJ	0	11	12	1	active	11	11	12	0	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	1	15	20	2	ADJP	1	15	19	4	CC	0	15	16	1	either	15	15	16	0	JJ	0	16	17	1	wild-type	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	JJ	0	18	19	1	mutant	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	SBAR	1	20	27	2	IN	0	20	21	1	as	20	20	21	0	S	0	21	27	1	VP	0	21	27	3	VBN	0	21	22	1	indicated	21	21	22	0	ADVP	0	22	23	1	RB	0	22	23	1	together	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	with	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	a	24	24	25	0	NN	0	25	26	1	Bax-luciferase	25	25	26	0	NN	0	26	27	1	reporter	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	36
**	11398	11400	SYM	**	O	_	_
P	11401	11402	NN	p	O	_	_
=	11402	11403	JJ	=	O	_	_
0.013	11403	11408	CD	0.013	O	_	_
;	11408	11409	:	;	O	_	_
****	11410	11414	CD	****	O	_	_
P	11415	11416	NN	p	O	_	_
=	11416	11417	JJ	=	O	_	_
0.0001	11417	11423	CD	0.0001	O	_	_
(	11424	11425	NN	(	O	_	_
C	11425	11426	NN	c	O	_	_
)	11426	11427	CD	)	O	_	_
Saos2	11428	11433	NN	saos2	O	_	_
cells	11434	11439	NNS	cell	O	_	_
were	11440	11444	VBD	be	O	_	_
transfected	11445	11456	VBN	transfect	O	_	_
with	11457	11461	IN	with	O	_	_
a	11462	11463	DT	a	O	_	_
Bax-luciferase	11464	11478	NN	bax-luciferase	B-GENE	_	_
reporter	11479	11487	NN	reporter	I-GENE	_	_
,	11487	11488	,	,	O	_	_
ASPP2	11489	11494	NN	aspp2	B-GENE	_	_
and	11495	11498	CC	and	O	_	_
p53	11499	11502	NN	p53	B-GENE	_	_
and	11503	11506	CC	and	O	_	_
treated	11507	11514	VBN	treat	O	_	_
with	11515	11519	IN	with	O	_	_
20	11520	11522	CD	20	O	_	_
microM	11523	11529	NN	microm	O	_	_
UO126	11530	11535	NN	uo126	O	_	_
or	11536	11538	CC	or	O	_	_
DMSO	11539	11543	NN	dmso	O	_	_
for	11544	11547	IN	for	O	_	_
20	11548	11550	CD	20	O	_	_
hours	11551	11556	NNS	hour	O	_	_
.	11556	11557	.	.	O	_	_
D	1
6
1	0	dep
1	3	dep
3	2	amod
6	1	dep
6	5	num
6	10	rcmod
9	7	amod
9	8	num
10	15	ccomp
10	25	ccomp
13	12	nn
15	13	nsubjpass
15	14	auxpass
15	19	prep_with
15	21	prep_with
15	23	prep_with
15	25	conj_and
19	17	det
19	18	nn
19	21	conj_and
19	23	conj_and
25	13	nsubjpass
25	29	prep_with
25	31	prep_with
25	34	prep_for
29	27	num
29	28	nn
29	31	conj_or
34	33	num
EOX
Y	1
ROOT	0	0	36	1	FRAG	2	0	36	4	X	1	0	4	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	4	2	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.013	3	3	4	0	:	0	4	5	1	;	4	4	5	0	NP	0	5	35	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	SBAR	0	7	35	1	S	1	7	35	2	NP	2	7	10	3	JJ	0	7	8	1	=	7	7	8	0	CD	0	8	9	1	0.0001	8	8	9	0	NN	0	9	10	1	-LRB-	9	9	10	0	VP	0	10	35	2	NN	0	10	11	1	C	10	10	11	0	SBAR	0	11	35	1	S	1	11	35	2	NP	2	11	14	3	CD	0	11	12	1	-RRB-	11	11	12	0	NN	0	12	13	1	Saos2	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	1	14	35	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	35	3	VP	0	15	24	2	VBN	0	15	16	1	transfected	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	with	16	16	17	0	NP	2	17	24	7	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	Bax-luciferase	18	18	19	0	NN	0	19	20	1	reporter	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NN	0	21	22	1	ASPP2	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NN	0	23	24	1	p53	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	VP	0	25	35	3	VBN	0	25	26	1	treated	25	25	26	0	PP	0	26	32	2	IN	0	26	27	1	with	26	26	27	0	NP	0	27	32	3	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	microM	28	28	29	0	NN	0	29	30	1	UO126	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	DMSO	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	for	32	32	33	0	NP	1	33	35	2	CD	0	33	34	1	20	33	33	34	0	NNS	0	34	35	1	hours	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	21
Luciferase	11558	11568	NN	luciferase	B-GENE	_	_
activity	11569	11577	NN	activity	O	_	_
is	11578	11580	VBZ	be	O	_	_
shown	11581	11586	VBN	show	O	_	_
in	11587	11589	IN	in	O	_	_
the	11590	11593	DT	the	O	_	_
left	11594	11598	JJ	left	O	_	_
panel	11599	11604	NN	panel	O	_	_
and	11605	11608	CC	and	O	_	_
protein	11609	11616	NN	protein	O	_	_
expression	11617	11627	NN	expression	O	_	_
was	11628	11631	VBD	be	O	_	_
verified	11632	11640	VBN	verify	O	_	_
by	11641	11643	IN	by	O	_	_
Western	11644	11651	JJ	western	O	_	_
Blot	11652	11656	NN	blot	O	_	_
(	11657	11658	RB	(	O	_	_
right	11658	11663	JJ	right	O	_	_
panel	11664	11669	NN	panel	O	_	_
)	11669	11670	NN	)	O	_	_
.	11670	11671	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
3	12	conj_and
7	5	det
7	6	amod
10	9	nn
12	10	nsubjpass
12	11	auxpass
12	13	prep
15	14	amod
19	15	nn
19	17	amod
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	4	S	1	0	8	2	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	left	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	20	2	NP	1	9	11	2	NN	0	9	10	1	protein	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	VP	1	11	20	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	20	2	VBN	0	12	13	1	verified	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	by	13	13	14	0	NP	3	14	20	4	NP	1	14	16	2	JJ	0	14	15	1	Western	14	14	15	0	NN	0	15	16	1	Blot	15	15	16	0	ADJP	1	16	18	2	RB	0	16	17	1	-LRB-	16	16	17	0	JJ	0	17	18	1	right	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	-RRB-	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	5
****	11672	11676	NN	****	O	_	_
P	11677	11678	NN	p	O	_	_
=	11678	11679	JJ	=	O	_	_
0.0001	11679	11685	CD	0.0001	O	_	_
.	11685	11686	.	.	O	_	_
D	1
1
1	0	nn
1	3	num
3	2	quantmod
EOX
Y	1
ROOT	0	0	5	1	NP	0	0	5	3	NP	1	0	2	2	NN	0	0	1	1	****	0	0	1	0	NN	0	1	2	1	P	1	1	2	0	QP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.0001	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	22
To	11687	11689	TO	to	O	_	_
determine	11690	11699	VB	determine	O	_	_
the	11700	11703	DT	the	O	_	_
effect	11704	11710	NN	effect	O	_	_
of	11711	11713	IN	of	O	_	_
MAPK	11714	11718	NN	mapk	B-GENE	_	_
phosphorylation	11719	11734	NN	phosphorylation	O	_	_
on	11735	11737	IN	on	O	_	_
endogenous	11738	11748	JJ	endogenous	O	_	_
ASPP2	11749	11754	NN	aspp2	B-GENE	_	_
activity	11755	11763	NN	activity	O	_	_
,	11763	11764	,	,	O	_	_
cells	11765	11770	NNS	cell	O	_	_
were	11771	11775	VBD	be	O	_	_
treated	11776	11783	VBN	treat	O	_	_
with	11784	11788	IN	with	O	_	_
a	11789	11790	DT	a	O	_	_
MAPK	11791	11795	NN	mapk	B-GENE	_	_
inhibitor	11796	11805	NN	inhibitor	O	_	_
,	11805	11806	,	,	O	_	_
UO126	11807	11812	NN	uo126	O	_	_
.	11812	11813	.	.	O	_	_
D	1
14
1	0	aux
1	3	dobj
1	10	prep_on
3	2	det
3	6	prep_of
6	5	nn
10	8	amod
10	9	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	18	prep_with
18	16	det
18	17	nn
18	20	appos
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	S	0	0	11	1	VP	1	0	11	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	11	3	VB	0	1	2	1	determine	1	1	2	0	NP	0	2	7	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	effect	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	MAPK	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	on	7	7	8	0	NP	2	8	11	3	JJ	0	8	9	1	endogenous	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	NN	0	10	11	1	activity	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	treated	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	21	3	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	NN	0	17	18	1	MAPK	17	17	18	0	NN	0	18	19	1	inhibitor	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	UO126	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	36
Inhibiting	11814	11824	VBG	inhibit	O	_	_
MAPK	11825	11829	NN	mapk	O	_	_
resulted	11830	11838	VBD	result	O	_	_
in	11839	11841	IN	in	O	_	_
a	11842	11843	DT	a	O	_	_
significant	11844	11855	JJ	significant	O	_	_
decrease	11856	11864	NN	decrease	O	_	_
in	11865	11867	IN	in	O	_	_
the	11868	11871	DT	the	O	_	_
ability	11872	11879	NN	ability	O	_	_
of	11880	11882	IN	of	O	_	_
ASPP2	11883	11888	NN	aspp2	B-GENE	_	_
to	11889	11891	TO	to	O	_	_
enhance	11892	11899	VB	enhance	O	_	_
the	11900	11903	DT	the	O	_	_
transcriptional	11904	11919	JJ	transcriptional	O	_	_
activity	11920	11928	NN	activity	O	_	_
of	11929	11931	IN	of	O	_	_
p53	11932	11935	NN	p53	B-GENE	_	_
compared	11936	11944	VBN	compare	O	_	_
to	11945	11947	TO	to	O	_	_
the	11948	11951	DT	the	O	_	_
control	11952	11959	NN	control	O	_	_
cells	11960	11965	NNS	cell	O	_	_
,	11977	11978	,	,	O	_	_
further	11979	11986	RB	further	O	_	_
validating	11987	11997	VBG	validate	O	_	_
the	11998	12001	DT	the	O	_	_
functional	12002	12012	JJ	functional	O	_	_
role	12013	12017	NN	role	O	_	_
of	12018	12020	IN	of	O	_	_
ASPP2	12021	12026	NN	aspp2	B-GENE	_	_
phosphorylation	12027	12042	NN	phosphorylation	O	_	_
by	12043	12045	IN	by	O	_	_
MAPK	12046	12050	NN	mapk	O	_	_
.	12050	12051	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	6	prep_in
2	13	xcomp
2	26	xcomp
6	4	det
6	5	amod
6	9	prep_in
9	8	det
9	11	prep_of
13	12	aux
13	16	dobj
13	20	prepc_compared_to
13	23	pobj
16	14	det
16	15	amod
16	18	prep_of
23	21	det
23	22	nn
26	25	advmod
26	29	dobj
26	34	prep_by
29	27	det
29	28	amod
29	32	prep_of
32	31	nn
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	1	0	2	2	VBG	0	0	1	1	Inhibiting	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	35	5	VBD	0	2	3	1	resulted	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	12	2	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	significant	5	5	6	0	NN	0	6	7	1	decrease	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	in	7	7	8	0	NP	0	8	12	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	ability	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	24	1	VP	1	12	24	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	24	3	VB	0	13	14	1	enhance	13	13	14	0	NP	0	14	19	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	JJ	0	15	16	1	transcriptional	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	PP	0	19	24	2	VBN	0	19	20	1	compared	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	2	21	24	3	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	control	22	22	23	0	NNS	0	23	24	1	cells	23	23	24	0	,	0	24	25	1	,	24	24	25	0	S	1	25	35	2	ADVP	0	25	26	1	RB	0	25	26	1	further	25	25	26	0	VP	0	26	35	3	VBG	0	26	27	1	validating	26	26	27	0	NP	0	27	33	2	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	ADJP	0	28	29	1	JJ	0	28	29	1	functional	28	28	29	0	NN	0	29	30	1	role	29	29	30	0	PP	0	30	33	2	IN	0	30	31	1	of	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	ASPP2	31	31	32	0	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	by	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	MAPK	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	18
Moreover	12052	12060	RB	moreover	O	_	_
,	12060	12061	,	,	O	_	_
another	12062	12069	DT	another	O	_	_
MAPK	12070	12074	NN	mapk	B-GENE	_	_
inhibitor	12075	12084	NN	inhibitor	O	_	_
,	12084	12085	,	,	O	_	_
PD	12086	12088	NN	pd	O	_	_
98059	12089	12094	CD	98059	O	_	_
,	12094	12095	,	,	O	_	_
also	12096	12100	RB	also	O	_	_
inhibited	12101	12110	VBD	inhibit	O	_	_
ASPP2	12111	12116	NN	aspp2	B-GENE	_	_
function	12117	12125	NN	function	O	_	_
to	12126	12128	TO	to	O	_	_
a	12129	12130	DT	a	O	_	_
similar	12131	12138	JJ	similar	O	_	_
extent	12139	12145	NN	extent	O	_	_
.	12157	12158	.	.	O	_	_
D	1
10
4	2	det
4	3	nn
4	6	appos
6	7	num
10	0	advmod
10	4	nsubj
10	9	advmod
10	12	dobj
10	16	prep_to
12	11	nn
16	14	det
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	S	4	0	18	6	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	9	4	NP	2	2	5	3	DT	0	2	3	1	another	2	2	3	0	NN	0	3	4	1	MAPK	3	3	4	0	NN	0	4	5	1	inhibitor	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	8	2	NN	0	6	7	1	PD	6	6	7	0	CD	0	7	8	1	98059	7	7	8	0	,	0	8	9	1	,	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	0	10	17	3	VBD	0	10	11	1	inhibited	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	ASPP2	11	11	12	0	NN	0	12	13	1	function	12	12	13	0	PP	0	13	17	2	TO	0	13	14	1	to	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	JJ	0	15	16	1	similar	15	15	16	0	NN	0	16	17	1	extent	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	32
Interestingly	12159	12172	RB	interestingly	O	_	_
,	12172	12173	,	,	O	_	_
the	12174	12177	DT	the	O	_	_
endogenous	12178	12188	JJ	endogenous	B-GENE	_	_
ASPP2	12189	12194	NN	aspp2	I-GENE	_	_
protein	12195	12202	NN	protein	I-GENE	_	_
level	12203	12208	NN	level	O	_	_
was	12209	12212	VBD	be	O	_	_
slightly	12213	12221	RB	slightly	O	_	_
decreased	12222	12231	VBN	decrease	O	_	_
following	12232	12241	VBG	follow	O	_	_
RAS	12242	12245	NN	ra	B-GENE	_	_
/	12245	12246	:	/	B-GENE	_	_
MAPK	12246	12250	NN	mapk	I-GENE	_	_
pathway	12251	12258	NN	pathway	O	_	_
inhibition	12259	12269	NN	inhibition	O	_	_
by	12270	12272	IN	by	O	_	_
UO126	12273	12278	NN	uo126	O	_	_
treatment	12279	12288	NN	treatment	O	_	_
while	12314	12319	IN	while	O	_	_
RAS	12320	12323	NN	ra	B-GENE	_	_
/	12323	12324	:	/	B-GENE	_	_
MAPK	12324	12328	NN	mapk	I-GENE	_	_
pathway	12329	12336	NN	pathway	O	_	_
activation	12337	12347	NN	activation	O	_	_
resulted	12348	12356	VBD	result	O	_	_
in	12357	12359	IN	in	O	_	_
the	12360	12363	DT	the	O	_	_
increased	12364	12373	VBN	increase	O	_	_
ASPP2	12374	12379	NN	aspp2	B-GENE	_	_
expression	12380	12390	NN	expression	O	_	_
.	12414	12415	.	.	O	_	_
D	1
9
6	2	det
6	3	amod
6	4	nn
6	5	nn
9	0	advmod
9	6	nsubjpass
9	7	auxpass
9	8	advmod
9	11	prep_following
11	15	dep
11	25	rcmod
15	12	punct
15	13	nn
15	14	nn
15	18	prep_by
15	21	punct
18	17	nn
18	20	prep_while
24	22	nn
24	23	nn
25	24	nsubj
25	30	prep_in
30	27	det
30	28	amod
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	3	0	32	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	4	2	7	5	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	protein	5	5	6	0	NN	0	6	7	1	level	6	6	7	0	VP	2	7	31	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	slightly	8	8	9	0	VP	0	9	31	2	VBN	0	9	10	1	decreased	9	9	10	0	PP	0	10	31	2	VBG	0	10	11	1	following	10	10	11	0	NP	0	11	31	2	NP	0	11	22	2	NP	0	11	12	1	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	22	3	:	0	12	13	1	/	12	12	13	0	NP	0	13	21	2	NP	2	13	16	3	NN	0	13	14	1	MAPK	13	13	14	0	NN	0	14	15	1	pathway	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	21	2	NP	1	17	19	2	NN	0	17	18	1	UO126	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	while	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	RAS	20	20	21	0	:	0	21	22	1	/	21	21	22	0	SBAR	0	22	31	1	S	1	22	31	2	NP	2	22	25	3	NN	0	22	23	1	MAPK	22	22	23	0	NN	0	23	24	1	pathway	23	23	24	0	NN	0	24	25	1	activation	24	24	25	0	VP	0	25	31	2	VBD	0	25	26	1	resulted	25	25	26	0	PP	0	26	31	2	IN	0	26	27	1	in	26	26	27	0	NP	3	27	31	4	DT	0	27	28	1	the	27	27	28	0	VBN	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	ASPP2	29	29	30	0	NN	0	30	31	1	expression	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	26
The	12416	12419	DT	the	O	_	_
mRNA	12420	12424	NN	mrna	O	_	_
level	12425	12430	NN	level	O	_	_
of	12431	12433	IN	of	O	_	_
ASPP2	12434	12439	NN	aspp2	B-GENE	_	_
was	12440	12443	VBD	be	O	_	_
not	12444	12447	RB	not	O	_	_
affected	12448	12456	VBN	affect	O	_	_
upon	12457	12461	IN	upon	O	_	_
RAS	12462	12465	NN	ra	B-GENE	_	_
/	12465	12466	:	/	B-GENE	_	_
MAPK	12466	12470	NN	mapk	I-GENE	_	_
pathway	12471	12478	NN	pathway	O	_	_
activation	12479	12489	NN	activation	O	_	_
,	12502	12503	,	,	O	_	_
indicating	12504	12514	VBG	indicate	O	_	_
that	12515	12519	IN	that	O	_	_
the	12520	12523	DT	the	O	_	_
regulation	12524	12534	NN	regulation	O	_	_
is	12535	12537	VBZ	be	O	_	_
not	12538	12541	RB	not	O	_	_
at	12542	12544	IN	at	O	_	_
the	12545	12548	DT	the	O	_	_
transcriptional	12549	12564	JJ	transcriptional	O	_	_
level	12565	12570	NN	level	O	_	_
.	12570	12571	.	.	O	_	_
D	1
7
2	0	det
2	1	nn
2	4	prep_of
7	2	nsubjpass
7	5	auxpass
7	6	neg
7	15	prepc_upon
9	12	dep
9	13	dep
12	10	punct
12	11	nn
15	9	nsubj
15	19	ccomp
18	17	det
19	16	mark
19	18	nsubj
19	20	neg
19	24	prep_at
24	22	det
24	23	amod
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mRNA	1	1	2	0	NN	0	2	3	1	level	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	2	5	25	3	VBD	0	5	6	1	was	5	5	6	0	RB	0	6	7	1	not	6	6	7	0	VP	0	7	25	2	VBN	0	7	8	1	affected	7	7	8	0	PP	0	8	25	2	IN	0	8	9	1	upon	8	8	9	0	S	1	9	25	2	NP	0	9	15	4	NP	0	9	10	1	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	13	2	:	0	10	11	1	/	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	activation	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	25	2	VBG	0	15	16	1	indicating	15	15	16	0	SBAR	1	16	25	2	IN	0	16	17	1	that	16	16	17	0	S	1	17	25	2	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	regulation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	is	19	19	20	0	RB	0	20	21	1	not	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	at	21	21	22	0	NP	2	22	25	3	DT	0	22	23	1	the	22	22	23	0	JJ	0	23	24	1	transcriptional	23	23	24	0	NN	0	24	25	1	level	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	19
Thus	12572	12576	RB	thus	O	_	_
we	12577	12579	PRP	we	O	_	_
investigated	12580	12592	VBD	investigate	O	_	_
whether	12593	12600	IN	whether	O	_	_
RAS	12601	12604	NNP	RAS	B-GENE	_	_
/	12604	12605	:	/	B-GENE	_	_
MAPK	12605	12609	NN	mapk	I-GENE	_	_
pathway	12610	12617	NN	pathway	O	_	_
activation	12618	12628	NN	activation	O	_	_
could	12629	12634	MD	could	O	_	_
result	12635	12641	VB	result	O	_	_
in	12642	12644	IN	in	O	_	_
the	12645	12648	DT	the	O	_	_
increased	12649	12658	VBN	increase	O	_	_
protein	12659	12666	NN	protein	O	_	_
stability	12667	12676	NN	stability	O	_	_
of	12677	12679	IN	of	O	_	_
ASPP2	12680	12685	NN	aspp2	B-GENE	_	_
.	12685	12686	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	4	dep
4	3	mark
4	5	punct
4	10	dep
8	6	nn
8	7	nn
10	8	nsubj
10	9	aux
10	15	prep_in
15	12	det
15	13	amod
15	14	nn
15	17	prep_of
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	18	2	VBD	0	2	3	1	investigated	2	2	3	0	SBAR	1	3	18	2	IN	0	3	4	1	whether	3	3	4	0	FRAG	0	4	18	3	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	:	0	5	6	1	/	5	5	6	0	S	1	6	18	2	NP	2	6	9	3	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	VP	1	9	18	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	18	2	VB	0	10	11	1	result	10	10	11	0	PP	0	11	18	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	18	2	NP	3	12	16	4	DT	0	12	13	1	the	12	12	13	0	VBN	0	13	14	1	increased	13	13	14	0	NN	0	14	15	1	protein	14	14	15	0	NN	0	15	16	1	stability	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	21
The	12687	12690	DT	the	O	_	_
ASPP2	12691	12696	NN	aspp2	B-GENE	_	_
protein	12697	12704	NN	protein	I-GENE	_	_
levels	12705	12711	NNS	level	O	_	_
in	12712	12714	IN	in	O	_	_
the	12715	12718	DT	the	O	_	_
presence	12719	12727	NN	presence	O	_	_
or	12728	12730	CC	or	O	_	_
absence	12731	12738	NN	absence	O	_	_
of	12739	12741	IN	of	O	_	_
oncogenic	12742	12751	JJ	oncogenic	O	_	_
RAS	12752	12755	NN	ra	O	_	_
were	12756	12760	VBD	be	O	_	_
measured	12761	12769	VBN	measure	O	_	_
after	12770	12775	IN	after	O	_	_
cycloheximide	12776	12789	NN	cycloheximide	O	_	_
(	12790	12791	CD	(	O	_	_
CHX	12791	12794	NNP	CHX	O	_	_
)	12794	12795	CD	)	O	_	_
addition	12796	12804	NN	addition	O	_	_
.	12823	12824	.	.	O	_	_
D	1
13
3	0	det
3	1	nn
3	2	nn
3	6	prep_in
3	8	prep_in
6	5	det
6	8	conj_or
6	11	prep_of
11	10	amod
13	3	nsubjpass
13	12	auxpass
13	17	prep_after
17	15	nn
17	19	dep
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	12	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NN	0	2	3	1	protein	2	2	3	0	NNS	0	3	4	1	levels	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	12	2	NP	1	5	9	4	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	presence	6	6	7	0	CC	0	7	8	1	or	7	7	8	0	NN	0	8	9	1	absence	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	oncogenic	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	VP	1	12	20	2	VBD	0	12	13	1	were	12	12	13	0	VP	0	13	20	2	VBN	0	13	14	1	measured	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	after	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	NN	0	15	16	1	cycloheximide	15	15	16	0	CD	0	16	17	1	-LRB-	16	16	17	0	NNP	0	17	18	1	CHX	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	-RRB-	18	18	19	0	NN	0	19	20	1	addition	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	49
ASPP2	12825	12830	NN	aspp2	B-GENE	_	_
was	12831	12834	VBD	be	O	_	_
a	12835	12836	DT	a	O	_	_
bit	12837	12840	NN	bit	O	_	_
more	12841	12845	RBR	more	O	_	_
s	12846	12847	NNS	s	O	_	_
oncogenic	12858	12867	JJ	oncogenic	O	_	_
RAS	12868	12871	NN	ra	O	_	_
is	12872	12874	VBZ	be	O	_	_
induced	12875	12882	VBN	induce	O	_	_
in	12883	12885	IN	in	O	_	_
HKe3	12886	12890	NN	hke3	B-GENE	_	_
ER	12891	12893	NN	er	I-GENE	_	_
:	12893	12894	:	:	O	_	_
HRASV12	12894	12901	NN	hrasv12	O	_	_
cells	12902	12907	NNS	cell	O	_	_
or	12921	12923	CC	or	O	_	_
co	12924	12926	NN	co	O	_	_
transfected	12927	12938	VBN	transfect	O	_	_
in	12939	12941	IN	in	O	_	_
Saos2	12942	12947	NN	saos2	O	_	_
cells	12948	12953	NNS	cell	O	_	_
:	12966	12967	:	:	O	_	_
ASPP2	12968	12973	NN	aspp2	B-GENE	_	_
levels	12974	12980	NNS	level	O	_	_
were	12981	12985	VBD	be	O	_	_
considerably	12986	12998	RB	considerably	O	_	_
decreased	12999	13008	VBN	decrease	O	_	_
without	13009	13016	IN	without	O	_	_
oncogenic	13017	13026	JJ	oncogenic	O	_	_
RAS	13027	13030	NN	ra	O	_	_
,	13030	13031	,	,	O	_	_
while	13032	13037	IN	while	O	_	_
in	13038	13040	IN	in	O	_	_
the	13041	13044	DT	the	O	_	_
presence	13045	13053	NN	presence	O	_	_
of	13054	13056	IN	of	O	_	_
HRAS	13057	13061	NNP	HRAS	B-GENE	_	_
V12	13062	13065	NNP	V12	I-GENE	_	_
,	13065	13066	,	,	O	_	_
ASPP2	13067	13072	NN	aspp2	B-GENE	_	_
protein	13073	13080	NN	protein	I-GENE	_	_
levels	13081	13087	NNS	level	O	_	_
remained	13088	13096	VBD	remain	O	_	_
high	13097	13101	JJ	high	O	_	_
after	13102	13107	IN	after	O	_	_
CHX	13108	13111	NN	chx	O	_	_
treatment	13112	13121	NN	treatment	O	_	_
.	13121	13122	.	.	O	_	_
D	1
5
3	2	det
4	3	npadvmod
5	0	nsubj
5	1	cop
5	4	advmod
5	9	rcmod
5	18	parataxis
5	27	parataxis
7	6	amod
9	7	nsubjpass
9	8	auxpass
9	12	prep_in
12	11	nn
15	14	nn
15	17	conj_or
18	15	nsubj
18	17	nsubj
18	21	prep_in
21	20	nn
24	23	nn
27	24	nsubjpass
27	25	auxpass
27	26	advmod
27	30	prep_without
27	44	advcl
30	29	amod
35	34	det
35	38	prep_of
38	37	nn
42	40	nn
42	41	nn
44	32	mark
44	35	prep_in
44	42	nsubj
44	43	cop
44	47	prep_after
47	46	nn
EOX
Y	1
ROOT	0	0	49	1	S	0	0	49	6	S	1	0	13	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	13	3	VBD	0	1	2	1	was	1	1	2	0	ADVP	1	2	5	2	NP	1	2	4	2	DT	0	2	3	1	a	2	2	3	0	NN	0	3	4	1	bit	3	3	4	0	RBR	0	4	5	1	more	4	4	5	0	NP	0	5	13	2	NP	0	5	6	1	NNS	0	5	6	1	s	5	5	6	0	SBAR	0	6	13	1	S	1	6	13	2	NP	1	6	8	2	JJ	0	6	7	1	oncogenic	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	1	8	13	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	13	2	VBN	0	9	10	1	induced	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	S	1	14	22	2	NP	1	14	18	4	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NN	0	17	18	1	co	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	Saos2	20	20	21	0	NNS	0	21	22	1	cells	21	21	22	0	:	0	22	23	1	:	22	22	23	0	S	1	23	48	2	NP	1	23	25	2	NN	0	23	24	1	ASPP2	23	23	24	0	NNS	0	24	25	1	levels	24	24	25	0	VP	1	25	48	2	VBD	0	25	26	1	were	25	25	26	0	VP	1	26	48	5	ADVP	0	26	27	1	RB	0	26	27	1	considerably	26	26	27	0	VBN	0	27	28	1	decreased	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	without	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	oncogenic	29	29	30	0	NN	0	30	31	1	RAS	30	30	31	0	,	0	31	32	1	,	31	31	32	0	SBAR	1	32	48	2	IN	0	32	33	1	while	32	32	33	0	S	3	33	48	4	PP	0	33	39	2	IN	0	33	34	1	in	33	33	34	0	NP	0	34	39	2	NP	1	34	36	2	DT	0	34	35	1	the	34	34	35	0	NN	0	35	36	1	presence	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	of	36	36	37	0	NP	1	37	39	2	NNP	0	37	38	1	HRAS	37	37	38	0	NNP	0	38	39	1	V12	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	2	40	43	3	NN	0	40	41	1	ASPP2	40	40	41	0	NN	0	41	42	1	protein	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	VP	1	43	48	3	VBD	0	43	44	1	remained	43	43	44	0	ADJP	0	44	45	1	JJ	0	44	45	1	high	44	44	45	0	PP	0	45	48	2	IN	0	45	46	1	after	45	45	46	0	NP	1	46	48	2	NN	0	46	47	1	CHX	46	46	47	0	NN	0	47	48	1	treatment	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	29
These	13123	13128	DT	these	O	_	_
data	13129	13133	NNS	datum	O	_	_
indicate	13134	13142	VBP	indicate	O	_	_
that	13143	13147	IN	that	O	_	_
ASPP2	13148	13153	NN	aspp2	B-GENE	_	_
phosphorylation	13154	13169	NN	phosphorylation	O	_	_
by	13170	13172	IN	by	O	_	_
RAS	13173	13176	NN	ra	B-GENE	_	_
/	13176	13177	:	/	B-GENE	_	_
MAPK	13177	13181	NN	mapk	I-GENE	_	_
is	13182	13184	VBZ	be	O	_	_
necessary	13185	13194	JJ	necessary	O	_	_
for	13195	13198	IN	for	O	_	_
ASPP2	13199	13204	NN	aspp2	B-GENE	_	_
full	13205	13209	JJ	full	O	_	_
pro-apoptotic	13210	13223	JJ	pro-apoptotic	O	_	_
activity	13224	13232	NN	activity	O	_	_
and	13233	13236	CC	and	O	_	_
this	13237	13241	DT	this	O	_	_
may	13242	13245	MD	may	O	_	_
be	13246	13248	VB	be	O	_	_
mediated	13249	13257	VBN	mediate	O	_	_
by	13258	13260	IN	by	O	_	_
the	13261	13264	DT	the	O	_	_
stabilization	13265	13278	NN	stabilization	O	_	_
of	13279	13281	IN	of	O	_	_
ASPP2	13282	13287	NN	aspp2	B-GENE	_	_
protein	13288	13295	NN	protein	I-GENE	_	_
.	13295	13296	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	21	ccomp
5	4	nn
5	7	prep_by
5	11	dep
11	8	punct
11	9	nsubj
11	10	cop
11	16	prep_for
11	18	prep_for
16	13	nn
16	14	amod
16	15	amod
16	18	conj_and
21	3	mark
21	5	nsubjpass
21	19	aux
21	20	auxpass
21	24	agent
24	23	det
24	27	prep_of
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	28	2	VBP	0	2	3	1	indicate	2	2	3	0	SBAR	1	3	28	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	28	2	NP	0	4	19	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	RAS	7	7	8	0	PRN	1	8	19	2	:	0	8	9	1	/	8	8	9	0	S	1	9	19	2	NP	0	9	10	1	NN	0	9	10	1	MAPK	9	9	10	0	VP	1	10	19	2	VBZ	0	10	11	1	is	10	10	11	0	ADJP	0	11	19	2	JJ	0	11	12	1	necessary	11	11	12	0	PP	0	12	19	2	IN	0	12	13	1	for	12	12	13	0	NP	0	13	19	3	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	JJ	0	14	15	1	full	14	14	15	0	JJ	0	15	16	1	pro-apoptotic	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NP	0	18	19	1	DT	0	18	19	1	this	18	18	19	0	VP	1	19	28	2	MD	0	19	20	1	may	19	19	20	0	VP	1	20	28	2	VB	0	20	21	1	be	20	20	21	0	VP	0	21	28	2	VBN	0	21	22	1	mediated	21	21	22	0	PP	0	22	28	2	IN	0	22	23	1	by	22	22	23	0	NP	0	23	28	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	stabilization	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	of	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	protein	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	11
Ser827	13297	13303	NN	ser827	O	_	_
phosphorylation	13304	13319	NN	phosphorylation	O	_	_
is	13320	13322	VBZ	be	O	_	_
required	13323	13331	VBN	require	O	_	_
for	13332	13335	IN	for	O	_	_
RAS	13336	13339	NN	ra	B-GENE	_	_
induced	13340	13347	VBD	induce	O	_	_
translocation	13348	13361	NN	translocation	O	_	_
of	13362	13364	IN	of	O	_	_
ASPP2	13365	13370	NN	aspp2	B-GENE	_	_
.	13370	13371	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	6	advcl
6	4	mark
6	5	nsubj
6	7	dobj
7	9	prep_of
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	1	0	2	2	NN	0	0	1	1	Ser827	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	10	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	10	2	VBN	0	3	4	1	required	3	3	4	0	SBAR	1	4	10	2	IN	0	4	5	1	for	4	4	5	0	S	1	5	10	2	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	VP	0	6	10	2	VBD	0	6	7	1	induced	6	6	7	0	NP	0	7	10	2	NP	0	7	8	1	NN	0	7	8	1	translocation	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ASPP2	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	26
It	13372	13374	PRP	it	O	_	_
has	13375	13378	VBZ	have	O	_	_
recently	13379	13387	RB	recently	O	_	_
been	13388	13392	VBN	be	O	_	_
shown	13393	13398	VBN	show	O	_	_
that	13399	13403	IN	that	O	_	_
activation	13404	13414	NN	activation	O	_	_
of	13415	13417	IN	of	O	_	_
RAS	13418	13421	NN	ra	O	_	_
results	13422	13429	VBZ	result	O	_	_
in	13430	13432	IN	in	O	_	_
ASPP2	13433	13438	NN	aspp2	B-GENE	_	_
translocation	13439	13452	NN	translocation	O	_	_
from	13453	13457	IN	from	O	_	_
the	13458	13461	DT	the	O	_	_
plasma	13462	13468	NN	plasma	O	_	_
membrane	13469	13477	NN	membrane	O	_	_
to	13478	13480	TO	to	O	_	_
the	13481	13484	DT	the	O	_	_
cytosol	13485	13492	NN	cytosol	O	_	_
and	13493	13496	CC	and	O	_	_
nucleus	13497	13504	NN	nucleus	O	_	_
[	13505	13506	NN	[	O	_	_
2	13506	13507	CD	2	O	_	_
]	13507	13508	NN	]	O	_	_
.	13508	13509	.	.	O	_	_
D	1
4
4	0	nsubjpass
4	1	aux
4	2	advmod
4	3	auxpass
4	9	ccomp
6	8	prep_of
9	5	mark
9	6	nsubj
9	12	prep_in
9	22	prep_to
12	11	nn
12	16	prep_from
16	14	det
16	15	nn
19	21	conj_and
22	18	det
22	19	nn
22	21	nn
22	24	dep
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	2	1	25	3	VBZ	0	1	2	1	has	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	VP	1	3	25	2	VBN	0	3	4	1	been	3	3	4	0	VP	0	4	25	2	VBN	0	4	5	1	shown	4	4	5	0	SBAR	1	5	25	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	25	2	NP	0	6	9	2	NP	0	6	7	1	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	RAS	8	8	9	0	VP	0	9	25	3	VBZ	0	9	10	1	results	9	9	10	0	PP	0	10	17	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	17	2	NP	1	11	13	2	NN	0	11	12	1	ASPP2	11	11	12	0	NN	0	12	13	1	translocation	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	from	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	plasma	15	15	16	0	NN	0	16	17	1	membrane	16	16	17	0	PP	0	17	25	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	25	2	NP	2	18	23	3	DT	0	18	19	1	the	18	18	19	0	NP	0	19	22	3	NN	0	19	20	1	cytosol	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NN	0	21	22	1	nucleus	21	21	22	0	NN	0	22	23	1	[	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	2	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	16
We	13510	13512	PRP	we	O	_	_
therefore	13513	13522	RB	therefore	O	_	_
tested	13523	13529	VBD	test	O	_	_
whether	13530	13537	IN	whether	O	_	_
MAPK	13538	13542	NN	mapk	B-GENE	_	_
phosphorylation	13543	13558	NN	phosphorylation	O	_	_
at	13559	13561	IN	at	O	_	_
Ser827	13562	13568	NN	ser827	O	_	_
could	13569	13574	MD	could	O	_	_
affect	13575	13581	VB	affect	O	_	_
the	13582	13585	DT	the	O	_	_
cellular	13586	13594	JJ	cellular	O	_	_
localization	13595	13607	NN	localization	O	_	_
of	13608	13610	IN	of	O	_	_
ASPP2	13611	13616	NN	aspp2	B-GENE	_	_
.	13616	13617	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	9	ccomp
5	4	nn
5	7	prep_at
9	3	mark
9	5	nsubj
9	8	aux
9	12	dobj
12	10	det
12	11	amod
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	therefore	1	1	2	0	VP	0	2	15	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	15	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	15	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	at	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	Ser827	7	7	8	0	VP	1	8	15	2	MD	0	8	9	1	could	8	8	9	0	VP	0	9	15	2	VB	0	9	10	1	affect	9	9	10	0	NP	0	10	15	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	cellular	11	11	12	0	NN	0	12	13	1	localization	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	34
Interestingly	13618	13631	RB	interestingly	O	_	_
,	13631	13632	,	,	O	_	_
we	13633	13635	PRP	we	O	_	_
observed	13636	13644	VBD	observe	O	_	_
that	13645	13649	IN	that	O	_	_
in	13650	13652	IN	in	O	_	_
contrast	13653	13661	NN	contrast	O	_	_
to	13662	13664	TO	to	O	_	_
wild	13665	13669	JJ	wild	B-GENE	_	_
type	13670	13674	NN	type	I-GENE	_	_
ASPP2	13675	13680	NN	aspp2	I-GENE	_	_
,	13680	13681	,	,	O	_	_
ASPP2	13682	13687	NN	aspp2	B-GENE	_	_
(	13688	13689	CD	(	I-GENE	_	_
S827A	13689	13694	NN	s827a	I-GENE	_	_
)	13694	13695	NN	)	I-GENE	_	_
remains	13696	13703	VBZ	remain	O	_	_
at	13704	13706	IN	at	O	_	_
the	13707	13710	DT	the	O	_	_
plasma	13711	13717	NN	plasma	O	_	_
membrane	13718	13726	NN	membrane	O	_	_
following	13727	13736	VBG	follow	O	_	_
RAS	13737	13740	NN	ra	O	_	_
activation	13741	13751	NN	activation	O	_	_
by	13752	13754	IN	by	O	_	_
4-OHT	13755	13760	NN	4-oht	O	_	_
in	13761	13763	IN	in	O	_	_
the	13764	13767	DT	the	O	_	_
HKe3	13768	13772	NN	hke3	B-GENE	_	_
ER	13773	13775	NN	er	I-GENE	_	_
:	13775	13776	:	:	O	_	_
HRASV12	13776	13783	NN	hrasv12	O	_	_
system	13784	13790	NN	system	O	_	_
.	13802	13803	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	16	ccomp
6	9	prep_to
9	8	amod
15	10	nn
15	12	dep
15	14	nn
16	4	mark
16	6	prep_in
16	20	prep_at
20	18	det
20	19	nn
20	23	prep_following
23	22	nn
23	25	prep_by
25	29	prep_in
25	32	dep
29	27	det
29	28	nn
32	31	nn
EOX
Y	1
ROOT	0	0	34	1	S	3	0	34	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	33	2	VBD	0	3	4	1	observed	3	3	4	0	SBAR	1	4	33	2	IN	0	4	5	1	that	4	4	5	0	S	2	5	33	3	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	10	2	NP	0	6	7	1	NN	0	6	7	1	contrast	6	6	7	0	PP	0	7	10	2	TO	0	7	8	1	to	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	wild	8	8	9	0	NN	0	9	10	1	type	9	9	10	0	NP	5	10	16	6	NN	0	10	11	1	ASPP2	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CD	0	13	14	1	-LRB-	13	13	14	0	NN	0	14	15	1	S827A	14	14	15	0	NN	0	15	16	1	-RRB-	15	15	16	0	VP	0	16	33	2	VBZ	0	16	17	1	remains	16	16	17	0	PP	0	17	33	2	IN	0	17	18	1	at	17	17	18	0	NP	0	18	33	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	plasma	19	19	20	0	NN	0	20	21	1	membrane	20	20	21	0	PP	0	21	33	2	VBG	0	21	22	1	following	21	21	22	0	NP	0	22	33	2	NP	1	22	24	2	NN	0	22	23	1	RAS	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	33	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	33	3	NP	0	25	30	2	NP	0	25	26	1	NN	0	25	26	1	4-OHT	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	in	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	NN	0	28	29	1	HKe3	28	28	29	0	NN	0	29	30	1	ER	29	29	30	0	:	0	30	31	1	:	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	HRASV12	31	31	32	0	NN	0	32	33	1	system	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	35
This	13804	13808	DT	this	O	_	_
suggests	13809	13817	VBZ	suggest	O	_	_
that	13818	13822	IN	that	O	_	_
ASPP2	13823	13828	NN	aspp2	B-GENE	_	_
binding	13829	13836	NN	binding	O	_	_
to	13837	13839	TO	to	O	_	_
RAS	13840	13843	NN	ra	B-GENE	_	_
at	13844	13846	IN	at	O	_	_
the	13847	13850	DT	the	O	_	_
plasma	13851	13857	NN	plasma	O	_	_
membrane	13858	13866	NN	membrane	O	_	_
occurs	13867	13873	VBZ	occur	O	_	_
prior	13874	13879	RB	prior	O	_	_
to	13880	13882	TO	to	O	_	_
MAPK	13883	13887	NN	mapk	B-GENE	_	_
phosphorylation	13888	13903	NN	phosphorylation	O	_	_
of	13904	13906	IN	of	O	_	_
ASPP2	13907	13912	NN	aspp2	B-GENE	_	_
and	13913	13916	CC	and	O	_	_
that	13917	13921	IN	that	O	_	_
Ser	13922	13925	NN	ser	O	_	_
827	13926	13929	CD	827	O	_	_
phosphorylation	13930	13945	NN	phosphorylation	O	_	_
is	13946	13948	VBZ	be	O	_	_
required	13949	13957	VBN	require	O	_	_
for	13958	13961	IN	for	O	_	_
RAS	13962	13965	NN	ra	B-GENE	_	_
induced	13966	13973	VBD	induce	O	_	_
translocation	13974	13987	NN	translocation	O	_	_
of	13988	13990	IN	of	O	_	_
ASPP2	13991	13996	NN	aspp2	B-GENE	_	_
to	13997	13999	TO	to	O	_	_
the	14000	14003	DT	the	O	_	_
cytosol	14004	14011	NN	cytosol	O	_	_
.	14011	14012	.	.	O	_	_
D	1
1
1	0	nsubj
1	11	ccomp
1	27	ccomp
4	3	nn
4	6	prep_to
6	10	prep_at
10	8	det
10	9	nn
11	2	mark
11	4	nsubj
11	15	prep_prior_to
11	27	conj_and
15	14	nn
15	17	prep_of
20	24	rcmod
22	21	num
24	22	nsubjpass
24	23	auxpass
24	26	prep_for
27	19	mark
27	20	nsubj
27	28	dobj
27	33	prep_to
28	30	prep_of
33	32	det
EOX
Y	1
ROOT	0	0	35	1	S	1	0	35	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	34	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	0	2	34	3	SBAR	1	2	18	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	18	2	NP	0	3	11	2	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	binding	4	4	5	0	PP	0	5	11	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	11	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	at	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	plasma	9	9	10	0	NN	0	10	11	1	membrane	10	10	11	0	VP	0	11	18	2	VBZ	0	11	12	1	occurs	11	11	12	0	PP	1	12	18	2	RB	0	12	13	1	prior	12	12	13	0	PP	0	13	18	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	NN	0	14	15	1	MAPK	14	14	15	0	NN	0	15	16	1	phosphorylation	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	SBAR	1	19	34	2	IN	0	19	20	1	that	19	19	20	0	S	1	20	34	2	NP	0	20	27	2	NP	0	20	21	1	NN	0	20	21	1	Ser	20	20	21	0	SBAR	0	21	27	1	S	1	21	27	2	NP	1	21	23	2	CD	0	21	22	1	827	21	21	22	0	NN	0	22	23	1	phosphorylation	22	22	23	0	VP	1	23	27	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	27	2	VBN	0	24	25	1	required	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	for	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	34	3	VBD	0	27	28	1	induced	27	27	28	0	NP	0	28	31	2	NP	0	28	29	1	NN	0	28	29	1	translocation	28	28	29	0	PP	0	29	31	2	IN	0	29	30	1	of	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	ASPP2	30	30	31	0	PP	0	31	34	2	TO	0	31	32	1	to	31	31	32	0	NP	1	32	34	2	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	cytosol	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	31
Wild-type	14023	14032	JJ	wild-type	O	_	_
ASPP2	14033	14038	NN	aspp2	O	_	_
,	14038	14039	,	,	O	_	_
but	14040	14043	CC	but	O	_	_
not	14044	14047	RB	not	O	_	_
mutant	14048	14054	JJ	mutant	O	_	_
ASPP2	14055	14060	NN	aspp2	O	_	_
(	14061	14062	CD	(	O	_	_
S827A	14062	14067	NN	s827a	O	_	_
)	14067	14068	NN	)	O	_	_
,	14068	14069	,	,	O	_	_
translocates	14070	14082	VBZ	translocate	O	_	_
to	14083	14085	TO	to	O	_	_
the	14086	14089	DT	the	O	_	_
cytosol	14090	14097	NN	cytosol	O	_	_
and	14098	14101	CC	and	O	_	_
nucleus	14102	14109	NN	nucleus	O	_	_
upon	14110	14114	IN	upon	O	_	_
oncogenic	14115	14124	JJ	oncogenic	O	_	_
RAS	14125	14128	NN	ra	B-GENE	_	_
activation	14129	14139	NN	activation	O	_	_
and	14140	14143	CC	and	O	_	_
this	14144	14148	DT	this	O	_	_
results	14149	14156	VBZ	result	O	_	_
in	14157	14159	IN	in	O	_	_
an	14160	14162	DT	a	O	_	_
increased	14163	14172	VBN	increase	O	_	_
interaction	14173	14184	NN	interaction	O	_	_
with	14185	14189	IN	with	O	_	_
p53	14190	14193	NN	p53	B-GENE	_	_
.	14193	14194	.	.	O	_	_
D	1
11
1	0	amod
1	6	conj_but
6	4	neg
6	5	amod
9	8	nn
11	1	nsubj
11	6	nsubj
11	14	prep_to
11	16	prep_to
11	23	conj_and
14	13	det
14	16	conj_and
14	20	prep_upon
20	18	amod
20	19	nn
23	22	nsubj
23	27	prep_in
27	25	det
27	26	amod
27	29	prep_with
EOX
Y	1
ROOT	0	0	31	1	S	0	0	31	4	S	1	0	21	2	NP	0	0	11	5	NP	1	0	2	2	JJ	0	0	1	1	Wild-type	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	,	0	2	3	1	,	2	2	3	0	CC	0	3	4	1	but	3	3	4	0	NP	0	4	10	2	NP	2	4	7	3	RB	0	4	5	1	not	4	4	5	0	JJ	0	5	6	1	mutant	5	5	6	0	NN	0	6	7	1	ASPP2	6	6	7	0	NP	2	7	10	3	CD	0	7	8	1	-LRB-	7	7	8	0	NN	0	8	9	1	S827A	8	8	9	0	NN	0	9	10	1	-RRB-	9	9	10	0	,	0	10	11	1	,	10	10	11	0	VP	0	11	21	2	VBZ	0	11	12	1	translocates	11	11	12	0	PP	0	12	21	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	21	2	NP	1	13	17	4	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	cytosol	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	nucleus	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	upon	17	17	18	0	NP	2	18	21	3	JJ	0	18	19	1	oncogenic	18	18	19	0	NN	0	19	20	1	RAS	19	19	20	0	NN	0	20	21	1	activation	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	S	1	22	30	2	NP	0	22	23	1	DT	0	22	23	1	this	22	22	23	0	VP	0	23	30	2	VBZ	0	23	24	1	results	23	23	24	0	PP	0	24	30	2	IN	0	24	25	1	in	24	24	25	0	NP	0	25	30	2	NP	2	25	28	3	DT	0	25	26	1	an	25	25	26	0	VBN	0	26	27	1	increased	26	26	27	0	NN	0	27	28	1	interaction	27	27	28	0	PP	0	28	30	2	IN	0	28	29	1	with	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	p53	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	30
(	14195	14196	NN	(	O	_	_
A	14196	14197	NN	a	O	_	_
)	14197	14198	CD	)	O	_	_
RAS	14199	14202	NN	ra	O	_	_
activation	14203	14213	NN	activation	O	_	_
induces	14214	14221	VBZ	induce	O	_	_
cytoplasmic	14222	14233	JJ	cytoplasmic	O	_	_
and	14234	14237	CC	and	O	_	_
nuclear	14238	14245	JJ	nuclear	O	_	_
translocation	14246	14259	NN	translocation	O	_	_
of	14260	14262	IN	of	O	_	_
wild-type	14263	14272	JJ	wild-type	O	_	_
ASPP2	14273	14278	NN	aspp2	O	_	_
but	14279	14282	CC	but	O	_	_
not	14283	14286	RB	not	O	_	_
ASPP2	14287	14292	NN	aspp2	O	_	_
(	14293	14294	CD	(	O	_	_
S827A	14294	14299	NN	s827a	O	_	_
)	14299	14300	NN	)	O	_	_
in	14301	14303	IN	in	O	_	_
HKe3	14304	14308	NN	hke3	B-GENE	_	_
ER	14309	14311	NN	er	I-GENE	_	_
:	14311	14312	:	:	O	_	_
HRAS12	14312	14318	NN	hras12	O	_	_
cells	14319	14324	NNS	cell	O	_	_
as	14325	14327	IN	as	O	_	_
detected	14328	14336	VBN	detect	O	_	_
by	14337	14339	IN	by	O	_	_
immunofluorescence	14340	14358	NN	immunofluorescence	O	_	_
.	14358	14359	.	.	O	_	_
D	1

1	4	dep
4	3	nn
5	1	nsubj
5	9	dobj
6	8	conj_and
9	6	amod
9	8	amod
9	12	prep_of
9	14	cc
12	11	amod
18	15	nn
18	17	nn
18	21	prep_in
18	24	dep
21	20	nn
24	23	nn
24	26	dep
26	25	mark
26	28	prep_by
EOX
Y	1
ROOT	0	0	30	1	S	1	0	30	3	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	29	2	VBZ	0	5	6	1	induces	5	5	6	0	NP	0	6	29	3	NP	0	6	13	2	NP	1	6	10	2	ADJP	0	6	9	3	JJ	0	6	7	1	cytoplasmic	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	JJ	0	8	9	1	nuclear	8	8	9	0	NN	0	9	10	1	translocation	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	JJ	0	11	12	1	wild-type	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CONJP	1	13	15	2	CC	0	13	14	1	but	13	13	14	0	RB	0	14	15	1	not	14	14	15	0	NP	0	15	29	3	NP	0	15	22	2	NP	3	15	19	4	NN	0	15	16	1	ASPP2	15	15	16	0	CD	0	16	17	1	-LRB-	16	16	17	0	NN	0	17	18	1	S827A	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	HKe3	20	20	21	0	NN	0	21	22	1	ER	21	21	22	0	:	0	22	23	1	:	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	HRAS12	23	23	24	0	NNS	0	24	25	1	cells	24	24	25	0	SBAR	1	25	29	2	IN	0	25	26	1	as	25	25	26	0	S	0	26	29	1	VP	0	26	29	2	VBN	0	26	27	1	detected	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	by	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	immunofluorescence	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	9
Arrows	14360	14366	NNS	arrow	O	_	_
indicate	14367	14375	VBP	indicate	O	_	_
cell	14376	14380	NN	cell	O	_	_
membrane	14381	14389	NN	membrane	O	_	_
and	14390	14393	CC	and	O	_	_
stars	14394	14399	NNS	star	O	_	_
indicate	14400	14408	VBP	indicate	O	_	_
cytosol	14409	14416	NN	cytosol	O	_	_
.	14416	14417	.	.	O	_	_
D	1
1
1	0	nsubj
1	6	ccomp
3	2	nn
3	5	conj_and
6	3	nsubj
6	5	nsubj
6	7	dobj
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Arrows	0	0	1	0	VP	0	1	8	2	VBP	0	1	2	1	indicate	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	6	3	NP	1	2	4	2	NN	0	2	3	1	cell	2	2	3	0	NN	0	3	4	1	membrane	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	stars	5	5	6	0	VP	0	6	8	2	VBP	0	6	7	1	indicate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	cytosol	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
(	14418	14419	NN	(	O	_	_
B	14419	14420	NN	b	O	_	_
)	14420	14421	CD	)	O	_	_
RAS	14422	14425	NN	ra	B-GENE	_	_
activation	14426	14436	NN	activation	O	_	_
enhances	14437	14445	VBZ	enhance	O	_	_
the	14446	14449	DT	the	O	_	_
binding	14450	14457	NN	binding	O	_	_
of	14458	14460	IN	of	O	_	_
wild-type	14461	14470	JJ	wild-type	O	_	_
ASPP2	14471	14476	NN	aspp2	O	_	_
but	14477	14480	CC	but	O	_	_
not	14481	14484	RB	not	O	_	_
ASPP2	14485	14490	NN	aspp2	O	_	_
(	14491	14492	CD	(	O	_	_
S827A	14492	14497	NN	s827a	O	_	_
)	14497	14498	NN	)	O	_	_
to	14499	14501	TO	to	O	_	_
p53	14502	14505	NN	p53	B-GENE	_	_
.	14505	14506	.	.	O	_	_
D	1

1	5	rcmod
1	12	cc
4	3	nn
5	4	nsubj
5	7	dobj
7	6	det
7	10	prep_of
10	9	amod
16	13	nn
16	15	nn
16	18	prep_to
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	11	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	SBAR	0	2	11	1	S	1	2	11	2	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	enhances	5	5	6	0	NP	0	6	11	2	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	binding	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	of	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	wild-type	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	CONJP	1	11	13	2	CC	0	11	12	1	but	11	11	12	0	RB	0	12	13	1	not	12	12	13	0	NP	0	13	19	2	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	19	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	27
Total	14507	14512	JJ	total	O	_	_
cell	14513	14517	NN	cell	O	_	_
lysates	14518	14525	NNS	lysate	O	_	_
from	14526	14530	IN	from	O	_	_
HKe3	14531	14535	NN	hke3	B-GENE	_	_
ER	14536	14538	NN	er	I-GENE	_	_
:	14538	14539	:	:	O	_	_
HRASV12	14539	14546	NN	hrasv12	O	_	_
cells	14547	14552	NNS	cell	O	_	_
treated	14553	14560	VBN	treat	O	_	_
with	14561	14565	IN	with	O	_	_
or	14566	14568	CC	or	O	_	_
without	14569	14576	IN	without	O	_	_
4-OHT	14577	14582	NN	4-oht	O	_	_
were	14583	14587	VBD	be	O	_	_
immunoprecipitated	14588	14606	VBN	immunoprecipitate	O	_	_
with	14607	14611	IN	with	O	_	_
an	14612	14614	DT	a	O	_	_
anti	14615	14619	JJ	anti	B-GENE	_	_
p53	14620	14623	NN	p53	I-GENE	_	_
antibody	14624	14632	NN	antibody	I-GENE	_	_
or	14633	14635	CC	or	O	_	_
control	14636	14643	NN	control	B-GENE	_	_
IgG	14644	14647	NN	igg	I-GENE	_	_
as	14648	14650	IN	as	O	_	_
indicated	14651	14660	VBN	indicate	O	_	_
.	14660	14661	.	.	O	_	_
D	1
15
2	0	amod
2	1	nn
2	5	prep_from
5	4	nn
5	8	dep
8	7	nn
8	9	vmod
9	9	conj_or
9	13	prep_with
9	13	prep_without
15	2	nsubjpass
15	14	auxpass
15	20	prep_with
15	23	prep_with
20	17	det
20	18	amod
20	19	nn
20	23	conj_or
20	25	prep_as
23	22	nn
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	14	2	NP	2	0	3	3	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	cell	1	1	2	0	NNS	0	2	3	1	lysates	2	2	3	0	PP	0	3	14	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	14	3	NP	1	4	6	2	NN	0	4	5	1	HKe3	4	4	5	0	NN	0	5	6	1	ER	5	5	6	0	:	0	6	7	1	:	6	6	7	0	NP	0	7	14	2	NP	1	7	9	2	NN	0	7	8	1	HRASV12	7	7	8	0	NNS	0	8	9	1	cells	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	treated	9	9	10	0	PP	0	10	14	4	IN	0	10	11	1	with	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	IN	0	12	13	1	without	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	4-OHT	13	13	14	0	VP	1	14	26	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	26	2	VBN	0	15	16	1	immunoprecipitated	15	15	16	0	PP	0	16	26	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	26	2	NP	0	17	24	3	NP	3	17	21	4	DT	0	17	18	1	an	17	17	18	0	JJ	0	18	19	1	anti	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	control	22	22	23	0	NN	0	23	24	1	IgG	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	43
As	14662	14664	IN	as	O	_	_
the	14665	14668	DT	the	O	_	_
translocation	14669	14682	NN	translocation	O	_	_
of	14683	14685	IN	of	O	_	_
wild-type	14686	14695	JJ	wild-type	O	_	_
ASPP2	14696	14701	NN	aspp2	O	_	_
from	14702	14706	IN	from	O	_	_
the	14707	14710	DT	the	O	_	_
plasma	14711	14717	NN	plasma	O	_	_
membrane	14718	14726	NN	membrane	O	_	_
to	14727	14729	TO	to	O	_	_
the	14730	14733	DT	the	O	_	_
cytosol	14734	14741	NN	cytosol	O	_	_
and	14742	14745	CC	and	O	_	_
nucleus	14746	14753	NN	nucleus	O	_	_
results	14754	14761	NNS	result	O	_	_
in	14762	14764	IN	in	O	_	_
increased	14765	14774	VBN	increase	O	_	_
binding	14775	14782	NN	binding	O	_	_
to	14783	14785	TO	to	O	_	_
p53	14786	14789	NN	p53	B-GENE	_	_
[	14790	14791	NN	[	I-GENE	_	_
2	14791	14792	CD	2	I-GENE	_	_
]	14792	14793	NN	]	I-GENE	_	_
,	14793	14794	,	,	O	_	_
we	14795	14797	PRP	we	O	_	_
tested	14798	14804	VBD	test	O	_	_
whether	14805	14812	IN	whether	O	_	_
the	14813	14816	DT	the	O	_	_
p53	14817	14820	NN	p53	B-GENE	_	_
binding	14821	14828	NN	binding	O	_	_
ability	14829	14836	NN	ability	O	_	_
of	14837	14839	IN	of	O	_	_
ASPP2	14840	14845	NN	aspp2	B-GENE	_	_
phosphorylation	14846	14861	NN	phosphorylation	O	_	_
mutant	14862	14868	NN	mutant	O	_	_
would	14869	14874	MD	would	O	_	_
be	14875	14877	VB	be	O	_	_
influenced	14878	14888	VBN	influence	O	_	_
by	14889	14891	IN	by	O	_	_
RAS	14892	14895	NN	ra	B-GENE	_	_
activation	14896	14906	NN	activation	O	_	_
.	14906	14907	.	.	O	_	_
D	1
26
2	1	det
2	5	prep_of
2	18	prep_in
5	4	amod
5	9	prep_from
9	7	det
9	8	nn
9	15	prep_to
12	14	conj_and
15	11	det
15	12	nn
15	14	nn
18	17	amod
18	21	prep_to
21	20	nn
21	23	dep
23	22	num
26	2	prep_as
26	25	nsubj
26	38	ccomp
31	28	det
31	29	nn
31	30	nn
31	35	prep_of
35	33	nn
35	34	nn
38	27	mark
38	31	nsubjpass
38	36	aux
38	37	auxpass
38	41	agent
41	40	nn
EOX
Y	1
ROOT	0	0	43	1	S	3	0	43	5	PP	0	0	24	2	IN	0	0	1	1	As	0	0	1	0	NP	0	1	24	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	translocation	2	2	3	0	PP	0	3	16	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	16	2	NP	1	4	6	2	JJ	0	4	5	1	wild-type	4	4	5	0	NN	0	5	6	1	ASPP2	5	5	6	0	PP	0	6	16	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	16	2	NP	2	7	10	3	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	plasma	8	8	9	0	NN	0	9	10	1	membrane	9	9	10	0	PP	0	10	16	2	TO	0	10	11	1	to	10	10	11	0	NP	2	11	16	3	DT	0	11	12	1	the	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	cytosol	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	nucleus	14	14	15	0	NNS	0	15	16	1	results	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	in	16	16	17	0	NP	0	17	24	2	NP	1	17	19	2	VBN	0	17	18	1	increased	17	17	18	0	NN	0	18	19	1	binding	18	18	19	0	PP	0	19	24	2	TO	0	19	20	1	to	19	19	20	0	NP	0	20	24	2	NP	1	20	22	2	NN	0	20	21	1	p53	20	20	21	0	NN	0	21	22	1	[	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	2	22	22	23	0	NN	0	23	24	1	]	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	PRP	0	25	26	1	we	25	25	26	0	VP	0	26	42	2	VBD	0	26	27	1	tested	26	26	27	0	SBAR	1	27	42	2	IN	0	27	28	1	whether	27	27	28	0	S	1	28	42	2	NP	0	28	36	2	NP	3	28	32	4	DT	0	28	29	1	the	28	28	29	0	NN	0	29	30	1	p53	29	29	30	0	NN	0	30	31	1	binding	30	30	31	0	NN	0	31	32	1	ability	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	2	33	36	3	NN	0	33	34	1	ASPP2	33	33	34	0	NN	0	34	35	1	phosphorylation	34	34	35	0	NN	0	35	36	1	mutant	35	35	36	0	VP	1	36	42	2	MD	0	36	37	1	would	36	36	37	0	VP	1	37	42	2	VB	0	37	38	1	be	37	37	38	0	VP	0	38	42	2	VBN	0	38	39	1	influenced	38	38	39	0	PP	0	39	42	2	IN	0	39	40	1	by	39	39	40	0	NP	1	40	42	2	NN	0	40	41	1	RAS	40	40	41	0	NN	0	41	42	1	activation	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	33
Indeed	14908	14914	RB	indeed	O	_	_
,	14914	14915	,	,	O	_	_
upon	14916	14920	IN	upon	O	_	_
activation	14921	14931	NN	activation	O	_	_
of	14932	14934	IN	of	O	_	_
RAS	14935	14938	NN	ra	O	_	_
by	14939	14941	IN	by	O	_	_
4-OHT	14942	14947	NN	4-oht	O	_	_
in	14948	14950	IN	in	O	_	_
HKe3	14951	14955	NN	hke3	B-GENE	_	_
ER	14956	14958	NN	er	I-GENE	_	_
:	14958	14959	:	:	O	_	_
HRASV12	14959	14966	NN	hrasv12	O	_	_
cells	14967	14972	NNS	cell	O	_	_
,	14972	14973	,	,	O	_	_
we	14974	14976	PRP	we	O	_	_
observed	14977	14985	VBD	observe	O	_	_
an	14986	14988	DT	a	O	_	_
increase	14989	14997	NN	increase	O	_	_
in	14998	15000	IN	in	O	_	_
the	15001	15004	DT	the	O	_	_
amount	15005	15011	NN	amount	O	_	_
of	15012	15014	IN	of	O	_	_
p53	15015	15018	NN	p53	B-GENE	_	_
co	15019	15021	NN	co	O	_	_
immunoprecipitated	15022	15040	VBN	immunoprecipitate	O	_	_
with	15041	15045	IN	with	O	_	_
transfected	15046	15057	VBN	transfect	O	_	_
V5	15058	15060	NN	v5	O	_	_
tagged	15061	15067	VBD	tag	O	_	_
wild-type	15068	15077	JJ	wild-type	O	_	_
ASPP2	15078	15083	NN	aspp2	O	_	_
.	15118	15119	.	.	O	_	_
D	1
16
3	5	prep_of
7	10	prep_in
7	13	dep
10	9	nn
13	12	nn
16	0	advmod
16	3	prep_upon
16	7	prep_by
16	15	nsubj
16	29	ccomp
18	17	det
18	21	prep_in
21	20	det
21	24	prep_of
24	23	nn
24	25	vmod
25	27	prepc_with
27	28	dobj
29	18	nsubj
29	31	dobj
31	30	amod
EOX
Y	1
ROOT	0	0	33	1	S	5	0	33	7	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	14	2	PP	0	2	6	2	IN	0	2	3	1	upon	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	activation	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	PP	0	6	14	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	14	3	NP	0	7	11	2	NP	0	7	8	1	NN	0	7	8	1	4-OHT	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	HKe3	9	9	10	0	NN	0	10	11	1	ER	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	HRASV12	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	PRP	0	15	16	1	we	15	15	16	0	VP	0	16	32	2	VBD	0	16	17	1	observed	16	16	17	0	SBAR	0	17	32	1	S	1	17	32	2	NP	0	17	29	2	NP	1	17	19	2	DT	0	17	18	1	an	17	17	18	0	NN	0	18	19	1	increase	18	18	19	0	PP	0	19	29	2	IN	0	19	20	1	in	19	19	20	0	NP	0	20	29	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	amount	21	21	22	0	PP	0	22	29	2	IN	0	22	23	1	of	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	p53	23	23	24	0	NN	0	24	25	1	co	24	24	25	0	VP	0	25	29	2	VBN	0	25	26	1	immunoprecipitated	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	with	26	26	27	0	S	0	27	29	1	VP	0	27	29	2	VBN	0	27	28	1	transfected	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	V5	28	28	29	0	VP	0	29	32	2	VBD	0	29	30	1	tagged	29	29	30	0	NP	1	30	32	2	JJ	0	30	31	1	wild-type	30	30	31	0	NN	0	31	32	1	ASPP2	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	24
Under	15120	15125	IN	under	O	_	_
the	15126	15129	DT	the	O	_	_
same	15130	15134	JJ	same	O	_	_
conditions	15135	15145	NNS	condition	O	_	_
,	15145	15146	,	,	O	_	_
the	15147	15150	DT	the	O	_	_
amount	15151	15157	NN	amount	O	_	_
of	15158	15160	IN	of	O	_	_
p53	15161	15164	NN	p53	B-GENE	_	_
in	15165	15167	IN	in	O	_	_
complex	15168	15175	NN	complex	O	_	_
with	15176	15180	IN	with	O	_	_
transfected	15181	15192	VBN	transfect	O	_	_
V5-ASPP2	15193	15201	NN	v5-aspp2	O	_	_
(	15202	15203	CD	(	O	_	_
S827A	15203	15208	NN	s827a	O	_	_
)	15208	15209	NN	)	O	_	_
is	15210	15212	VBZ	be	O	_	_
not	15213	15216	RB	not	O	_	_
affected	15217	15225	VBN	affect	O	_	_
by	15226	15228	IN	by	O	_	_
RAS	15229	15232	NN	ra	B-GENE	_	_
activation	15233	15243	NN	activation	O	_	_
.	15278	15279	.	.	O	_	_
D	1

3	1	det
3	2	amod
6	5	det
6	8	prep_of
8	10	prep_in
10	11	prep
12	3	prep_under
12	6	nsubj
16	13	nn
16	15	nn
16	19	rcmod
19	17	auxpass
19	18	neg
19	22	agent
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	4	2	IN	0	0	1	1	Under	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	same	2	2	3	0	NNS	0	3	4	1	conditions	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	12	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	amount	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	12	2	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	12	2	NP	0	10	11	1	NN	0	10	11	1	complex	10	10	11	0	PP	0	11	12	1	IN	0	11	12	1	with	11	11	12	0	VP	0	12	23	2	VBN	0	12	13	1	transfected	12	12	13	0	NP	0	13	23	2	NP	3	13	17	4	NN	0	13	14	1	V5-ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	SBAR	0	17	23	1	S	0	17	23	1	VP	2	17	23	3	VBZ	0	17	18	1	is	17	17	18	0	RB	0	18	19	1	not	18	18	19	0	VP	0	19	23	2	VBN	0	19	20	1	affected	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	by	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	RAS	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Together	15280	15288	RB	together	O	_	_
these	15289	15294	DT	these	O	_	_
data	15295	15299	NNS	datum	O	_	_
illustrate	15300	15310	VBP	illustrate	O	_	_
that	15311	15315	IN	that	O	_	_
phosphorylation	15316	15331	NN	phosphorylation	O	_	_
of	15332	15334	IN	of	O	_	_
ASPP2	15335	15340	NN	aspp2	B-GENE	_	_
at	15341	15343	IN	at	O	_	_
Ser827	15344	15350	NN	ser827	O	_	_
by	15351	15353	IN	by	O	_	_
MAPK	15354	15358	NN	mapk	O	_	_
is	15359	15361	VBZ	be	O	_	_
necessary	15362	15371	JJ	necessary	O	_	_
for	15372	15375	IN	for	O	_	_
its	15376	15379	PRP$	its	O	_	_
ASPP2	15380	15385	NN	aspp2	O	_	_
to	15386	15388	TO	to	O	_	_
fully	15389	15394	RB	fully	O	_	_
enhance	15395	15402	VB	enhance	O	_	_
p53	15403	15406	NN	p53	B-GENE	_	_
's	15406	15408	POS	's	I-GENE	_	_
pro-apoptotic	15409	15422	JJ	pro-apoptotic	O	_	_
activity	15423	15431	NN	activity	O	_	_
.	15431	15432	.	.	O	_	_
D	1
3
2	1	det
3	0	advmod
3	2	nsubj
3	13	ccomp
5	7	prep_of
7	9	prep_at
9	11	prep_by
13	4	mark
13	5	nsubj
13	12	cop
13	16	prep_for
16	15	poss
16	19	vmod
19	17	aux
19	18	advmod
19	23	dobj
23	20	poss
23	22	amod
EOX
Y	1
ROOT	0	0	25	1	S	2	0	25	4	ADVP	0	0	1	1	RB	0	0	1	1	Together	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	these	1	1	2	0	NNS	0	2	3	1	data	2	2	3	0	VP	0	3	24	2	VBP	0	3	4	1	illustrate	3	3	4	0	SBAR	1	4	24	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	24	2	NP	0	5	12	2	NP	0	5	6	1	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	12	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	Ser827	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	by	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	MAPK	11	11	12	0	VP	1	12	24	2	VBZ	0	12	13	1	is	12	12	13	0	ADJP	0	13	24	2	JJ	0	13	14	1	necessary	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	for	14	14	15	0	NP	1	15	24	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	S	0	17	24	1	VP	1	17	24	2	TO	0	17	18	1	to	17	17	18	0	VP	1	18	24	3	ADVP	0	18	19	1	RB	0	18	19	1	fully	18	18	19	0	VB	0	19	20	1	enhance	19	19	20	0	NP	2	20	24	3	NP	0	20	22	2	NN	0	20	21	1	p53	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	2
Discussion	15433	15443	NN	discussion	O	_	_
.	15443	15444	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Discussion	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	28
ASPP2	15445	15450	NN	aspp2	B-GENE	_	_
is	15451	15453	VBZ	be	O	_	_
a	15454	15455	DT	a	O	_	_
haploinsufficient	15456	15473	JJ	haploinsufficient	O	_	_
tumor	15474	15479	NN	tumor	O	_	_
suppressor	15480	15490	NN	suppressor	O	_	_
[	15491	15492	CD	[	O	_	_
15	15492	15494	CD	15	O	_	_
]	15494	15495	NN	]	O	_	_
[	15496	15497	CD	[	O	_	_
16	15497	15499	CD	16	O	_	_
]	15499	15500	NN	]	O	_	_
and	15501	15504	CC	and	O	_	_
it	15505	15507	PRP	it	O	_	_
can	15508	15511	MD	can	O	_	_
cooperate	15512	15521	VB	cooperate	O	_	_
with	15522	15526	IN	with	O	_	_
p53	15527	15530	NN	p53	B-GENE	_	_
to	15531	15533	TO	to	O	_	_
suppress	15534	15542	VB	suppress	O	_	_
tumour	15543	15549	NN	tumour	O	_	_
growth	15550	15556	NN	growth	O	_	_
in	15557	15559	FW	in	O	_	_
vivo	15560	15564	FW	vivo	O	_	_
[	15565	15566	FW	[	O	_	_
15	15566	15568	CD	15	O	_	_
]	15568	15569	NN	]	O	_	_
.	15569	15570	.	.	O	_	_
D	1
15
7	6	number
8	0	nsubj
8	1	cop
8	2	det
8	3	amod
8	4	nn
8	5	nn
8	7	num
8	11	dep
8	13	conj_and
10	9	number
11	10	num
15	8	dep
15	13	dep
15	14	aux
15	17	prep_with
15	19	xcomp
15	26	nsubj
19	18	aux
19	21	dobj
21	20	nn
21	22	prep
22	24	pobj
24	23	nn
26	25	num
EOX
Y	1
ROOT	0	0	28	1	SINV	1	0	28	4	S	1	0	14	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	14	2	VBZ	0	1	2	1	is	1	1	2	0	NP	0	2	14	4	NP	5	2	9	6	DT	0	2	3	1	a	2	2	3	0	JJ	0	3	4	1	haploinsufficient	3	3	4	0	NN	0	4	5	1	tumor	4	4	5	0	NN	0	5	6	1	suppressor	5	5	6	0	ADJP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	[	6	6	7	0	CD	0	7	8	1	15	7	7	8	0	NN	0	8	9	1	]	8	8	9	0	NP	1	9	12	2	QP	1	9	11	2	CD	0	9	10	1	[	9	9	10	0	CD	0	10	11	1	16	10	10	11	0	NN	0	11	12	1	]	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	0	13	14	1	PRP	0	13	14	1	it	13	13	14	0	VP	1	14	25	2	MD	0	14	15	1	can	14	14	15	0	VP	0	15	25	3	VB	0	15	16	1	cooperate	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	S	0	18	25	1	VP	1	18	25	2	TO	0	18	19	1	to	18	18	19	0	VP	0	19	25	2	VB	0	19	20	1	suppress	19	19	20	0	NP	0	20	25	2	NP	1	20	22	2	NN	0	20	21	1	tumour	20	20	21	0	NN	0	21	22	1	growth	21	21	22	0	PP	0	22	25	2	FW	0	22	23	1	in	22	22	23	0	NP	1	23	25	2	FW	0	23	24	1	vivo	23	23	24	0	FW	0	24	25	1	[	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	15	25	25	26	0	NN	0	26	27	1	]	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	16
In	15571	15573	IN	in	O	_	_
human	15574	15579	JJ	human	O	_	_
cancer	15580	15586	NN	cancer	O	_	_
,	15586	15587	,	,	O	_	_
ASPP2	15588	15593	NN	aspp2	B-GENE	_	_
expression	15594	15604	NN	expression	O	_	_
is	15605	15607	VBZ	be	O	_	_
down	15608	15612	RB	down	O	_	_
regulated	15613	15622	VBN	regulate	O	_	_
by	15623	15625	IN	by	O	_	_
DNA	15626	15629	NN	dna	O	_	_
methylation	15630	15641	NN	methylation	O	_	_
[	15642	15643	CD	[	O	_	_
9,17-19	15643	15650	CD	9,17-19	O	_	_
]	15650	15651	NN	]	O	_	_
.	15651	15652	.	.	O	_	_
D	1
8
2	1	amod
5	4	nn
8	2	prep_in
8	5	nsubjpass
8	6	auxpass
8	7	advmod
8	11	agent
11	10	nn
11	14	dep
14	12	num
14	13	num
EOX
Y	1
ROOT	0	0	16	1	S	3	0	16	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	human	1	1	2	0	NN	0	2	3	1	cancer	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	expression	5	5	6	0	VP	2	6	15	3	VBZ	0	6	7	1	is	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	down	7	7	8	0	VP	0	8	15	2	VBN	0	8	9	1	regulated	8	8	9	0	PP	0	9	15	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	15	2	NP	1	10	12	2	NN	0	10	11	1	DNA	10	10	11	0	NN	0	11	12	1	methylation	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	9,17-19	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	20
Importantly	15653	15664	RB	importantly	O	_	_
,	15664	15665	,	,	O	_	_
in	15666	15668	IN	in	O	_	_
diffuse	15669	15676	JJ	diffuse	O	_	_
large	15677	15682	JJ	large	O	_	_
B	15683	15684	NN	b	O	_	_
cell	15685	15689	NN	cell	O	_	_
lymphomas	15690	15699	NNS	lymphoma	O	_	_
,	15699	15700	,	,	O	_	_
reduced	15701	15708	VBD	reduce	O	_	_
ASPP2	15709	15714	NN	aspp2	B-GENE	_	_
expression	15715	15725	NN	expression	O	_	_
associates	15726	15736	VBZ	associate	O	_	_
with	15737	15741	IN	with	O	_	_
poor	15742	15746	JJ	poor	O	_	_
prognosis	15747	15756	NN	prognosis	O	_	_
[	15757	15758	CD	[	O	_	_
20	15758	15760	CD	20	O	_	_
]	15760	15761	NN	]	O	_	_
.	15761	15762	.	.	O	_	_
D	1
9
7	3	amod
7	4	amod
7	5	nn
7	6	nn
9	0	advmod
9	7	prep_in
9	12	ccomp
11	10	nn
12	11	nsubj
12	15	prep_with
12	18	dep
15	14	amod
17	16	number
18	17	num
EOX
Y	1
ROOT	0	0	20	1	S	4	0	20	6	ADVP	0	0	1	1	RB	0	0	1	1	Importantly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	in	2	2	3	0	NP	4	3	8	5	JJ	0	3	4	1	diffuse	3	3	4	0	JJ	0	4	5	1	large	4	4	5	0	NN	0	5	6	1	B	5	5	6	0	NN	0	6	7	1	cell	6	6	7	0	NNS	0	7	8	1	lymphomas	7	7	8	0	,	0	8	9	1	,	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	reduced	9	9	10	0	SBAR	0	10	19	1	S	1	10	19	2	NP	1	10	12	2	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	expression	11	11	12	0	VP	0	12	19	2	VBZ	0	12	13	1	associates	12	12	13	0	PP	0	13	19	3	IN	0	13	14	1	with	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	poor	14	14	15	0	NN	0	15	16	1	prognosis	15	15	16	0	NP	1	16	19	2	QP	1	16	18	2	CD	0	16	17	1	[	16	16	17	0	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	]	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	21
ASPP2	15763	15768	NN	aspp2	B-GENE	_	_
expression	15769	15779	NN	expression	O	_	_
is	15780	15782	VBZ	be	O	_	_
also	15783	15787	RB	also	O	_	_
down	15788	15792	RB	down	O	_	_
regulated	15793	15802	VBN	regulate	O	_	_
in	15803	15805	IN	in	O	_	_
both	15806	15810	CC	both	O	_	_
invasive	15811	15819	JJ	invasive	O	_	_
and	15820	15823	CC	and	O	_	_
metastatic	15824	15834	JJ	metastatic	O	_	_
cells	15835	15840	NNS	cell	O	_	_
compared	15841	15849	VBN	compare	O	_	_
with	15850	15854	IN	with	O	_	_
normal	15855	15861	JJ	normal	O	_	_
breast	15862	15868	NN	breast	O	_	_
epithelium	15869	15879	NN	epithelium	O	_	_
[	15880	15881	CD	[	O	_	_
21	15881	15883	CD	21	O	_	_
]	15883	15884	NN	]	O	_	_
.	15884	15885	.	.	O	_	_
D	1
5
1	0	nn
5	1	nsubjpass
5	2	auxpass
5	3	advmod
5	4	advmod
5	11	prep_in
5	13	prepc_compared_with
5	16	pobj
8	7	preconj
8	10	conj_and
11	8	amod
11	10	amod
16	14	amod
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	VP	2	2	20	3	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	also	3	3	4	0	VP	1	4	20	4	ADVP	0	4	5	1	RB	0	4	5	1	down	4	4	5	0	VBN	0	5	6	1	regulated	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	1	7	12	2	ADJP	1	7	11	4	CC	0	7	8	1	both	7	7	8	0	JJ	0	8	9	1	invasive	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	JJ	0	10	11	1	metastatic	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	PP	0	12	20	2	VBN	0	12	13	1	compared	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	with	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	normal	14	14	15	0	NN	0	15	16	1	breast	15	15	16	0	NN	0	16	17	1	epithelium	16	16	17	0	X	0	17	20	1	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	21	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	15
These	15886	15891	DT	these	O	_	_
findings	15892	15900	NNS	finding	O	_	_
established	15901	15912	VBD	establish	O	_	_
ASPP2	15913	15918	NN	aspp2	O	_	_
as	15919	15921	IN	as	O	_	_
a	15922	15923	DT	a	O	_	_
tumor	15924	15929	NN	tumor	O	_	_
suppressor	15930	15940	NN	suppressor	O	_	_
and	15941	15944	CC	and	O	_	_
an	15945	15947	DT	a	O	_	_
activator	15948	15957	NN	activator	O	_	_
of	15958	15960	IN	of	O	_	_
p53	15961	15964	NN	p53	B-GENE	_	_
family	15965	15971	NN	family	I-GENE	_	_
.	15971	15972	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	3	dobj
2	7	prep_as
2	10	prep_as
7	5	det
7	6	nn
7	10	conj_and
10	9	det
10	13	prep_of
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	findings	1	1	2	0	VP	0	2	14	3	VBD	0	2	3	1	established	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	14	2	IN	0	4	5	1	as	4	4	5	0	NP	0	5	14	3	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	tumor	6	6	7	0	NN	0	7	8	1	suppressor	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	an	9	9	10	0	NN	0	10	11	1	activator	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	of	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	p53	12	12	13	0	NN	0	13	14	1	family	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	17
ASPP2	15973	15978	NN	aspp2	B-GENE	_	_
is	15979	15981	VBZ	be	O	_	_
involved	15982	15990	VBN	involve	O	_	_
in	15991	15993	IN	in	O	_	_
both	15994	15998	CC	both	O	_	_
senescence	15999	16009	NN	senescence	O	_	_
in	16010	16012	IN	in	O	_	_
fibroblasts	16013	16024	NNS	fibroblast	O	_	_
and	16025	16028	CC	and	O	_	_
apoptosis	16029	16038	NN	apoptosis	O	_	_
in	16039	16041	IN	in	O	_	_
cancer	16042	16048	NN	cancer	O	_	_
cells	16049	16054	NNS	cell	O	_	_
[	16055	16056	VBP	[	O	_	_
2,10	16056	16060	CD	2,10	O	_	_
]	16060	16061	CD	]	O	_	_
.	16061	16062	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_in
2	13	conj_and
5	4	dep
5	7	prep_in
9	12	prep_in
12	11	nn
13	9	nsubj
13	15	dobj
15	14	number
EOX
Y	1
ROOT	0	0	17	1	S	0	0	17	4	S	1	0	8	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	8	2	VBZ	0	1	2	1	is	1	1	2	0	VP	0	2	8	2	VBN	0	2	3	1	involved	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CC	0	4	5	1	both	4	4	5	0	NN	0	5	6	1	senescence	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	fibroblasts	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	16	2	NP	0	9	13	2	NP	0	9	10	1	NN	0	9	10	1	apoptosis	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	cancer	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	0	13	16	2	VBP	0	13	14	1	[	13	13	14	0	NP	0	14	16	1	QP	1	14	16	2	CD	0	14	15	1	2,10	14	14	15	0	CD	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	11
ASPP2	16063	16068	NN	aspp2	B-GENE	_	_
acts	16069	16073	VBZ	act	O	_	_
at	16074	16076	IN	at	O	_	_
several	16077	16084	JJ	several	O	_	_
steps	16085	16090	NNS	step	O	_	_
in	16091	16093	IN	in	O	_	_
promoting	16094	16103	VBG	promote	O	_	_
senescence	16104	16114	NN	senescence	O	_	_
in	16115	16117	IN	in	O	_	_
fibroblasts	16118	16129	NNS	fibroblast	O	_	_
.	16129	16130	.	.	O	_	_
D	1
1
1	0	nsubj
1	4	prep_at
1	6	prepc_in
4	3	amod
6	7	dobj
6	9	prep_in
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	acts	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	at	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	several	3	3	4	0	NNS	0	4	5	1	steps	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	S	0	6	10	1	VP	0	6	10	3	VBG	0	6	7	1	promoting	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	senescence	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	fibroblasts	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	29
It	16131	16133	PRP	it	O	_	_
can	16134	16137	MD	can	O	_	_
do	16138	16140	VB	do	O	_	_
so	16141	16143	RB	so	O	_	_
in	16144	16146	IN	in	O	_	_
a	16147	16148	DT	a	O	_	_
RAS	16149	16152	NN	ra	O	_	_
dependent	16153	16162	JJ	dependent	O	_	_
,	16162	16163	,	,	O	_	_
p53	16164	16167	NN	p53	B-GENE	_	_
independent	16168	16179	JJ	independent	O	_	_
manner	16180	16186	NN	manner	O	_	_
,	16186	16187	,	,	O	_	_
through	16188	16195	IN	through	O	_	_
its	16196	16199	PRP$	its	O	_	_
ability	16200	16207	NN	ability	O	_	_
to	16208	16210	TO	to	O	_	_
bind	16211	16215	VB	bind	O	_	_
ATG5	16216	16220	NN	atg5	O	_	_
and	16221	16224	CC	and	O	_	_
to	16225	16227	TO	to	O	_	_
inhibit	16228	16235	VB	inhibit	O	_	_
RAS	16236	16239	NN	ra	O	_	_
induced	16240	16247	VBN	induce	O	_	_
autophagy	16248	16257	NN	autophagy	O	_	_
[	16258	16259	CD	[	O	_	_
10	16259	16261	CD	10	O	_	_
]	16261	16262	NN	]	O	_	_
.	16262	16263	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	aux
2	3	advmod
2	15	prep_through
3	6	prep_in
6	5	det
6	7	amod
6	11	appos
11	9	nn
11	10	amod
15	14	poss
15	17	dep
15	21	dep
17	16	aux
17	18	dobj
17	21	conj_and
21	20	aux
21	22	dobj
22	23	vmod
23	24	dobj
24	25	num
24	27	dep
27	26	num
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	28	2	MD	0	1	2	1	can	1	1	2	0	VP	0	2	28	3	VB	0	2	3	1	do	2	2	3	0	ADVP	0	3	13	2	RB	0	3	4	1	so	3	3	4	0	PP	0	4	13	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	13	4	NP	0	5	8	2	NP	1	5	7	2	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	dependent	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	p53	9	9	10	0	JJ	0	10	11	1	independent	10	10	11	0	NN	0	11	12	1	manner	11	11	12	0	,	0	12	13	1	,	12	12	13	0	PP	0	13	28	2	IN	0	13	14	1	through	13	13	14	0	NP	1	14	28	3	PRP$	0	14	15	1	its	14	14	15	0	NN	0	15	16	1	ability	15	15	16	0	S	0	16	28	1	VP	0	16	28	3	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	19	2	VB	0	17	18	1	bind	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ATG5	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	VP	1	20	28	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	28	2	VB	0	21	22	1	inhibit	21	21	22	0	NP	0	22	28	2	NP	0	22	23	1	NN	0	22	23	1	RAS	22	22	23	0	VP	0	23	28	2	VBN	0	23	24	1	induced	23	23	24	0	NP	0	24	28	2	NP	0	24	26	2	NN	0	24	25	1	autophagy	24	24	25	0	CD	0	25	26	1	[	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	10	26	26	27	0	NN	0	27	28	1	]	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	22
Additionally	16264	16276	RB	additionally	O	_	_
,	16276	16277	,	,	O	_	_
it	16278	16280	PRP	it	O	_	_
can	16281	16284	MD	can	O	_	_
bind	16285	16289	VB	bind	O	_	_
active	16290	16296	JJ	active	O	_	_
RAS	16297	16300	NN	ra	O	_	_
directly	16301	16309	RB	directly	O	_	_
leading	16310	16317	VBG	lead	O	_	_
to	16318	16320	TO	to	O	_	_
enhanced	16321	16329	VBN	enhance	O	_	_
activation	16330	16340	NN	activation	O	_	_
of	16341	16343	IN	of	O	_	_
c-Raf	16344	16349	NN	c-raf	B-GENE	_	_
/	16349	16350	:	/	B-GENE	_	_
MAPK	16350	16354	NN	mapk	I-GENE	_	_
mediated	16355	16363	VBD	mediate	O	_	_
senescence	16364	16374	NN	senescence	O	_	_
[	16375	16376	NN	[	O	_	_
6	16376	16377	CD	6	O	_	_
]	16377	16378	NN	]	O	_	_
.	16378	16379	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	aux
4	6	dobj
6	5	amod
6	8	vmod
6	16	dep
6	20	dep
8	7	advmod
8	11	prep_to
11	10	amod
11	13	prep_of
16	14	punct
16	15	nsubj
16	18	dobj
18	17	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	it	2	2	3	0	VP	1	3	21	2	MD	0	3	4	1	can	3	3	4	0	VP	0	4	21	2	VB	0	4	5	1	bind	4	4	5	0	NP	0	5	21	3	NP	0	5	14	2	NP	1	5	7	2	JJ	0	5	6	1	active	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	VP	1	7	14	3	ADVP	0	7	8	1	RB	0	7	8	1	directly	7	7	8	0	VBG	0	8	9	1	leading	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	0	10	14	2	NP	1	10	12	2	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	c-Raf	13	13	14	0	PRN	1	14	19	2	:	0	14	15	1	/	14	14	15	0	S	1	15	19	2	NP	0	15	16	1	NN	0	15	16	1	MAPK	15	15	16	0	VP	0	16	19	2	VBD	0	16	17	1	mediated	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	senescence	17	17	18	0	NN	0	18	19	1	[	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	6	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	23
We	16380	16382	PRP	we	O	_	_
and	16383	16386	CC	and	O	_	_
others	16387	16393	NNS	other	O	_	_
have	16394	16398	VBP	have	O	_	_
recently	16399	16407	RB	recently	O	_	_
shown	16408	16413	VBN	show	O	_	_
that	16414	16418	IN	that	O	_	_
ASPP2	16419	16424	NN	aspp2	B-GENE	_	_
can	16425	16428	MD	can	O	_	_
potentiate	16429	16439	VB	potentiate	O	_	_
RAS	16440	16443	NN	ra	O	_	_
signaling	16444	16453	NN	signaling	O	_	_
by	16454	16456	IN	by	O	_	_
binding	16457	16464	VBG	bind	O	_	_
directly	16465	16473	RB	directly	O	_	_
via	16474	16477	IN	via	O	_	_
the	16478	16481	DT	the	O	_	_
ASPP2	16482	16487	NN	aspp2	O	_	_
N-terminus	16488	16498	NN	n-terminus	O	_	_
[	16499	16500	CD	[	O	_	_
2,6	16500	16503	CD	2,6	O	_	_
]	16503	16504	NN	]	O	_	_
.	16504	16505	.	.	O	_	_
D	1
5
0	2	conj_and
5	0	nsubj
5	2	nsubj
5	3	aux
5	4	advmod
5	9	ccomp
9	6	mark
9	7	nsubj
9	8	aux
9	11	dobj
9	13	prep_by
11	10	nn
13	14	advmod
13	18	prep_via
18	16	det
18	17	nn
18	21	dep
20	19	number
21	20	num
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	3	3	PRP	0	0	1	1	We	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NNS	0	2	3	1	others	2	2	3	0	VP	2	3	22	3	VBP	0	3	4	1	have	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	recently	4	4	5	0	VP	0	5	22	2	VBN	0	5	6	1	shown	5	5	6	0	SBAR	1	6	22	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	22	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	22	2	MD	0	8	9	1	can	8	8	9	0	VP	0	9	22	3	VB	0	9	10	1	potentiate	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	RAS	10	10	11	0	NN	0	11	12	1	signaling	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	22	2	NP	0	13	14	1	VBG	0	13	14	1	binding	13	13	14	0	PP	1	14	22	3	ADVP	0	14	15	1	RB	0	14	15	1	directly	14	14	15	0	IN	0	15	16	1	via	15	15	16	0	NP	0	16	22	2	NP	2	16	19	3	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	N-terminus	18	18	19	0	NP	1	19	22	2	QP	1	19	21	2	CD	0	19	20	1	[	19	19	20	0	CD	0	20	21	1	2,6	20	20	21	0	NN	0	21	22	1	]	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	18
Moreover	16506	16514	RB	moreover	O	_	_
,	16514	16515	,	,	O	_	_
the	16516	16519	DT	the	O	_	_
RAS-ASPP	16520	16528	NN	ras-aspp	O	_	_
interaction	16529	16540	NN	interaction	O	_	_
enhances	16541	16549	VBZ	enhance	O	_	_
the	16550	16553	DT	the	O	_	_
transcription	16554	16567	NN	transcription	O	_	_
function	16568	16576	NN	function	O	_	_
of	16577	16579	IN	of	O	_	_
p53	16580	16583	NN	p53	B-GENE	_	_
in	16584	16586	IN	in	O	_	_
cancer	16587	16593	NN	cancer	O	_	_
cells	16594	16599	NNS	cell	O	_	_
[	16600	16601	VBP	[	O	_	_
2	16601	16602	CD	2	O	_	_
]	16602	16603	CD	]	O	_	_
.	16603	16604	.	.	O	_	_
D	1
5
4	2	det
4	3	nn
5	0	advmod
5	4	nsubj
5	14	ccomp
8	6	det
8	7	nn
8	10	prep_of
10	13	prep_in
13	12	nn
14	8	nsubj
14	16	dobj
16	15	number
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	RAS-ASPP	3	3	4	0	NN	0	4	5	1	interaction	4	4	5	0	VP	0	5	17	2	VBZ	0	5	6	1	enhances	5	5	6	0	SBAR	0	6	17	1	S	1	6	17	2	NP	0	6	14	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	transcription	7	7	8	0	NN	0	8	9	1	function	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	14	2	NP	0	10	11	1	NN	0	10	11	1	p53	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	in	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	cancer	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	0	14	17	2	VBP	0	14	15	1	[	14	14	15	0	NP	0	15	17	1	QP	1	15	17	2	CD	0	15	16	1	2	15	15	16	0	CD	0	16	17	1	]	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	17
Until	16605	16610	IN	until	O	_	_
now	16611	16614	RB	now	O	_	_
,	16614	16615	,	,	O	_	_
it	16616	16618	PRP	it	O	_	_
has	16619	16622	VBZ	have	O	_	_
been	16623	16627	VBN	be	O	_	_
unclear	16628	16635	JJ	unclear	O	_	_
how	16636	16639	WRB	how	O	_	_
RAS	16640	16643	NNP	RAS	B-GENE	_	_
could	16644	16649	MD	could	O	_	_
affect	16650	16656	VB	affect	O	_	_
ASPP2	16657	16662	NN	aspp2	B-GENE	_	_
to	16663	16665	TO	to	O	_	_
enhance	16666	16673	VB	enhance	O	_	_
p53	16674	16677	NN	p53	B-GENE	_	_
function	16678	16686	NN	function	O	_	_
.	16686	16687	.	.	O	_	_
D	1
6
0	1	pobj
6	0	prep
6	3	nsubj
6	4	aux
6	5	cop
6	10	ccomp
10	7	advmod
10	8	nsubj
10	9	aux
10	11	dobj
10	13	xcomp
13	12	aux
13	15	dobj
15	14	nn
EOX
Y	1
ROOT	0	0	17	1	S	3	0	17	5	PP	0	0	2	2	IN	0	0	1	1	Until	0	0	1	0	NP	0	1	2	1	RB	0	1	2	1	now	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	it	3	3	4	0	VP	1	4	16	2	VBZ	0	4	5	1	has	4	4	5	0	VP	1	5	16	3	VBN	0	5	6	1	been	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unclear	6	6	7	0	SBAR	1	7	16	2	WHADVP	0	7	8	1	WRB	0	7	8	1	how	7	7	8	0	S	1	8	16	2	NP	0	8	9	1	NNP	0	8	9	1	RAS	8	8	9	0	VP	1	9	16	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	16	3	VB	0	10	11	1	affect	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	16	1	VP	1	12	16	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	16	2	VB	0	13	14	1	enhance	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	p53	14	14	15	0	NN	0	15	16	1	function	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	45
We	16688	16690	PRP	we	O	_	_
show	16691	16695	VBP	show	O	_	_
here	16696	16700	RB	here	O	_	_
that	16701	16705	IN	that	O	_	_
ASPP2	16706	16711	NN	aspp2	B-GENE	_	_
is	16712	16714	VBZ	be	O	_	_
phosphorylated	16715	16729	VBN	phosphorylate	O	_	_
by	16730	16732	IN	by	O	_	_
the	16733	16736	DT	the	O	_	_
RAS	16737	16740	NN	ra	B-GENE	_	_
/	16740	16741	:	/	B-GENE	_	_
Raf/MAPK	16741	16749	NN	raf/mapk	B-GENE	_	_
pathway	16750	16757	NN	pathway	O	_	_
and	16758	16761	CC	and	O	_	_
that	16762	16766	IN	that	O	_	_
this	16767	16771	DT	this	O	_	_
phosphorylation	16772	16787	NN	phosphorylation	O	_	_
leads	16788	16793	VBZ	lead	O	_	_
to	16794	16796	TO	to	O	_	_
its	16797	16800	PRP$	its	O	_	_
increased	16801	16810	VBN	increase	O	_	_
translocation	16811	16824	NN	translocation	O	_	_
to	16825	16827	TO	to	O	_	_
the	16828	16831	DT	the	O	_	_
cytosol	16832	16839	NN	cytosol	O	_	_
/	16839	16840	:	/	O	_	_
nucleus	16840	16847	NN	nucleus	O	_	_
and	16848	16851	CC	and	O	_	_
increased	16852	16861	VBD	increase	O	_	_
binding	16862	16869	NN	binding	O	_	_
to	16870	16872	TO	to	O	_	_
p53	16873	16876	NN	p53	B-GENE	_	_
,	16876	16877	,	,	O	_	_
providing	16878	16887	VBG	provide	O	_	_
an	16888	16890	DT	a	O	_	_
explanation	16891	16902	NN	explanation	O	_	_
of	16903	16905	IN	of	O	_	_
how	16906	16909	WRB	how	O	_	_
RAS	16910	16913	NNP	RAS	B-GENE	_	_
can	16914	16917	MD	can	O	_	_
activate	16918	16926	VB	activate	O	_	_
p53	16927	16930	NN	p53	B-GENE	_	_
pro-apoptotic	16931	16944	JJ	pro-apoptotic	O	_	_
functions	16945	16954	NNS	function	O	_	_
.	16965	16966	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	advmod
1	6	ccomp
6	3	mark
6	4	nsubjpass
6	5	auxpass
6	9	agent
6	31	prep_to
6	33	xcomp
9	8	det
9	17	dep
9	26	dep
9	29	dep
12	11	nn
12	14	conj_and
16	15	det
17	10	punct
17	12	dep
17	14	dep
17	16	nsubj
17	21	prep_to
17	25	punct
21	19	poss
21	20	amod
21	24	prep_to
24	23	det
26	29	conj_and
29	28	amod
33	35	dobj
35	34	det
35	40	prepc_of
40	37	advmod
40	38	nsubj
40	39	aux
40	43	dobj
43	41	nn
43	42	amod
EOX
Y	1
ROOT	0	0	45	1	S	1	0	45	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	44	3	VBP	0	1	2	1	show	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	here	2	2	3	0	SBAR	1	3	44	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	44	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	44	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	44	5	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	30	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	30	3	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	26	3	:	0	10	11	1	/	10	10	11	0	SBAR	1	11	25	2	NP	0	11	15	3	NP	1	11	13	2	NN	0	11	12	1	Raf/MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	ADJP	0	14	15	1	IN	0	14	15	1	that	14	14	15	0	S	1	15	25	2	NP	1	15	17	2	DT	0	15	16	1	this	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	VP	0	17	25	2	VBZ	0	17	18	1	leads	17	17	18	0	PP	0	18	25	2	TO	0	18	19	1	to	18	18	19	0	NP	0	19	25	2	NP	2	19	22	3	PRP$	0	19	20	1	its	19	19	20	0	VBN	0	20	21	1	increased	20	20	21	0	NN	0	21	22	1	translocation	21	21	22	0	PP	0	22	25	2	TO	0	22	23	1	to	22	22	23	0	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	cytosol	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	0	26	30	3	NP	0	26	27	1	NN	0	26	27	1	nucleus	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	NP	1	28	30	2	VBD	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	binding	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	,	0	32	33	1	,	32	32	33	0	S	0	33	44	1	VP	0	33	44	2	VBG	0	33	34	1	providing	33	33	34	0	NP	0	34	44	2	NP	1	34	36	2	DT	0	34	35	1	an	34	34	35	0	NN	0	35	36	1	explanation	35	35	36	0	PP	0	36	44	2	IN	0	36	37	1	of	36	36	37	0	SBAR	1	37	44	2	WHADVP	0	37	38	1	WRB	0	37	38	1	how	37	37	38	0	S	1	38	44	2	NP	0	38	39	1	NNP	0	38	39	1	RAS	38	38	39	0	VP	1	39	44	2	MD	0	39	40	1	can	39	39	40	0	VP	0	40	44	2	VB	0	40	41	1	activate	40	40	41	0	NP	2	41	44	3	NN	0	41	42	1	p53	41	41	42	0	JJ	0	42	43	1	pro-apoptotic	42	42	43	0	NNS	0	43	44	1	functions	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	20
Additionally	16967	16979	RB	additionally	O	_	_
,	16979	16980	,	,	O	_	_
RAS	16981	16984	NN	ra	B-GENE	_	_
/	16984	16985	:	/	B-GENE	_	_
Raf/MAPK	16985	16993	NN	raf/mapk	B-GENE	_	_
pathway	16994	17001	NN	pathway	O	_	_
activation	17002	17012	NN	activation	O	_	_
stabilizes	17013	17023	VBZ	stabilize	O	_	_
ASPP2	17024	17029	NN	aspp2	B-GENE	_	_
protein	17030	17037	NN	protein	I-GENE	_	_
,	17037	17038	,	,	O	_	_
although	17039	17047	IN	although	O	_	_
the	17048	17051	DT	the	O	_	_
underlying	17052	17062	VBG	underlie	O	_	_
mechanism	17063	17072	NN	mechanism	O	_	_
remains	17073	17080	VBZ	remain	O	_	_
to	17081	17083	TO	to	O	_	_
be	17084	17086	VB	be	O	_	_
investigated	17087	17099	VBN	investigate	O	_	_
.	17099	17100	.	.	O	_	_
D	1
7
2	4	dep
4	3	punct
4	6	dep
6	5	nn
7	0	advmod
7	2	nsubj
7	9	dobj
7	15	advcl
9	8	nn
14	12	det
14	13	amod
15	11	mark
15	14	nsubj
15	18	xcomp
18	16	aux
18	17	auxpass
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PRN	1	3	7	2	:	0	3	4	1	/	3	3	4	0	NP	0	4	7	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	pathway	5	5	6	0	NN	0	6	7	1	activation	6	6	7	0	VP	0	7	19	4	VBZ	0	7	8	1	stabilizes	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	protein	9	9	10	0	,	0	10	11	1	,	10	10	11	0	SBAR	1	11	19	2	IN	0	11	12	1	although	11	11	12	0	S	1	12	19	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	VBG	0	13	14	1	underlying	13	13	14	0	NN	0	14	15	1	mechanism	14	14	15	0	VP	0	15	19	2	VBZ	0	15	16	1	remains	15	15	16	0	S	0	16	19	1	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	1	17	19	2	VB	0	17	18	1	be	17	17	18	0	VP	0	18	19	1	VBN	0	18	19	1	investigated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	9
Diagram	17111	17118	NN	diagram	O	_	_
summarizes	17119	17129	VBZ	summarize	O	_	_
the	17130	17133	DT	the	O	_	_
inter-regulation	17134	17150	NN	inter-regulation	O	_	_
between	17151	17158	IN	between	O	_	_
ASPP2	17159	17164	NN	aspp2	B-GENE	_	_
and	17165	17168	CC	and	O	_	_
RAS	17169	17172	NN	ra	B-GENE	_	_
.	17172	17173	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
3	2	det
3	5	prep_between
3	7	prep_between
5	7	conj_and
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NN	0	0	1	1	Diagram	0	0	1	0	VP	0	1	8	2	VBZ	0	1	2	1	summarizes	1	1	2	0	NP	0	2	8	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	inter-regulation	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	between	4	4	5	0	NP	0	5	8	3	NN	0	5	6	1	ASPP2	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	22
ASPP2	17174	17179	NN	aspp2	B-GENE	_	_
binds	17180	17185	VBZ	bind	O	_	_
active	17186	17192	JJ	active	O	_	_
RAS	17193	17196	NN	ra	O	_	_
at	17197	17199	IN	at	O	_	_
the	17200	17203	DT	the	O	_	_
plasma	17204	17210	NN	plasma	O	_	_
membrane	17211	17219	NN	membrane	O	_	_
,	17219	17220	,	,	O	_	_
thereby	17221	17228	RB	thereby	O	_	_
increasing	17229	17239	VBG	increase	O	_	_
RAS	17240	17243	NN	ra	O	_	_
signaling	17244	17253	NN	signaling	O	_	_
to	17254	17256	TO	to	O	_	_
its	17257	17260	PRP$	its	O	_	_
downstream	17261	17271	JJ	downstream	O	_	_
pathway	17272	17279	NN	pathway	O	_	_
effectors	17280	17289	NNS	effector	O	_	_
Raf	17290	17293	NN	raf	B-GENE	_	_
/	17293	17294	:	/	B-GENE	_	_
MAPK	17294	17298	NN	mapk	I-GENE	_	_
.	17298	17299	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	7	prep_at
1	10	vmod
3	2	amod
7	5	det
7	6	nn
10	9	advmod
10	12	dobj
10	18	prep_to
12	11	nn
18	14	poss
18	15	amod
18	16	nn
18	17	nn
18	20	dep
20	19	punct
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	21	5	VBZ	0	1	2	1	binds	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	active	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	at	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	plasma	6	6	7	0	NN	0	7	8	1	membrane	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	21	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	21	3	VBG	0	10	11	1	increasing	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	RAS	11	11	12	0	NN	0	12	13	1	signaling	12	12	13	0	PP	0	13	21	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	21	2	NP	4	14	19	5	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NNS	0	17	18	1	effectors	17	17	18	0	NN	0	18	19	1	Raf	18	18	19	0	PRN	1	19	21	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	MAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	17
Activated	17300	17309	VBN	activate	O	_	_
MAPK	17310	17314	NN	mapk	O	_	_
phosphorylates	17315	17329	VBZ	phosphorylate	O	_	_
ASPP2	17330	17335	NN	aspp2	B-GENE	_	_
which	17336	17341	WDT	which	O	_	_
can	17342	17345	MD	can	O	_	_
then	17346	17350	RB	then	O	_	_
relocate	17351	17359	VB	relocate	O	_	_
to	17360	17362	TO	to	O	_	_
the	17363	17366	DT	the	O	_	_
nucleus	17367	17374	NN	nucleus	O	_	_
and	17375	17378	CC	and	O	_	_
activate	17379	17387	VBP	activate	O	_	_
p53	17388	17391	NN	p53	B-GENE	_	_
pro-apoptotic	17392	17405	JJ	pro-apoptotic	O	_	_
signaling	17406	17415	NN	signaling	O	_	_
.	17415	17416	.	.	O	_	_
D	1
0
0	1	dobj
0	2	dep
0	3	nsubj
3	7	ccomp
3	12	ccomp
7	4	nsubj
7	5	aux
7	6	advmod
7	10	prep_to
7	12	conj_and
10	9	det
12	4	nsubj
12	15	dobj
15	13	nn
15	14	amod
EOX
Y	1
ROOT	0	0	17	1	SINV	0	0	17	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	phosphorylates	2	2	3	0	NP	0	3	16	2	NN	0	3	4	1	ASPP2	3	3	4	0	SBAR	1	4	16	2	WHNP	0	4	5	1	WDT	0	4	5	1	which	4	4	5	0	S	0	5	16	1	VP	0	5	16	3	VP	2	5	11	3	MD	0	5	6	1	can	5	5	6	0	RB	0	6	7	1	then	6	6	7	0	VP	0	7	11	2	VB	0	7	8	1	relocate	7	7	8	0	PP	0	8	11	2	TO	0	8	9	1	to	8	8	9	0	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	nucleus	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	16	2	VBP	0	12	13	1	activate	12	12	13	0	NP	2	13	16	3	NN	0	13	14	1	p53	13	13	14	0	JJ	0	14	15	1	pro-apoptotic	14	14	15	0	NN	0	15	16	1	signaling	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	30
Thus	17417	17421	RB	thus	O	_	_
ASPP2	17422	17427	NN	aspp2	O	_	_
is	17428	17430	VBZ	be	O	_	_
both	17431	17435	DT	both	O	_	_
upstream	17436	17444	JJ	upstream	O	_	_
of	17445	17447	IN	of	O	_	_
RAS	17448	17451	NN	ra	B-GENE	_	_
,	17451	17452	,	,	O	_	_
by	17453	17455	IN	by	O	_	_
binding	17456	17463	VBG	bind	O	_	_
active	17464	17470	JJ	active	O	_	_
RAS	17471	17474	NN	ra	O	_	_
and	17475	17478	CC	and	O	_	_
enhancing	17479	17488	VBG	enhance	O	_	_
its	17489	17492	PRP$	its	O	_	_
downstream	17493	17503	JJ	downstream	O	_	_
pathway	17504	17511	NN	pathway	O	_	_
activity	17512	17520	NN	activity	O	_	_
,	17520	17521	,	,	O	_	_
as	17522	17524	RB	as	O	_	_
well	17525	17529	RB	well	O	_	_
as	17530	17532	IN	as	O	_	_
downstream	17533	17543	JJ	downstream	O	_	_
of	17544	17546	IN	of	O	_	_
the	17547	17550	DT	the	O	_	_
RAS	17551	17554	NN	ra	B-GENE	_	_
/	17554	17555	:	/	B-GENE	_	_
RAF/MAPK	17555	17563	NN	raf/mapk	B-GENE	_	_
pathway	17564	17571	NN	pathway	O	_	_
.	17571	17572	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	11	prep_by
4	13	conj_and
11	9	amod
11	10	amod
13	1	nsubj
13	17	dobj
13	22	dobj
17	14	poss
17	15	amod
17	16	nn
17	22	conj_and
22	25	prep_of
25	24	det
25	28	dep
28	26	punct
28	27	nn
EOX
Y	1
ROOT	0	0	30	1	S	0	0	30	4	S	2	0	12	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	4	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	both	3	3	4	0	JJ	0	4	5	1	upstream	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	VBG	0	9	10	1	binding	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	S	0	13	29	1	VP	0	13	29	2	VBG	0	13	14	1	enhancing	13	13	14	0	NP	0	14	29	4	NP	3	14	18	4	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	,	0	18	19	1	,	18	18	19	0	CONJP	1	19	22	3	RB	0	19	20	1	as	19	19	20	0	RB	0	20	21	1	well	20	20	21	0	IN	0	21	22	1	as	21	21	22	0	NP	0	22	29	2	NP	0	22	23	1	JJ	0	22	23	1	downstream	22	22	23	0	PP	0	23	29	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	29	2	NP	1	24	26	2	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	RAS	25	25	26	0	PRN	1	26	29	2	:	0	26	27	1	/	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	RAF/MAPK	27	27	28	0	NN	0	28	29	1	pathway	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	15
It	17573	17575	PRP	it	O	_	_
is	17576	17578	VBZ	be	O	_	_
likely	17579	17585	JJ	likely	O	_	_
that	17586	17590	IN	that	O	_	_
this	17591	17595	DT	this	O	_	_
possible	17596	17604	JJ	possible	O	_	_
feedback	17605	17613	NN	feedback	O	_	_
loop	17614	17618	NN	loop	O	_	_
leads	17619	17624	VBZ	lead	O	_	_
to	17625	17627	TO	to	O	_	_
an	17628	17630	DT	a	O	_	_
amplified	17631	17640	VBN	amplify	O	_	_
pro-apoptotic	17641	17654	JJ	pro-apoptotic	O	_	_
signal	17655	17661	NN	signal	O	_	_
.	17661	17662	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	8	ccomp
7	4	det
7	5	amod
7	6	nn
8	3	mark
8	7	nsubj
8	13	prep_to
13	10	det
13	11	amod
13	12	amod
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	14	3	VBZ	0	1	2	1	is	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	likely	2	2	3	0	SBAR	1	3	14	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	14	2	NP	3	4	8	4	DT	0	4	5	1	this	4	4	5	0	JJ	0	5	6	1	possible	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	NN	0	7	8	1	loop	7	7	8	0	VP	0	8	14	2	VBZ	0	8	9	1	leads	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	an	10	10	11	0	VBN	0	11	12	1	amplified	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	24
In	17663	17665	IN	in	O	_	_
a	17666	17667	DT	a	O	_	_
scenario	17668	17676	NN	scenario	O	_	_
where	17677	17682	WRB	where	O	_	_
RAS	17683	17686	NNP	RAS	O	_	_
is	17687	17689	VBZ	be	O	_	_
mutated	17690	17697	VBN	mutate	O	_	_
and	17698	17701	CC	and	O	_	_
thereby	17702	17709	RB	thereby	O	_	_
constitutively	17710	17724	RB	constitutively	O	_	_
active	17725	17731	JJ	active	O	_	_
,	17731	17732	,	,	O	_	_
it	17733	17735	PRP	it	O	_	_
binds	17736	17741	VBZ	bind	O	_	_
ASPP2	17742	17747	NN	aspp2	B-GENE	_	_
,	17747	17748	,	,	O	_	_
resulting	17749	17758	VBG	result	O	_	_
in	17759	17761	IN	in	O	_	_
increased	17762	17771	VBN	increase	O	_	_
RAS	17772	17775	NN	ra	B-GENE	_	_
/	17775	17776	:	/	B-GENE	_	_
MAPK	17776	17780	NN	mapk	I-GENE	_	_
signaling	17781	17790	NN	signaling	O	_	_
.	17790	17791	.	.	O	_	_
D	1
13
2	1	det
2	5	rcmod
5	3	advmod
5	4	nsubj
5	6	dep
5	8	dep
5	10	dep
6	8	conj_and
6	10	conj_and
10	9	advmod
13	2	prep_in
13	12	nsubj
13	14	dobj
13	16	vmod
16	19	prep_in
19	18	amod
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	11	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	11	2	NP	1	1	3	2	DT	0	1	2	1	a	1	1	2	0	NN	0	2	3	1	scenario	2	2	3	0	SBAR	1	3	11	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	UCP	0	6	11	4	VP	0	6	7	1	VBN	0	6	7	1	mutated	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	thereby	8	8	9	0	ADJP	1	9	11	2	RB	0	9	10	1	constitutively	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	it	12	12	13	0	VP	0	13	23	4	VBZ	0	13	14	1	binds	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBG	0	16	17	1	resulting	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	VBN	0	18	19	1	increased	18	18	19	0	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	signaling	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
This	17792	17796	DT	this	O	_	_
in	17797	17799	IN	in	O	_	_
turn	17800	17804	NN	turn	O	_	_
activates	17805	17814	VBZ	activate	O	_	_
ASPP2	17815	17820	NN	aspp2	B-GENE	_	_
via	17821	17824	IN	via	O	_	_
MAPK	17825	17829	NN	mapk	B-GENE	_	_
phosphorylation	17830	17845	NN	phosphorylation	O	_	_
which	17846	17851	WDT	which	O	_	_
will	17852	17856	MD	will	O	_	_
translocate	17857	17868	VB	translocate	O	_	_
and	17869	17872	CC	and	O	_	_
activate	17873	17881	VB	activate	O	_	_
p53	17882	17885	NN	p53	B-GENE	_	_
to	17886	17888	TO	to	O	_	_
promote	17889	17896	VB	promote	O	_	_
apoptosis	17897	17906	NN	apoptosis	O	_	_
.	17906	17907	.	.	O	_	_
D	1
3
0	2	prep_in
3	0	nsubj
3	4	dobj
4	7	prep_via
4	10	rcmod
4	12	rcmod
7	6	nn
10	8	nsubj
10	9	aux
10	12	conj_and
10	13	dobj
10	15	xcomp
12	8	nsubj
15	14	aux
15	16	dobj
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	turn	2	2	3	0	VP	0	3	17	2	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	17	3	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	via	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	phosphorylation	7	7	8	0	SBAR	1	8	17	2	WHNP	0	8	9	1	WDT	0	8	9	1	which	8	8	9	0	S	0	9	17	1	VP	1	9	17	2	MD	0	9	10	1	will	9	9	10	0	VP	0	10	17	5	VB	0	10	11	1	translocate	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VB	0	12	13	1	activate	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	S	0	14	17	1	VP	1	14	17	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	17	2	VB	0	15	16	1	promote	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	apoptosis	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	19
ASPP2	17908	17913	NN	aspp2	B-GENE	_	_
will	17914	17918	MD	will	O	_	_
also	17919	17923	RB	also	O	_	_
continue	17924	17932	VB	continue	O	_	_
to	17933	17935	TO	to	O	_	_
bind	17936	17940	VB	bind	O	_	_
active	17941	17947	JJ	active	O	_	_
RAS	17948	17951	NN	ra	O	_	_
,	17951	17952	,	,	O	_	_
thereby	17953	17960	RB	thereby	O	_	_
propagating	17961	17972	VBG	propagate	O	_	_
the	17973	17976	DT	the	O	_	_
pro-apoptotic	17977	17990	JJ	pro-apoptotic	O	_	_
signal	17991	17997	NN	signal	O	_	_
from	17998	18002	IN	from	O	_	_
RAS	18003	18006	NN	ra	O	_	_
to	18007	18009	TO	to	O	_	_
p53	18010	18013	NN	p53	B-GENE	_	_
.	18013	18014	.	.	O	_	_
D	1
3
3	0	nsubj
3	1	aux
3	2	advmod
3	5	xcomp
5	4	aux
5	7	dobj
5	10	vmod
7	6	amod
10	9	advmod
10	13	dobj
10	15	prep_from
10	17	prep_to
13	11	det
13	12	amod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	18	3	MD	0	1	2	1	will	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	0	3	18	2	VB	0	3	4	1	continue	3	3	4	0	S	0	4	18	1	VP	1	4	18	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	18	4	VB	0	5	6	1	bind	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	active	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	18	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	18	4	VBG	0	10	11	1	propagating	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	from	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	RAS	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	43
If	18015	18017	IN	if	O	_	_
RAS	18018	18021	NN	ra	O	_	_
is	18022	18024	VBZ	be	O	_	_
only	18025	18029	RB	only	O	_	_
temporarily	18030	18041	RB	temporarily	O	_	_
active	18042	18048	JJ	active	O	_	_
,	18048	18049	,	,	O	_	_
as	18050	18052	IN	as	O	_	_
happens	18053	18060	VBZ	happen	O	_	_
in	18061	18063	IN	in	O	_	_
natural	18064	18071	JJ	natural	O	_	_
growth	18072	18078	NN	growth	O	_	_
conditions	18079	18089	NNS	condition	O	_	_
,	18089	18090	,	,	O	_	_
one	18091	18094	CD	one	O	_	_
could	18095	18100	MD	could	O	_	_
hypothesize	18101	18112	VB	hypothesize	O	_	_
that	18113	18117	IN	that	O	_	_
ASPP2	18118	18123	NN	aspp2	B-GENE	_	_
would	18124	18129	MD	would	O	_	_
bind	18130	18134	VB	bind	O	_	_
active	18135	18141	JJ	active	O	_	_
RAS	18142	18145	NN	ra	O	_	_
,	18145	18146	,	,	O	_	_
potentiate	18147	18157	VB	potentiate	O	_	_
its	18158	18161	PRP$	its	O	_	_
downstream	18162	18172	JJ	downstream	O	_	_
pathways	18173	18181	NNS	pathway	O	_	_
,	18181	18182	,	,	O	_	_
and	18183	18186	CC	and	O	_	_
MAPK	18187	18191	NN	mapk	B-GENE	_	_
mediated	18192	18200	VBD	mediate	O	_	_
phosphorylation	18201	18216	NN	phosphorylation	O	_	_
of	18217	18219	IN	of	O	_	_
ASPP2	18220	18225	NN	aspp2	B-GENE	_	_
would	18226	18231	MD	would	O	_	_
lead	18232	18236	VB	lead	O	_	_
to	18237	18239	TO	to	O	_	_
increased	18240	18249	VBN	increase	O	_	_
binding	18250	18257	NN	binding	O	_	_
to	18258	18260	TO	to	O	_	_
p53	18261	18264	NN	p53	B-GENE	_	_
.	18264	18265	.	.	O	_	_
D	1
16
5	0	mark
5	1	nsubj
5	2	cop
5	3	advmod
5	4	advmod
5	8	advcl
8	7	mark
8	12	prep_in
12	10	amod
12	11	nn
16	5	advcl
16	14	nsubj
16	15	aux
16	20	ccomp
16	31	conj_and
20	17	mark
20	18	nsubj
20	19	aux
20	22	dobj
20	24	dep
22	21	amod
24	27	dobj
27	25	poss
27	26	amod
31	30	nsubj
31	36	ccomp
32	34	prep_of
36	32	nsubj
36	35	aux
36	39	prep_to
39	38	amod
39	41	prep_to
EOX
Y	1
ROOT	0	0	43	1	S	0	0	43	5	S	3	0	28	4	SBAR	1	0	13	2	IN	0	0	1	1	If	0	0	1	0	S	1	1	13	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	2	2	13	5	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	only	3	3	4	0	ADJP	1	4	6	2	RB	0	4	5	1	temporarily	4	4	5	0	JJ	0	5	6	1	active	5	5	6	0	,	0	6	7	1	,	6	6	7	0	SBAR	1	7	13	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBZ	0	8	9	1	happens	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	in	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	natural	10	10	11	0	NN	0	11	12	1	growth	11	11	12	0	NNS	0	12	13	1	conditions	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	15	1	CD	0	14	15	1	one	14	14	15	0	VP	1	15	28	2	MD	0	15	16	1	could	15	15	16	0	VP	0	16	28	2	VB	0	16	17	1	hypothesize	16	16	17	0	SBAR	1	17	28	2	IN	0	17	18	1	that	17	17	18	0	S	1	18	28	2	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	28	4	MD	0	19	20	1	would	19	19	20	0	VP	0	20	23	2	VB	0	20	21	1	bind	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	active	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	,	0	23	24	1	,	23	23	24	0	VP	0	24	28	2	VB	0	24	25	1	potentiate	24	24	25	0	NP	2	25	28	3	PRP$	0	25	26	1	its	25	25	26	0	JJ	0	26	27	1	downstream	26	26	27	0	NNS	0	27	28	1	pathways	27	27	28	0	,	0	28	29	1	,	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	S	1	30	42	2	NP	0	30	31	1	NN	0	30	31	1	MAPK	30	30	31	0	VP	0	31	42	2	VBD	0	31	32	1	mediated	31	31	32	0	SBAR	0	32	42	1	S	1	32	42	2	NP	0	32	35	2	NP	0	32	33	1	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	of	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	ASPP2	34	34	35	0	VP	1	35	42	2	MD	0	35	36	1	would	35	35	36	0	VP	0	36	42	2	VB	0	36	37	1	lead	36	36	37	0	PP	0	37	42	2	TO	0	37	38	1	to	37	37	38	0	NP	0	38	42	2	NP	1	38	40	2	VBN	0	38	39	1	increased	38	38	39	0	NN	0	39	40	1	binding	39	39	40	0	PP	0	40	42	2	TO	0	40	41	1	to	40	40	41	0	NP	0	41	42	1	NN	0	41	42	1	p53	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	31
However	18266	18273	RB	however	O	_	_
,	18273	18274	,	,	O	_	_
once	18275	18279	RB	once	O	_	_
RAS	18280	18283	NNP	RAS	B-GENE	_	_
reverts	18284	18291	VBZ	revert	O	_	_
to	18292	18294	TO	to	O	_	_
its	18295	18298	PRP$	its	O	_	_
inactive	18299	18307	JJ	inactive	O	_	_
state	18308	18313	NN	state	O	_	_
,	18313	18314	,	,	O	_	_
it	18315	18317	PRP	it	O	_	_
would	18318	18323	MD	would	O	_	_
be	18324	18326	VB	be	O	_	_
unable	18327	18333	JJ	unable	O	_	_
to	18334	18336	TO	to	O	_	_
bind	18337	18341	VB	bind	O	_	_
to	18342	18344	TO	to	O	_	_
ASPP2	18345	18350	NN	aspp2	B-GENE	_	_
and	18351	18354	CC	and	O	_	_
would	18355	18360	MD	would	O	_	_
therefore	18361	18370	RB	therefore	O	_	_
be	18371	18373	VB	be	O	_	_
unable	18374	18380	JJ	unable	O	_	_
to	18381	18383	TO	to	O	_	_
amplify	18384	18391	VB	amplify	O	_	_
the	18392	18395	DT	the	O	_	_
RAS	18396	18399	NN	ra	O	_	_
signal	18400	18406	NN	signal	O	_	_
to	18407	18409	TO	to	O	_	_
p53	18410	18413	NN	p53	B-GENE	_	_
.	18413	18414	.	.	O	_	_
D	1
13
4	2	advmod
4	3	nsubj
4	8	prep_to
8	6	poss
8	7	amod
13	0	advmod
13	4	advcl
13	10	nsubj
13	11	aux
13	12	cop
13	15	xcomp
13	22	conj_and
15	14	aux
15	17	prep_to
22	10	nsubj
22	19	aux
22	20	advmod
22	21	cop
22	24	xcomp
24	23	aux
24	27	dobj
24	29	prep_to
27	25	det
27	26	nn
EOX
Y	1
ROOT	0	0	31	1	S	5	0	31	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	9	2	RB	0	2	3	1	once	2	2	3	0	S	1	3	9	2	NP	0	3	4	1	NNP	0	3	4	1	RAS	3	3	4	0	VP	0	4	9	2	VBZ	0	4	5	1	reverts	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	JJ	0	7	8	1	inactive	7	7	8	0	NN	0	8	9	1	state	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	PRP	0	10	11	1	it	10	10	11	0	VP	0	11	30	3	VP	1	11	18	2	MD	0	11	12	1	would	11	11	12	0	VP	1	12	18	2	VB	0	12	13	1	be	12	12	13	0	ADJP	0	13	18	2	JJ	0	13	14	1	unable	13	13	14	0	S	0	14	18	1	VP	1	14	18	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	18	2	VB	0	15	16	1	bind	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	2	19	30	3	MD	0	19	20	1	would	19	19	20	0	ADVP	0	20	21	1	RB	0	20	21	1	therefore	20	20	21	0	VP	1	21	30	2	VB	0	21	22	1	be	21	21	22	0	ADJP	0	22	30	2	JJ	0	22	23	1	unable	22	22	23	0	S	0	23	30	1	VP	1	23	30	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	30	3	VB	0	24	25	1	amplify	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	the	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	NN	0	27	28	1	signal	27	27	28	0	PP	0	28	30	2	TO	0	28	29	1	to	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	p53	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	27
Only	18415	18419	RB	only	O	_	_
in	18420	18422	IN	in	O	_	_
conditions	18423	18433	NNS	condition	O	_	_
where	18434	18439	WRB	where	O	_	_
RAS	18440	18443	NN	ra	O	_	_
is	18444	18446	VBZ	be	O	_	_
constitutively	18447	18461	RB	constitutively	O	_	_
active	18462	18468	JJ	active	O	_	_
would	18469	18474	MD	would	O	_	_
the	18475	18478	DT	the	O	_	_
ASPP2	18479	18484	NN	aspp2	O	_	_
feedback	18485	18493	NN	feedback	O	_	_
loop	18494	18498	NN	loop	O	_	_
reach	18499	18504	VBP	reach	O	_	_
a	18505	18506	DT	a	O	_	_
threshold	18507	18516	NN	threshold	O	_	_
of	18517	18519	IN	of	O	_	_
signaling	18520	18529	VBG	signal	O	_	_
high	18530	18534	JJ	high	O	_	_
enough	18535	18541	JJ	enough	O	_	_
to	18542	18544	TO	to	O	_	_
result	18545	18551	VB	result	O	_	_
in	18552	18554	IN	in	O	_	_
p53	18555	18558	NN	p53	B-GENE	_	_
dependent	18559	18568	JJ	dependent	O	_	_
apoptosis	18569	18578	NN	apoptosis	O	_	_
.	18578	18579	.	.	O	_	_
D	1
13
0	2	prep_in
2	7	rcmod
7	3	advmod
7	4	nsubj
7	5	cop
7	6	advmod
7	8	ccomp
12	9	det
12	10	nn
12	11	nn
13	0	advmod
13	12	nsubj
13	19	xcomp
15	14	det
15	17	prepc_of
17	18	acomp
19	15	nsubj
19	21	xcomp
21	20	aux
21	25	prep_in
25	23	nn
25	24	amod
EOX
Y	1
ROOT	0	0	27	1	S	2	0	27	4	ADVP	0	0	9	2	RB	0	0	1	1	Only	0	0	1	0	PP	0	1	9	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	9	2	NP	0	2	3	1	NNS	0	2	3	1	conditions	2	2	3	0	SBAR	1	3	9	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	9	2	NP	0	4	5	1	NN	0	4	5	1	RAS	4	4	5	0	VP	1	5	9	2	VBZ	0	5	6	1	is	5	5	6	0	ADJP	1	6	9	3	RB	0	6	7	1	constitutively	6	6	7	0	JJ	0	7	8	1	active	7	7	8	0	SBAR	0	8	9	1	S	0	8	9	1	VP	0	8	9	1	MD	0	8	9	1	would	8	8	9	0	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	feedback	11	11	12	0	NN	0	12	13	1	loop	12	12	13	0	VP	0	13	26	2	VBP	0	13	14	1	reach	13	13	14	0	S	1	14	26	2	NP	0	14	19	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	threshold	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	of	16	16	17	0	S	0	17	19	1	VP	0	17	19	2	VBG	0	17	18	1	signaling	17	17	18	0	ADJP	0	18	19	1	JJ	0	18	19	1	high	18	18	19	0	ADJP	0	19	26	2	JJ	0	19	20	1	enough	19	19	20	0	S	0	20	26	1	VP	1	20	26	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	26	2	VB	0	21	22	1	result	21	21	22	0	PP	0	22	26	2	IN	0	22	23	1	in	22	22	23	0	NP	2	23	26	3	NN	0	23	24	1	p53	23	23	24	0	JJ	0	24	25	1	dependent	24	24	25	0	NN	0	25	26	1	apoptosis	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	32
The	18580	18583	DT	the	O	_	_
ability	18584	18591	NN	ability	O	_	_
of	18592	18594	IN	of	O	_	_
oncogenic	18595	18604	JJ	oncogenic	O	_	_
RAS	18605	18608	NN	ra	O	_	_
to	18609	18611	TO	to	O	_	_
stimulate	18612	18621	VB	stimulate	O	_	_
apoptosis	18622	18631	NN	apoptosis	O	_	_
allows	18632	18638	VBZ	allow	O	_	_
the	18639	18642	DT	the	O	_	_
cell	18643	18647	NN	cell	O	_	_
to	18648	18650	TO	to	O	_	_
have	18651	18655	VB	have	O	_	_
a	18656	18657	DT	a	O	_	_
fail-proof	18658	18668	JJ	fail-proof	O	_	_
mechanism	18669	18678	NN	mechanism	O	_	_
:	18678	18679	:	:	O	_	_
mutated	18680	18687	VBN	mutate	O	_	_
RAS	18688	18691	NN	ra	O	_	_
signals	18692	18699	NNS	signal	O	_	_
to	18700	18702	TO	to	O	_	_
p53	18703	18706	NN	p53	B-GENE	_	_
via	18707	18710	IN	via	O	_	_
ASPP2	18711	18716	NN	aspp2	B-GENE	_	_
to	18717	18719	TO	to	O	_	_
induce	18720	18726	VB	induce	O	_	_
apoptosis	18727	18736	NN	apoptosis	O	_	_
instead	18737	18744	RB	instead	O	_	_
of	18745	18747	IN	of	O	_	_
uncontrolled	18748	18760	JJ	uncontrolled	O	_	_
proliferation	18761	18774	NN	proliferation	O	_	_
.	18774	18775	.	.	O	_	_
D	1
8
1	0	det
1	4	prep_of
4	3	amod
4	6	vmod
6	5	aux
6	7	dobj
8	1	nsubj
8	10	dobj
10	9	det
10	12	vmod
12	11	aux
12	15	dobj
15	13	det
15	14	amod
15	17	vmod
17	19	dobj
17	21	prep_to
17	25	xcomp
19	18	nn
21	23	prep_via
25	24	aux
25	26	dobj
26	30	prep_instead_of
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	0	0	8	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ability	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	8	3	JJ	0	3	4	1	oncogenic	3	3	4	0	NN	0	4	5	1	RAS	4	4	5	0	S	0	5	8	1	VP	1	5	8	2	TO	0	5	6	1	to	5	5	6	0	VP	0	6	8	2	VB	0	6	7	1	stimulate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	apoptosis	7	7	8	0	VP	0	8	31	2	VBZ	0	8	9	1	allows	8	8	9	0	NP	1	9	31	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	cell	10	10	11	0	S	0	11	31	1	VP	1	11	31	2	TO	0	11	12	1	to	11	11	12	0	VP	0	12	31	2	VB	0	12	13	1	have	12	12	13	0	NP	0	13	31	3	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	fail-proof	14	14	15	0	NN	0	15	16	1	mechanism	15	15	16	0	:	0	16	17	1	:	16	16	17	0	VP	0	17	31	4	VBN	0	17	18	1	mutated	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	RAS	18	18	19	0	NNS	0	19	20	1	signals	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	S	0	24	31	1	VP	1	24	31	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	31	2	VB	0	25	26	1	induce	25	25	26	0	NP	0	26	31	2	NP	0	26	27	1	NN	0	26	27	1	apoptosis	26	26	27	0	PP	1	27	31	3	RB	0	27	28	1	instead	27	27	28	0	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	uncontrolled	29	29	30	0	NN	0	30	31	1	proliferation	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	40
However	18776	18783	RB	however	O	_	_
,	18783	18784	,	,	O	_	_
under	18785	18790	IN	under	O	_	_
normal	18791	18797	JJ	normal	O	_	_
conditions	18798	18808	NNS	condition	O	_	_
,	18808	18809	,	,	O	_	_
growth	18810	18816	NN	growth	O	_	_
factors	18817	18824	NNS	factor	O	_	_
or	18825	18827	CC	or	O	_	_
growth	18828	18834	NN	growth	O	_	_
receptors	18835	18844	NNS	receptor	O	_	_
would	18845	18850	MD	would	O	_	_
only	18851	18855	RB	only	O	_	_
activate	18856	18864	VB	activate	O	_	_
RAS	18865	18868	NN	ra	B-GENE	_	_
for	18869	18872	IN	for	O	_	_
short	18873	18878	JJ	short	O	_	_
periods	18879	18886	NNS	period	O	_	_
of	18887	18889	IN	of	O	_	_
time	18890	18894	NN	time	O	_	_
,	18894	18895	,	,	O	_	_
preventing	18896	18906	VBG	prevent	O	_	_
the	18907	18910	DT	the	O	_	_
amplification	18911	18924	NN	amplification	O	_	_
of	18925	18927	IN	of	O	_	_
ASPP2	18928	18933	NN	aspp2	B-GENE	_	_
signaling	18934	18943	NN	signaling	O	_	_
to	18944	18946	TO	to	O	_	_
p53	18947	18950	NN	p53	B-GENE	_	_
via	18951	18954	IN	via	O	_	_
the	18955	18958	DT	the	O	_	_
feedback	18959	18967	NN	feedback	O	_	_
loop	18968	18972	NN	loop	O	_	_
,	18972	18973	,	,	O	_	_
thereby	18974	18981	RB	thereby	O	_	_
eliminating	18982	18993	VBG	eliminate	O	_	_
the	18994	18997	DT	the	O	_	_
apoptotic	18998	19007	JJ	apoptotic	O	_	_
stimulus	19008	19016	NN	stimulus	O	_	_
.	19016	19017	.	.	O	_	_
D	1
13
4	3	amod
7	6	nn
7	10	conj_or
10	9	nn
13	0	advmod
13	4	prep_under
13	7	nsubj
13	10	nsubj
13	11	aux
13	12	advmod
13	14	dobj
13	17	prep_for
13	21	vmod
13	35	xcomp
17	16	amod
17	19	prep_of
21	23	dobj
21	28	prep_to
23	22	det
23	26	prep_of
26	25	nn
28	32	prep_via
32	30	det
32	31	nn
35	34	advmod
35	38	dobj
38	36	det
38	37	amod
EOX
Y	1
ROOT	0	0	40	1	S	5	0	40	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	under	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	normal	3	3	4	0	NNS	0	4	5	1	conditions	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	11	3	NP	1	6	8	2	NN	0	6	7	1	growth	6	6	7	0	NNS	0	7	8	1	factors	7	7	8	0	CC	0	8	9	1	or	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	growth	9	9	10	0	NNS	0	10	11	1	receptors	10	10	11	0	VP	2	11	39	3	MD	0	11	12	1	would	11	11	12	0	ADVP	0	12	13	1	RB	0	12	13	1	only	12	12	13	0	VP	0	13	39	7	VB	0	13	14	1	activate	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	RAS	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	for	15	15	16	0	NP	0	16	20	2	NP	1	16	18	2	JJ	0	16	17	1	short	16	16	17	0	NNS	0	17	18	1	periods	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	time	19	19	20	0	,	0	20	21	1	,	20	20	21	0	S	0	21	33	1	VP	0	21	33	3	VBG	0	21	22	1	preventing	21	21	22	0	NP	0	22	27	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	amplification	23	23	24	0	PP	0	24	27	2	IN	0	24	25	1	of	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	ASPP2	25	25	26	0	NN	0	26	27	1	signaling	26	26	27	0	PP	0	27	33	2	TO	0	27	28	1	to	27	27	28	0	NP	0	28	33	2	NP	0	28	29	1	NN	0	28	29	1	p53	28	28	29	0	PP	0	29	33	2	IN	0	29	30	1	via	29	29	30	0	NP	2	30	33	3	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	feedback	31	31	32	0	NN	0	32	33	1	loop	32	32	33	0	,	0	33	34	1	,	33	33	34	0	S	1	34	39	2	ADVP	0	34	35	1	RB	0	34	35	1	thereby	34	34	35	0	VP	0	35	39	2	VBG	0	35	36	1	eliminating	35	35	36	0	NP	2	36	39	3	DT	0	36	37	1	the	36	36	37	0	JJ	0	37	38	1	apoptotic	37	37	38	0	NN	0	38	39	1	stimulus	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	39
The	19018	19021	DT	the	O	_	_
novel	19022	19027	JJ	novel	O	_	_
RAS	19028	19031	NN	ra	B-GENE	_	_
/	19031	19032	:	/	I-GENE	_	_
Raf/MAPK	19032	19040	NN	raf/mapk	B-GENE	_	_
/	19040	19041	:	/	B-GENE	_	_
ASPP2	19041	19046	NN	aspp2	I-GENE	_	_
pathway	19047	19054	NN	pathway	O	_	_
is	19055	19057	VBZ	be	O	_	_
thus	19058	19062	RB	thus	O	_	_
involved	19063	19071	VBN	involve	O	_	_
in	19072	19074	IN	in	O	_	_
an	19075	19077	DT	a	O	_	_
important	19078	19087	JJ	important	O	_	_
feedback	19088	19096	NN	feedback	O	_	_
loop	19097	19101	NN	loop	O	_	_
between	19102	19109	IN	between	O	_	_
RAS	19110	19113	NN	ra	B-GENE	_	_
and	19114	19117	CC	and	O	_	_
p53	19118	19121	NN	p53	B-GENE	_	_
,	19121	19122	,	,	O	_	_
and	19123	19126	CC	and	O	_	_
is	19127	19129	VBZ	be	O	_	_
an	19130	19132	DT	a	O	_	_
effective	19133	19142	JJ	effective	O	_	_
way	19143	19146	NN	way	O	_	_
for	19147	19150	IN	for	O	_	_
mutant	19151	19157	JJ	mutant	O	_	_
RAS	19158	19161	NN	ra	O	_	_
to	19162	19164	TO	to	O	_	_
induce	19165	19171	VB	induce	O	_	_
apoptosis	19172	19181	NN	apoptosis	O	_	_
in	19182	19184	IN	in	O	_	_
cancer	19185	19191	NN	cancer	O	_	_
cells	19192	19197	NNS	cell	O	_	_
with	19198	19202	IN	with	O	_	_
wild-type	19203	19212	JJ	wild-type	B-GENE	_	_
p53	19213	19216	NN	p53	I-GENE	_	_
.	19216	19217	.	.	O	_	_
D	1
2
2	0	det
2	1	amod
2	3	punct
2	10	dep
2	25	dep
4	7	dep
7	5	punct
7	6	nn
10	4	nsubjpass
10	8	auxpass
10	9	advmod
10	15	prep_in
10	25	conj_and
15	12	det
15	13	amod
15	14	nn
15	17	prep_between
15	19	prep_between
17	19	conj_and
25	22	cop
25	23	det
25	24	amod
25	28	prep_for
25	30	vmod
28	27	amod
30	29	aux
30	31	dobj
30	37	prep_with
31	34	prep_in
34	33	nn
37	36	amod
EOX
Y	1
ROOT	0	0	39	1	FRAG	0	0	39	4	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	novel	1	1	2	0	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	S	1	4	38	2	NP	0	4	8	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	PRN	1	5	8	2	:	0	5	6	1	/	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	ASPP2	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	VP	0	8	38	4	VP	2	8	20	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	20	2	VBN	0	10	11	1	involved	10	10	11	0	PP	0	11	20	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	20	2	NP	3	12	16	4	DT	0	12	13	1	an	12	12	13	0	JJ	0	13	14	1	important	13	13	14	0	NN	0	14	15	1	feedback	14	14	15	0	NN	0	15	16	1	loop	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	between	16	16	17	0	NP	0	17	20	3	NN	0	17	18	1	RAS	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	,	0	20	21	1	,	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	1	22	38	2	VBZ	0	22	23	1	is	22	22	23	0	NP	0	23	38	3	NP	2	23	26	3	DT	0	23	24	1	an	23	23	24	0	JJ	0	24	25	1	effective	24	24	25	0	NN	0	25	26	1	way	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	for	26	26	27	0	NP	1	27	29	2	JJ	0	27	28	1	mutant	27	27	28	0	NN	0	28	29	1	RAS	28	28	29	0	S	0	29	38	1	VP	1	29	38	2	TO	0	29	30	1	to	29	29	30	0	VP	0	30	38	3	VB	0	30	31	1	induce	30	30	31	0	NP	0	31	35	2	NP	0	31	32	1	NN	0	31	32	1	apoptosis	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	NN	0	33	34	1	cancer	33	33	34	0	NNS	0	34	35	1	cells	34	34	35	0	PP	0	35	38	2	IN	0	35	36	1	with	35	35	36	0	NP	1	36	38	2	JJ	0	36	37	1	wild-type	36	36	37	0	NN	0	37	38	1	p53	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	4
Materials	19218	19227	NNPS	Materials	O	_	_
and	19228	19231	CC	and	O	_	_
Methods	19232	19239	NNS	method	O	_	_
.	19239	19240	.	.	O	_	_
D	1
0
0	2	conj_and
EOX
Y	1
ROOT	0	0	4	1	NP	0	0	4	2	NP	0	0	3	3	NP	0	0	1	1	NNPS	0	0	1	1	Materials	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NP	0	2	3	1	NNS	0	2	3	1	Methods	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	7
Cell	19241	19245	NN	cell	O	_	_
culture	19246	19253	NN	culture	O	_	_
,	19253	19254	,	,	O	_	_
plasmids	19255	19263	NNS	plasmid	O	_	_
and	19264	19267	CC	and	O	_	_
siRNA	19268	19273	NN	sirna	O	_	_
.	19273	19274	.	.	O	_	_
D	1
1
1	0	nn
1	3	appos
1	5	appos
3	5	conj_and
EOX
Y	1
ROOT	0	0	7	1	NP	0	0	7	4	NP	1	0	2	2	NN	0	0	1	1	Cell	0	0	1	0	NN	0	1	2	1	culture	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	6	3	NP	0	3	4	1	NNS	0	3	4	1	plasmids	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	siRNA	5	5	6	0	.	0	6	7	1	.	6	6	7	0
EOS
T	16
Saos2	19275	19280	NN	saos2	O	_	_
cells	19281	19286	NNS	cell	O	_	_
were	19287	19291	VBD	be	O	_	_
obtained	19292	19300	VBN	obtain	O	_	_
from	19301	19305	IN	from	O	_	_
the	19306	19309	DT	the	O	_	_
American	19310	19318	JJ	american	O	_	_
Type	19319	19323	NN	type	O	_	_
Culture	19324	19331	NN	culture	O	_	_
Collection	19332	19342	NN	collection	O	_	_
(	19343	19344	CD	(	O	_	_
Manassas	19344	19352	NNP	Manassas	O	_	_
,	19352	19353	,	,	O	_	_
VA	19354	19356	NNP	VA	O	_	_
)	19356	19357	CD	)	O	_	_
.	19357	19358	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	8	prep_from
3	11	dobj
8	5	det
8	6	amod
8	7	nn
11	9	nn
11	13	appos
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	15	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	15	3	VBN	0	3	4	1	obtained	3	3	4	0	PP	0	4	9	2	IN	0	4	5	1	from	4	4	5	0	NP	3	5	9	4	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	American	6	6	7	0	NN	0	7	8	1	Type	7	7	8	0	NN	0	8	9	1	Culture	8	8	9	0	NP	0	9	15	3	NP	2	9	12	3	NN	0	9	10	1	Collection	9	9	10	0	CD	0	10	11	1	-LRB-	10	10	11	0	NNP	0	11	12	1	Manassas	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	0	13	15	2	NNP	0	13	14	1	VA	13	13	14	0	CD	0	14	15	1	-RRB-	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	16
HKe3	19359	19363	NN	hke3	B-GENE	_	_
ER	19364	19366	NN	er	O	_	_
:	19366	19367	:	:	O	_	_
HRASV12	19367	19374	NN	hrasv12	O	_	_
cells	19375	19380	NNS	cell	O	_	_
were	19381	19385	VBD	be	O	_	_
kindly	19386	19392	RB	kindly	O	_	_
provided	19393	19401	VBN	provide	O	_	_
by	19402	19404	IN	by	O	_	_
Dr	19405	19407	NNP	Dr	O	_	_
Julian	19408	19414	NNP	Julian	O	_	_
Downward	19415	19423	NNP	Downward	O	_	_
[	19424	19425	CD	[	O	_	_
2,10,11	19425	19432	CD	2,10,11	O	_	_
]	19432	19433	NN	]	O	_	_
.	19433	19434	.	.	O	_	_
D	1
1
1	0	nn
1	7	dep
4	3	nn
7	4	nsubjpass
7	5	auxpass
7	6	advmod
7	11	agent
7	14	dep
11	9	nn
11	10	nn
13	12	number
14	13	num
EOX
Y	1
ROOT	0	0	16	1	FRAG	0	0	16	4	NP	1	0	2	2	NN	0	0	1	1	HKe3	0	0	1	0	NN	0	1	2	1	ER	1	1	2	0	:	0	2	3	1	:	2	2	3	0	S	1	3	15	2	NP	1	3	5	2	NN	0	3	4	1	HRASV12	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	2	5	15	3	VBD	0	5	6	1	were	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	kindly	6	6	7	0	VP	0	7	15	2	VBN	0	7	8	1	provided	7	7	8	0	PP	0	8	15	3	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	NNP	0	9	10	1	Dr	9	9	10	0	NNP	0	10	11	1	Julian	10	10	11	0	NNP	0	11	12	1	Downward	11	11	12	0	NP	1	12	15	2	QP	1	12	14	2	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	2,10,11	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	29
Cells	19435	19440	NNS	cell	O	_	_
were	19441	19445	VBD	be	O	_	_
cultured	19446	19454	VBN	culture	O	_	_
in	19455	19457	IN	in	O	_	_
DMEM	19458	19462	NNP	DMEM	O	_	_
supplemented	19463	19475	VBN	supplement	O	_	_
with	19476	19480	IN	with	O	_	_
10	19481	19483	CD	10	O	_	_
%	19483	19484	NN	%	O	_	_
fetal	19485	19490	JJ	fetal	O	_	_
bovine	19491	19497	JJ	bovine	O	_	_
serum	19498	19503	NN	serum	O	_	_
(	19504	19505	CD	(	O	_	_
FBS	19505	19508	NN	fb	O	_	_
)	19508	19509	NN	)	O	_	_
and	19510	19513	CC	and	O	_	_
penicillin	19514	19524	NN	penicillin	O	_	_
streptomycin	19525	19537	NN	streptomycin	O	_	_
(	19538	19539	CD	(	O	_	_
Gibco-BRL	19539	19548	NNP	Gibco-BRL	O	_	_
,	19548	19549	,	,	O	_	_
Invitrogen	19550	19560	NNP	Invitrogen	O	_	_
Ltd	19561	19564	NNP	Ltd	O	_	_
,	19564	19565	,	,	O	_	_
Paisley	19566	19573	NNP	Paisley	O	_	_
,	19573	19574	,	,	O	_	_
UK	19575	19577	NNP	UK	O	_	_
)	19577	19578	CD	)	O	_	_
.	19578	19579	.	.	O	_	_
D	1

2	0	nsubjpass
2	1	auxpass
2	4	prep_in
4	5	vmod
5	11	prep_with
5	16	prep_with
8	7	number
11	8	amod
11	9	amod
11	10	amod
11	16	conj_and
14	13	nn
16	19	dep
19	17	nn
19	26	appos
26	21	nn
26	22	nn
26	24	appos
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	28	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	28	2	VBN	0	2	3	1	cultured	2	2	3	0	PP	0	3	28	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	28	2	NP	0	4	5	1	NNP	0	4	5	1	DMEM	4	4	5	0	VP	0	5	28	2	VBN	0	5	6	1	supplemented	5	5	6	0	PP	0	6	28	2	IN	0	6	7	1	with	6	6	7	0	NP	0	7	28	3	NP	0	7	15	2	NP	3	7	12	4	ADJP	1	7	9	2	CD	0	7	8	1	10	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	JJ	0	9	10	1	fetal	9	9	10	0	JJ	0	10	11	1	bovine	10	10	11	0	NN	0	11	12	1	serum	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	NN	0	13	14	1	FBS	13	13	14	0	NN	0	14	15	1	-RRB-	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NP	0	16	28	2	NP	0	16	17	1	NN	0	16	17	1	penicillin	16	16	17	0	NP	0	17	28	3	NP	2	17	20	3	NN	0	17	18	1	streptomycin	17	17	18	0	CD	0	18	19	1	-LRB-	18	18	19	0	NNP	0	19	20	1	Gibco-BRL	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	5	21	28	7	NNP	0	21	22	1	Invitrogen	21	21	22	0	NNP	0	22	23	1	Ltd	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NNP	0	24	25	1	Paisley	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NNP	0	26	27	1	UK	26	26	27	0	CD	0	27	28	1	-RRB-	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	42
For	19580	19583	IN	for	O	_	_
growth	19584	19590	NN	growth	O	_	_
factor	19591	19597	NN	factor	O	_	_
stimulation	19598	19609	NN	stimulation	O	_	_
,	19609	19610	,	,	O	_	_
cells	19611	19616	NNS	cell	O	_	_
were	19617	19621	VBD	be	O	_	_
serum	19622	19627	NN	serum	O	_	_
starved	19628	19635	VBN	starve	O	_	_
for	19636	19639	IN	for	O	_	_
indicated	19640	19649	JJ	indicated	O	_	_
time	19650	19654	NN	time	O	_	_
,	19654	19655	,	,	O	_	_
followed	19656	19664	VBN	follow	O	_	_
by	19665	19667	IN	by	O	_	_
stimulation	19668	19679	NN	stimulation	O	_	_
with	19680	19684	IN	with	O	_	_
20	19685	19687	CD	20	O	_	_
%	19687	19688	NN	%	O	_	_
serum	19689	19694	NN	serum	O	_	_
plus	19695	19699	CC	plus	O	_	_
epidermal	19700	19709	JJ	epidermal	B-GENE	_	_
growth	19710	19716	NN	growth	I-GENE	_	_
factor	19717	19723	NN	factor	I-GENE	_	_
(	19724	19725	CD	(	B-GENE	_	_
EGF	19725	19728	NN	egf	I-GENE	_	_
)	19728	19729	NN	)	O	_	_
,	19729	19730	,	,	O	_	_
EGF	19731	19734	NN	egf	B-GENE	_	_
alone	19735	19740	RB	alone	O	_	_
or	19741	19743	CC	or	O	_	_
insulin	19744	19751	NN	insulin	B-GENE	_	_
(	19752	19753	CD	(	O	_	_
Sigma	19753	19758	NNP	Sigma	O	_	_
,	19758	19759	,	,	O	_	_
Dorset	19760	19766	NNP	Dorset	O	_	_
,	19766	19767	,	,	O	_	_
UK	19768	19770	NNP	UK	O	_	_
)	19770	19771	CD	)	O	_	_
as	19772	19774	IN	as	O	_	_
indicated	19775	19784	VBN	indicate	O	_	_
.	19784	19785	.	.	O	_	_
D	1
7
3	1	nn
3	2	nn
7	3	prep_for
7	5	nsubj
7	6	cop
7	8	vmod
8	11	prep_for
11	10	amod
11	13	vmod
13	15	agent
13	37	dobj
15	19	prep_with
18	17	number
19	18	amod
19	20	prep
26	21	amod
26	22	nn
26	23	nn
26	25	nn
26	28	conj_or
26	31	conj_or
28	29	advmod
37	33	nn
37	35	appos
37	40	prep_as
EOX
Y	1
ROOT	0	0	42	1	S	3	0	42	5	PP	0	0	4	2	IN	0	0	1	1	For	0	0	1	0	NP	2	1	4	3	NN	0	1	2	1	growth	1	1	2	0	NN	0	2	3	1	factor	2	2	3	0	NN	0	3	4	1	stimulation	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	41	2	VBD	0	6	7	1	were	6	6	7	0	NP	0	7	41	2	NP	0	7	8	1	NN	0	7	8	1	serum	7	7	8	0	VP	0	8	41	2	VBN	0	8	9	1	starved	8	8	9	0	PP	0	9	41	2	IN	0	9	10	1	for	9	9	10	0	NP	0	10	41	3	NP	1	10	12	2	JJ	0	10	11	1	indicated	10	10	11	0	NN	0	11	12	1	time	11	11	12	0	,	0	12	13	1	,	12	12	13	0	VP	0	13	41	3	VBN	0	13	14	1	followed	13	13	14	0	PP	0	14	33	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	33	2	NP	0	15	16	1	NN	0	15	16	1	stimulation	15	15	16	0	PP	0	16	33	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	33	2	NP	1	17	20	2	ADJP	1	17	19	2	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	%	18	18	19	0	NN	0	19	20	1	serum	19	19	20	0	PP	0	20	33	2	CC	0	20	21	1	plus	20	20	21	0	NP	0	21	33	5	NP	5	21	27	6	JJ	0	21	22	1	epidermal	21	21	22	0	NN	0	22	23	1	growth	22	22	23	0	NN	0	23	24	1	factor	23	23	24	0	CD	0	24	25	1	-LRB-	24	24	25	0	NN	0	25	26	1	EGF	25	25	26	0	NN	0	26	27	1	-RRB-	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	EGF	28	28	29	0	RB	0	29	30	1	alone	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	33	2	NN	0	31	32	1	insulin	31	31	32	0	CD	0	32	33	1	-LRB-	32	32	33	0	NP	0	33	41	2	NP	4	33	39	6	NNP	0	33	34	1	Sigma	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NNP	0	35	36	1	Dorset	35	35	36	0	,	0	36	37	1	,	36	36	37	0	NNP	0	37	38	1	UK	37	37	38	0	CD	0	38	39	1	-RRB-	38	38	39	0	PP	0	39	41	2	IN	0	39	40	1	as	39	39	40	0	NP	0	40	41	1	VBN	0	40	41	1	indicated	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	13
Full-length	19786	19797	JJ	full-length	O	_	_
ASPP2	19798	19803	NN	aspp2	O	_	_
and	19804	19807	CC	and	O	_	_
ASPP2	19808	19813	NN	aspp2	O	_	_
(	19814	19815	CD	(	O	_	_
693-1128	19815	19823	CD	693-1128	O	_	_
)	19823	19824	NN	)	O	_	_
was	19825	19828	VBD	be	O	_	_
tagged	19829	19835	VBN	tag	O	_	_
with	19836	19840	IN	with	O	_	_
the	19841	19844	DT	the	O	_	_
V5-epitope	19845	19855	NN	v5-epitope	O	_	_
.	19855	19856	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
6	5	dep
8	1	nsubjpass
8	3	nsubjpass
8	7	auxpass
8	11	prep_with
11	10	det
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	7	2	NP	1	0	4	4	JJ	0	0	1	1	Full-length	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	ADJP	1	4	7	2	QP	1	4	6	2	CD	0	4	5	1	-LRB-	4	4	5	0	CD	0	5	6	1	693-1128	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	tagged	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	with	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	V5-epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	13
HRASV12	19857	19864	NN	hrasv12	O	_	_
and	19865	19868	CC	and	O	_	_
KRASV12	19869	19876	NN	krasv12	O	_	_
were	19877	19881	VBD	be	O	_	_
tagged	19882	19888	VBN	tag	O	_	_
with	19889	19893	IN	with	O	_	_
the	19894	19897	DT	the	O	_	_
haemagglutinin	19898	19912	NN	haemagglutinin	B-GENE	_	_
(	19913	19914	CD	(	I-GENE	_	_
HA	19914	19916	NNP	HA	I-GENE	_	_
)	19916	19917	CD	)	I-GENE	_	_
epitope	19918	19925	NN	epitope	I-GENE	_	_
.	19925	19926	.	.	O	_	_
D	1
4
0	2	conj_and
4	0	nsubjpass
4	2	nsubjpass
4	3	auxpass
4	7	prep_with
4	11	xcomp
7	6	det
11	9	nn
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	3	3	NN	0	0	1	1	HRASV12	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NN	0	2	3	1	KRASV12	2	2	3	0	VP	1	3	12	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	tagged	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	with	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	haemagglutinin	7	7	8	0	S	0	8	12	1	NP	3	8	12	4	CD	0	8	9	1	-LRB-	8	8	9	0	NNP	0	9	10	1	HA	9	9	10	0	CD	0	10	11	1	-RRB-	10	10	11	0	NN	0	11	12	1	epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	33
All	19927	19930	DT	all	O	_	_
expression	19931	19941	NN	expression	O	_	_
plasmids	19942	19950	NNS	plasmid	O	_	_
used	19951	19955	VBN	use	O	_	_
in	19956	19958	IN	in	O	_	_
this	19959	19963	DT	this	O	_	_
study	19964	19969	NN	study	O	_	_
were	19970	19974	VBD	be	O	_	_
driven	19975	19981	VBN	drive	O	_	_
by	19982	19984	IN	by	O	_	_
the	19985	19988	DT	the	O	_	_
cytomegalovirus	19989	20004	NN	cytomegalovirus	B-GENE	_	_
immediate-early	20005	20020	JJ	immediate-early	I-GENE	_	_
promoter	20021	20029	NN	promoter	I-GENE	_	_
,	20029	20030	,	,	O	_	_
with	20031	20035	IN	with	O	_	_
the	20036	20039	DT	the	O	_	_
exception	20040	20049	NN	exception	O	_	_
of	20050	20052	IN	of	O	_	_
the	20053	20056	DT	the	O	_	_
RAS	20057	20060	NN	ra	B-GENE	_	_
and	20061	20064	CC	and	O	_	_
Raf	20065	20068	NN	raf	B-GENE	_	_
CAAX	20069	20073	NN	caax	I-GENE	_	_
plasmids	20074	20082	NNS	plasmid	O	_	_
which	20083	20088	WDT	which	O	_	_
were	20089	20093	VBD	be	O	_	_
driven	20094	20100	VBN	drive	O	_	_
by	20101	20103	IN	by	O	_	_
the	20104	20107	DT	the	O	_	_
EF1a	20108	20112	NN	ef1a	B-GENE	_	_
promoter	20113	20121	NN	promoter	I-GENE	_	_
.	20121	20122	.	.	O	_	_
D	1
8
2	0	det
2	1	nn
2	3	vmod
3	6	prep_in
6	5	det
8	2	nsubjpass
8	7	auxpass
8	13	agent
8	17	prep_with
13	10	det
13	11	nn
13	12	amod
17	16	det
17	20	prep_of
17	24	prep_of
17	27	rcmod
20	19	det
20	24	conj_and
24	22	nn
24	23	nn
27	25	nsubjpass
27	26	auxpass
27	31	agent
31	29	det
31	30	nn
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	7	2	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	NNS	0	2	3	1	plasmids	2	2	3	0	VP	0	3	7	2	VBN	0	3	4	1	used	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	in	4	4	5	0	NP	1	5	7	2	DT	0	5	6	1	this	5	5	6	0	NN	0	6	7	1	study	6	6	7	0	VP	1	7	32	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	32	4	VBN	0	8	9	1	driven	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	by	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	cytomegalovirus	11	11	12	0	JJ	0	12	13	1	immediate-early	12	12	13	0	NN	0	13	14	1	promoter	13	13	14	0	,	0	14	15	1	,	14	14	15	0	PP	0	15	32	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	32	3	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	exception	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	25	3	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	RAS	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	2	22	25	3	NN	0	22	23	1	Raf	22	22	23	0	NN	0	23	24	1	CAAX	23	23	24	0	NNS	0	24	25	1	plasmids	24	24	25	0	SBAR	1	25	32	2	WHNP	0	25	26	1	WDT	0	25	26	1	which	25	25	26	0	S	0	26	32	1	VP	1	26	32	2	VBD	0	26	27	1	were	26	26	27	0	VP	0	27	32	2	VBN	0	27	28	1	driven	27	27	28	0	PP	0	28	32	2	IN	0	28	29	1	by	28	28	29	0	NP	2	29	32	3	DT	0	29	30	1	the	29	29	30	0	NN	0	30	31	1	EF1a	30	30	31	0	NN	0	31	32	1	promoter	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	16
The	20123	20126	DT	the	O	_	_
ASPP2	20127	20132	NN	aspp2	B-GENE	_	_
mutants	20133	20140	NNS	mutant	I-GENE	_	_
were	20141	20145	VBD	be	O	_	_
constructed	20146	20157	VBN	construct	O	_	_
using	20158	20163	VBG	use	O	_	_
the	20164	20167	DT	the	O	_	_
QuickChange	20168	20179	NNP	QuickChange	O	_	_
Site	20180	20184	NN	site	O	_	_
Directed	20185	20193	NNP	Directed	O	_	_
Mutagenesis	20194	20205	NN	mutagenesis	O	_	_
Kit	20206	20209	NN	kit	O	_	_
(	20210	20211	CD	(	O	_	_
Stratagene	20211	20221	JJ	stratagene	O	_	_
)	20221	20222	NN	)	O	_	_
.	20222	20223	.	.	O	_	_
D	1

2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	5	xcomp
5	11	xcomp
8	6	det
8	7	nn
11	8	nsubj
11	9	nn
11	10	nn
14	13	dep
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NNS	0	2	3	1	mutants	2	2	3	0	VP	1	3	15	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	15	2	VBN	0	4	5	1	constructed	4	4	5	0	S	0	5	15	1	VP	0	5	15	2	VBG	0	5	6	1	using	5	5	6	0	S	1	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NNP	0	7	8	1	QuickChange	7	7	8	0	NN	0	8	9	1	Site	8	8	9	0	NP	0	9	15	2	NP	2	9	12	3	NNP	0	9	10	1	Directed	9	9	10	0	NN	0	10	11	1	Mutagenesis	10	10	11	0	NN	0	11	12	1	Kit	11	11	12	0	ADJP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	JJ	0	13	14	1	Stratagene	13	13	14	0	NN	0	14	15	1	-RRB-	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	9
siRNA	20224	20229	NN	sirna	O	_	_
oligos	20230	20236	NNS	oligo	O	_	_
against	20237	20244	IN	against	O	_	_
ASPP2	20245	20250	NN	aspp2	O	_	_
were	20251	20255	VBD	be	O	_	_
purchased	20256	20265	VBN	purchase	O	_	_
from	20266	20270	IN	from	O	_	_
Dharmacon	20271	20280	NNP	Dharmacon	O	_	_
.	20280	20281	.	.	O	_	_
D	1
5
1	0	nn
1	3	prep_against
5	1	nsubjpass
5	4	auxpass
5	7	prep_from
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	siRNA	0	0	1	0	NNS	0	1	2	1	oligos	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	against	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	8	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	8	2	VBN	0	5	6	1	purchased	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	8	1	NNP	0	7	8	1	Dharmacon	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Sequences	20282	20291	NNS	sequence	O	_	_
are	20292	20295	VBP	be	O	_	_
available	20296	20305	JJ	available	O	_	_
from	20306	20310	IN	from	O	_	_
Dharmacon	20311	20320	NNP	Dharmacon	O	_	_
or	20321	20323	CC	or	O	_	_
upon	20324	20328	IN	upon	O	_	_
request	20329	20336	NN	request	O	_	_
.	20336	20337	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	2	conj_or
2	4	prep_from
2	7	prep_upon
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Sequences	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	available	2	2	3	0	PP	0	3	8	3	PP	0	3	5	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	5	1	NNP	0	4	5	1	Dharmacon	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	upon	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	request	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
We	20338	20340	PRP	we	O	_	_
used	20341	20345	VBD	use	O	_	_
siGENOME	20346	20354	NN	sigenome	B-GENE	_	_
RISC-Free	20355	20364	JJ	risc-free	I-GENE	_	_
siRNA	20365	20370	NN	sirna	I-GENE	_	_
(	20371	20372	CD	(	O	_	_
Dharmacon	20372	20381	NNP	Dharmacon	O	_	_
,	20381	20382	,	,	O	_	_
Lafayette	20383	20392	NNP	Lafayette	O	_	_
,	20392	20393	,	,	O	_	_
CO	20394	20396	NNP	CO	O	_	_
,	20396	20397	,	,	O	_	_
United	20398	20404	NNP	United	O	_	_
States	20405	20411	NNPS	States	O	_	_
)	20411	20412	RB	)	O	_	_
as	20413	20415	IN	as	O	_	_
a	20416	20417	DT	a	O	_	_
negative	20418	20426	JJ	negative	O	_	_
control	20427	20434	NN	control	O	_	_
.	20434	20435	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	dobj
1	6	dep
1	18	prep_as
2	3	amod
6	4	nn
6	8	appos
6	10	appos
6	13	appos
13	12	nn
18	16	det
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	19	4	VBD	0	1	2	1	used	1	1	2	0	NP	0	2	4	2	NN	0	2	3	1	siGENOME	2	2	3	0	JJ	0	3	4	1	RISC-Free	3	3	4	0	FRAG	0	4	14	1	NP	0	4	14	7	NP	2	4	7	3	NN	0	4	5	1	siRNA	4	4	5	0	CD	0	5	6	1	-LRB-	5	5	6	0	NNP	0	6	7	1	Dharmacon	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Lafayette	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	CO	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	United	12	12	13	0	NNPS	0	13	14	1	States	13	13	14	0	PP	1	14	19	3	ADVP	0	14	15	1	RB	0	14	15	1	-RRB-	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	JJ	0	17	18	1	negative	17	17	18	0	NN	0	18	19	1	control	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	36
Cells	20436	20441	NNS	cell	O	_	_
were	20442	20446	VBD	be	O	_	_
transfected	20447	20458	VBN	transfect	O	_	_
with	20459	20463	IN	with	O	_	_
the	20464	20467	DT	the	O	_	_
indicated	20468	20477	VBN	indicate	O	_	_
siRNA	20478	20483	NN	sirna	O	_	_
oligos	20484	20490	NNS	oligo	O	_	_
at	20491	20493	IN	at	O	_	_
a	20494	20495	DT	a	O	_	_
final	20496	20501	JJ	final	O	_	_
concentration	20502	20515	NN	concentration	O	_	_
of	20516	20518	IN	of	O	_	_
35nM	20519	20523	NN	35nm	O	_	_
using	20524	20529	VBG	use	O	_	_
Dharmafect	20530	20540	NN	dharmafect	O	_	_
1	20541	20542	CD	1	O	_	_
reagent	20543	20550	NN	reagent	O	_	_
(	20551	20552	CD	(	O	_	_
Dharmacon	20552	20561	NNP	Dharmacon	O	_	_
,	20561	20562	,	,	O	_	_
Lafayette	20563	20572	NNP	Lafayette	O	_	_
,	20572	20573	,	,	O	_	_
CO	20574	20576	NNP	CO	O	_	_
,	20576	20577	,	,	O	_	_
United	20578	20584	NNP	United	O	_	_
States	20585	20591	NNPS	States	O	_	_
)	20591	20592	NN	)	O	_	_
,	20592	20593	,	,	O	_	_
according	20594	20603	VBG	accord	O	_	_
to	20604	20606	TO	to	O	_	_
the	20607	20610	DT	the	O	_	_
manufacturer	20611	20623	NN	manufacturer	O	_	_
's	20623	20625	POS	's	O	_	_
instructions	20626	20638	NNS	instruction	O	_	_
.	20638	20639	.	.	O	_	_
D	1

2	0	nsubjpass
2	1	auxpass
2	7	prep_with
2	11	prep_at
2	30	prepc_according_to
2	34	pobj
7	4	det
7	5	amod
7	6	nn
11	9	det
11	10	amod
11	13	prep_of
13	14	vmod
14	17	dobj
17	15	nn
17	16	num
27	19	nn
27	21	appos
27	23	appos
27	25	appos
27	26	nn
32	31	det
34	32	poss
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	35	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	35	5	VBN	0	2	3	1	transfected	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	with	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	VBN	0	5	6	1	indicated	5	5	6	0	NN	0	6	7	1	siRNA	6	6	7	0	NNS	0	7	8	1	oligos	7	7	8	0	PP	0	8	28	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	28	2	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	final	10	10	11	0	NN	0	11	12	1	concentration	11	11	12	0	PP	0	12	28	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	28	2	NP	0	13	14	1	NN	0	13	14	1	35nM	13	13	14	0	VP	0	14	28	3	VBG	0	14	15	1	using	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	Dharmafect	15	15	16	0	CD	0	16	17	1	1	16	16	17	0	NN	0	17	18	1	reagent	17	17	18	0	S	0	18	28	1	NP	9	18	28	10	CD	0	18	19	1	-LRB-	18	18	19	0	NNP	0	19	20	1	Dharmacon	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NNP	0	21	22	1	Lafayette	21	21	22	0	,	0	22	23	1	,	22	22	23	0	NNP	0	23	24	1	CO	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NNP	0	25	26	1	United	25	25	26	0	NNPS	0	26	27	1	States	26	26	27	0	NN	0	27	28	1	-RRB-	27	27	28	0	,	0	28	29	1	,	28	28	29	0	PP	0	29	35	2	VBG	0	29	30	1	according	29	29	30	0	PP	0	30	35	2	TO	0	30	31	1	to	30	30	31	0	NP	1	31	35	2	NP	1	31	34	3	DT	0	31	32	1	the	31	31	32	0	NN	0	32	33	1	manufacturer	32	32	33	0	POS	0	33	34	1	's	33	33	34	0	NNS	0	34	35	1	instructions	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	5
Generation	20640	20650	NN	generation	O	_	_
of	20651	20653	IN	of	O	_	_
Phosphor-ASPP2	20654	20668	NN	phosphor-aspp2	O	_	_
Antibody	20669	20677	NN	antibody	O	_	_
.	20677	20678	.	.	O	_	_
D	1
0
0	3	prep_of
3	2	nn
EOX
Y	1
ROOT	0	0	5	1	NP	0	0	5	3	NP	0	0	1	1	NN	0	0	1	1	Generation	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	of	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	Phosphor-ASPP2	2	2	3	0	NN	0	3	4	1	Antibody	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	34
Using	20679	20684	VBG	use	O	_	_
the	20685	20688	DT	the	O	_	_
peptide	20689	20696	NN	peptide	O	_	_
CPAPSpPGLDY	20697	20708	NN	cpapsppgldy	O	_	_
(	20709	20710	CD	(	O	_	_
representing	20710	20722	VBG	represent	O	_	_
residues	20723	20731	NNS	residue	O	_	_
824-832	20732	20739	CD	824-832	O	_	_
)	20739	20740	CD	)	O	_	_
with	20741	20745	IN	with	O	_	_
the	20746	20749	DT	the	O	_	_
serine	20750	20756	NN	serine	O	_	_
phosphorylated	20757	20771	VBN	phosphorylate	O	_	_
as	20772	20774	IN	as	O	_	_
an	20775	20777	DT	a	O	_	_
immunogen	20778	20787	NN	immunogen	O	_	_
,	20787	20788	,	,	O	_	_
a	20789	20790	DT	a	O	_	_
rabbit	20791	20797	NN	rabbit	B-GENE	_	_
polyclonal	20798	20808	JJ	polyclonal	I-GENE	_	_
antibody	20809	20817	NN	antibody	I-GENE	_	_
NGH.S4	20818	20824	NN	ngh.s4	I-GENE	_	_
which	20825	20830	WDT	which	O	_	_
specifically	20831	20843	RB	specifically	O	_	_
recognizes	20844	20854	VBZ	recognize	O	_	_
phosphorylated	20855	20869	VBN	phosphorylate	O	_	_
ASPP2	20870	20875	NN	aspp2	B-GENE	_	_
at	20876	20878	IN	at	O	_	_
amino	20879	20884	NN	amino	O	_	_
acid	20885	20889	NN	acid	O	_	_
827	20890	20893	CD	827	O	_	_
was	20894	20897	VBD	be	O	_	_
raised	20898	20904	VBN	raise	O	_	_
.	20904	20905	.	.	O	_	_
D	1
32
0	3	dobj
0	5	vmod
3	1	det
3	2	nn
5	6	dobj
5	11	prep_with
8	7	num
11	10	det
11	12	vmod
12	15	prep_as
15	14	det
21	17	det
21	18	nn
21	19	amod
21	20	nn
21	24	rcmod
24	22	nsubj
24	23	advmod
24	25	dep
25	26	dobj
25	29	prep_at
29	28	nn
29	30	num
32	0	vmod
32	21	nsubjpass
32	31	auxpass
EOX
Y	1
ROOT	0	0	34	1	S	3	0	34	5	S	0	0	16	1	VP	0	0	16	3	VBG	0	0	1	1	Using	0	0	1	0	NP	2	1	5	4	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	peptide	2	2	3	0	NN	0	3	4	1	CPAPSpPGLDY	3	3	4	0	CD	0	4	5	1	-LRB-	4	4	5	0	S	0	5	16	1	VP	0	5	16	3	VBG	0	5	6	1	representing	5	5	6	0	NP	0	6	7	1	NNS	0	6	7	1	residues	6	6	7	0	PP	1	7	16	3	NP	1	7	9	2	CD	0	7	8	1	824-832	7	7	8	0	CD	0	8	9	1	-RRB-	8	8	9	0	IN	0	9	10	1	with	9	9	10	0	NP	0	10	16	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	serine	11	11	12	0	VP	0	12	16	2	VBN	0	12	13	1	phosphorylated	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	as	13	13	14	0	NP	1	14	16	2	DT	0	14	15	1	an	14	14	15	0	NN	0	15	16	1	immunogen	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	31	2	NP	4	17	22	5	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	rabbit	18	18	19	0	JJ	0	19	20	1	polyclonal	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	NN	0	21	22	1	NGH.S4	21	21	22	0	SBAR	1	22	31	2	WHNP	0	22	23	1	WDT	0	22	23	1	which	22	22	23	0	S	1	23	31	2	ADVP	0	23	24	1	RB	0	23	24	1	specifically	23	23	24	0	VP	0	24	31	2	VBZ	0	24	25	1	recognizes	24	24	25	0	VP	0	25	31	3	VBN	0	25	26	1	phosphorylated	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	ASPP2	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	at	27	27	28	0	NP	1	28	31	3	NN	0	28	29	1	amino	28	28	29	0	NN	0	29	30	1	acid	29	29	30	0	CD	0	30	31	1	827	30	30	31	0	VP	1	31	33	2	VBD	0	31	32	1	was	31	31	32	0	VP	0	32	33	1	VBN	0	32	33	1	raised	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	24
An	20906	20908	DT	a	O	_	_
affinity	20909	20917	NN	affinity	O	_	_
column	20918	20924	NN	column	O	_	_
was	20925	20928	VBD	be	O	_	_
made	20929	20933	VBN	make	O	_	_
by	20934	20936	IN	by	O	_	_
cross	20937	20942	NN	cross	O	_	_
linking	20943	20950	VBG	link	O	_	_
the	20951	20954	DT	the	O	_	_
phospho-peptide	20955	20970	NN	phospho-peptide	O	_	_
to	20971	20973	TO	to	O	_	_
epoxy-sepharose-6B	20974	20992	NN	epoxy-sepharose-6b	O	_	_
(	20993	20994	CD	(	O	_	_
Amersham	20994	21002	NNP	Amersham	O	_	_
Pharmacia	21003	21012	NNP	Pharmacia	O	_	_
Biotech	21013	21020	NNP	Biotech	O	_	_
)	21020	21021	CD	)	O	_	_
according	21022	21031	VBG	accord	O	_	_
to	21032	21034	TO	to	O	_	_
the	21035	21038	DT	the	O	_	_
manufacturer	21039	21051	NN	manufacturer	O	_	_
's	21051	21053	POS	's	O	_	_
instructions	21054	21066	NNS	instruction	O	_	_
.	21066	21067	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	6	agent
4	7	xcomp
4	18	prepc_according_to
4	22	pobj
7	9	dobj
7	11	prep_to
7	15	dobj
9	8	det
15	13	nn
15	14	nn
20	19	det
22	20	poss
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	An	0	0	1	0	NN	0	1	2	1	affinity	1	1	2	0	NN	0	2	3	1	column	2	2	3	0	VP	1	3	23	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	23	4	VBN	0	4	5	1	made	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	by	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	cross	6	6	7	0	S	0	7	17	1	VP	0	7	17	4	VBG	0	7	8	1	linking	7	7	8	0	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	phospho-peptide	9	9	10	0	PP	0	10	13	2	TO	0	10	11	1	to	10	10	11	0	NP	0	11	13	2	NN	0	11	12	1	epoxy-sepharose-6B	11	11	12	0	CD	0	12	13	1	-LRB-	12	12	13	0	NP	0	13	17	2	NP	2	13	16	3	NNP	0	13	14	1	Amersham	13	13	14	0	NNP	0	14	15	1	Pharmacia	14	14	15	0	NNP	0	15	16	1	Biotech	15	15	16	0	NP	0	16	17	1	CD	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	23	2	VBG	0	17	18	1	according	17	17	18	0	PP	0	18	23	2	TO	0	18	19	1	to	18	18	19	0	NP	1	19	23	2	NP	1	19	22	3	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	manufacturer	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	NNS	0	22	23	1	instructions	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	40
Serum	21068	21073	NN	serum	O	_	_
from	21074	21078	IN	from	O	_	_
the	21079	21082	DT	the	O	_	_
final	21083	21088	JJ	final	O	_	_
bleed	21089	21094	VB	bleed	O	_	_
was	21095	21098	VBD	be	O	_	_
clarified	21099	21108	VBN	clarify	O	_	_
by	21109	21111	IN	by	O	_	_
centrifugation	21112	21126	NN	centrifugation	O	_	_
and	21127	21130	CC	and	O	_	_
filtration	21131	21141	NN	filtration	O	_	_
through	21142	21149	IN	through	O	_	_
a	21150	21151	DT	a	O	_	_
0.45	21152	21156	CD	0.45	O	_	_
mum	21156	21159	NN	mum	O	_	_
filter	21160	21166	NN	filter	O	_	_
and	21167	21170	CC	and	O	_	_
was	21171	21174	VBD	be	O	_	_
supplemented	21175	21187	VBN	supplement	O	_	_
with	21188	21192	IN	with	O	_	_
1X	21193	21195	NN	1x	O	_	_
TTBS	21196	21200	NN	ttb	O	_	_
(	21201	21202	CD	(	O	_	_
0.5	21202	21205	CD	0.5	O	_	_
M	21206	21207	NN	m	O	_	_
NaCl	21208	21212	NN	nacl	O	_	_
,	21212	21213	,	,	O	_	_
20	21214	21216	CD	20	O	_	_
mM	21217	21219	NN	mm	O	_	_
Tris	21220	21224	NNP	Tris	O	_	_
[	21225	21226	CD	[	O	_	_
pH	21226	21228	NN	ph	O	_	_
8.0	21229	21232	CD	8.0	O	_	_
]	21232	21233	NN	]	O	_	_
,	21233	21234	,	,	O	_	_
0.1	21235	21238	CD	0.1	O	_	_
%	21238	21239	NN	%	O	_	_
Tween-20	21240	21248	NN	tween-20	O	_	_
)	21248	21249	NN	)	O	_	_
.	21249	21250	.	.	O	_	_
D	1

0	3	prep_from
3	2	det
4	0	nsubj
4	6	dep
4	18	dep
6	5	auxpass
6	8	agent
6	10	agent
6	15	prep_through
6	18	conj_and
6	25	dobj
6	33	nsubjpass
8	10	conj_and
15	12	det
15	13	num
15	14	nn
18	17	auxpass
18	21	prep_with
18	33	nsubjpass
21	20	nn
25	23	num
25	24	nn
25	29	appos
29	27	num
29	28	nn
33	30	num
33	31	nn
33	32	num
36	35	number
38	36	amod
38	37	nn
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Serum	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	from	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	final	3	3	4	0	VP	0	4	39	3	VP	0	4	34	2	VB	0	4	5	1	bleed	4	4	5	0	SBAR	0	5	34	1	SINV	0	5	34	2	VP	1	5	30	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	30	4	VP	0	6	16	3	VBN	0	6	7	1	clarified	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	centrifugation	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	filtration	10	10	11	0	PP	0	11	16	2	IN	0	11	12	1	through	11	11	12	0	NP	3	12	16	4	DT	0	12	13	1	a	12	12	13	0	CD	0	13	14	1	0.45	13	13	14	0	NN	0	14	15	1	mum	14	14	15	0	NN	0	15	16	1	filter	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	VP	1	17	22	2	VBD	0	17	18	1	was	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	supplemented	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	1X	20	20	21	0	NN	0	21	22	1	TTBS	21	21	22	0	NP	0	22	30	3	NP	2	22	26	3	QP	1	22	24	2	CD	0	22	23	1	-LRB-	22	22	23	0	CD	0	23	24	1	0.5	23	23	24	0	NN	0	24	25	1	M	24	24	25	0	NN	0	25	26	1	NaCl	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	mM	28	28	29	0	NNP	0	29	30	1	Tris	29	29	30	0	NP	3	30	34	4	CD	0	30	31	1	[	30	30	31	0	NN	0	31	32	1	pH	31	31	32	0	CD	0	32	33	1	8.0	32	32	33	0	NN	0	33	34	1	]	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	2	35	39	3	ADJP	1	35	37	2	CD	0	35	36	1	0.1	35	35	36	0	NN	0	36	37	1	%	36	36	37	0	NN	0	37	38	1	Tween-20	37	37	38	0	NN	0	38	39	1	-RRB-	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	20
This	21251	21255	DT	this	O	_	_
was	21256	21259	VBD	be	O	_	_
passed	21260	21266	VBN	pass	O	_	_
over	21267	21271	IN	over	O	_	_
the	21272	21275	DT	the	O	_	_
affinity	21276	21284	NN	affinity	O	_	_
column	21285	21291	NN	column	O	_	_
and	21292	21295	CC	and	O	_	_
washed	21296	21302	VBN	wash	O	_	_
with	21303	21307	IN	with	O	_	_
TTBS	21308	21312	NN	ttb	O	_	_
until	21313	21318	IN	until	O	_	_
the	21319	21322	DT	the	O	_	_
flow-through	21323	21335	JJ	flow-through	O	_	_
had	21336	21339	VBD	have	O	_	_
an	21340	21342	DT	a	O	_	_
OD280nm	21343	21350	NN	od280nm	O	_	_
<	21351	21352	JJR	<	O	_	_
0.01	21352	21356	CD	0.01	O	_	_
.	21356	21357	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_over
2	8	conj_and
2	18	dobj
6	4	det
6	5	nn
8	0	nsubjpass
8	10	prep_with
8	14	advcl
13	12	det
14	11	mark
14	13	nsubj
14	17	dobj
17	15	det
17	16	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	19	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	19	4	VP	0	2	7	2	VBN	0	2	3	1	passed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	over	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	affinity	5	5	6	0	NN	0	6	7	1	column	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	VP	0	8	18	3	VBN	0	8	9	1	washed	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	TTBS	10	10	11	0	SBAR	1	11	18	2	IN	0	11	12	1	until	11	11	12	0	S	1	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	flow-through	13	13	14	0	VP	0	14	18	2	VBD	0	14	15	1	had	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	an	15	15	16	0	NN	0	16	17	1	OD280nm	16	16	17	0	JJR	0	17	18	1	<	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	0.01	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	22
The	21358	21361	DT	the	O	_	_
antibody	21362	21370	NN	antibody	O	_	_
was	21371	21374	VBD	be	O	_	_
then	21375	21379	RB	then	O	_	_
eluted	21380	21386	VBN	elute	O	_	_
with	21387	21391	IN	with	O	_	_
0.2	21392	21395	CD	0.2	O	_	_
M	21395	21396	NN	m	O	_	_
glycine	21397	21404	NN	glycine	O	_	_
(	21405	21406	CD	(	O	_	_
pH	21406	21408	NN	ph	O	_	_
2.8	21409	21412	CD	2.8	O	_	_
)	21412	21413	NN	)	O	_	_
and	21414	21417	CC	and	O	_	_
neutralized	21418	21429	VBD	neutralize	O	_	_
with	21430	21434	IN	with	O	_	_
Tris-HCl	21435	21443	NN	tris-hcl	O	_	_
(	21444	21445	CD	(	O	_	_
pH	21445	21447	NN	ph	O	_	_
8.0	21448	21451	CD	8.0	O	_	_
)	21451	21452	NN	)	O	_	_
.	21452	21453	.	.	O	_	_
D	1

1	0	det
4	1	dep
4	2	auxpass
4	3	advmod
4	8	prep_with
4	14	conj_and
8	6	num
8	7	nn
12	10	nn
12	11	num
14	16	prep_with
20	18	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	SINV	1	0	13	3	FRAG	0	0	2	1	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	antibody	1	1	2	0	VP	2	2	9	3	VBD	0	2	3	1	was	2	2	3	0	RB	0	3	4	1	then	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	eluted	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	CD	0	6	7	1	0.2	6	6	7	0	NN	0	7	8	1	M	7	7	8	0	NN	0	8	9	1	glycine	8	8	9	0	NP	3	9	13	4	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	pH	10	10	11	0	CD	0	11	12	1	2.8	11	11	12	0	NN	0	12	13	1	-RRB-	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	SINV	0	14	21	2	VP	0	14	17	2	VBD	0	14	15	1	neutralized	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	Tris-HCl	16	16	17	0	NP	3	17	21	4	CD	0	17	18	1	-LRB-	17	17	18	0	NN	0	18	19	1	pH	18	18	19	0	CD	0	19	20	1	8.0	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	33
A	21454	21455	DT	a	O	_	_
second	21456	21462	JJ	second	O	_	_
phospho	21463	21470	NN	phospho	O	_	_
specific	21471	21479	JJ	specific	O	_	_
antibody	21480	21488	NN	antibody	O	_	_
ES1	21489	21492	NN	es1	O	_	_
was	21493	21496	VBD	be	O	_	_
raised	21497	21503	VBN	raise	O	_	_
against	21504	21511	IN	against	O	_	_
the	21512	21515	DT	the	O	_	_
peptide	21516	21523	NN	peptide	O	_	_
SDMPAPS	21524	21531	NNP	SDMPAPS	O	_	_
[	21531	21532	CD	[	O	_	_
P	21532	21533	NN	p	O	_	_
]	21533	21534	CD	]	O	_	_
PGLDYE	21534	21540	NN	pgldye	O	_	_
where	21541	21546	WRB	where	O	_	_
S	21547	21548	NN	s	O	_	_
[	21548	21549	CD	[	O	_	_
P	21549	21550	NN	p	O	_	_
]	21550	21551	NN	]	O	_	_
is	21552	21554	VBZ	be	O	_	_
the	21555	21558	DT	the	O	_	_
phosphorylated	21559	21573	VBN	phosphorylate	O	_	_
serine	21574	21580	NN	serine	O	_	_
827	21581	21584	CD	827	O	_	_
,	21584	21585	,	,	O	_	_
and	21586	21589	CC	and	O	_	_
was	21590	21593	VBD	be	O	_	_
conjugated	21594	21604	VBN	conjugate	O	_	_
to	21605	21607	TO	to	O	_	_
KLH	21608	21611	NNP	KLH	O	_	_
.	21611	21612	.	.	O	_	_
D	1
7
2	0	det
2	1	amod
2	5	dep
5	3	amod
5	4	nn
7	2	nsubjpass
7	6	auxpass
7	11	prep_against
7	15	dobj
7	29	conj_and
11	9	det
11	10	nn
11	12	num
15	13	nn
15	14	num
15	22	rcmod
17	16	advmod
20	18	num
20	19	nn
22	17	dobj
22	20	nsubj
22	21	cop
22	23	vmod
23	24	dobj
24	25	num
29	2	nsubjpass
29	28	auxpass
29	31	prep_to
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	6	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	second	1	1	2	0	NN	0	2	3	1	phospho	2	2	3	0	NP	2	3	6	3	JJ	0	3	4	1	specific	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	NN	0	5	6	1	ES1	5	5	6	0	VP	0	6	32	4	VP	1	6	26	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	26	3	VBN	0	7	8	1	raised	7	7	8	0	PP	0	8	13	2	IN	0	8	9	1	against	8	8	9	0	NP	2	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NNP	0	11	12	1	SDMPAPS	11	11	12	0	CD	0	12	13	1	[	12	12	13	0	NP	0	13	26	2	NP	2	13	16	3	NN	0	13	14	1	P	13	13	14	0	CD	0	14	15	1	]	14	14	15	0	NN	0	15	16	1	PGLDYE	15	15	16	0	SBAR	1	16	26	2	WHNP	1	16	18	2	WHADVP	0	16	17	1	WRB	0	16	17	1	where	16	16	17	0	NN	0	17	18	1	S	17	17	18	0	S	1	18	26	2	NP	2	18	21	3	CD	0	18	19	1	[	18	18	19	0	NN	0	19	20	1	P	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	VP	1	21	26	2	VBZ	0	21	22	1	is	21	21	22	0	NP	0	22	26	2	NP	0	22	23	1	DT	0	22	23	1	the	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	phosphorylated	23	23	24	0	NP	0	24	26	2	NN	0	24	25	1	serine	24	24	25	0	CD	0	25	26	1	827	25	25	26	0	,	0	26	27	1	,	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	VP	1	28	32	2	VBD	0	28	29	1	was	28	28	29	0	VP	0	29	32	2	VBN	0	29	30	1	conjugated	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NNP	0	31	32	1	KLH	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	13
The	21613	21616	DT	the	O	_	_
serum	21617	21622	NN	serum	O	_	_
was	21623	21626	VBD	be	O	_	_
double	21627	21633	JJ	double	O	_	_
affinity	21634	21642	NN	affinity	O	_	_
purified	21643	21651	VBN	purify	O	_	_
against	21652	21659	IN	against	O	_	_
the	21660	21663	DT	the	O	_	_
non	21664	21667	JJ	non	O	_	_
phosphorylated	21668	21682	JJ	phosphorylated	O	_	_
peptide	21683	21690	NN	peptide	O	_	_
SDMPAPSPGLDYE	21691	21704	NNP	SDMPAPSPGLDYE	O	_	_
.	21704	21705	.	.	O	_	_
D	1
4
1	0	det
4	1	nsubj
4	2	cop
4	3	amod
4	5	vmod
5	10	prep_against
10	7	det
10	8	amod
10	9	amod
10	11	appos
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	serum	1	1	2	0	VP	1	2	12	2	VBD	0	2	3	1	was	2	2	3	0	NP	0	3	12	2	NP	1	3	5	2	JJ	0	3	4	1	double	3	3	4	0	NN	0	4	5	1	affinity	4	4	5	0	VP	0	5	12	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	against	6	6	7	0	NP	0	7	12	2	NP	3	7	11	4	DT	0	7	8	1	the	7	7	8	0	JJ	0	8	9	1	non	8	8	9	0	JJ	0	9	10	1	phosphorylated	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	SDMPAPSPGLDYE	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	3
Transactivation	21706	21721	NN	transactivation	O	_	_
Assay	21722	21727	NN	assay	O	_	_
.	21727	21728	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Transactivation	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Assay	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	18
Saos2	21729	21734	NN	saos2	O	_	_
cells	21735	21740	NNS	cell	O	_	_
(	21741	21742	VBP	(	O	_	_
7	21742	21743	CD	7	O	_	_
x	21744	21745	CC	x	O	_	_
105	21746	21749	CD	105	O	_	_
)	21749	21750	NN	)	O	_	_
were	21751	21755	VBD	be	O	_	_
plated	21756	21762	VBN	plate	O	_	_
24	21763	21765	CD	24	O	_	_
hours	21766	21771	NNS	hour	O	_	_
prior	21772	21777	RB	prior	O	_	_
to	21778	21780	TO	to	O	_	_
transfection	21781	21793	NN	transfection	O	_	_
in	21794	21796	IN	in	O	_	_
6-cm-diameter	21797	21810	JJ	6-cm-diameter	O	_	_
dishes	21811	21817	NNS	dish	O	_	_
.	21817	21818	.	.	O	_	_
D	1

1	0	nn
2	1	nsubj
2	8	ccomp
3	4	cc
6	5	num
8	3	nsubjpass
8	7	auxpass
8	10	npadvmod
8	13	prep_prior_to
10	9	num
13	16	prep_in
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	0	2	17	2	VBP	0	2	3	1	-LRB-	2	2	3	0	SBAR	0	3	17	1	S	1	3	17	2	NP	0	3	7	3	NP	0	3	4	1	CD	0	3	4	1	7	3	3	4	0	CC	0	4	5	1	x	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	105	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	17	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	17	2	VBN	0	8	9	1	plated	8	8	9	0	PP	1	9	17	3	ADVP	1	9	12	2	NP	1	9	11	2	CD	0	9	10	1	24	9	9	10	0	NNS	0	10	11	1	hours	10	10	11	0	RB	0	11	12	1	prior	11	11	12	0	TO	0	12	13	1	to	12	12	13	0	NP	0	13	17	2	NP	0	13	14	1	NN	0	13	14	1	transfection	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	in	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	6-cm-diameter	15	15	16	0	NNS	0	16	17	1	dishes	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	10
All	21819	21822	DT	all	O	_	_
transactivation	21823	21838	NN	transactivation	O	_	_
assays	21839	21845	NNS	assay	O	_	_
contained	21846	21855	VBD	contain	O	_	_
1	21856	21857	CD	1	O	_	_
mug	21858	21861	NN	mug	O	_	_
of	21862	21864	IN	of	O	_	_
reporter	21865	21873	NN	reporter	O	_	_
plasmid	21874	21881	NN	plasmid	O	_	_
.	21881	21882	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	dobj
5	4	num
5	8	prep_of
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	transactivation	1	1	2	0	NNS	0	2	3	1	assays	2	2	3	0	VP	0	3	9	2	VBD	0	3	4	1	contained	3	3	4	0	NP	0	4	9	2	NP	1	4	6	2	CD	0	4	5	1	1	4	4	5	0	NN	0	5	6	1	mug	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	reporter	7	7	8	0	NN	0	8	9	1	plasmid	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	27
50	21883	21885	CD	50	O	_	_
ng	21886	21888	NN	ng	O	_	_
of	21889	21891	IN	of	O	_	_
p53	21892	21895	NN	p53	B-GENE	_	_
,	21895	21896	,	,	I-GENE	_	_
4	21897	21898	CD	4	I-GENE	_	_
mug	21899	21902	NN	mug	I-GENE	_	_
of	21903	21905	IN	of	I-GENE	_	_
ASPP2	21906	21911	NN	aspp2	I-GENE	_	_
,	21911	21912	,	,	I-GENE	_	_
and	21913	21916	CC	and	I-GENE	_	_
1.5	21917	21920	CD	1.5	I-GENE	_	_
mug	21921	21924	NN	mug	I-GENE	_	_
of	21925	21927	IN	of	I-GENE	_	_
HRASV12	21928	21935	NN	hrasv12	I-GENE	_	_
or	21936	21938	CC	or	I-GENE	_	_
KRASV12	21939	21946	NN	krasv12	I-GENE	_	_
or	21947	21949	CC	or	O	_	_
Raf	21950	21953	NN	raf	B-GENE	_	_
CAAX	21954	21958	NN	caax	I-GENE	_	_
expression	21959	21969	NN	expression	O	_	_
plasmids	21970	21978	NNS	plasmid	O	_	_
were	21979	21983	VBD	be	O	_	_
used	21984	21988	VBN	use	O	_	_
as	21989	21991	IN	as	O	_	_
indicated	21992	22001	VBN	indicate	O	_	_
.	22001	22002	.	.	O	_	_
D	1
23
1	0	num
1	3	prep_of
1	6	conj_and
1	12	conj_and
6	5	num
6	8	prep_of
12	11	num
12	14	prep_of
12	16	prep_of
12	21	prep_of
14	16	conj_or
14	21	conj_or
21	18	nn
21	19	nn
21	20	nn
23	1	nsubjpass
23	6	nsubjpass
23	12	nsubjpass
23	22	auxpass
23	25	prep_as
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	22	6	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	50	0	0	1	0	NN	0	1	2	1	ng	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	p53	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	4	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NP	0	11	22	2	NP	1	11	13	2	CD	0	11	12	1	1.5	11	11	12	0	NN	0	12	13	1	mug	12	12	13	0	PP	0	13	22	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	22	3	NP	0	14	17	3	NN	0	14	15	1	HRASV12	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	KRASV12	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NP	3	18	22	4	NN	0	18	19	1	Raf	18	18	19	0	NN	0	19	20	1	CAAX	19	19	20	0	NN	0	20	21	1	expression	20	20	21	0	NNS	0	21	22	1	plasmids	21	21	22	0	VP	1	22	26	2	VBD	0	22	23	1	were	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	used	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	24
Cells	22003	22008	NNS	cell	O	_	_
were	22009	22013	VBD	be	O	_	_
lysed	22014	22019	VBN	lyse	O	_	_
in	22020	22022	IN	in	O	_	_
reporter	22023	22031	NN	reporter	O	_	_
lysis	22032	22037	NN	lysis	O	_	_
buffer	22038	22044	NN	buffer	O	_	_
16	22045	22047	CD	16	O	_	_
to	22048	22050	TO	to	O	_	_
24	22051	22053	CD	24	O	_	_
hours	22054	22059	NNS	hour	O	_	_
after	22060	22065	IN	after	O	_	_
transfection	22066	22078	NN	transfection	O	_	_
and	22079	22082	CC	and	O	_	_
assayed	22083	22090	VBN	assay	O	_	_
using	22091	22096	VBG	use	O	_	_
the	22097	22100	DT	the	O	_	_
luciferase	22101	22111	NN	luciferase	B-GENE	_	_
assay	22112	22117	NN	assay	O	_	_
kit	22118	22121	NN	kit	O	_	_
(	22122	22123	CD	(	O	_	_
Promega	22123	22130	NNP	Promega	O	_	_
)	22130	22131	CD	)	O	_	_
.	22131	22132	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_in
2	10	npadvmod
2	12	prep_after
2	14	conj_and
6	4	nn
6	5	nn
9	7	number
9	8	dep
10	9	num
14	0	nsubjpass
14	15	xcomp
15	19	dobj
19	16	det
19	17	nn
19	18	nn
19	21	dep
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	23	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	23	3	VP	0	2	13	3	VBN	0	2	3	1	lysed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	in	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	reporter	4	4	5	0	NN	0	5	6	1	lysis	5	5	6	0	NN	0	6	7	1	buffer	6	6	7	0	PP	1	7	13	3	NP	1	7	11	2	QP	2	7	10	3	CD	0	7	8	1	16	7	7	8	0	TO	0	8	9	1	to	8	8	9	0	CD	0	9	10	1	24	9	9	10	0	NNS	0	10	11	1	hours	10	10	11	0	IN	0	11	12	1	after	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	transfection	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	23	2	VBN	0	14	15	1	assayed	14	14	15	0	S	0	15	23	1	VP	0	15	23	2	VBG	0	15	16	1	using	15	15	16	0	NP	0	16	23	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	luciferase	17	17	18	0	NN	0	18	19	1	assay	18	18	19	0	NN	0	19	20	1	kit	19	19	20	0	NP	1	20	23	3	CD	0	20	21	1	-LRB-	20	20	21	0	NNP	0	21	22	1	Promega	21	21	22	0	CD	0	22	23	1	-RRB-	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	38
The	22133	22136	DT	the	O	_	_
fold	22137	22141	JJ	fold	O	_	_
increase	22142	22150	NN	increase	O	_	_
of	22151	22153	IN	of	O	_	_
p53	22154	22157	NN	p53	B-GENE	_	_
and	22158	22161	CC	and	O	_	_
ASPP	22162	22166	NN	aspp	B-GENE	_	_
by	22167	22169	IN	by	O	_	_
HRASV12	22170	22177	NN	hrasv12	B-GENE	_	_
/	22177	22178	:	/	B-GENE	_	_
KRASV12/Raf	22178	22189	NN	krasv12/raf	B-GENE	_	_
CAAX	22190	22194	NN	caax	O	_	_
was	22195	22198	VBD	be	O	_	_
determined	22199	22209	VBN	determine	O	_	_
by	22210	22212	IN	by	O	_	_
the	22213	22216	DT	the	O	_	_
activity	22217	22225	NN	activity	O	_	_
of	22226	22228	IN	of	O	_	_
p53	22229	22232	NN	p53	B-GENE	_	_
and	22233	22236	CC	and	O	_	_
ASPP	22237	22241	NN	aspp	B-GENE	_	_
in	22242	22244	IN	in	O	_	_
combination	22245	22256	NN	combination	O	_	_
with	22257	22261	IN	with	O	_	_
RASV12	22262	22268	NN	rasv12	B-GENE	_	_
/	22268	22269	:	/	I-GENE	_	_
Raf	22269	22272	NN	raf	I-GENE	_	_
CAAX	22273	22277	NN	caax	I-GENE	_	_
divided	22278	22285	VBN	divide	O	_	_
by	22286	22288	IN	by	O	_	_
the	22289	22292	DT	the	O	_	_
activity	22293	22301	NN	activity	O	_	_
of	22302	22304	IN	of	O	_	_
p53	22305	22308	NN	p53	B-GENE	_	_
and	22309	22312	CC	and	O	_	_
ASPP	22313	22317	NN	aspp	B-GENE	_	_
alone	22318	22323	RB	alone	O	_	_
.	22323	22324	.	.	O	_	_
D	1
28
2	0	det
2	1	amod
2	4	prep_of
2	6	prep_of
2	8	prep_by
2	13	dep
2	27	dep
4	6	conj_and
11	10	nn
13	9	punct
13	11	nsubjpass
13	12	auxpass
13	16	agent
13	22	prep_in
13	24	prep_with
13	25	punct
16	15	det
16	18	prep_of
16	20	prep_of
18	20	conj_and
27	26	nn
28	2	nsubj
28	31	prep_by
28	36	advmod
31	30	det
31	33	prep_of
31	35	prep_of
33	35	conj_and
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	28	3	NP	0	0	9	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	fold	1	1	2	0	NN	0	2	3	1	increase	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	7	3	NN	0	4	5	1	p53	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	HRASV12	8	8	9	0	PRN	1	9	26	3	:	0	9	10	1	/	9	9	10	0	S	1	10	25	2	NP	1	10	12	2	NN	0	10	11	1	KRASV12/Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	1	12	25	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	25	4	VBN	0	13	14	1	determined	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	21	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	21	3	NN	0	18	19	1	p53	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NN	0	20	21	1	ASPP	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	combination	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	with	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	RASV12	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	Raf	26	26	27	0	NN	0	27	28	1	CAAX	27	27	28	0	VP	0	28	37	3	VBN	0	28	29	1	divided	28	28	29	0	PP	0	29	36	2	IN	0	29	30	1	by	29	29	30	0	NP	0	30	36	2	NP	1	30	32	2	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	activity	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	0	33	36	3	NN	0	33	34	1	p53	33	33	34	0	CC	0	34	35	1	and	34	34	35	0	NN	0	35	36	1	ASPP	35	35	36	0	ADVP	0	36	37	1	RB	0	36	37	1	alone	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	4
Western	22325	22332	NN	western	O	_	_
blot	22333	22337	NN	blot	O	_	_
analysis	22338	22346	NN	analysis	O	_	_
.	22346	22347	.	.	O	_	_
D	1
0
0	2	dep
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	0	0	4	3	NP	0	0	1	1	NN	0	0	1	1	Western	0	0	1	0	NP	1	1	3	2	NN	0	1	2	1	blot	1	1	2	0	NN	0	2	3	1	analysis	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	97
For	22348	22351	IN	for	O	_	_
Western	22352	22359	NN	western	O	_	_
blotting	22360	22368	NN	blotting	O	_	_
,	22368	22369	,	,	O	_	_
cells	22370	22375	NNS	cell	O	_	_
were	22376	22380	VBD	be	O	_	_
lysed	22381	22386	VBN	lyse	O	_	_
in	22387	22389	IN	in	O	_	_
either	22390	22396	CC	either	O	_	_
NP40	22397	22401	NN	np40	O	_	_
lysis	22402	22407	NN	lysis	O	_	_
buffer	22408	22414	NN	buffer	O	_	_
(	22415	22416	NN	(	O	_	_
1	22416	22417	CD	1	O	_	_
%	22417	22418	NN	%	O	_	_
Nonidet	22419	22426	NNP	Nonidet	O	_	_
P40	22427	22430	NN	p40	O	_	_
,	22430	22431	,	,	O	_	_
50	22432	22434	CD	50	O	_	_
mM	22435	22437	NN	mm	O	_	_
Tris	22438	22442	NNP	Tris	O	_	_
[	22443	22444	CD	[	O	_	_
pH	22444	22446	NN	ph	O	_	_
8.0	22447	22450	CD	8.0	O	_	_
]	22450	22451	NN	]	O	_	_
,	22451	22452	,	,	O	_	_
150	22453	22456	CD	150	O	_	_
mM	22457	22459	NN	mm	O	_	_
NaCl	22460	22464	NN	nacl	O	_	_
,	22464	22465	,	,	O	_	_
and	22466	22469	CC	and	O	_	_
1	22470	22471	CD	1	O	_	_
mM	22472	22474	NN	mm	O	_	_
EDTA	22475	22479	NN	edta	O	_	_
)	22479	22480	NN	)	O	_	_
,	22480	22481	,	,	O	_	_
RIPA	22482	22486	NN	ripa	O	_	_
buffer	22487	22493	NN	buffer	O	_	_
(	22494	22495	NN	(	O	_	_
150	22495	22498	CD	150	O	_	_
mM	22499	22501	NN	mm	O	_	_
NaCl	22502	22506	NN	nacl	O	_	_
,	22506	22507	,	,	O	_	_
1	22508	22509	CD	1	O	_	_
%	22509	22510	NN	%	O	_	_
Nonidet	22511	22518	NNP	Nonidet	O	_	_
P40	22519	22522	NN	p40	O	_	_
,	22522	22523	,	,	O	_	_
0.5	22524	22527	CD	0.5	O	_	_
%	22527	22528	NN	%	O	_	_
sodium	22529	22535	NN	sodium	O	_	_
deoxycholate	22536	22548	NN	deoxycholate	O	_	_
,	22548	22549	,	,	O	_	_
0.1	22550	22553	CD	0.1	O	_	_
%	22553	22554	NN	%	O	_	_
sodium	22555	22561	NN	sodium	O	_	_
dodecyl	22562	22569	NN	dodecyl	O	_	_
sulfate	22570	22577	NN	sulfate	O	_	_
,	22577	22578	,	,	O	_	_
50	22579	22581	CD	50	O	_	_
mM	22582	22584	NN	mm	O	_	_
Tris-HCl	22585	22593	NN	tris-hcl	O	_	_
[	22594	22595	CD	[	O	_	_
pH	22595	22597	NN	ph	O	_	_
8.0	22598	22601	CD	8.0	O	_	_
]	22601	22602	CD	]	O	_	_
)	22602	22603	NN	)	O	_	_
,	22603	22604	,	,	O	_	_
Urea	22605	22609	NN	urea	O	_	_
solution	22610	22618	NN	solution	O	_	_
(	22619	22620	CD	(	O	_	_
8	22620	22621	CD	8	O	_	_
M	22622	22623	NN	m	O	_	_
Urea	22624	22628	NN	urea	O	_	_
,	22628	22629	,	,	O	_	_
1	22630	22631	CD	1	O	_	_
M	22632	22633	NN	m	O	_	_
Thiourea	22634	22642	NN	thiourea	O	_	_
,	22642	22643	,	,	O	_	_
0.5	22644	22647	CD	0.5	O	_	_
%	22647	22648	NN	%	O	_	_
CHAPS	22649	22654	NNS	chap	O	_	_
,	22654	22655	,	,	O	_	_
50	22656	22658	CD	50	O	_	_
mM	22659	22661	NN	mm	O	_	_
DTT	22662	22665	NN	dtt	O	_	_
,	22665	22666	,	,	O	_	_
and	22667	22670	CC	and	O	_	_
24	22671	22673	CD	24	O	_	_
mM	22674	22676	NN	mm	O	_	_
Spermine	22677	22685	NN	spermine	O	_	_
)	22685	22686	CD	)	O	_	_
or	22687	22689	CC	or	O	_	_
luciferase	22690	22700	NN	luciferase	B-GENE	_	_
lysis	22701	22706	NN	lysis	I-GENE	_	_
buffer	22707	22713	NN	buffer	I-GENE	_	_
.	22713	22714	.	.	O	_	_
D	1
6
2	1	nn
6	2	prep_for
6	4	nsubjpass
6	5	auxpass
6	11	prep_in
6	85	conj_and
11	8	dep
11	9	nn
11	10	nn
11	16	dep
11	20	dep
11	28	dep
14	13	number
16	14	amod
16	15	nn
20	18	num
20	19	nn
20	22	dep
20	24	dep
22	21	num
24	23	num
28	26	num
28	27	nn
34	31	num
34	32	nn
34	33	nn
34	41	appos
34	46	appos
34	54	appos
34	61	appos
34	69	appos
34	77	appos
34	81	appos
41	36	nn
41	37	nn
41	39	num
41	40	nn
44	43	number
46	44	amod
46	45	nn
46	51	appos
49	48	number
51	49	amod
51	50	nn
54	53	num
54	57	dep
57	55	nn
57	56	nn
61	59	num
61	60	nn
61	63	dep
63	62	num
65	64	number
66	65	dep
69	68	nn
69	73	dep
73	71	num
73	72	nn
77	75	num
77	76	nn
80	79	number
81	80	amod
85	83	num
85	84	nn
90	88	num
90	89	nn
91	90	dep
91	95	conj_or
95	93	nn
95	94	nn
EOX
Y	1
ROOT	0	0	97	1	S	0	0	97	8	S	3	0	29	4	PP	0	0	3	2	IN	0	0	1	1	For	0	0	1	0	NP	1	1	3	2	NN	0	1	2	1	Western	1	1	2	0	NN	0	2	3	1	blotting	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	29	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	29	2	VBN	0	6	7	1	lysed	6	6	7	0	PP	0	7	29	2	IN	0	7	8	1	in	7	7	8	0	NP	1	8	29	6	CC	0	8	9	1	either	8	8	9	0	NP	0	9	17	2	NP	2	9	12	3	NN	0	9	10	1	NP40	9	9	10	0	NN	0	10	11	1	lysis	10	10	11	0	NN	0	11	12	1	buffer	11	11	12	0	NP	3	12	17	4	NN	0	12	13	1	-LRB-	12	12	13	0	ADJP	1	13	15	2	CD	0	13	14	1	1	13	13	14	0	NN	0	14	15	1	%	14	14	15	0	NNP	0	15	16	1	Nonidet	15	15	16	0	NN	0	16	17	1	P40	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	25	3	NP	2	18	21	3	CD	0	18	19	1	50	18	18	19	0	NN	0	19	20	1	mM	19	19	20	0	NNP	0	20	21	1	Tris	20	20	21	0	NP	1	21	23	2	CD	0	21	22	1	[	21	21	22	0	NN	0	22	23	1	pH	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	8.0	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	150	26	26	27	0	NN	0	27	28	1	mM	27	27	28	0	NN	0	28	29	1	NaCl	28	28	29	0	,	0	29	30	1	,	29	29	30	0	CC	0	30	31	1	and	30	30	31	0	S	1	31	86	2	NP	0	31	83	16	NP	3	31	35	4	CD	0	31	32	1	1	31	31	32	0	NN	0	32	33	1	mM	32	32	33	0	NN	0	33	34	1	EDTA	33	33	34	0	NN	0	34	35	1	-RRB-	34	34	35	0	,	0	35	36	1	,	35	35	36	0	NP	5	36	42	6	NN	0	36	37	1	RIPA	36	36	37	0	NN	0	37	38	1	buffer	37	37	38	0	NN	0	38	39	1	-LRB-	38	38	39	0	CD	0	39	40	1	150	39	39	40	0	NN	0	40	41	1	mM	40	40	41	0	NN	0	41	42	1	NaCl	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NP	0	43	52	3	NP	2	43	47	3	ADJP	1	43	45	2	CD	0	43	44	1	1	43	43	44	0	NN	0	44	45	1	%	44	44	45	0	NNP	0	45	46	1	Nonidet	45	45	46	0	NN	0	46	47	1	P40	46	46	47	0	,	0	47	48	1	,	47	47	48	0	NP	2	48	52	3	ADJP	1	48	50	2	CD	0	48	49	1	0.5	48	48	49	0	NN	0	49	50	1	%	49	49	50	0	NN	0	50	51	1	sodium	50	50	51	0	NN	0	51	52	1	deoxycholate	51	51	52	0	,	0	52	53	1	,	52	52	53	0	NP	0	53	58	2	NP	1	53	55	2	CD	0	53	54	1	0.1	53	53	54	0	NN	0	54	55	1	%	54	54	55	0	NP	2	55	58	3	NN	0	55	56	1	sodium	55	55	56	0	NN	0	56	57	1	dodecyl	56	56	57	0	NN	0	57	58	1	sulfate	57	57	58	0	,	0	58	59	1	,	58	58	59	0	NP	0	59	67	2	NP	2	59	62	3	CD	0	59	60	1	50	59	59	60	0	NN	0	60	61	1	mM	60	60	61	0	NN	0	61	62	1	Tris-HCl	61	61	62	0	NP	0	62	67	2	NP	1	62	64	2	CD	0	62	63	1	[	62	62	63	0	NN	0	63	64	1	pH	63	63	64	0	ADJP	1	64	67	2	QP	1	64	66	2	CD	0	64	65	1	8.0	64	64	65	0	CD	0	65	66	1	]	65	65	66	0	NN	0	66	67	1	-RRB-	66	66	67	0	,	0	67	68	1	,	67	67	68	0	NP	0	68	74	2	NP	1	68	70	2	NN	0	68	69	1	Urea	68	68	69	0	NN	0	69	70	1	solution	69	69	70	0	NP	2	70	74	3	QP	1	70	72	2	CD	0	70	71	1	-LRB-	70	70	71	0	CD	0	71	72	1	8	71	71	72	0	NN	0	72	73	1	M	72	72	73	0	NN	0	73	74	1	Urea	73	73	74	0	,	0	74	75	1	,	74	74	75	0	NP	2	75	78	3	CD	0	75	76	1	1	75	75	76	0	NN	0	76	77	1	M	76	76	77	0	NN	0	77	78	1	Thiourea	77	77	78	0	,	0	78	79	1	,	78	78	79	0	NP	1	79	82	2	ADJP	1	79	81	2	CD	0	79	80	1	0.5	79	79	80	0	NN	0	80	81	1	%	80	80	81	0	NNS	0	81	82	1	CHAPS	81	81	82	0	,	0	82	83	1	,	82	82	83	0	NP	2	83	86	3	CD	0	83	84	1	50	83	83	84	0	NN	0	84	85	1	mM	84	84	85	0	NN	0	85	86	1	DTT	85	85	86	0	,	0	86	87	1	,	86	86	87	0	CC	0	87	88	1	and	87	87	88	0	S	1	88	96	2	NP	2	88	91	3	CD	0	88	89	1	24	88	88	89	0	NN	0	89	90	1	mM	89	89	90	0	NN	0	90	91	1	Spermine	90	90	91	0	NP	0	91	96	3	NP	0	91	92	1	CD	0	91	92	1	-RRB-	91	91	92	0	CC	0	92	93	1	or	92	92	93	0	NP	2	93	96	3	NN	0	93	94	1	luciferase	93	93	94	0	NN	0	94	95	1	lysis	94	94	95	0	NN	0	95	96	1	buffer	95	95	96	0	.	0	96	97	1	.	96	96	97	0
EOS
T	19
Between	22715	22722	IN	between	O	_	_
35	22723	22725	CD	35	O	_	_
and	22726	22729	CC	and	O	_	_
150	22730	22733	CD	150	O	_	_
mug	22734	22737	NN	mug	O	_	_
of	22738	22740	IN	of	O	_	_
extract	22741	22748	NN	extract	O	_	_
was	22749	22752	VBD	be	O	_	_
mixed	22753	22758	VBN	mix	O	_	_
with	22759	22763	IN	with	O	_	_
6x	22764	22766	JJ	6x	O	_	_
sample	22767	22773	NN	sample	O	_	_
buffer	22774	22780	NN	buffer	O	_	_
and	22781	22784	CC	and	O	_	_
loaded	22785	22791	VBN	load	O	_	_
on	22792	22794	IN	on	O	_	_
SDS-PAGE	22795	22803	NN	sds-page	O	_	_
gels	22804	22808	NNS	gel	O	_	_
.	22808	22809	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
4	1	num
4	3	num
4	6	prep_of
8	4	nsubjpass
8	7	auxpass
8	12	prep_with
8	14	conj_and
12	10	amod
12	11	nn
14	4	nsubjpass
14	17	prep_on
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	7	2	NP	1	0	5	2	QP	0	0	4	3	NP	1	0	2	2	IN	0	0	1	1	Between	0	0	1	0	CD	0	1	2	1	35	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	150	3	3	4	0	NN	0	4	5	1	mug	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	extract	6	6	7	0	VP	1	7	18	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	18	3	VP	0	8	13	2	VBN	0	8	9	1	mixed	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	6x	10	10	11	0	NN	0	11	12	1	sample	11	11	12	0	NN	0	12	13	1	buffer	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	18	2	VBN	0	14	15	1	loaded	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
The	22810	22813	DT	the	O	_	_
gels	22814	22818	NNS	gel	O	_	_
were	22819	22823	VBD	be	O	_	_
wet	22824	22827	JJ	wet	O	_	_
transferred	22828	22839	VBN	transfer	O	_	_
onto	22840	22844	IN	onto	O	_	_
Protran	22845	22852	NNP	Protran	O	_	_
nitrocellulose	22853	22867	NN	nitrocellulose	O	_	_
membrane	22868	22876	NN	membrane	O	_	_
and	22877	22880	CC	and	O	_	_
the	22881	22884	DT	the	O	_	_
resulting	22885	22894	VBG	result	O	_	_
blots	22895	22900	NNS	blot	O	_	_
were	22901	22905	VBD	be	O	_	_
blocked	22906	22913	VBN	block	O	_	_
and	22914	22917	CC	and	O	_	_
incubated	22918	22927	VBN	incubate	O	_	_
first	22928	22933	RB	first	O	_	_
in	22934	22936	IN	in	O	_	_
primary	22937	22944	JJ	primary	O	_	_
antibody	22945	22953	NN	antibody	O	_	_
and	22954	22957	CC	and	O	_	_
then	22958	22962	RB	then	O	_	_
with	22963	22967	IN	with	O	_	_
the	22968	22971	DT	the	O	_	_
appropriate	22972	22983	JJ	appropriate	O	_	_
secondary	22984	22993	JJ	secondary	O	_	_
horseradish	22994	23005	NN	horseradish	B-GENE	_	_
peroxidase	23006	23016	NN	peroxidase	I-GENE	_	_
conjugated	23017	23027	VBN	conjugate	I-GENE	_	_
antibody	23028	23036	NN	antibody	I-GENE	_	_
(	23037	23038	CD	(	O	_	_
Dako	23038	23042	NNP	Dako	O	_	_
)	23042	23043	CD	)	O	_	_
.	23043	23044	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	4	ccomp
3	14	conj_and
3	16	conj_and
4	8	prep_onto
8	6	nn
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	14	conj_and
14	16	conj_and
14	17	advmod
14	20	prep_in
14	22	advmod
14	28	prep_with
16	12	nsubjpass
20	19	amod
28	24	det
28	25	amod
28	26	amod
28	27	nn
28	29	vmod
29	30	dobj
30	32	dep
EOX
Y	1
ROOT	0	0	35	1	S	0	0	35	4	S	1	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	gels	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	ADJP	0	3	9	2	JJ	0	3	4	1	wet	3	3	4	0	SBAR	0	4	9	1	S	0	4	9	1	VP	0	4	9	2	VBN	0	4	5	1	transferred	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	onto	5	5	6	0	NP	2	6	9	3	NNP	0	6	7	1	Protran	6	6	7	0	NN	0	7	8	1	nitrocellulose	7	7	8	0	NN	0	8	9	1	membrane	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	34	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	VBG	0	11	12	1	resulting	11	11	12	0	NNS	0	12	13	1	blots	12	12	13	0	VP	1	13	34	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	34	4	VBN	0	14	15	1	blocked	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	VBN	0	16	17	1	incubated	16	16	17	0	PP	1	17	34	4	RB	0	17	18	1	first	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	21	2	JJ	0	19	20	1	primary	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	PP	1	22	34	3	RB	0	22	23	1	then	22	22	23	0	IN	0	23	24	1	with	23	23	24	0	NP	0	24	34	2	NP	4	24	29	5	DT	0	24	25	1	the	24	24	25	0	JJ	0	25	26	1	appropriate	25	25	26	0	JJ	0	26	27	1	secondary	26	26	27	0	NN	0	27	28	1	horseradish	27	27	28	0	NN	0	28	29	1	peroxidase	28	28	29	0	VP	0	29	34	2	VBN	0	29	30	1	conjugated	29	29	30	0	NP	0	30	34	2	NP	0	30	32	2	NN	0	30	31	1	antibody	30	30	31	0	CD	0	31	32	1	-LRB-	31	31	32	0	NP	0	32	34	2	NNP	0	32	33	1	Dako	32	32	33	0	CD	0	33	34	1	-RRB-	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	20
The	23045	23048	DT	the	O	_	_
blot	23049	23053	NN	blot	O	_	_
was	23054	23057	VBD	be	O	_	_
exposed	23058	23065	VBN	expose	O	_	_
to	23066	23068	TO	to	O	_	_
hyperfilm	23069	23078	NN	hyperfilm	O	_	_
following	23079	23088	VBG	follow	O	_	_
the	23089	23092	DT	the	O	_	_
use	23093	23096	NN	use	O	_	_
of	23097	23099	IN	of	O	_	_
enhanced	23100	23108	VBN	enhance	O	_	_
chemiluminescence	23109	23126	NN	chemiluminescence	O	_	_
substrate	23127	23136	NN	substrate	O	_	_
solution	23137	23145	NN	solution	O	_	_
(	23146	23147	CD	(	O	_	_
Amersham	23147	23155	NNP	Amersham	O	_	_
Life	23156	23160	NNP	Life	O	_	_
Science	23161	23168	NNP	Science	O	_	_
)	23168	23169	CD	)	O	_	_
.	23169	23170	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	prep_to
5	6	vmod
6	8	iobj
6	17	dobj
8	7	det
8	12	prep_of
12	10	amod
12	11	nn
17	13	nn
17	15	nn
17	16	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	blot	1	1	2	0	VP	1	2	19	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	19	2	VBN	0	3	4	1	exposed	3	3	4	0	PP	0	4	19	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	19	2	NP	0	5	6	1	NN	0	5	6	1	hyperfilm	5	5	6	0	VP	0	6	19	3	VBG	0	6	7	1	following	6	6	7	0	NP	0	7	13	2	NP	1	7	9	2	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	use	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	2	10	13	3	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	chemiluminescence	11	11	12	0	NN	0	12	13	1	substrate	12	12	13	0	NP	0	13	19	2	NP	4	13	18	5	NN	0	13	14	1	solution	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NNP	0	15	16	1	Amersham	15	15	16	0	NNP	0	16	17	1	Life	16	16	17	0	NNP	0	17	18	1	Science	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	55
Primary	23171	23178	JJ	primary	O	_	_
antibodies	23179	23189	NNS	antibody	O	_	_
were	23190	23194	VBD	be	O	_	_
from	23195	23199	IN	from	O	_	_
:	23199	23200	:	:	O	_	_
Abcam	23201	23206	NNP	Abcam	O	_	_
Inc.	23207	23211	NNP	Inc.	O	_	_
,	23211	23212	,	,	O	_	_
Cambridge	23213	23222	NNP	Cambridge	O	_	_
,	23222	23223	,	,	O	_	_
MA	23224	23226	NNP	MA	O	_	_
,	23226	23227	,	,	O	_	_
USA	23228	23231	NNP	USA	O	_	_
(	23232	23233	CD	(	B-GENE	_	_
beta-actin	23233	23243	NN	beta-actin	I-GENE	_	_
,	23243	23244	,	,	O	_	_
beta-Tubulin	23245	23257	NN	beta-tubulin	B-GENE	_	_
)	23257	23258	NN	)	O	_	_
,	23258	23259	,	,	O	_	_
Upstate	23260	23267	NNP	Upstate	O	_	_
Millipore	23268	23277	NNP	Millipore	O	_	_
Corporate	23278	23287	NNP	Corporate	O	_	_
Headquarters	23288	23300	NN	headquarters	O	_	_
,	23300	23301	,	,	O	_	_
Billerica	23302	23311	NNP	Billerica	O	_	_
,	23311	23312	,	,	O	_	_
MA	23313	23315	NNP	MA	O	_	_
USA	23316	23319	NNP	USA	O	_	_
(	23320	23321	CD	(	O	_	_
RAS	23321	23324	NNP	RAS	O	_	_
Clone	23325	23330	NN	clone	O	_	_
10	23331	23333	CD	10	O	_	_
)	23333	23334	NN	)	O	_	_
,	23334	23335	,	,	O	_	_
Cell	23336	23340	NN	cell	O	_	_
Signaling	23341	23350	NN	signaling	O	_	_
Technology	23351	23361	NN	technology	O	_	_
,	23361	23362	,	,	O	_	_
Inc.	23363	23367	NNP	Inc.	O	_	_
,	23367	23368	,	,	O	_	_
Danvers	23369	23376	NNP	Danvers	O	_	_
,	23376	23377	,	,	O	_	_
MA	23378	23380	NNP	MA	O	_	_
,	23380	23381	,	,	O	_	_
USA	23382	23385	NNP	USA	O	_	_
(	23386	23387	CD	(	O	_	_
Phospho-ERK	23387	23398	NN	phospho-erk	B-GENE	_	_
/	23398	23399	:	/	B-GENE	_	_
MAPK	23399	23403	NN	mapk	I-GENE	_	_
,	23403	23404	,	,	O	_	_
ERK	23405	23408	NN	erk	B-GENE	_	_
/	23408	23409	:	/	B-GENE	_	_
MAPK	23409	23413	NN	mapk	I-GENE	_	_
)	23413	23414	NN	)	O	_	_
.	23414	23415	.	.	O	_	_
D	1

1	0	amod
2	1	nsubj
2	3	prep
6	5	nn
6	8	appos
6	10	appos
6	14	appos
6	22	appos
6	24	appos
6	29	appos
14	12	nn
17	16	nn
22	19	nn
22	20	nn
22	21	nn
29	26	nn
29	27	nn
30	31	num
32	6	dep
32	30	dep
32	36	appos
32	38	appos
32	40	appos
32	42	appos
32	44	appos
32	50	appos
36	34	nn
36	35	nn
44	46	dep
46	48	dep
48	47	punct
53	51	punct
53	52	nn
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	4	S	1	0	4	2	NP	1	0	2	2	JJ	0	0	1	1	Primary	0	0	1	0	NNS	0	1	2	1	antibodies	1	1	2	0	VP	0	2	4	2	VBD	0	2	3	1	were	2	2	3	0	PP	0	3	4	1	IN	0	3	4	1	from	3	3	4	0	:	0	4	5	1	:	4	4	5	0	FRAG	2	5	54	3	X	2	5	51	3	NP	0	5	30	15	NP	1	5	7	2	NNP	0	5	6	1	Abcam	5	5	6	0	NNP	0	6	7	1	Inc.	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Cambridge	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	MA	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	NNP	0	12	13	1	USA	12	12	13	0	CD	0	13	14	1	-LRB-	13	13	14	0	NN	0	14	15	1	beta-actin	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	beta-Tubulin	16	16	17	0	NN	0	17	18	1	-RRB-	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	3	19	23	4	NNP	0	19	20	1	Upstate	19	19	20	0	NNP	0	20	21	1	Millipore	20	20	21	0	NNP	0	21	22	1	Corporate	21	21	22	0	NN	0	22	23	1	Headquarters	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	25	1	NNP	0	24	25	1	Billerica	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	3	26	30	4	NNP	0	26	27	1	MA	26	26	27	0	NNP	0	27	28	1	USA	27	27	28	0	CD	0	28	29	1	-LRB-	28	28	29	0	NNP	0	29	30	1	RAS	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	Clone	30	30	31	0	CD	0	31	32	1	10	31	31	32	0	NP	0	32	51	13	NP	0	32	33	1	NN	0	32	33	1	-RRB-	32	32	33	0	,	0	33	34	1	,	33	33	34	0	NP	2	34	37	3	NN	0	34	35	1	Cell	34	34	35	0	NN	0	35	36	1	Signaling	35	35	36	0	NN	0	36	37	1	Technology	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NNP	0	38	39	1	Inc.	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	0	40	41	1	NNP	0	40	41	1	Danvers	40	40	41	0	,	0	41	42	1	,	41	41	42	0	NP	0	42	43	1	NNP	0	42	43	1	MA	42	42	43	0	,	0	43	44	1	,	43	43	44	0	NP	0	44	49	2	NP	0	44	45	1	NNP	0	44	45	1	USA	44	44	45	0	NP	1	45	49	3	CD	0	45	46	1	-LRB-	45	45	46	0	NN	0	46	47	1	Phospho-ERK	46	46	47	0	PRN	1	47	49	2	:	0	47	48	1	/	47	47	48	0	NP	0	48	49	1	NN	0	48	49	1	MAPK	48	48	49	0	,	0	49	50	1	,	49	49	50	0	NP	0	50	51	1	NN	0	50	51	1	ERK	50	50	51	0	:	0	51	52	1	/	51	51	52	0	NP	1	52	54	2	NN	0	52	53	1	MAPK	52	52	53	0	NN	0	53	54	1	-RRB-	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	42
The	23416	23419	DT	the	O	_	_
V5	23420	23422	NN	v5	O	_	_
epitope	23423	23430	NN	epitope	O	_	_
is	23431	23433	VBZ	be	O	_	_
recognized	23434	23444	VBN	recognize	O	_	_
by	23445	23447	IN	by	O	_	_
the	23448	23451	DT	the	O	_	_
mouse	23452	23457	NN	mouse	B-GENE	_	_
monoclonal	23458	23468	JJ	monoclonal	I-GENE	_	_
anti	23469	23473	JJ	anti	I-GENE	_	_
V5	23474	23476	NN	v5	I-GENE	_	_
antibody	23477	23485	NN	antibody	I-GENE	_	_
(	23486	23487	CD	(	O	_	_
Invitrogen	23487	23497	NNP	Invitrogen	O	_	_
,	23497	23498	,	,	O	_	_
Paisley	23499	23506	NNP	Paisley	O	_	_
,	23506	23507	,	,	O	_	_
UK	23508	23510	NNP	UK	O	_	_
)	23510	23511	NNP	)	O	_	_
and	23512	23515	CC	and	O	_	_
the	23516	23519	DT	the	O	_	_
haemagglutinin	23520	23534	NN	haemagglutinin	B-GENE	_	_
epitope	23535	23542	NN	epitope	O	_	_
is	23543	23545	VBZ	be	O	_	_
recognized	23546	23556	VBN	recognize	O	_	_
by	23557	23559	IN	by	O	_	_
the	23560	23563	DT	the	O	_	_
anti	23564	23568	JJ	anti	B-GENE	_	_
HA	23569	23571	NN	ha	I-GENE	_	_
antibody	23572	23580	NN	antibody	I-GENE	_	_
(	23581	23582	CD	(	B-GENE	_	_
mAb	23582	23585	NN	mab	I-GENE	_	_
)	23585	23586	CD	)	O	_	_
(	23587	23588	CD	(	O	_	_
Covance	23588	23595	NNP	Covance	O	_	_
,	23595	23596	,	,	O	_	_
Princeton	23597	23606	NNP	Princeton	O	_	_
,	23606	23607	,	,	O	_	_
NJ	23608	23610	NNP	NJ	O	_	_
USA	23611	23614	NNP	USA	O	_	_
)	23614	23615	NN	)	O	_	_
.	23615	23616	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	7	agent
4	10	dobj
7	6	det
10	8	amod
10	9	amod
10	24	rcmod
13	11	nn
13	15	conj_and
13	22	conj_and
18	17	nn
22	20	det
22	21	nn
24	13	nsubjpass
24	15	nsubjpass
24	22	nsubjpass
24	23	auxpass
24	29	agent
29	26	det
29	27	amod
29	28	nn
29	31	dep
33	36	dep
36	34	nn
40	38	nn
40	39	nn
EOX
Y	1
ROOT	0	0	42	1	S	1	0	42	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	V5	1	1	2	0	NN	0	2	3	1	epitope	2	2	3	0	VP	1	3	41	2	VBZ	0	3	4	1	is	3	3	4	0	VP	0	4	41	3	VBN	0	4	5	1	recognized	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	mouse	7	7	8	0	NP	0	8	41	2	NP	2	8	11	3	JJ	0	8	9	1	monoclonal	8	8	9	0	JJ	0	9	10	1	anti	9	9	10	0	NN	0	10	11	1	V5	10	10	11	0	SBAR	0	11	41	1	S	1	11	41	2	NP	0	11	23	7	NP	2	11	14	3	NN	0	11	12	1	antibody	11	11	12	0	CD	0	12	13	1	-LRB-	12	12	13	0	NNP	0	13	14	1	Invitrogen	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	NNP	0	15	16	1	Paisley	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	UK	17	17	18	0	NNP	0	18	19	1	-RRB-	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NP	2	20	23	3	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	haemagglutinin	21	21	22	0	NN	0	22	23	1	epitope	22	22	23	0	VP	1	23	41	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	41	2	VBN	0	24	25	1	recognized	24	24	25	0	PP	0	25	41	2	IN	0	25	26	1	by	25	25	26	0	NP	0	26	41	4	NP	0	26	32	2	NP	3	26	30	4	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	anti	27	27	28	0	NN	0	28	29	1	HA	28	28	29	0	NN	0	29	30	1	antibody	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	-LRB-	30	30	31	0	NN	0	31	32	1	mAb	31	31	32	0	NP	0	32	37	2	NP	0	32	34	1	QP	1	32	34	2	CD	0	32	33	1	-RRB-	32	32	33	0	CD	0	33	34	1	-LRB-	33	33	34	0	NP	2	34	37	3	NNP	0	34	35	1	Covance	34	34	35	0	,	0	35	36	1	,	35	35	36	0	NNP	0	36	37	1	Princeton	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	2	38	41	3	NNP	0	38	39	1	NJ	38	38	39	0	NNP	0	39	40	1	USA	39	39	40	0	NN	0	40	41	1	-RRB-	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	20
To	23617	23619	TO	to	O	_	_
detect	23620	23626	VB	detect	O	_	_
RAS	23627	23630	NN	ra	B-GENE	_	_
by	23631	23633	IN	by	O	_	_
immunoprecipitation	23634	23653	NN	immunoprecipitation	O	_	_
the	23654	23657	DT	the	O	_	_
rat	23658	23661	NN	rat	B-GENE	_	_
monoclonal	23662	23672	JJ	monoclonal	I-GENE	_	_
antibody	23673	23681	NN	antibody	I-GENE	_	_
238	23682	23685	CD	238	I-GENE	_	_
was	23686	23689	VBD	be	O	_	_
used	23690	23694	VBN	use	O	_	_
(	23695	23696	CD	(	O	_	_
Santa	23696	23701	NNP	Santa	O	_	_
Cruz	23702	23706	NNP	Cruz	O	_	_
,	23706	23707	,	,	O	_	_
CA	23708	23710	NNP	CA	B-GENE	_	_
USA	23711	23714	NNP	USA	I-GENE	_	_
)	23714	23715	NN	)	O	_	_
.	23715	23716	.	.	O	_	_
D	1

1	0	aux
1	2	dobj
1	4	prep_by
6	5	det
6	7	amod
7	8	dep
8	9	num
11	1	dep
11	6	nsubjpass
11	10	auxpass
11	14	dobj
14	13	nn
18	16	nn
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	2	0	20	4	S	0	0	5	1	VP	1	0	5	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	5	3	VB	0	1	2	1	detect	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	immunoprecipitation	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	rat	6	6	7	0	ADJP	0	7	10	2	JJ	0	7	8	1	monoclonal	7	7	8	0	NP	0	8	10	2	NN	0	8	9	1	antibody	8	8	9	0	CD	0	9	10	1	238	9	9	10	0	VP	1	10	19	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	19	2	VBN	0	11	12	1	used	11	11	12	0	NP	0	12	19	3	NP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	NNP	0	13	14	1	Santa	13	13	14	0	NNP	0	14	15	1	Cruz	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	2	16	19	3	NNP	0	16	17	1	CA	16	16	17	0	NNP	0	17	18	1	USA	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	31
The	23717	23720	DT	the	O	_	_
mouse	23721	23726	NN	mouse	O	_	_
and	23727	23730	CC	and	O	_	_
rabbit	23731	23737	NN	rabbit	O	_	_
antibodies	23738	23748	NNS	antibody	O	_	_
to	23749	23751	TO	to	O	_	_
ASPP2	23752	23757	NN	aspp2	B-GENE	_	_
were	23758	23762	VBD	be	O	_	_
described	23763	23772	VBN	describe	O	_	_
previously	23773	23783	RB	previously	O	_	_
[	23784	23785	CD	[	O	_	_
9	23785	23786	CD	9	O	_	_
]	23786	23787	NN	]	O	_	_
:	23787	23788	:	:	O	_	_
rabbit	23789	23795	NN	rabbit	O	_	_
anti	23796	23800	JJ	anti	O	_	_
ASPP2	23801	23806	NN	aspp2	B-GENE	_	_
polyclonal	23807	23817	JJ	polyclonal	I-GENE	_	_
antibody	23818	23826	NN	antibody	I-GENE	_	_
ASPP2	23827	23832	NN	aspp2	I-GENE	_	_
/	23832	23833	:	/	I-GENE	_	_
77	23833	23835	CD	77	I-GENE	_	_
and	23836	23839	CC	and	O	_	_
mouse	23840	23845	NN	mouse	B-GENE	_	_
monoclonal	23846	23856	JJ	monoclonal	I-GENE	_	_
anti	23857	23861	JJ	anti	I-GENE	_	_
ASPP2	23862	23867	NN	aspp2	I-GENE	_	_
antibody	23868	23876	NN	antibody	I-GENE	_	_
DX54	23877	23881	NN	dx54	O	_	_
.10	23881	23884	CD	.10	O	_	_
.	23884	23885	.	.	O	_	_
D	1
8
1	3	conj_and
4	0	det
4	1	nn
4	3	nn
4	6	prep_to
8	4	nsubjpass
8	7	auxpass
8	9	advmod
8	12	dobj
11	10	number
12	11	num
12	16	dep
12	28	dep
16	14	nn
16	15	amod
16	19	dep
19	17	amod
19	18	nn
21	27	conj_and
27	23	nn
27	24	amod
27	25	amod
27	26	nn
28	20	punct
28	21	dep
28	27	dep
28	29	num
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	7	2	NP	2	0	5	3	DT	0	0	1	1	The	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	mouse	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	rabbit	3	3	4	0	NNS	0	4	5	1	antibodies	4	4	5	0	PP	0	5	7	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	30	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	30	3	VBN	0	8	9	1	described	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	previously	9	9	10	0	NP	0	10	30	2	NP	1	10	20	2	QP	1	10	12	2	CD	0	10	11	1	[	10	10	11	0	CD	0	11	12	1	9	11	11	12	0	NX	0	12	20	3	NP	0	12	13	1	NN	0	12	13	1	]	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	rabbit	14	14	15	0	JJ	0	15	16	1	anti	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	polyclonal	17	17	18	0	NN	0	18	19	1	antibody	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	PRN	1	20	30	2	:	0	20	21	1	/	20	20	21	0	S	1	21	30	2	NP	0	21	28	3	NP	0	21	22	1	CD	0	21	22	1	77	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NP	4	23	28	5	NN	0	23	24	1	mouse	23	23	24	0	JJ	0	24	25	1	monoclonal	24	24	25	0	JJ	0	25	26	1	anti	25	25	26	0	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	antibody	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	DX54	28	28	29	0	CD	0	29	30	1	.10	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	9
The	23886	23889	DT	the	O	_	_
mouse	23890	23895	NN	mouse	B-GENE	_	_
monoclonal	23896	23906	JJ	monoclonal	I-GENE	_	_
DO-1	23907	23911	NN	do-1	I-GENE	_	_
is	23912	23914	VBZ	be	O	_	_
specific	23915	23923	JJ	specific	O	_	_
to	23924	23926	TO	to	O	_	_
p53	23927	23930	NN	p53	B-GENE	_	_
.	23930	23931	.	.	O	_	_
D	1
5
3	0	det
3	1	nn
3	2	amod
5	3	nsubj
5	4	cop
5	7	prep_to
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mouse	1	1	2	0	JJ	0	2	3	1	monoclonal	2	2	3	0	NN	0	3	4	1	DO-1	3	3	4	0	VP	1	4	8	2	VBZ	0	4	5	1	is	4	4	5	0	ADJP	0	5	8	2	JJ	0	5	6	1	specific	5	5	6	0	PP	0	6	8	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	p53	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	21
Signals	23932	23939	NNS	signal	O	_	_
were	23940	23944	VBD	be	O	_	_
detected	23945	23953	VBN	detect	O	_	_
using	23954	23959	VBG	use	O	_	_
ECL	23960	23963	NN	ecl	O	_	_
detection	23964	23973	NN	detection	O	_	_
system	23974	23980	NN	system	O	_	_
(	23981	23982	CD	(	O	_	_
GE	23982	23984	NNP	GE	O	_	_
Healthcare	23985	23995	NNP	Healthcare	O	_	_
,	23995	23996	,	,	O	_	_
Pollards	23997	24005	NNP	Pollards	O	_	_
Wood	24006	24010	NNP	Wood	O	_	_
,	24010	24011	,	,	O	_	_
Chalfont	24012	24020	NNP	Chalfont	O	_	_
,	24020	24021	,	,	O	_	_
Buckinghamshire	24022	24037	NNP	Buckinghamshire	O	_	_
,	24037	24038	,	,	O	_	_
UK	24039	24041	NNP	UK	O	_	_
)	24041	24042	CD	)	O	_	_
.	24042	24043	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	3	xcomp
3	6	dobj
6	4	nn
6	5	nn
6	9	dep
9	8	nn
9	18	appos
18	11	nn
18	12	nn
18	14	appos
18	16	appos
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	NNS	0	0	1	1	Signals	0	0	1	0	VP	1	1	20	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	20	2	VBN	0	2	3	1	detected	2	2	3	0	S	0	3	20	1	VP	0	3	20	2	VBG	0	3	4	1	using	3	3	4	0	NP	0	4	20	2	NP	2	4	7	3	NN	0	4	5	1	ECL	4	4	5	0	NN	0	5	6	1	detection	5	5	6	0	NN	0	6	7	1	system	6	6	7	0	NP	0	7	20	3	NP	2	7	10	3	CD	0	7	8	1	-LRB-	7	7	8	0	NNP	0	8	9	1	GE	8	8	9	0	NNP	0	9	10	1	Healthcare	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	7	11	20	9	NNP	0	11	12	1	Pollards	11	11	12	0	NNP	0	12	13	1	Wood	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NNP	0	14	15	1	Chalfont	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NNP	0	16	17	1	Buckinghamshire	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NNP	0	18	19	1	UK	18	18	19	0	CD	0	19	20	1	-RRB-	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	2
Immunofluorescence	24044	24062	NN	immunofluorescence	O	_	_
.	24062	24063	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Immunofluorescence	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	55
Cells	24064	24069	NNS	cell	O	_	_
were	24070	24074	VBD	be	O	_	_
fixed	24075	24080	VBN	fix	O	_	_
in	24081	24083	IN	in	O	_	_
4	24084	24085	CD	4	O	_	_
%	24085	24086	NN	%	O	_	_
PBS-paraformaldeyde	24087	24106	NN	pbs-paraformaldeyde	O	_	_
for	24107	24110	IN	for	O	_	_
15	24111	24113	CD	15	O	_	_
min	24114	24117	NN	min	O	_	_
,	24117	24118	,	,	O	_	_
incubated	24119	24128	VBN	incubate	O	_	_
in	24129	24131	IN	in	O	_	_
0.2	24132	24135	CD	0.2	O	_	_
%	24135	24136	NN	%	O	_	_
Triton-X-100	24137	24149	NN	triton-x-100	O	_	_
for	24150	24153	IN	for	O	_	_
5	24154	24155	CD	5	O	_	_
min	24156	24159	NN	min	O	_	_
,	24159	24160	,	,	O	_	_
then	24161	24165	RB	then	O	_	_
in	24166	24168	IN	in	O	_	_
0.2	24169	24172	CD	0.2	O	_	_
%	24172	24173	NN	%	O	_	_
Fish	24174	24178	NN	fish	O	_	_
Skin	24179	24183	NN	skin	O	_	_
Gelatine	24184	24192	NN	gelatine	O	_	_
in	24193	24195	IN	in	O	_	_
PBS	24196	24199	NNP	PBS	O	_	_
for	24200	24203	IN	for	O	_	_
10	24204	24206	CD	10	O	_	_
min	24207	24210	NN	min	O	_	_
and	24211	24214	CC	and	O	_	_
stained	24215	24222	VBN	stain	O	_	_
for	24223	24226	IN	for	O	_	_
1	24227	24228	CD	1	O	_	_
hr	24229	24231	NN	hr	O	_	_
with	24232	24236	IN	with	O	_	_
anti	24237	24241	JJ	anti	O	_	_
V5	24242	24244	NN	v5	O	_	_
(	24245	24246	CD	(	O	_	_
Invitrogen	24246	24256	NNP	Invitrogen	O	_	_
,	24256	24257	,	,	O	_	_
Paisley	24258	24265	NNP	Paisley	O	_	_
,	24265	24266	,	,	O	_	_
UK	24267	24269	NNP	UK	O	_	_
)	24269	24270	CD	)	O	_	_
or	24271	24273	CC	or	O	_	_
with	24274	24278	IN	with	O	_	_
anti	24279	24283	JJ	anti	B-GENE	_	_
ASPP2	24284	24289	NN	aspp2	I-GENE	_	_
with	24290	24294	IN	with	O	_	_
DX54	24295	24299	NN	dx54	B-GENE	_	_
.10	24299	24302	CD	.10	I-GENE	_	_
.	24302	24303	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_in
2	11	conj_and
2	33	conj_and
5	4	number
6	5	amod
6	9	prep_for
9	8	num
11	0	nsubjpass
11	15	prep_in
11	31	prep_for
14	13	number
15	14	amod
15	18	prep_for
15	20	advmod
15	26	dep
18	17	num
20	23	prep_in
23	22	num
26	24	nn
26	25	nn
26	28	prep_in
31	30	num
33	0	nsubjpass
33	33	conj_or
33	36	prep_for
33	50	prep_with
33	52	prep_with
36	35	num
36	39	prep_with
39	38	amod
39	45	dep
45	41	nn
45	43	appos
50	49	amod
52	53	num
EOX
Y	1
ROOT	0	0	55	1	S	1	0	55	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	54	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	54	5	VP	0	2	10	2	VBN	0	2	3	1	fixed	2	2	3	0	PP	0	3	10	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	10	2	NP	1	4	7	2	ADJP	1	4	6	2	CD	0	4	5	1	4	4	4	5	0	NN	0	5	6	1	%	5	5	6	0	NN	0	6	7	1	PBS-paraformaldeyde	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	for	7	7	8	0	NP	1	8	10	2	CD	0	8	9	1	15	8	8	9	0	NN	0	9	10	1	min	9	9	10	0	,	0	10	11	1	,	10	10	11	0	VP	0	11	32	3	VBN	0	11	12	1	incubated	11	11	12	0	PP	0	12	29	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	29	4	NP	0	13	19	2	NP	1	13	16	2	ADJP	1	13	15	2	CD	0	13	14	1	0.2	13	13	14	0	NN	0	14	15	1	%	14	14	15	0	NN	0	15	16	1	Triton-X-100	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	for	16	16	17	0	NP	1	17	19	2	CD	0	17	18	1	5	17	17	18	0	NN	0	18	19	1	min	18	18	19	0	,	0	19	20	1	,	19	19	20	0	ADVP	0	20	24	2	RB	0	20	21	1	then	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	in	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	0.2	22	22	23	0	NN	0	23	24	1	%	23	23	24	0	NP	0	24	29	2	NP	2	24	27	3	NN	0	24	25	1	Fish	24	24	25	0	NN	0	25	26	1	Skin	25	25	26	0	NN	0	26	27	1	Gelatine	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	in	27	27	28	0	NP	0	28	29	1	NNP	0	28	29	1	PBS	28	28	29	0	PP	0	29	32	2	IN	0	29	30	1	for	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	10	30	30	31	0	NN	0	31	32	1	min	31	31	32	0	CC	0	32	33	1	and	32	32	33	0	VP	0	33	54	3	VBN	0	33	34	1	stained	33	33	34	0	PP	0	34	51	3	PP	0	34	47	2	IN	0	34	35	1	for	34	34	35	0	NP	0	35	47	2	NP	1	35	37	2	CD	0	35	36	1	1	35	35	36	0	NN	0	36	37	1	hr	36	36	37	0	PP	0	37	47	2	IN	0	37	38	1	with	37	37	38	0	NP	0	38	47	2	NP	1	38	41	3	JJ	0	38	39	1	anti	38	38	39	0	NN	0	39	40	1	V5	39	39	40	0	CD	0	40	41	1	-LRB-	40	40	41	0	NP	4	41	47	6	NNP	0	41	42	1	Invitrogen	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NNP	0	43	44	1	Paisley	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NNP	0	45	46	1	UK	45	45	46	0	CD	0	46	47	1	-RRB-	46	46	47	0	CC	0	47	48	1	or	47	47	48	0	PP	0	48	51	2	IN	0	48	49	1	with	48	48	49	0	NP	1	49	51	2	JJ	0	49	50	1	anti	49	49	50	0	NN	0	50	51	1	ASPP2	50	50	51	0	PP	0	51	54	2	IN	0	51	52	1	with	51	51	52	0	NP	0	52	54	2	NN	0	52	53	1	DX54	52	52	53	0	CD	0	53	54	1	.10	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	15
Antibodies	24304	24314	NNS	antibody	O	_	_
were	24315	24319	VBD	be	O	_	_
used	24320	24324	VBN	use	O	_	_
at	24325	24327	IN	at	O	_	_
1:100	24328	24333	CD	1:100	O	_	_
dilution	24334	24342	NN	dilution	O	_	_
in	24343	24345	IN	in	O	_	_
0.2	24346	24349	CD	0.2	O	_	_
%	24349	24350	NN	%	O	_	_
Fish	24351	24355	NN	fish	O	_	_
Skin	24356	24360	NN	skin	O	_	_
Gelatine-PBS	24361	24373	NN	gelatine-pb	O	_	_
,	24373	24374	,	,	O	_	_
respectively	24375	24387	RB	respectively	O	_	_
.	24387	24388	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_at
2	13	advmod
5	4	num
5	8	prep_in
8	7	num
8	11	dep
11	9	nn
11	10	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	NNS	0	0	1	1	Antibodies	0	0	1	0	VP	1	1	14	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	14	4	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	at	3	3	4	0	NP	0	4	12	2	NP	1	4	6	2	CD	0	4	5	1	1:100	4	4	5	0	NN	0	5	6	1	dilution	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	CD	0	7	8	1	0.2	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	Fish	9	9	10	0	NN	0	10	11	1	Skin	10	10	11	0	NN	0	11	12	1	Gelatine-PBS	11	11	12	0	,	0	12	13	1	,	12	12	13	0	ADVP	0	13	14	1	RB	0	13	14	1	respectively	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	23
Staining	24389	24397	VBG	stain	O	_	_
with	24398	24402	IN	with	O	_	_
the	24403	24406	DT	the	O	_	_
secondary	24407	24416	JJ	secondary	O	_	_
antibody	24417	24425	NN	antibody	O	_	_
and	24426	24429	CC	and	O	_	_
Hoechst	24430	24437	NNP	Hoechst	O	_	_
was	24438	24441	VBD	be	O	_	_
performed	24442	24451	VBN	perform	O	_	_
as	24452	24454	IN	as	O	_	_
described	24455	24464	VBN	describe	O	_	_
[	24465	24466	NN	[	O	_	_
2	24466	24467	CD	2	O	_	_
]	24467	24468	NN	]	O	_	_
,	24468	24469	,	,	O	_	_
followed	24470	24478	VBN	follow	O	_	_
by	24479	24481	IN	by	O	_	_
visualisation	24482	24495	NN	visualisation	O	_	_
under	24496	24501	IN	under	O	_	_
a	24502	24503	DT	a	O	_	_
fluorescence	24504	24516	NN	fluorescence	O	_	_
microscope	24517	24527	NN	microscope	O	_	_
.	24527	24528	.	.	O	_	_
D	1
0
0	4	prep_with
0	6	prep_with
0	8	aux
0	13	nsubj
4	2	det
4	3	amod
4	6	conj_and
8	7	auxpass
8	11	prep_as
11	10	amod
13	12	num
13	15	vmod
15	17	agent
15	21	prep_under
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	SINV	0	0	23	4	VP	0	0	7	2	VBG	0	0	1	1	Staining	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	with	1	1	2	0	NP	0	2	7	3	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	secondary	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NP	0	6	7	1	NNP	0	6	7	1	Hoechst	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	performed	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	as	9	9	10	0	NP	1	10	12	2	VBN	0	10	11	1	described	10	10	11	0	NN	0	11	12	1	[	11	11	12	0	NP	0	12	22	3	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NN	0	13	14	1	]	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	22	3	VBN	0	15	16	1	followed	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	visualisation	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	under	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	fluorescence	20	20	21	0	NN	0	21	22	1	microscope	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	2
Immunoprecipitation	24529	24548	NN	immunoprecipitation	O	_	_
.	24548	24549	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Immunoprecipitation	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	58
For	24550	24553	IN	for	O	_	_
immunoprecipitation	24554	24573	NN	immunoprecipitation	O	_	_
,	24573	24574	,	,	O	_	_
cells	24575	24580	NNS	cell	O	_	_
were	24581	24585	VBD	be	O	_	_
lysed	24586	24591	VBN	lyse	O	_	_
in	24592	24594	IN	in	O	_	_
IP	24595	24597	NNP	IP	O	_	_
buffer	24598	24604	NN	buffer	O	_	_
(	24605	24606	CD	(	O	_	_
20	24606	24608	CD	20	O	_	_
mM	24609	24611	NN	mm	O	_	_
Trish-HCl	24612	24621	NN	trish-hcl	O	_	_
[	24622	24623	CD	[	O	_	_
pH	24623	24625	NN	ph	O	_	_
7.5	24626	24629	CD	7.5	O	_	_
]	24629	24630	NN	]	O	_	_
,	24630	24631	,	,	O	_	_
1	24632	24633	CD	1	O	_	_
mM	24634	24636	NN	mm	O	_	_
EDTA	24637	24641	NN	edta	O	_	_
,	24641	24642	,	,	O	_	_
1	24643	24644	CD	1	O	_	_
M	24645	24646	NN	m	O	_	_
KCl	24647	24650	NN	kcl	O	_	_
,	24650	24651	,	,	O	_	_
5	24652	24653	CD	5	O	_	_
mM	24654	24656	NN	mm	O	_	_
MgCl2	24657	24662	NN	mgcl2	O	_	_
,	24663	24664	,	,	O	_	_
10	24665	24667	CD	10	O	_	_
%	24667	24668	NN	%	O	_	_
v	24669	24670	LS	v	O	_	_
/	24670	24671	:	/	O	_	_
v	24671	24672	LS	v	O	_	_
glycerol	24673	24681	NN	glycerol	O	_	_
,	24681	24682	,	,	O	_	_
1	24683	24684	CD	1	O	_	_
%	24684	24685	NN	%	O	_	_
v	24686	24687	LS	v	O	_	_
/	24687	24688	:	/	O	_	_
v	24688	24689	LS	v	O	_	_
Triton	24690	24696	NNP	Triton	O	_	_
X-100	24697	24702	NN	x-100	O	_	_
,	24702	24703	,	,	O	_	_
0.05	24704	24708	CD	0.05	O	_	_
%	24708	24709	NN	%	O	_	_
v	24710	24711	LS	v	O	_	_
/	24711	24712	:	/	O	_	_
v	24712	24713	LS	v	O	_	_
2-Mercaptoethanol	24714	24731	NN	2-mercaptoethanol	O	_	_
and	24732	24735	CC	and	O	_	_
protease	24736	24744	NN	protease	O	_	_
and	24745	24748	CC	and	O	_	_
phosphatase	24749	24760	NN	phosphatase	O	_	_
inhibitors	24761	24771	NNS	inhibitor	O	_	_
)	24771	24772	NN	)	O	_	_
.	24772	24773	.	.	O	_	_
D	1
5
5	1	prep_for
5	3	nsubjpass
5	4	auxpass
5	8	prep_in
5	14	dep
5	20	dep
8	7	nn
14	10	num
14	11	nn
14	12	nn
14	13	num
14	16	amod
16	15	number
20	18	num
20	19	nn
20	24	appos
20	28	appos
20	31	appos
20	32	dep
20	33	punct
20	35	dep
20	39	dep
20	40	punct
20	43	dep
20	47	dep
20	48	punct
24	22	num
24	23	nn
28	26	num
28	27	nn
31	30	num
35	34	dep
35	38	dep
38	37	num
43	41	dep
43	42	nn
43	46	dep
46	45	num
49	50	dep
49	52	dep
49	55	dep
50	52	conj_and
50	55	conj_and
55	54	nn
56	49	prep
EOX
Y	1
ROOT	0	0	58	1	S	2	0	58	6	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	immunoprecipitation	1	1	2	0	,	0	2	3	1	,	2	2	3	0	S	1	3	17	2	NP	0	3	4	1	NNS	0	3	4	1	cells	3	3	4	0	VP	1	4	17	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	17	2	VBN	0	5	6	1	lysed	5	5	6	0	PP	0	6	17	3	IN	0	6	7	1	in	6	6	7	0	NP	1	7	9	2	NNP	0	7	8	1	IP	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	NP	0	9	17	2	NP	4	9	15	5	QP	1	9	11	2	CD	0	9	10	1	-LRB-	9	9	10	0	CD	0	10	11	1	20	10	10	11	0	NN	0	11	12	1	mM	11	11	12	0	NN	0	12	13	1	Trish-HCl	12	12	13	0	CD	0	13	14	1	[	13	13	14	0	NN	0	14	15	1	pH	14	14	15	0	ADJP	1	15	17	2	CD	0	15	16	1	7.5	15	15	16	0	NN	0	16	17	1	]	16	16	17	0	,	0	17	18	1	,	17	17	18	0	FRAG	0	18	57	3	FRAG	0	18	48	4	FRAG	0	18	40	4	FRAG	0	18	33	2	NP	0	18	32	7	NP	2	18	21	3	CD	0	18	19	1	1	18	18	19	0	NN	0	19	20	1	mM	19	19	20	0	NN	0	20	21	1	EDTA	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	2	22	25	3	CD	0	22	23	1	1	22	22	23	0	NN	0	23	24	1	M	23	23	24	0	NN	0	24	25	1	KCl	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	5	26	26	27	0	NN	0	27	28	1	mM	27	27	28	0	NN	0	28	29	1	MgCl2	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	10	30	30	31	0	NN	0	31	32	1	%	31	31	32	0	LS	0	32	33	1	v	32	32	33	0	:	0	33	34	1	/	33	33	34	0	FRAG	0	34	39	3	NP	1	34	36	2	LS	0	34	35	1	v	34	34	35	0	NN	0	35	36	1	glycerol	35	35	36	0	,	0	36	37	1	,	36	36	37	0	NP	1	37	39	2	CD	0	37	38	1	1	37	37	38	0	NN	0	38	39	1	%	38	38	39	0	LS	0	39	40	1	v	39	39	40	0	:	0	40	41	1	/	40	40	41	0	FRAG	0	41	47	3	NP	2	41	44	3	LS	0	41	42	1	v	41	41	42	0	NNP	0	42	43	1	Triton	42	42	43	0	NN	0	43	44	1	X-100	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NP	1	45	47	2	CD	0	45	46	1	0.05	45	45	46	0	NN	0	46	47	1	%	46	46	47	0	LS	0	47	48	1	v	47	47	48	0	:	0	48	49	1	/	48	48	49	0	FRAG	1	49	57	2	PP	0	49	56	2	LS	0	49	50	1	v	49	49	50	0	NP	0	50	56	3	NP	0	50	53	3	NN	0	50	51	1	2-Mercaptoethanol	50	50	51	0	CC	0	51	52	1	and	51	51	52	0	NN	0	52	53	1	protease	52	52	53	0	CC	0	53	54	1	and	53	53	54	0	NP	1	54	56	2	NN	0	54	55	1	phosphatase	54	54	55	0	NNS	0	55	56	1	inhibitors	55	55	56	0	NP	0	56	57	1	NN	0	56	57	1	-RRB-	56	56	57	0	.	0	57	58	1	.	57	57	58	0
EOS
T	33
1-4	24774	24777	CD	1-4	O	_	_
mg	24778	24780	NN	mg	O	_	_
of	24781	24783	IN	of	O	_	_
lysate	24784	24790	NN	lysate	O	_	_
was	24791	24794	VBD	be	O	_	_
pre	24795	24798	JJ	pre	O	_	_
cleared	24799	24806	VBN	clear	O	_	_
with	24807	24811	IN	with	O	_	_
protein	24812	24819	NN	protein	O	_	_
G	24820	24821	NN	g	O	_	_
beads	24822	24827	NNS	bead	O	_	_
for	24828	24831	IN	for	O	_	_
30	24832	24834	CD	30	O	_	_
min	24835	24838	NN	min	O	_	_
at	24839	24841	IN	at	O	_	_
4degreesC	24842	24851	NN	4degreesc	O	_	_
and	24852	24855	CC	and	O	_	_
subsequently	24856	24868	RB	subsequently	O	_	_
incubated	24869	24878	VBN	incubate	O	_	_
with	24879	24883	IN	with	O	_	_
antibody	24884	24892	NN	antibody	O	_	_
pre	24893	24896	JJ	pre	O	_	_
bound	24897	24902	VBN	bind	O	_	_
to	24903	24905	TO	to	O	_	_
protein	24906	24913	NN	protein	O	_	_
G	24914	24915	NN	g	O	_	_
beads	24916	24921	NNS	bead	O	_	_
for	24922	24925	IN	for	O	_	_
2-16	24926	24930	CD	2-16	O	_	_
hrs	24931	24934	NNS	hr	O	_	_
at	24935	24937	IN	at	O	_	_
4degreesC	24938	24947	NN	4degreesc	O	_	_
.	24947	24948	.	.	O	_	_
D	1
5
1	0	num
1	3	prep_of
5	1	nsubj
5	4	cop
5	6	ccomp
5	18	ccomp
6	10	prep_with
6	13	prep_for
6	15	prep_at
6	18	conj_and
10	8	nn
10	9	nn
13	12	num
18	17	advmod
18	20	prep_with
20	21	amod
20	22	vmod
22	26	prep_to
22	29	prep_for
26	24	nn
26	25	nn
29	28	num
29	31	prep_at
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	1-4	0	0	1	0	NN	0	1	2	1	mg	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	lysate	3	3	4	0	VP	1	4	32	2	VBD	0	4	5	1	was	4	4	5	0	ADJP	0	5	32	2	JJ	0	5	6	1	pre	5	5	6	0	SBAR	0	6	32	1	S	0	6	32	3	S	0	6	16	1	VP	0	6	16	4	VBN	0	6	7	1	cleared	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	protein	8	8	9	0	NN	0	9	10	1	G	9	9	10	0	NNS	0	10	11	1	beads	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	CD	0	12	13	1	30	12	12	13	0	NN	0	13	14	1	min	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	at	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	4degreesC	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	S	1	17	32	2	ADVP	0	17	18	1	RB	0	17	18	1	subsequently	17	17	18	0	VP	0	18	32	2	VBN	0	18	19	1	incubated	18	18	19	0	PP	0	19	32	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	32	2	NP	0	20	22	2	NN	0	20	21	1	antibody	20	20	21	0	JJ	0	21	22	1	pre	21	21	22	0	VP	0	22	32	3	VBN	0	22	23	1	bound	22	22	23	0	PP	0	23	27	2	TO	0	23	24	1	to	23	23	24	0	NP	2	24	27	3	NN	0	24	25	1	protein	24	24	25	0	NN	0	25	26	1	G	25	25	26	0	NNS	0	26	27	1	beads	26	26	27	0	PP	0	27	32	2	IN	0	27	28	1	for	27	27	28	0	NP	0	28	32	2	NP	1	28	30	2	CD	0	28	29	1	2-16	28	28	29	0	NNS	0	29	30	1	hrs	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	at	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	4degreesC	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	10
The	24949	24952	DT	the	O	_	_
beads	24953	24958	NNS	bead	O	_	_
were	24959	24963	VBD	be	O	_	_
washed	24964	24970	VBN	wash	O	_	_
three	24971	24976	CD	three	O	_	_
times	24977	24982	NNS	time	O	_	_
with	24983	24987	IN	with	O	_	_
NP40	24988	24992	NN	np40	O	_	_
buffer	24993	24999	NN	buffer	O	_	_
.	24999	25000	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	dobj
3	8	prep_with
5	4	num
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	beads	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	9	3	VBN	0	3	4	1	washed	3	3	4	0	NP	1	4	6	2	CD	0	4	5	1	three	4	4	5	0	NNS	0	5	6	1	times	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	with	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	NP40	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	15
The	25001	25004	DT	the	O	_	_
immunoprecipitation	25005	25024	NN	immunoprecipitation	O	_	_
beads	25025	25030	NNS	bead	O	_	_
were	25031	25035	VBD	be	O	_	_
mixed	25036	25041	VBN	mix	O	_	_
with	25042	25046	IN	with	O	_	_
6x	25047	25049	JJ	6x	O	_	_
sample	25050	25056	NN	sample	O	_	_
buffer	25057	25063	NN	buffer	O	_	_
and	25064	25067	CC	and	O	_	_
loaded	25068	25074	VBN	load	O	_	_
on	25075	25077	IN	on	O	_	_
SDS-PAGE	25078	25086	NN	sds-page	O	_	_
gels	25087	25091	NNS	gel	O	_	_
.	25091	25092	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	8	prep_with
4	10	conj_and
8	6	amod
8	7	nn
10	2	nsubjpass
10	13	prep_on
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	immunoprecipitation	1	1	2	0	NNS	0	2	3	1	beads	2	2	3	0	VP	1	3	14	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	14	3	VP	0	4	9	2	VBN	0	4	5	1	mixed	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	JJ	0	6	7	1	6x	6	6	7	0	NN	0	7	8	1	sample	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	14	2	VBN	0	10	11	1	loaded	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	on	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SDS-PAGE	12	12	13	0	NNS	0	13	14	1	gels	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	5
In	25093	25095	FW	in	O	_	_
vitro	25096	25101	FW	vitro	O	_	_
phosphorylation	25102	25117	NN	phosphorylation	O	_	_
assay	25118	25123	NN	assay	O	_	_
.	25123	25124	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	NP	0	0	5	3	NP	2	0	3	3	FW	0	0	1	1	In	0	0	1	0	FW	0	1	2	1	vitro	1	1	2	0	NN	0	2	3	1	phosphorylation	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	assay	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	69
2	25125	25126	CD	2	O	_	_
mug	25127	25130	NN	mug	O	_	_
of	25131	25133	IN	of	O	_	_
GST-ASPP2	25134	25143	NN	gst-aspp2	O	_	_
(	25144	25145	CD	(	O	_	_
693-1128	25145	25153	CD	693-1128	O	_	_
)	25153	25154	NN	)	O	_	_
expressed	25155	25164	VBN	express	O	_	_
in	25165	25167	IN	in	O	_	_
E.	25168	25170	FW	e.	O	_	_
coli	25171	25175	FW	coli	O	_	_
,	25175	25176	,	,	O	_	_
2	25177	25178	CD	2	O	_	_
mug	25179	25182	NN	mug	O	_	_
of	25183	25185	IN	of	O	_	_
1mg	25186	25189	JJ	1mg	O	_	_
/	25189	25190	:	/	O	_	_
ml	25190	25192	NN	ml	O	_	_
recombinant	25193	25204	JJ	recombinant	O	_	_
Histone	25205	25212	NN	histone	O	_	_
2B	25213	25215	NN	2b	O	_	_
or	25216	25218	CC	or	O	_	_
2	25219	25220	CD	2	O	_	_
mul	25221	25224	NN	mul	O	_	_
of	25225	25227	IN	of	O	_	_
water	25228	25233	NN	water	O	_	_
was	25234	25237	VBD	be	O	_	_
incubated	25238	25247	VBN	incubate	O	_	_
in	25248	25250	IN	in	O	_	_
30	25251	25253	CD	30	O	_	_
mul	25254	25257	NN	mul	O	_	_
of	25258	25260	IN	of	O	_	_
reaction	25261	25269	NN	reaction	O	_	_
mixture	25270	25277	NN	mixture	O	_	_
containing	25278	25288	VBG	contain	O	_	_
50	25289	25291	CD	50	O	_	_
mM	25292	25294	NN	mm	O	_	_
Tris-HCl	25295	25303	NN	tris-hcl	O	_	_
,	25303	25304	,	,	O	_	_
pH	25305	25307	NN	ph	O	_	_
7.5	25308	25311	CD	7.5	O	_	_
,	25311	25312	,	,	O	_	_
0.1	25313	25316	CD	0.1	O	_	_
%	25316	25317	NN	%	O	_	_
2-mercaptoethanol	25318	25335	NN	2-mercaptoethanol	O	_	_
,	25335	25336	,	,	O	_	_
1	25337	25338	CD	1	O	_	_
muM	25339	25342	NN	mum	O	_	_
microcystine	25343	25355	NN	microcystine	O	_	_
and	25356	25359	CC	and	O	_	_
100	25360	25363	CD	100	O	_	_
muM	25364	25367	JJ	mum	O	_	_
[	25368	25369	NN	[	O	_	_
gamma-32P	25369	25378	NN	gamma-32p	O	_	_
]	25378	25379	CD	]	O	_	_
ATP	25379	25382	NN	atp	O	_	_
(	25383	25384	NN	(	O	_	_
10	25384	25386	CD	10	O	_	_
000	25387	25390	CD	000	O	_	_
c.p.m.	25391	25397	NN	c.p.m.	O	_	_
/	25397	25398	:	/	O	_	_
pmol	25398	25402	NN	pmol	O	_	_
)	25402	25403	NN	)	O	_	_
at	25404	25406	IN	at	O	_	_
30degreesC	25407	25417	NNP	30degreesC	O	_	_
for	25418	25421	IN	for	O	_	_
30	25422	25424	CD	30	O	_	_
min	25425	25428	NN	min	O	_	_
.	25428	25429	.	.	O	_	_
D	1

1	0	num
1	3	prep_of
6	5	num
7	1	nsubj
7	10	prep_in
7	13	dobj
10	9	nn
13	12	num
13	15	prep_of
13	17	dep
17	16	punct
17	27	rcmod
17	60	punct
20	18	amod
20	19	nn
20	23	conj_or
23	22	num
23	25	prep_of
27	20	nsubjpass
27	23	nsubjpass
27	26	auxpass
27	30	prep_in
27	34	xcomp
30	29	num
30	33	prep_of
33	32	nn
34	37	dobj
34	39	dobj
34	44	dobj
34	48	dobj
34	53	dobj
37	35	num
37	36	nn
37	39	conj_and
37	44	conj_and
37	48	conj_and
37	53	conj_and
39	40	num
44	42	num
44	43	nn
48	46	num
48	47	nn
53	50	num
53	51	amod
53	52	nn
56	54	num
56	55	nn
56	59	dep
58	57	number
59	58	num
62	61	nn
62	64	prep_at
64	67	prep_for
67	66	num
EOX
Y	1
ROOT	0	0	69	1	S	1	0	69	3	NP	0	0	7	2	NP	1	0	2	2	CD	0	0	1	1	2	0	0	1	0	NN	0	1	2	1	mug	1	1	2	0	PP	0	2	7	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	7	2	NP	0	3	5	2	NN	0	3	4	1	GST-ASPP2	3	3	4	0	CD	0	4	5	1	-LRB-	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	693-1128	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	0	7	68	3	VP	0	7	11	2	VBN	0	7	8	1	expressed	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	11	2	FW	0	9	10	1	E.	9	9	10	0	FW	0	10	11	1	coli	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	68	4	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NN	0	13	14	1	mug	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	16	1	JJ	0	15	16	1	1mg	15	15	16	0	PRN	1	16	61	3	:	0	16	17	1	/	16	16	17	0	NP	0	17	60	2	NP	0	17	18	1	NN	0	17	18	1	ml	17	17	18	0	SBAR	0	18	60	1	S	1	18	60	2	NP	0	18	26	3	NP	2	18	21	3	JJ	0	18	19	1	recombinant	18	18	19	0	NN	0	19	20	1	Histone	19	19	20	0	NN	0	20	21	1	2B	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NP	0	22	26	2	NP	1	22	24	2	CD	0	22	23	1	2	22	22	23	0	NN	0	23	24	1	mul	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	water	25	25	26	0	VP	1	26	60	2	VBD	0	26	27	1	was	26	26	27	0	VP	0	27	60	3	VBN	0	27	28	1	incubated	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	in	28	28	29	0	NP	0	29	34	2	NP	1	29	31	2	CD	0	29	30	1	30	29	29	30	0	NN	0	30	31	1	mul	30	30	31	0	PP	0	31	34	2	IN	0	31	32	1	of	31	31	32	0	NP	1	32	34	2	NN	0	32	33	1	reaction	32	32	33	0	NN	0	33	34	1	mixture	33	33	34	0	S	0	34	60	1	VP	0	34	60	2	VBG	0	34	35	1	containing	34	34	35	0	NP	0	35	60	9	NP	2	35	38	3	CD	0	35	36	1	50	35	35	36	0	NN	0	36	37	1	mM	36	36	37	0	NN	0	37	38	1	Tris-HCl	37	37	38	0	,	0	38	39	1	,	38	38	39	0	NP	0	39	41	2	NN	0	39	40	1	pH	39	39	40	0	CD	0	40	41	1	7.5	40	40	41	0	,	0	41	42	1	,	41	41	42	0	NP	2	42	45	3	CD	0	42	43	1	0.1	42	42	43	0	NN	0	43	44	1	%	43	43	44	0	NN	0	44	45	1	2-mercaptoethanol	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	2	46	49	3	CD	0	46	47	1	1	46	46	47	0	NN	0	47	48	1	muM	47	47	48	0	NN	0	48	49	1	microcystine	48	48	49	0	CC	0	49	50	1	and	49	49	50	0	NP	0	50	60	2	NP	3	50	54	4	CD	0	50	51	1	100	50	50	51	0	JJ	0	51	52	1	muM	51	51	52	0	NN	0	52	53	1	[	52	52	53	0	NN	0	53	54	1	gamma-32P	53	53	54	0	NP	0	54	60	2	NP	2	54	57	3	CD	0	54	55	1	]	54	54	55	0	NN	0	55	56	1	ATP	55	55	56	0	NN	0	56	57	1	-LRB-	56	56	57	0	NP	1	57	60	2	QP	1	57	59	2	CD	0	57	58	1	10	57	57	58	0	CD	0	58	59	1	000	58	58	59	0	NN	0	59	60	1	c.p.m.	59	59	60	0	:	0	60	61	1	/	60	60	61	0	NP	0	61	68	2	NP	1	61	63	2	NN	0	61	62	1	pmol	61	61	62	0	NN	0	62	63	1	-RRB-	62	62	63	0	PP	0	63	68	2	IN	0	63	64	1	at	63	63	64	0	NP	0	64	68	2	NP	0	64	65	1	NNP	0	64	65	1	30degreesC	64	64	65	0	PP	0	65	68	2	IN	0	65	66	1	for	65	65	66	0	NP	1	66	68	2	CD	0	66	67	1	30	66	66	67	0	NN	0	67	68	1	min	67	67	68	0	.	0	68	69	1	.	68	68	69	0
EOS
T	11
0.35	25430	25434	CD	0.35	B-GENE	_	_
units	25435	25440	NNS	unit	I-GENE	_	_
MAPK1	25441	25446	NN	mapk1	I-GENE	_	_
or	25447	25449	CC	or	I-GENE	_	_
0.1	25450	25453	CD	0.1	I-GENE	_	_
units	25454	25459	NNS	unit	I-GENE	_	_
p38	25460	25463	NN	p38	I-GENE	_	_
SAPK	25464	25468	NN	sapk	I-GENE	_	_
were	25469	25473	VBD	be	O	_	_
used	25474	25478	VBN	use	O	_	_
.	25478	25479	.	.	O	_	_
D	1
9
1	0	num
1	2	dep
1	5	conj_or
5	4	num
5	7	dep
7	6	nn
9	1	nsubjpass
9	5	nsubjpass
9	8	auxpass
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	CD	0	0	1	1	0.35	0	0	1	0	NNS	0	1	2	1	units	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	MAPK1	2	2	3	0	CC	0	3	4	1	or	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CD	0	4	5	1	0.1	4	4	5	0	NNS	0	5	6	1	units	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	p38	6	6	7	0	NN	0	7	8	1	SAPK	7	7	8	0	VP	1	8	10	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	10	1	VBN	0	9	10	1	used	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	27
The	25480	25483	DT	the	O	_	_
reactions	25484	25493	NNS	reaction	O	_	_
were	25494	25498	VBD	be	O	_	_
terminated	25499	25509	VBN	terminate	O	_	_
as	25510	25512	IN	as	O	_	_
described	25513	25522	VBN	describe	O	_	_
[	25523	25524	NN	[	O	_	_
12	25524	25526	CD	12	O	_	_
]	25526	25527	NN	]	O	_	_
and	25528	25531	CC	and	O	_	_
analyzed	25532	25540	VBN	analyze	O	_	_
by	25541	25543	IN	by	O	_	_
chromatography	25544	25558	NN	chromatography	O	_	_
on	25559	25561	IN	on	O	_	_
a	25562	25563	DT	a	O	_	_
C18	25564	25567	NN	c18	O	_	_
column	25568	25574	NN	column	O	_	_
or	25575	25577	CC	or	O	_	_
resolved	25578	25586	VBN	resolve	O	_	_
on	25587	25589	IN	on	O	_	_
SDS-PAGE	25590	25598	NN	sds-page	O	_	_
gels	25599	25603	NNS	gel	O	_	_
and	25604	25607	CC	and	O	_	_
visualized	25608	25618	VBN	visualize	O	_	_
by	25619	25621	IN	by	O	_	_
autoradiograph	25622	25636	NN	autoradiograph	O	_	_
.	25636	25637	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	advcl
3	10	advcl
3	18	advcl
3	23	advcl
5	4	mark
5	8	dobj
5	10	conj_and
5	18	conj_or
5	23	conj_and
8	6	nn
8	7	num
10	12	prep_by
12	16	prep_on
16	14	det
16	15	nn
18	21	prep_on
21	20	nn
23	25	prep_by
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	reactions	1	1	2	0	VP	1	2	26	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	26	2	VBN	0	3	4	1	terminated	3	3	4	0	SBAR	1	4	26	2	IN	0	4	5	1	as	4	4	5	0	S	0	5	26	3	S	0	5	22	1	VP	0	5	22	5	VP	0	5	9	2	VBN	0	5	6	1	described	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	[	6	6	7	0	CD	0	7	8	1	12	7	7	8	0	NN	0	8	9	1	]	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	17	2	VBN	0	10	11	1	analyzed	10	10	11	0	PP	0	11	17	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	17	2	NP	0	12	13	1	NN	0	12	13	1	chromatography	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	on	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	C18	15	15	16	0	NN	0	16	17	1	column	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	resolved	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	on	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	SDS-PAGE	20	20	21	0	NNS	0	21	22	1	gels	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	S	0	23	26	1	VP	0	23	26	2	VBN	0	23	24	1	visualized	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	autoradiograph	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	4
Quantitative	25638	25650	JJ	quantitative	O	_	_
reverse	25651	25658	JJ	reverse	O	_	_
transcription-PCR	25659	25676	NN	transcription-pcr	O	_	_
.	25676	25677	.	.	O	_	_
D	1
2
2	0	amod
2	1	amod
EOX
Y	1
ROOT	0	0	4	1	FRAG	0	0	4	2	NP	2	0	3	3	JJ	0	0	1	1	Quantitative	0	0	1	0	JJ	0	1	2	1	reverse	1	1	2	0	NN	0	2	3	1	transcription-PCR	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	34
Real-time	25678	25687	JJ	real-time	O	_	_
reverse	25688	25695	JJ	reverse	B-GENE	_	_
transcriptase-PCR	25696	25713	NN	transcriptase-pcr	I-GENE	_	_
was	25714	25717	VBD	be	O	_	_
performed	25718	25727	VBN	perform	O	_	_
using	25728	25733	VBG	use	O	_	_
gene	25734	25738	NN	gene	O	_	_
specific	25739	25747	JJ	specific	O	_	_
primers	25748	25755	NNS	primer	O	_	_
(	25756	25757	VBP	(	O	_	_
QuantiTect	25757	25767	NNP	QuantiTect	O	_	_
Primer	25768	25774	NN	primer	O	_	_
Assays	25775	25781	NNS	assay	O	_	_
)	25781	25782	VBP	)	O	_	_
for	25783	25786	IN	for	O	_	_
human	25787	25792	JJ	human	B-GENE	_	_
ASPP2	25793	25798	NN	aspp2	I-GENE	_	_
or	25799	25801	CC	or	O	_	_
GAPDH	25802	25807	NN	gapdh	B-GENE	_	_
with	25808	25812	IN	with	O	_	_
the	25813	25816	DT	the	O	_	_
QuantiTect	25817	25827	NNP	QuantiTect	O	_	_
SYBR	25828	25832	NNP	SYBR	O	_	_
Green	25833	25838	NNP	Green	O	_	_
RT-PCR	25839	25845	NN	rt-pcr	O	_	_
Kit	25846	25849	NN	kit	O	_	_
(	25850	25851	CD	(	O	_	_
Qiagen	25851	25857	NNP	Qiagen	O	_	_
,	25857	25858	,	,	O	_	_
Hilden	25859	25865	NNP	Hilden	O	_	_
,	25865	25866	,	,	O	_	_
Germany	25867	25874	NNP	Germany	O	_	_
)	25874	25875	CD	)	O	_	_
.	25875	25876	.	.	O	_	_
D	1

2	0	amod
2	1	amod
4	2	nsubjpass
4	3	auxpass
4	5	xcomp
5	8	dobj
8	6	nn
8	7	amod
9	4	dep
9	27	nsubj
12	10	nn
12	11	nn
13	12	nsubj
13	16	prep_for
13	18	prep_for
13	24	prep_with
16	15	amod
16	18	conj_or
24	20	det
24	21	nn
24	22	nn
24	23	nn
27	25	nn
27	29	appos
29	31	appos
EOX
Y	1
ROOT	0	0	34	1	SINV	1	0	34	4	S	1	0	9	2	NP	2	0	3	3	JJ	0	0	1	1	Real-time	0	0	1	0	JJ	0	1	2	1	reverse	1	1	2	0	NN	0	2	3	1	transcriptase-PCR	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	performed	4	4	5	0	S	0	5	9	1	VP	0	5	9	2	VBG	0	5	6	1	using	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	gene	6	6	7	0	JJ	0	7	8	1	specific	7	7	8	0	NNS	0	8	9	1	primers	8	8	9	0	VP	0	9	25	2	VBP	0	9	10	1	-LRB-	9	9	10	0	SBAR	0	10	25	1	S	1	10	25	2	NP	2	10	13	3	NNP	0	10	11	1	QuantiTect	10	10	11	0	NN	0	11	12	1	Primer	11	11	12	0	NNS	0	12	13	1	Assays	12	12	13	0	VP	0	13	25	3	VBP	0	13	14	1	-RRB-	13	13	14	0	PP	0	14	19	2	IN	0	14	15	1	for	14	14	15	0	NP	1	15	19	4	JJ	0	15	16	1	human	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NN	0	18	19	1	GAPDH	18	18	19	0	PP	0	19	25	2	IN	0	19	20	1	with	19	19	20	0	NP	4	20	25	5	DT	0	20	21	1	the	20	20	21	0	NNP	0	21	22	1	QuantiTect	21	21	22	0	NNP	0	22	23	1	SYBR	22	22	23	0	NNP	0	23	24	1	Green	23	23	24	0	NN	0	24	25	1	RT-PCR	24	24	25	0	NP	0	25	33	3	NP	2	25	28	3	NN	0	25	26	1	Kit	25	25	26	0	CD	0	26	27	1	-LRB-	26	26	27	0	NNP	0	27	28	1	Qiagen	27	27	28	0	,	0	28	29	1	,	28	28	29	0	NP	0	29	33	3	NP	0	29	30	1	NNP	0	29	30	1	Hilden	29	29	30	0	,	0	30	31	1	,	30	30	31	0	NP	0	31	33	2	NNP	0	31	32	1	Germany	31	31	32	0	CD	0	32	33	1	-RRB-	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	12
Relative	25877	25885	JJ	relative	O	_	_
transcript	25886	25896	NN	transcript	O	_	_
levels	25897	25903	NNS	level	O	_	_
of	25904	25906	IN	of	O	_	_
ASPP2	25907	25912	NN	aspp2	B-GENE	_	_
were	25913	25917	VBD	be	O	_	_
normalized	25918	25928	VBN	normalize	O	_	_
to	25929	25931	TO	to	O	_	_
GAPDH	25932	25937	NN	gapdh	B-GENE	_	_
mRNA	25938	25942	NN	mrna	I-GENE	_	_
levels	25943	25949	NNS	level	O	_	_
.	25949	25950	.	.	O	_	_
D	1
6
2	0	amod
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	prep_to
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	JJ	0	0	1	1	Relative	0	0	1	0	NN	0	1	2	1	transcript	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	normalized	6	6	7	0	PP	0	7	11	2	TO	0	7	8	1	to	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	GAPDH	8	8	9	0	NN	0	9	10	1	mRNA	9	9	10	0	NNS	0	10	11	1	levels	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	3
Statistical	25951	25962	JJ	statistical	O	_	_
analysis	25963	25971	NN	analysis	O	_	_
.	25971	25972	.	.	O	_	_
D	1
1
1	0	amod
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	JJ	0	0	1	1	Statistical	0	0	1	0	NN	0	1	2	1	analysis	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	14
SPSS	25973	25977	NNP	SPSS	O	_	_
for	25978	25981	IN	for	O	_	_
Windows	25982	25989	NNP	Windows	O	_	_
(	25990	25991	CD	(	O	_	_
SPSS	25991	25995	NNP	SPSS	O	_	_
Inc.	25996	26000	NNP	Inc.	O	_	_
)	26000	26001	NN	)	O	_	_
was	26002	26005	VBD	be	O	_	_
used	26006	26010	VBN	use	O	_	_
to	26011	26013	TO	to	O	_	_
analyze	26014	26021	VB	analyze	O	_	_
the	26022	26025	DT	the	O	_	_
data	26026	26030	NNS	datum	O	_	_
.	26030	26031	.	.	O	_	_
D	1
8
0	2	prep_for
6	4	nn
6	5	nn
8	0	nsubjpass
8	7	auxpass
8	10	xcomp
10	9	aux
10	12	dobj
12	11	det
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	NP	0	0	3	2	NP	0	0	1	1	NNP	0	0	1	1	SPSS	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	for	1	1	2	0	NP	0	2	3	1	NNP	0	2	3	1	Windows	2	2	3	0	NP	3	3	7	4	CD	0	3	4	1	-LRB-	3	3	4	0	NNP	0	4	5	1	SPSS	4	4	5	0	NNP	0	5	6	1	Inc.	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	13	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	13	2	VBN	0	8	9	1	used	8	8	9	0	S	0	9	13	1	VP	1	9	13	2	TO	0	9	10	1	to	9	9	10	0	VP	0	10	13	2	VB	0	10	11	1	analyze	10	10	11	0	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NNS	0	12	13	1	data	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	22
A	26032	26033	DT	a	O	_	_
two	26034	26037	CD	two	O	_	_
tailed	26038	26044	VBD	tail	O	_	_
unpaired	26045	26053	JJ	unpaired	O	_	_
t-test	26054	26060	NN	t-test	O	_	_
was	26061	26064	VBD	be	O	_	_
used	26065	26069	VBN	use	O	_	_
to	26070	26072	TO	to	O	_	_
compare	26073	26080	VB	compare	O	_	_
the	26081	26084	DT	the	O	_	_
statistical	26085	26096	JJ	statistical	O	_	_
significance	26097	26109	NN	significance	O	_	_
of	26110	26112	IN	of	O	_	_
the	26113	26116	DT	the	O	_	_
differences	26117	26128	NNS	difference	O	_	_
in	26129	26131	IN	in	O	_	_
data	26132	26136	NNS	datum	O	_	_
from	26137	26141	IN	from	O	_	_
the	26142	26145	DT	the	O	_	_
two	26146	26149	CD	two	O	_	_
groups	26150	26156	NNS	group	O	_	_
.	26156	26157	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	6	ccomp
4	3	amod
6	4	nsubjpass
6	5	auxpass
6	8	xcomp
8	7	aux
8	11	dobj
8	20	prep_from
11	9	det
11	10	amod
11	14	prep_of
14	13	det
14	16	prep_in
20	18	det
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	DT	0	0	1	1	A	0	0	1	0	CD	0	1	2	1	two	1	1	2	0	VP	0	2	21	2	VBD	0	2	3	1	tailed	2	2	3	0	SBAR	0	3	21	1	S	1	3	21	2	NP	1	3	5	2	JJ	0	3	4	1	unpaired	3	3	4	0	NN	0	4	5	1	t-test	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	S	0	7	21	1	VP	1	7	21	2	TO	0	7	8	1	to	7	7	8	0	VP	0	8	21	3	VB	0	8	9	1	compare	8	8	9	0	NP	0	9	17	2	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	statistical	10	10	11	0	NN	0	11	12	1	significance	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	differences	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	17	1	NNS	0	16	17	1	data	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	from	17	17	18	0	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	CD	0	19	20	1	two	19	19	20	0	NNS	0	20	21	1	groups	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	3
Supporting	26158	26168	VBG	support	O	_	_
Information	26169	26180	NN	information	O	_	_
.	26180	26181	.	.	O	_	_
D	1
0
0	1	dobj
EOX
Y	1
ROOT	0	0	3	1	S	0	0	3	2	VP	0	0	2	2	VBG	0	0	1	1	Supporting	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Information	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	11
p38	26192	26195	NN	p38	B-GENE	_	_
SAPK	26196	26200	NN	sapk	I-GENE	_	_
is	26201	26203	VBZ	be	O	_	_
not	26204	26207	RB	not	O	_	_
an	26208	26210	DT	a	O	_	_
efficient	26211	26220	JJ	efficient	O	_	_
kinase	26221	26227	NN	kinase	O	_	_
for	26228	26231	IN	for	O	_	_
ASPP2	26232	26237	NN	aspp2	B-GENE	_	_
phosphorylation	26238	26253	NN	phosphorylation	O	_	_
.	26253	26254	.	.	O	_	_
D	1
6
1	0	nn
6	1	nsubj
6	2	cop
6	3	neg
6	4	det
6	5	amod
6	9	prep_for
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	1	0	2	2	NN	0	0	1	1	p38	0	0	1	0	NN	0	1	2	1	SAPK	1	1	2	0	VP	2	2	10	3	VBZ	0	2	3	1	is	2	2	3	0	RB	0	3	4	1	not	3	3	4	0	NP	0	4	10	2	NP	2	4	7	3	DT	0	4	5	1	an	4	4	5	0	JJ	0	5	6	1	efficient	5	5	6	0	NN	0	6	7	1	kinase	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	for	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	22
ASPP2	26255	26260	NN	aspp2	O	_	_
(	26261	26262	CD	(	O	_	_
693-1128	26262	26270	CD	693-1128	O	_	_
)	26270	26271	NN	)	O	_	_
fragment	26272	26280	NN	fragment	O	_	_
was	26281	26284	VBD	be	O	_	_
used	26285	26289	VBN	use	O	_	_
as	26290	26292	IN	as	O	_	_
a	26293	26294	DT	a	O	_	_
substrate	26295	26304	NN	substrate	O	_	_
for	26305	26308	IN	for	O	_	_
an	26309	26311	DT	a	O	_	_
in	26312	26314	FW	in	O	_	_
vitro	26315	26320	FW	vitro	O	_	_
phosphorylation	26321	26336	NN	phosphorylation	O	_	_
assay	26337	26342	NN	assay	O	_	_
by	26343	26345	IN	by	O	_	_
the	26346	26349	DT	the	O	_	_
kinase	26350	26356	NN	kinase	O	_	_
p38	26357	26360	NN	p38	B-GENE	_	_
SAPK	26361	26365	NN	sapk	O	_	_
.	26365	26366	.	.	O	_	_
D	1
6
0	4	dep
4	2	num
6	0	nsubjpass
6	5	auxpass
6	9	prep_as
9	8	det
9	20	prep_for
13	12	nn
13	16	dep
15	14	nn
16	15	dep
16	19	pobj
19	17	det
19	18	nn
20	11	det
20	13	dep
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	5	2	NP	0	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	CD	0	1	2	1	-LRB-	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	693-1128	2	2	3	0	NN	0	3	4	1	-RRB-	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	PP	0	7	21	2	IN	0	7	8	1	as	7	7	8	0	NP	0	8	21	2	NP	1	8	10	2	DT	0	8	9	1	a	8	8	9	0	NN	0	9	10	1	substrate	9	9	10	0	PP	0	10	21	2	IN	0	10	11	1	for	10	10	11	0	NP	2	11	21	3	DT	0	11	12	1	an	11	11	12	0	UCP	0	12	20	2	ADVP	1	12	14	2	FW	0	12	13	1	in	12	12	13	0	FW	0	13	14	1	vitro	13	13	14	0	PP	1	14	20	2	NP	1	14	16	2	NN	0	14	15	1	phosphorylation	14	14	15	0	NN	0	15	16	1	assay	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	by	16	16	17	0	NP	2	17	20	3	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	kinase	18	18	19	0	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	19
As	26367	26369	IN	as	O	_	_
a	26370	26371	DT	a	O	_	_
negative	26372	26380	JJ	negative	O	_	_
control	26381	26388	NN	control	O	_	_
no	26389	26391	DT	no	O	_	_
substrate	26392	26401	NN	substrate	O	_	_
was	26402	26405	VBD	be	O	_	_
used	26406	26410	VBN	use	O	_	_
and	26411	26414	CC	and	O	_	_
Histone	26415	26422	NN	histone	O	_	_
2B	26423	26425	NN	2b	O	_	_
was	26426	26429	VBD	be	O	_	_
the	26430	26433	DT	the	O	_	_
substrate	26434	26443	NN	substrate	O	_	_
for	26444	26447	IN	for	O	_	_
the	26448	26451	DT	the	O	_	_
positive	26452	26460	JJ	positive	O	_	_
control	26461	26468	NN	control	O	_	_
.	26468	26469	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_as
7	5	nsubjpass
7	6	auxpass
7	13	conj_and
10	9	nn
13	10	nsubj
13	11	cop
13	12	det
13	17	prep_for
17	15	det
17	16	amod
EOX
Y	1
ROOT	0	0	19	1	S	0	0	19	4	S	2	0	8	3	PP	0	0	4	2	IN	0	0	1	1	As	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	a	1	1	2	0	JJ	0	2	3	1	negative	2	2	3	0	NN	0	3	4	1	control	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	no	4	4	5	0	NN	0	5	6	1	substrate	5	5	6	0	VP	1	6	8	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	used	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	18	2	NP	1	9	11	2	NN	0	9	10	1	Histone	9	9	10	0	NN	0	10	11	1	2B	10	10	11	0	VP	1	11	18	2	VBD	0	11	12	1	was	11	11	12	0	NP	0	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	substrate	13	13	14	0	PP	0	14	18	2	IN	0	14	15	1	for	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	positive	16	16	17	0	NN	0	17	18	1	control	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	23
32P	26470	26473	NN	32p	O	_	_
labelled	26474	26482	VBN	label	O	_	_
ATP	26483	26486	NN	atp	O	_	_
was	26487	26490	VBD	be	O	_	_
added	26491	26496	VBN	add	O	_	_
to	26497	26499	TO	to	O	_	_
the	26500	26503	DT	the	O	_	_
kinase	26504	26510	NN	kinase	O	_	_
assay	26511	26516	NN	assay	O	_	_
and	26517	26520	CC	and	O	_	_
the	26521	26524	DT	the	O	_	_
labelled	26525	26533	JJ	labelled	O	_	_
proteins	26534	26542	NNS	protein	O	_	_
were	26543	26547	VBD	be	O	_	_
resolved	26548	26556	VBN	resolve	O	_	_
on	26557	26559	IN	on	O	_	_
SDS-PAGE	26560	26568	NN	sds-page	O	_	_
gels	26569	26573	NNS	gel	O	_	_
and	26574	26577	CC	and	O	_	_
visualized	26578	26588	VBN	visualize	O	_	_
by	26589	26591	IN	by	O	_	_
autoradiograph	26592	26606	NN	autoradiograph	O	_	_
.	26606	26607	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_to
4	14	conj_and
4	19	conj_and
8	6	det
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	17	prep_on
14	19	conj_and
17	16	nn
19	12	nsubjpass
19	21	prep_by
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	32P	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	labelled	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ATP	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	added	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	kinase	7	7	8	0	NN	0	8	9	1	assay	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	labelled	11	11	12	0	NNS	0	12	13	1	proteins	12	12	13	0	VP	1	13	22	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	22	3	VP	0	14	18	2	VBN	0	14	15	1	resolved	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	visualized	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	by	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	autoradiograph	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	10
(	26608	26609	NN	(	B-GENE	_	_
TIF	26609	26612	NN	tif	I-GENE	_	_
)	26612	26613	CD	)	O	_	_
Click	26614	26619	VB	click	O	_	_
here	26620	26624	RB	here	O	_	_
for	26625	26628	IN	for	O	_	_
additional	26629	26639	JJ	additional	O	_	_
data	26640	26644	NNS	datum	O	_	_
file	26645	26649	NN	file	O	_	_
.	26649	26650	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	14
Phosphorylation	26661	26676	NN	phosphorylation	O	_	_
of	26677	26679	IN	of	O	_	_
ASPP2	26680	26685	NN	aspp2	B-GENE	_	_
by	26686	26688	IN	by	O	_	_
the	26689	26692	DT	the	O	_	_
Raf	26693	26696	NN	raf	B-GENE	_	_
/	26696	26697	:	/	B-GENE	_	_
MAPK	26697	26701	NN	mapk	I-GENE	_	_
pathway	26702	26709	NN	pathway	O	_	_
enhances	26710	26718	VBZ	enhance	O	_	_
p53	26719	26722	NN	p53	B-GENE	_	_
mediated	26723	26731	JJ	mediated	O	_	_
transactivation	26732	26747	NN	transactivation	O	_	_
.	26747	26748	.	.	O	_	_
D	1
0
0	2	prep_of
0	5	prep_by
0	6	punct
0	9	dep
5	4	det
8	7	nn
9	8	nsubj
9	12	dobj
12	10	nn
12	11	amod
EOX
Y	1
ROOT	0	0	14	1	FRAG	0	0	14	4	NP	0	0	6	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	by	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	Raf	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	13	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	13	2	VBZ	0	9	10	1	enhances	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	p53	10	10	11	0	JJ	0	11	12	1	mediated	11	11	12	0	NN	0	12	13	1	transactivation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	25
Saos2	26749	26754	NN	saos2	O	_	_
cells	26755	26760	NNS	cell	O	_	_
were	26761	26765	VBD	be	O	_	_
transfected	26766	26777	VBN	transfect	O	_	_
with	26778	26782	IN	with	O	_	_
a	26783	26784	DT	a	O	_	_
Bax-luciferase	26785	26799	NN	bax-luciferase	B-GENE	_	_
reporter	26800	26808	NN	reporter	I-GENE	_	_
,	26808	26809	,	,	O	_	_
ASPP2	26810	26815	NN	aspp2	B-GENE	_	_
and	26816	26819	CC	and	O	_	_
p53	26820	26823	NN	p53	B-GENE	_	_
and	26824	26827	CC	and	O	_	_
treated	26828	26835	VBN	treat	O	_	_
with	26836	26840	IN	with	O	_	_
100	26841	26844	CD	100	O	_	_
muM	26845	26848	NN	mum	O	_	_
PD	26849	26851	NN	pd	O	_	_
98059	26852	26857	CD	98059	O	_	_
or	26858	26860	CC	or	O	_	_
DMSO	26861	26865	NN	dmso	O	_	_
for	26866	26869	IN	for	O	_	_
20	26870	26872	CD	20	O	_	_
hours	26873	26878	NNS	hour	O	_	_
.	26878	26879	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	9	prep_with
3	11	prep_with
3	13	conj_and
7	5	det
7	6	nn
7	9	conj_and
7	11	conj_and
13	1	nsubjpass
13	17	prep_with
13	20	prep_with
17	15	num
17	16	nn
17	18	dep
17	20	conj_or
20	23	prep_for
23	22	num
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	24	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	24	3	VP	0	3	12	2	VBN	0	3	4	1	transfected	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	with	4	4	5	0	NP	2	5	12	7	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	Bax-luciferase	6	6	7	0	NN	0	7	8	1	reporter	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VP	0	13	24	2	VBN	0	13	14	1	treated	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	with	14	14	15	0	NP	0	15	24	3	NP	0	15	19	2	NP	2	15	18	3	CD	0	15	16	1	100	15	15	16	0	NN	0	16	17	1	muM	16	16	17	0	NN	0	17	18	1	PD	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	98059	18	18	19	0	CC	0	19	20	1	or	19	19	20	0	NP	0	20	24	2	NP	0	20	21	1	NN	0	20	21	1	DMSO	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	for	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	20	22	22	23	0	NNS	0	23	24	1	hours	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	9
The	26880	26883	DT	the	O	_	_
cells	26884	26889	NNS	cell	O	_	_
were	26890	26894	VBD	be	O	_	_
harvested	26895	26904	VBN	harvest	O	_	_
,	26904	26905	,	,	O	_	_
luciferase	26906	26916	NN	luciferase	B-GENE	_	_
activity	26917	26925	NN	activity	O	_	_
shown	26926	26931	VBN	show	O	_	_
.	26931	26932	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	6	dobj
6	5	nn
6	7	vmod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	8	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	8	3	VBN	0	3	4	1	harvested	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	8	2	NP	1	5	7	2	NN	0	5	6	1	luciferase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	shown	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	10
(	26933	26934	NN	(	B-GENE	_	_
TIF	26934	26937	NN	tif	I-GENE	_	_
)	26937	26938	CD	)	O	_	_
Click	26939	26944	VB	click	O	_	_
here	26945	26949	RB	here	O	_	_
for	26950	26953	IN	for	O	_	_
additional	26954	26964	JJ	additional	O	_	_
data	26965	26969	NNS	datum	O	_	_
file	26970	26974	NN	file	O	_	_
.	26974	26975	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	5
Oncogenic	26986	26995	JJ	oncogenic	O	_	_
RAS	26996	26999	NN	ra	O	_	_
stabilizes	27000	27010	VBZ	stabilize	O	_	_
ASPP2	27011	27016	NN	aspp2	B-GENE	_	_
.	27016	27017	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	3	dobj
EOX
Y	1
ROOT	0	0	5	1	S	1	0	5	3	NP	1	0	2	2	JJ	0	0	1	1	Oncogenic	0	0	1	0	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	4	2	VBZ	0	2	3	1	stabilizes	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	20
(	27018	27019	NN	(	O	_	_
A	27019	27020	NN	a	O	_	_
)	27020	27021	CD	)	O	_	_
Quantitative	27022	27034	JJ	quantitative	O	_	_
RT-PCR	27035	27041	NN	rt-pcr	O	_	_
analysis	27042	27050	NN	analysis	O	_	_
of	27051	27053	IN	of	O	_	_
ASPP2	27054	27059	NN	aspp2	B-GENE	_	_
mRNA	27060	27064	NN	mrna	I-GENE	_	_
levels	27065	27071	NNS	level	O	_	_
in	27072	27074	IN	in	O	_	_
HKe3	27075	27079	NN	hke3	B-GENE	_	_
ER	27080	27082	NN	er	I-GENE	_	_
:	27082	27083	:	:	O	_	_
HRASV12	27083	27090	NN	hrasv12	O	_	_
cells	27091	27096	NNS	cell	O	_	_
with	27097	27101	IN	with	O	_	_
indicated	27102	27111	JJ	indicated	O	_	_
treatment	27112	27121	NN	treatment	O	_	_
.	27121	27122	.	.	O	_	_
D	1
1
1	5	dep
1	15	dep
5	3	amod
5	4	nn
5	9	prep_of
9	7	nn
9	8	nn
9	12	prep_in
12	11	nn
15	14	nn
15	18	prep_with
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	13	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	0	2	13	2	NP	3	2	6	4	CD	0	2	3	1	-RRB-	2	2	3	0	JJ	0	3	4	1	Quantitative	3	3	4	0	NN	0	4	5	1	RT-PCR	4	4	5	0	NN	0	5	6	1	analysis	5	5	6	0	PP	0	6	13	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	mRNA	8	8	9	0	NNS	0	9	10	1	levels	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	19	2	NP	1	14	16	2	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	with	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	indicated	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
(	27123	27124	NN	(	O	_	_
B	27124	27125	NN	b	O	_	_
)	27125	27126	CD	)	O	_	_
HKe3	27127	27131	NN	hke3	B-GENE	_	_
ER	27132	27134	NN	er	O	_	_
:	27134	27135	:	:	O	_	_
HRASV12	27135	27142	NN	hrasv12	O	_	_
cells	27143	27148	NNS	cell	O	_	_
were	27149	27153	VBD	be	O	_	_
transfected	27154	27165	VBN	transfect	O	_	_
with	27166	27170	IN	with	O	_	_
ASPP2	27171	27176	NN	aspp2	B-GENE	_	_
wild-type	27177	27186	JJ	wild-type	I-GENE	_	_
(	27187	27188	NN	(	I-GENE	_	_
wt	27188	27190	JJ	wt	I-GENE	_	_
)	27190	27191	NN	)	I-GENE	_	_
expression	27192	27202	NN	expression	O	_	_
plasmid	27203	27210	NN	plasmid	O	_	_
in	27211	27213	IN	in	O	_	_
the	27214	27217	DT	the	O	_	_
presence	27218	27226	NN	presence	O	_	_
or	27227	27229	CC	or	O	_	_
absence	27230	27237	NN	absence	O	_	_
of	27238	27240	IN	of	O	_	_
4-OHT	27241	27246	NN	4-oht	O	_	_
.	27246	27247	.	.	O	_	_
D	1
1
1	4	dep
1	7	dep
4	3	nn
7	6	nn
7	9	rcmod
9	8	auxpass
9	10	prep
9	20	prep_in
9	22	prep_in
13	11	nn
13	12	amod
13	17	dep
17	14	amod
17	16	nn
20	19	det
20	22	conj_or
20	24	prep_of
EOX
Y	1
ROOT	0	0	26	1	NP	0	0	26	4	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	HKe3	3	3	4	0	NN	0	4	5	1	ER	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	25	2	NP	1	6	8	2	NN	0	6	7	1	HRASV12	6	6	7	0	NNS	0	7	8	1	cells	7	7	8	0	SBAR	0	8	25	1	S	0	8	25	1	VP	1	8	25	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	25	3	VBN	0	9	10	1	transfected	9	9	10	0	PP	0	10	18	2	IN	0	10	11	1	with	10	10	11	0	NP	0	11	18	2	NP	2	11	14	3	NN	0	11	12	1	ASPP2	11	11	12	0	JJ	0	12	13	1	wild-type	12	12	13	0	NN	0	13	14	1	-LRB-	13	13	14	0	NP	3	14	18	4	JJ	0	14	15	1	wt	14	14	15	0	NN	0	15	16	1	-RRB-	15	15	16	0	NN	0	16	17	1	expression	16	16	17	0	NN	0	17	18	1	plasmid	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	25	2	NP	1	19	23	4	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	presence	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NN	0	22	23	1	absence	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	4-OHT	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	23
16	27248	27250	CD	16	O	_	_
hours	27251	27256	NNS	hour	O	_	_
after	27257	27262	IN	after	O	_	_
transfection	27263	27275	NN	transfection	O	_	_
,	27275	27276	,	,	O	_	_
10	27277	27279	CD	10	O	_	_
mug	27280	27283	NN	mug	O	_	_
/	27283	27284	:	/	O	_	_
ml	27284	27286	NN	ml	O	_	_
cycloheximide	27287	27300	NN	cycloheximide	O	_	_
(	27301	27302	CD	(	O	_	_
CHX	27302	27305	NN	chx	O	_	_
)	27305	27306	NN	)	O	_	_
was	27307	27310	VBD	be	O	_	_
added	27311	27316	VBN	add	O	_	_
to	27317	27319	TO	to	O	_	_
the	27320	27323	DT	the	O	_	_
cells	27324	27329	NNS	cell	O	_	_
for	27330	27333	IN	for	O	_	_
the	27334	27337	DT	the	O	_	_
time	27338	27342	NN	time	O	_	_
indicated	27343	27352	VBD	indicate	O	_	_
.	27352	27353	.	.	O	_	_
D	1
1
1	0	num
1	3	prep_after
1	7	punct
1	21	dep
3	6	appos
6	5	num
9	8	nn
9	14	rcmod
12	11	nn
14	13	auxpass
14	17	prep_to
17	16	det
17	20	prep_for
20	19	det
21	9	nsubj
EOX
Y	1
ROOT	0	0	23	1	FRAG	0	0	23	4	NP	0	0	7	2	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	PP	0	2	7	2	IN	0	2	3	1	after	2	2	3	0	NP	0	3	7	3	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	10	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	:	0	7	8	1	/	7	7	8	0	S	1	8	22	2	NP	0	8	21	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	cycloheximide	9	9	10	0	SBAR	0	10	21	1	S	1	10	21	2	NP	2	10	13	3	CD	0	10	11	1	-LRB-	10	10	11	0	NN	0	11	12	1	CHX	11	11	12	0	NN	0	12	13	1	-RRB-	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	was	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	added	14	14	15	0	PP	0	15	21	2	TO	0	15	16	1	to	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NNS	0	17	18	1	cells	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	time	20	20	21	0	VP	0	21	22	1	VBD	0	21	22	1	indicated	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	12
The	27354	27357	DT	the	O	_	_
protein	27358	27365	NN	protein	O	_	_
levels	27366	27372	NNS	level	O	_	_
of	27373	27375	IN	of	O	_	_
V5-ASPP2	27376	27384	NN	v5-aspp2	O	_	_
were	27385	27389	VBD	be	O	_	_
determined	27390	27400	VBN	determine	O	_	_
by	27401	27403	IN	by	O	_	_
western	27404	27411	NN	western	O	_	_
blot	27412	27416	NN	blot	O	_	_
analysis	27417	27425	NN	analysis	O	_	_
.	27425	27426	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	agent
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	V5-ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	determined	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	western	8	8	9	0	NN	0	9	10	1	blot	9	9	10	0	NN	0	10	11	1	analysis	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	8
beta-Tubulin	27427	27439	NN	beta-tubulin	B-GENE	_	_
was	27440	27443	VBD	be	O	_	_
used	27444	27448	VBN	use	O	_	_
as	27449	27451	IN	as	O	_	_
a	27452	27453	DT	a	O	_	_
loading	27454	27461	VBG	load	O	_	_
control	27462	27469	NN	control	O	_	_
.	27469	27470	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-Tubulin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	23
(	27471	27472	NN	(	O	_	_
C	27472	27473	NN	c	O	_	_
)	27473	27474	CD	)	O	_	_
Saos2	27475	27480	NN	saos2	O	_	_
cells	27481	27486	NNS	cell	O	_	_
were	27487	27491	VBD	be	O	_	_
transfected	27492	27503	VBN	transfect	O	_	_
with	27504	27508	IN	with	O	_	_
ASPP2	27509	27514	NN	aspp2	B-GENE	_	_
wt	27515	27517	JJ	wt	O	_	_
expression	27518	27528	NN	expression	O	_	_
plasmid	27529	27536	NN	plasmid	O	_	_
in	27537	27539	IN	in	O	_	_
the	27540	27543	DT	the	O	_	_
presence	27544	27552	NN	presence	O	_	_
or	27553	27555	CC	or	O	_	_
absence	27556	27563	NN	absence	O	_	_
of	27564	27566	IN	of	O	_	_
co	27567	27569	NN	co	O	_	_
transfected	27570	27581	VBN	transfect	O	_	_
HRAS	27582	27586	NNP	HRAS	O	_	_
V12	27587	27590	NN	v12	O	_	_
.	27590	27591	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	11	prep_with
6	14	prep_in
6	16	prep_in
11	8	nn
11	9	amod
11	10	nn
14	13	det
14	16	conj_or
14	18	prep_of
18	19	vmod
19	21	dobj
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	22	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	22	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	with	7	7	8	0	NP	3	8	12	4	NN	0	8	9	1	ASPP2	8	8	9	0	JJ	0	9	10	1	wt	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	NN	0	11	12	1	plasmid	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	22	2	NP	1	13	17	4	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	presence	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	absence	16	16	17	0	PP	0	17	22	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	22	2	NP	0	18	19	1	NN	0	18	19	1	co	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	transfected	19	19	20	0	NP	1	20	22	2	NNP	0	20	21	1	HRAS	20	20	21	0	NN	0	21	22	1	V12	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
16	27592	27594	CD	16	O	_	_
hours	27595	27600	NNS	hour	O	_	_
after	27601	27606	IN	after	O	_	_
transfection	27607	27619	NN	transfection	O	_	_
,	27619	27620	,	,	O	_	_
50	27621	27623	CD	50	O	_	_
mug	27624	27627	NN	mug	O	_	_
/	27627	27628	:	/	O	_	_
ml	27628	27630	NN	ml	O	_	_
CHX	27631	27634	NN	chx	O	_	_
was	27635	27638	VBD	be	O	_	_
added	27639	27644	VBN	add	O	_	_
to	27645	27647	TO	to	O	_	_
the	27648	27651	DT	the	O	_	_
cells	27652	27657	NNS	cell	O	_	_
for	27658	27661	IN	for	O	_	_
the	27662	27665	DT	the	O	_	_
time	27666	27670	NN	time	O	_	_
indicated	27671	27680	VBD	indicate	O	_	_
.	27680	27681	.	.	O	_	_
D	1
18
1	0	num
6	5	num
6	11	dep
9	8	nn
11	7	punct
11	9	nsubjpass
11	10	auxpass
11	14	prep_to
14	13	det
14	17	prep_for
17	16	det
18	1	npadvmod
18	3	prep_after
18	6	nsubj
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	PP	1	0	4	3	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	IN	0	2	3	1	after	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	18	2	NP	1	5	7	2	CD	0	5	6	1	50	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PRN	1	7	18	2	:	0	7	8	1	/	7	7	8	0	S	1	8	18	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	CHX	9	9	10	0	VP	1	10	18	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	added	11	11	12	0	PP	0	12	18	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	cells	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	for	15	15	16	0	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	time	17	17	18	0	VP	0	18	19	1	VBD	0	18	19	1	indicated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	15
The	27682	27685	DT	the	O	_	_
protein	27686	27693	NN	protein	O	_	_
levels	27694	27700	NNS	level	O	_	_
of	27701	27703	IN	of	O	_	_
V5-ASPP2	27704	27712	NN	v5-aspp2	B-GENE	_	_
or	27713	27715	CC	or	O	_	_
HRAS	27716	27720	NN	hra	B-GENE	_	_
V12	27721	27724	NN	v12	I-GENE	_	_
were	27725	27729	VBD	be	O	_	_
determined	27730	27740	VBN	determine	O	_	_
by	27741	27743	IN	by	O	_	_
western	27744	27751	NN	western	O	_	_
blot	27752	27756	NN	blot	O	_	_
analysis	27757	27765	NN	analysis	O	_	_
.	27765	27766	.	.	O	_	_
D	1
9
2	0	det
2	1	nn
2	7	prep_of
4	6	conj_or
7	4	nn
7	6	nn
9	2	nsubjpass
9	8	auxpass
9	13	agent
13	11	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	8	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	of	3	3	4	0	NP	1	4	8	2	NP	0	4	7	3	NN	0	4	5	1	V5-ASPP2	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	NN	0	6	7	1	HRAS	6	6	7	0	NN	0	7	8	1	V12	7	7	8	0	VP	1	8	14	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	determined	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	by	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	western	11	11	12	0	NN	0	12	13	1	blot	12	12	13	0	NN	0	13	14	1	analysis	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	8
beta-actin	27767	27777	NN	beta-actin	B-GENE	_	_
was	27778	27781	VBD	be	O	_	_
used	27782	27786	VBN	use	O	_	_
as	27787	27789	IN	as	O	_	_
a	27790	27791	DT	a	O	_	_
loading	27792	27799	VBG	load	O	_	_
control	27800	27807	NN	control	O	_	_
.	27807	27808	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-actin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	10
(	27809	27810	NN	(	B-GENE	_	_
TIF	27810	27813	NN	tif	I-GENE	_	_
)	27813	27814	CD	)	O	_	_
Click	27815	27820	VB	click	O	_	_
here	27821	27825	RB	here	O	_	_
for	27826	27829	IN	for	O	_	_
additional	27830	27840	JJ	additional	O	_	_
data	27841	27845	NNS	datum	O	_	_
file	27846	27850	NN	file	O	_	_
.	27850	27851	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
EOD
